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Chapter 1 
General Introduction: stereoselectivity of reactive 
intermediates in glycosylation reactions 
Introduction 
Polysaccharides are nature’s most diverse class of biopolymers. This diversity is based on 
the set of constituting monosaccharide building blocks, which contain a large number of 
stereocenters and the repeating glycosidic linkages that interconnect the anomeric position 
of one monosaccharide in the carbohydrate chain with one of the hydroxyls of an adjacent 
subunit. Moreover the glycosidic bonds can occur in two configurations and the 
carbohydrate chain can be linear or branched. Next to this, carbohydrates can be covalently 
attached to proteins (glycoproteins) or lipids (glycolipids). Carbohydrates play a role as 
structural components and in the storage and transport of energy and are also involved in a 
broad array of biological processes such as immune defense, fertilization, cell growth and 
cell-cell adhesion. To elucidate these biological processes the availability of sufficient 
quantities of pure oligosaccharides and derivatives are indispensable. The isolation of 
oligosaccharides from natural sources is often hampered by the limited bioavailability and 
by purification problems to attain homogeneous samples of the target glycoconjugate. 
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Therefore, synthetic carbohydrate chemistry is the method of choice to supply sufficient 
amounts of well-defined oligosaccharides. In this thesis, strategies towards synthetically 
challenging and biologically relevant oligosaccharides are presented. The assembly of 
hyaluronan oligomers (1),1 having the dimer β-1,3-linked 2-acetamido-2-deoxy-D-glucose-
β-(1,4)-D-glucuronic acid as repeating unit and with a glucuronic acid or a glucosamine at 
the reducing end is described in Chapters 3 and 4, respectively. Chapter 5 presents the 
synthesis of an alginate trisaccharide (2) composed of 1,2-cis-linked L-guluronic acid 
residues2 (Figure 1). The stereoselectivity of L-gulopyranose, a relatively rare 
monosaccharide of which little is known regarding its behavior in glycosylation reactions, 
is explored in this Chapter. 
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Hyaluronan (1) and poly guluronate alginate (2).  
In addition to the target-orientated synthetic studies described in Chapter 3 to 5, This Thesis 
addresses some methodological issues. In Chapter 2 the conversion of suitably protected 
thioglycosides into 1-hydroxy donors is described. In Chapter 6 attention is focused on the 
stereodirecting effect of the glycosyl C-5 substituent in glycosylation reactions. The 
stereochemical outcome of glycosylations is surveyed using a set of epimeric D-
pyranosides having a C-5 methyl ester, a C-5 benzyloxymethyl or a C-5 methyl substituent. 
This chapter evaluates mechanistic aspects that play a role in the glycosidic bond forming 
process and describes the stereoselectivity of possible reactive intermediates. 
Stereoselectivity of reactive intermediates in glycosylation reactions 
Since the beginning of the 20th century the stereoselective introduction of glycosidic 
linkages3 is considered as one of the main challenges in synthetic carbohydrate chemistry. 
Glycosidic linkages can be divided into two general categories, namely: the 1,2-trans and 
1,2-cis fused glycosides (Figure 2).4 Despite tremendous progress in the field of synthetic 
carbohydrate chemistry the completely stereoselective introduction of 1,2-cis fused 
glycosidic bonds still poses a great challenge. 
General introduction 
11 
Figure 2 
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Numbering of D-hexose and nomenclature of the substituents on the anomeric center. 
Contrary, the selective introduction of 1,2-trans bonds generally represents no problem and 
can be attained with the aid of an ester or amide function at C-2 in the donor glycoside. 
Activation of the anomeric centre of a donor glycoside (8) leads to attack of the ester 
(amide) carbonyl on the anomeric center to give acyloxonium ion 10 (Scheme 1), a 
neighboring group on pyranosides can actively participate in the expulsion of the anomeric 
leaving group, leading directly to the acyloxonium ion. Subsequent nucleophilic attack in 
an SN2 like fashion then leads to the formation of a 1,2-trans bond (11) (Scheme 1).5 The 
glycosylation conditions need to be sufficiently acidic to prevent the formation of 
orthoester (12). Although the formation of a 1,2-trans bond by neighboring group 
participation is considered to be generally applicable, some striking exceptions have been 
reported in which trans/cis mixtures and even solely 1,2 cis bonds were formed using C-2 
acyl donor glycosides. Double stereodifferentiation,6 in which the donor and acceptor 
glycoside form a sterically mismatched pair (thereby causing a steric clash in the transition 
state of the glycosylation) can lead to the formation of anomeric mixtures. The presence of 
the bulky 4,6-O-silylidene group in galactose donors has even led to the isolation of solely 
1,2-cis linked products irrespectively of the nature of the protective group at C-2.7  
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Anchimeric assistance: 1,2-trans bond formation directly or via orthoester formation. 
An interesting new type of anchimeric assistance that allows the selective introduction of 
both 1,2-cis and 1,2-trans glycosidic bond has been developed by Boons and co-workers.8 
Key to their approach is the use of the chiral auxiliaries, (S) and (R)-
(ethoxycarbonyl)benzyl ether on O-2 in 13, 14 and 20, 21, respectively (Scheme 2). 
Activation of the trichloroacetimidate at the anomeric centre of 13 or 14 (S stereoisomer) 
leads to the formation of the most stable acyloxonium ion 16. Activation of 20 or 21 (R 
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stereoisomer) leads to 23. The S or R configuration of the C2-(ethoxycarbonyl)benzyl ether 
group determines whether a trans- or cis-decalin oxonium ion is formed, which is 
subsequently attacked in an SN2-like fashion to give either the 1,2-cis or 1,2-trans 
glycosidic bond. Good 1,2-cis glycosylations have been achieved using this type of 
anchimeric assistance as depicted in Scheme 2.8    
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Anchimeric assistance by (S) and (R)-(ethoxycarbonyl)benzyl ethers. Reagents and conditions: DCM, 
ROH, -78 °C, TMSOTf. 
The presence of ester functionalities at O-3 and O-4 and their possible anchimeric 
assistance via six- and seven-membered rings respectively, has been associated with the 
stereoselective outcome of glycosylation reactions.9 Although the mechanism of these 
reactions is still under debate,10 the effect of O-3 acetate functions on the α-selectivity of 
various glucose,8,9i mannose10,11 and mannuronate ester12 donors  is striking.  
Another strategy in controlling the stereoselectivity of glycosylations, entails tuning the 
nature of the anomeric leaving group in the donor glycoside such that SN2-like substitutions 
are favored. Anomeric halides have been shown to undergo an SN2 reaction under certain 
conditions. For example, anionic nucleophiles (cyanide, azide, malonate, thiolate, 
selenoate, or phenolate anions) can directly displace anomeric halides.13 Another important 
example of an SN2 substitution on an anomeric halide is the synthesis of β-mannosides 
from mannosyl bromides, which are activated by silver salts.14 The mild activator 
complexes the anomeric α-bromide 27, to allow substitution form the opposite face of the 
mannose core by the incoming alcohol nucleophile 28 (Scheme 3).  
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Scheme 3 
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SN2 reaction using insoluble silver oxide.14a Reagents and conditions: CHCl3, Ag2O, CaSO4, 1h   
In 1975 Lemieux reported that glycosylations of α-glycosyl bromides may proceed with 
retention to give the 1,2-cis-product by the use of tetraethylammonium bromide as additive. 
The reactivity of the donor as well as the nucleophilicity of the acceptor is of great 
influence on the success of this procedure. The 1,2-cis product formation is explained by 
SN2 substitution of the more reactive β-bromide (32) that is formed in situ by anomerization 
of the α-bromide (30).15 The rate of the anomerization should be substantially higher than 
the rate of the nucleophilic attack by the alcohol on the anomeric centre. More recently this 
method was elaborated with iodine as anomeric halide, facilitating the fast and α-selective 
glycosylation of glucoside 31 (Scheme 4).16 The group of Mukaiyama17 investigated 
various phosphine oxides as replacement of tetrabutyl ammonium halides to induce α-
selective glycosylations. The need of a strong nucleophile to attain a productive 
glycosylation limits the scope of many of these in situ anomerization glycosylation 
reactions.  
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In situ anomerization of glucosyl halides. Reagents and conditions: TBABr (30)/TBAI (31), DIPEA, 
Benzene, reflux. 
Trichloroacetimidates have also been exploited in SN2-like substitution reactions. Access to 
anomerically pure imidates can be achieved by choice of the appropriate base in the 
reaction of the starting lactol and trichloroacetonitrile. Strong bases, such as DBU, promote 
the formation of the thermodynamically favored α-imidates, whereas use of a weak base 
(K2CO3) leads to the formation of the kinetic β-imidate. The use of a mild promotor (e.g. 
BF3•Et2O) and low temperatures can help the direct displacement of the activated imidate 
and thus allow an SN2-like pathway.18 
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Solvents have been exploited to steer the stereoselectivity in glycosylation reactions. 
Empirically, diethylether, dioxane and tetrahydrofuran have been established to increase α-
selectivity.19 This phenomenon is rationalized by assuming the formation of an equatorially 
oriented oxonium ion (36), which is attacked in an SN2 type fashion (Scheme 5).20 It is 
however not clear why ether derived oxonium ions occupy an equatorial position. It is 
hypothesized that is due to the reversed anomeric effect, where a cation is favored in an 
equatorial position rather than in an axial position. However, the reversed anomeric effect is 
a debated subject.21 Boons and co-workers22 have recently demonstrated that thioethers 
(such as PhSEt or thiophene) can participate in a similar fashion and they provided 
spectroscopic evidence for the existence of the β-oriented sulfonium ion.  
Scheme 5 
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Ether “assisted” glycosylation. Reagents and conditions: Et2O, SiF4, 5 °C.19a 
Glycosylations using acetonitrile as solvent (or co-solvent) often lead to the predominant 
formation of β-products.19a In this case the axial α-nitrilium ion (39) has been invoked to 
account for the observed selectivity (Scheme 6).23 This hypothesis has been substantiated 
by studies in which the nitrilium ion intermediate has been trapped by a nucleophile to 
provide the axially oriented amide product. For example, Sinaÿ and co-workers 
demonstrated that nitrilium ion 39 (from 41) can be intercepted by o-chlorobenzoic acid 
(42) to give the α-imide adduct 43.24 Although many examples can be found in literature 
where acetonitile has a beneficial effect on the formation of the β-product, exceptions have 
been noted as well. For example, the group of Schmidt25 showed that acetonitrile mediated 
glycosylations of uronic acids resulted in the predominant formation of the α-product.  
Scheme 6 
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Schematic representation of acetonitrile assisted glycosylation. Reagents and conditions: a) MeCN, 
SiF4, HOR, 0 °C.19a; b) MeCN, 42, rT.24 
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Next to the anomeric leaving group that is installed on a glycoside, the reactivity of the 
activated species is of prime importance for the stereochemical outcome of a glycosylation. 
Considerable attention has been devoted to tuning the reactivity of glycosyl donors by 
varying the nature of the protective groups. Acyl protecting groups reduce the reactivity of 
glycosyl donors to a larger extent than alkyl protecting groups. On the basis of this 
tendency the group of Fraser-Reid termed glycosyl donors bearing an O-2 alkyl protecting 
group as ‘armed’ and their less reactive O-2 acyl bearing counterparts ‘disarmed’.26 
Overtime, the ‘armed-disarmed’ concept has been elaborated and it is now well established 
that the nature and position of all substituents on the glycoside core influence the donor 
reactivity. The reactivity of a broad range of thioglycosides has been determined, leading to 
the formulation of a relative reactivity scale, which spans over seven orders of magnitude.27 
4,6-O-Acetal groups provide an intermediate level of reactivity (‘semi-disarmed’). The 
group of Crich discovered that mannosyl sulfoxide donors protected with a 4,6-O 
benzylidene acetal (44, Scheme 7) are highly 1,2-cis selective, showing that acetal 
protecting groups can also have a decisive effect on the stereochemical outcome of 
glycosylations.28 The high selectivity observed in this mannosylation is impressive since 
formation of the β-mannosidic linkage is disfavored by both the anomeric and the Δ2-
effect.29 Over the years it became apparent that β-selective mannosylations could also be 
obtained using 4,6-O-benzylidene protected mannosides with different anomeric leaving 
groups and activation protocols.30 
Scheme 7 
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Glycosylation of 4,6-O benzylidene mannose. Reagents and conditions: 2,6-di-tert-butyl-4-
methylpyridine (DTBMP), Et2O/benzene (7/1), -78 °C, then Tf2O, 5 min, acceptor, -78 °C to rT.  
Guided by low temperature NMR experiments on the activation of 47,31 the group of Crich 
hypothesized that the observed β-selectivity comes from SN2 displacement of the 
intermediate α-anomeric triflate (49) or the corresponding contact ion pair (CIP, 50) 
(Scheme 8).32 The interference of the solvent separated ion pair or oxacarbenium ion 52 
allowing an SN1-like displacement is suppressed by the disarming effect of the benzylidene 
acetal.  
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Scheme 8 
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Proposed intermediates in mannosylation, α-anomeric triflate (49) and CIP (50).  
Kinetic studies of the hydrolysis of methyl glycosides, where formation of the 
oxacarbenium ion is considered to be the rate-determining step,33 have shown that the 4,6-
O-benzylidene acetal disfavors the development of charge at the anomeric center through 
both torsional and electronical factors. The group of Fraser-Reid demonstrated that cyclic 
acetals impede flattening of the ring and thereby the formation of the oxacarbenium ion.26 
The electronic factor was established by the group of Bols, who compared the acidic 
hydrolysis rate of glucosides 54-57, which differ in the orientation of O-6 (Figure 3).34 
Compound 55 with the O-6 substituent positioned trans (t) to the pyranosyl ring oxygen 
(and gauche to C-4, tg conformation) hydrolyzed at a lower rate than the glucosides 56 and 
57 having a gauche (g) orientation with the ring oxygen. It is postulated that this rate 
difference comes from charge-dipole interactions.35 The acid stability of 55 is enhanced 
because the electron withdrawing potency of the O-6 on the ring oxygen is larger in the tg 
conformation (55) than in the gt (56) and gg (57) conformation.  
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Relative rates of acidic hydrolysis of dinitrophenyl glucosides (relative to glucose 54). Reagents and 
conditions: pH 6.5 (0.4M KCl), 37 °C. 
Whereas in the mannose case the disarming effect of the 4,6-O-benzylidene (as in donor 47, 
Scheme 8) allows the SN2-like substitution of the anomeric α-triflate, the presence of the 
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4,6-O-benzylidene group in the corresponding glucosides leads to the predominant 
formation of α-linked glucosides (Scheme 9). Low temperature NMR experiments revealed 
the presence of an α-triflate intermediate (59)36 upon activation of 58. Obviously formation 
of α-linked products cannot arise from this species. Therefore, Crich and co-workers 
reasoned37 that glycosylations of 4,6-O-benzylidene glucose occur through the 
intermediacy of the solvent separated oxacarbenium ion via an SN1 like mechanism. It was 
argued that in such a mechanism, the trajectory of the attack on the oxacarbenium ion is 
dictated by the anomeric effect, which is α-directing.38 The different behavior of mannoside 
47 and glucoside 58 was explained by the steric interactions of the substituents on C2 and 
C3. Upon flattening of the pyranoside ring to accommodate the positive charge on the 
oxacarbenium ion, the steric interaction of the C-2 and C-3 substituents will increase, 
making this an unfavorable process. In glucose this steric interaction is absent and therefore 
benzylidene glucose more readily adopts the required flattened conformation. As a result 
the equilibrium between the glucosyl covalent triflate 59 and the solvent separated ion pair 
60 is shifted to the side of the ion pair.     
Scheme 9 
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Glycosylation of 58. Reagents and conditions: 2,4,6-tri-tert-butylpyrimidine (TTBP), 1-
benzenesulfinyl piperidine (BSP), DCM, -60 °C, then Tf2O, 5 min, acceptor, -60 °C to rT. 
Another view on the role of oxacarbenium ions on the stereoselectivity of glycosylations 
has emerged from studies by Woerpel and co-workers on the mechanism of C-
glycosylations. Pyranose oxacarbenium ions can adopt several conformations with the half 
chair conformations 4H3 63 and 3H4 62 being local energy minima.39 A nucleophile can 
attack these half-chair conformers following a pseudo axial trajectory with a preference for 
the diastereotopic face that leads to the more favorable chair-like product 64 (Scheme 10).40 
Nucleophilic attack on the oxacarbenium ion half-chair conformers 62 and 63 leads to the 
α- or the β-product respectively.41 If there are no prohibitive steric interactions in the 
transition states leading to the products, the ratio of the α- and β-products mirror the ratio of 
the half chair oxacarbenium ions. Experimental and computational studies have indicated 
that the stability of half-chair oxacarbenium ion conformers is affected by the position, the 
configuration and the nature of the substituents on the pyranose core.39  
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Oxacarbenium ion conformers and nucleophilic attack on the 4H3 conformer. 
Woerpel and co-workers conducted a set of experiments using tetrahydropyran acetals to 
establish the stabilizing/destabilizing effect of substituents on the 2, 3, 4 and 5 position of 
the pyranose core. These effects influence the equilibrium between the different conformers 
(3H4 and 4H3) and thereby control the stereoselectivity in the nucleophilic substitution of the 
oxacarbenium ion.42 Bowen and co-workers reported that electronegative (OH) substituents 
favor axial positions on C-3 and C-4, as opposed to an equatorial orientation which is 
favored from a steric point of view.39 This was experimentally corroborated by the set of 
allylations depicted in Scheme 11. Allylation of the 4-O-benzyl 67 (R = OBn) under the 
agency of BF3•OEt2 and allyltrimethylsilane yielded almost exclusively the 1,4-trans 
product whereas acetal 68 (R = CH2Bn) mainly provided the 1,4-cis product. C-Allylation 
of tetrahydropyrans 74 and 75 also led to the formation of trans and cis diastereomeric 
products respectively. The selectivity in these C-glycosylations was attributed to the 
difference in stability of the involved oxacarbenium ion intermediates. Oxacarbenium ion 
73 with R = CH2Bn is favored over its axial counterpart 72 because of unfavorable steric 
interactions in the latter. Subsitution of 73 along a pseudoaxial trajectory leads to the 
formation of the 1,4-cis product. In the 4-OBn case, the electronic preference of the 
substituent overrules its steric bias, making the axial conformer 72 (R = OBn) energetically 
most favorable. Allylation of 72 provides the 1,4-trans product. The selectivities of the C3 
substituted pyranosides can be explained in an analogous fashion.43 The preferred axial 
orientation of the alkoxy substituents has been ascribed to the electrostatic stabilization of 
the cationic anomeric center by the axially oriented C-3 or C-4 heteroatom. The difference 
in selectivity of alkyl and ether substituents at the C-2 position is smaller. As depicted in 
Scheme 11, the C-2 alkyl substituted (80) appears to have little effect on the stereochemical 
outcome, where a C-2 benzyloxy pyran (81) provides mainly the 1,2-cis product. The 
preference for C-2 benzyloxy oxacarbenium ion 85 (R = OBn) is thought to evolve from 
hyperconjugation between the axial C-H bond and the 2p orbital on the electrophilic 
carbon.44 The trans selectivity of C-5 substituted pyranoside 86 is believed to arise from 
steric interactions.45 
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Nucleophilic adition on 2-, 3-, 4- and 5-substituted tetrahydropyran acetals. Reagents and conditions: 
DCM, allyltrimethylsilane, -78 °C, BF3OEt2. 
The stabilizing effect of axially oriented alkoxy substituents at C-3 and C-4 has previously 
been observed in hydrolysis reactions of different glycosides. The nature and configuration 
(axial or equatorial) of the substituents on the pyranose ring influences the development of 
positive charge at the anomeric center and thereby the rate of hydrolysis. As demonstrated 
by Withers and co-workers, dinitrophenyl (DNP) galactoside 91 and DNP-alloside 92, both 
having one axial hydroxyl group, hydrolyze faster than DNP-glucoside 90 (Figure 4).46,47 
Bols and co-workers argue that equatorially placed hydroxyls have a larger electron 
withdrawing effect on the oxacarbenium ion than their axial counterparts, because of a 
more unfavorable charge-dipole interaction in the equatorial case.48,49 They also 
demonstrated that steric effects are less influential than the electronic effects caused by the 
orientation of the substituents for the rate of hydrolysis. As depicted in Figure 5, 
galactosides 97 and 96 hydrolyze faster than glucosides 93 and 94 and the presence of the 
methyl function has relatively little influence.50,51  
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Rate constants of spontaneous hydrolysis of dinitrophenyl glycosides in sec-1. Reagents and 
conditions: pH 6.5 (0.4 M KCl), 37 °C. 
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Figure 5 
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Relative rates of acid hydrolysis (glucose = 1). Reagents and conditions: 2 M HCl, 74 °C.  
Having determined the preference of each substituent on the pyranose oxacarbenium ion, 
Woerpel and co-workers45 investigated the effect of multiple substituents on the 
stereoselectivity of the C-glycosylation reaction. The stereodirecting contributions of the 
substituents revealed in Scheme 11 can not simply be added to account for the selectivities 
obtained in systems with multiple substituents. Steric interactions between the substituents 
and the incoming nucleophile effect both the ground state energies of the oxacarbenium ion 
conformers and the transition states leading to the α- and β-products. Four pentoses were 
examined for their stereopreference in a glycosylation with allyl trimethylsilane, as 
depicted in Scheme 12.44 Lyxose acetate 99, having the D-manno configuration at C-2, C-3 
and C-4, yielded mainly the 1,2-cis product, corresponding to nucleophilic attack on an 
oxacarbenium ion in the 3H4 conformer (101). This is in line with the results obtained with 
the acetals depicted in Scheme 11, even though the incoming nucleophile has an 
unfavorable steric interaction with the C-3 substituent. Ribose acetate donor 103 mainly 
provided the all cis product (104), originating from ion 105. Conformer 105 is energetically 
more favored than its congener 106, because the latter places only the C4 substituent in its 
most favorable orientation and suffers from a 1,3-diaxial interaction between the C-2 and 
C-4 functionality. Xylose acetate 107 reacts in a non selective manner to afford a 1/1 
mixture of anomers (108). The favorable orientation of the C-3 and C-4 benzyl ethers in ion 
110, is offset by the destabilizing steric interaction between the C-2 and C-4 substituents 
and the 1,3-diaxial interaction of the incoming nucleophile with the group at C-3. The cis-
preference of arabino acetate 111 is ascribed to the negative interaction of the nucleophile 
with C-3 in ion 113 in addition to the disfavored position of the C-2 and C-3 substituent in 
this conformer. These results show that the stereochemical outcome of the glycosylations is 
the result of both the stability of the oxacarbenium ion, which depends on a combination of 
steric and electronic substituent effects, and the steric interactions of the incoming 
nucleophile with the oxacarbenium ion.     
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Scheme 12 
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Nucleophilic adition on 2-, 3-, 4- and 5-substituted tetrahydropyran acetals. Reagents and conditions: 
DCM, allyltrimethylsilane, -78 °C, BF3OEt2. 
The 1,2-cis-selectivity of lyxose acetate 99 stands in contrast to the 1,2-trans-selectivity 
regularly obtained in O- or C-glycosylations using mannose donors, which only differs 
from 99 in the substituent on C5. For example, the group of Seeberger52 reported that the 
allylation of phosphate donor 115 proceeds with complete α-selectivity (Scheme 13). A 
notable difference between this C-allylation and the condensation studies by Woerpel 
described above is the relatively high temperature (0 °C) at which the mannosylation using 
115 was performed. Singh and Vankayalapati53 conduct the experiments with 
mannosylphosphate 116 at -78 °C, and obtained a 1:1 mixture of anomers (Scheme 13).  
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C-Glycosylations using mannosyl phosphates. Reagents and conditions: a) DCM, allyltrimethylsilane, 
0 °C, TMSOTf; b) DCM, allyltrimethylsilane, -78 °C, TMSOTf. 
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The α-products obtained in the condensations of 115 and 116 can be explained by attack on 
oxacarbenium ion 117, which has minimal steric interactions with the incoming 
nucleophile. Although 3H4 conformer 118 places the C-2, C-3 and C-4 substituents in the 
most favorable positions, this oxacarbenium ion suffers from 1,3-diaxial interactions of C-3 
with C-5. In addition, the incoming nucleophile is hindered by both the C-3 and C-5 
substituent. These steric interactions make the transition state for 118 to the β-product 
unfavorable, and product formation therefore arises (in part) from the higher ground state 
energy oxacarbenium ion 117, following a Curtin-Hammett kinetic scenario.54 Seeberger 
and co-workers also condensed mannose donor 115 with alcohol an O-nucleophile, yielding 
mainly the β-product (Scheme 14).53 This indicates that both the temperature and the 
reactivity of the nucleophile have a large effect on the selectivity of the reaction.55  
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Glycosylations on mannose by Seeberger and co-workers.53 Reagents and conditions: DCM, 
Nucleophile, -78 °C, TMSOTf. 
van den Bos et al. showed mannuronate esters donor 121 are highly β-selective (Scheme 
15).12 This selectivity can be the result of SN2 type substitution of an α-anomeric triflate, in 
analogy to the condensations of benzylidene mannosides.28 Alternatively, the β-selectivity 
of 121 may arise from 3H4 oxacarbenium ion 123, in which the C-5 ester occupies an axial 
position (Scheme 17). As such the ester should have a stabilizing effect on the positive 
charge at the anomeric center, similar to the effect of the axial C-3 and C-4 heteroatoms in 
the studies performed by Woepel and co-workers.43  
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Glycosylation with mannuronate ester 121. Reagents and conditions: a) TTBP, DCM, -60 °C, then 
Tf2O, -45 °C 15 min., Acceptor, to rT. 
To investigate the effect of the C-5 carboxylate on the selectivity of mannuronate esters, the 
“stripped” thioglycosides 125 and 126, having only a substituent at C-5, were 
investigated.56 As can be seen in Scheme 16, all condensations of C-5-carboxylate 125 
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provided substantially more of the 1,5-cis product than its benzyloxymethyl counterpart 
126. The β-selectivity of 125 can be accounted for by considering oxacarbenium ions 127 
and 128 as product forming intermediates. In 127 the axial position of the C-5 carboxylate 
ester minimizes the electron withdrawing nature of the substituent and allows for electron 
donation of the carboxylate carbonyl into the oxacarbenium ion. Similarly in mannuronate 
ester 121 the effect of the carboxylic ester works in concert with the other substituents on 
the ring favoring the formation of the 3H4 half chair 123 over the 4H3 conformer 122, giving 
rise to the high β-selectivity of the manuronate esters (Scheme 15). The additional 
stabilization that the uronate ester provides in the 4H3 half chair 123 as compared to its non-
oxidized counterpart 118 prevents a Curtin-Hammett scenario to take place. 
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Oxacarbenium ions of “stripped” uronate ester and its benzyloxymethyl counterpart. Reagents and 
conditions: TTBP, DCM, -78 °C, then Tf2O 5 min, then acceptor, -78 °C, 15 min. 
The stereodirecting effect of other functional groups has also been explained by attack of 
the nucleophile on the more stable oxacarbenium ion conformer. 2-Deoxy-2-thio, iodonium 
and selenium glycosides are known to yield 1,2-trans glycosidic linkages with good to 
excellent selectivity. This selectivity was long thought to arise from an episulfonium (or the 
corresponding selenonium / iodonium) ion 145 which is displaced in an SN2 type fashion by 
the incoming nucleophile (Scheme 17).57 However, computational58 and experimental59 
data suggest that the oxacarbenium ion 144 is more stable than the episulfonium ion 145. 
Product formation can therefore also arise from nucleophilic attack on the oxacarbenium 
ion rather than the episulfonium species. The preference for an oxacarbenium ion 
conformer with an axial C-2 substituent (see for example 151/152 in Scheme 18) is thought 
to arise from the stabilizing hyperconjugative interaction between σ C–SPh and π* C–O of 
the oxacarbenium ion.60  
Chapter 1 
24 
Scheme 17 
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Episulfonium ion in an Sn2 reaction pathway 
Roush and co-workers reported that the condensation of donor 147 and 148 with primary 
alcohol 153 proceeded with high β-selectivity to provide 154 and 155 (Scheme 18). 61,62 
With increasing bulk of the acceptor the trans-selectivity decreased (154 to 157 to 160). 
The 4H3 and 3H4 oxacarbenium ions 149-152 were invoked as product forming 
intermediates, of which 151 and 152 should be the most stable, but also the most sterically 
congested. The higher selectivity of 6-Br (148) versus 6-O-tosyl (147) was argued to result 
from the difference in inductive effect of the substituents.63 
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Glycosylations of C-2-SPh glucosides. Reagents and conditions: DCM, ROH, -78 °C, TMSOTf.  
Castillón also reported that hyperconjugative stabilization by the C-2 phenylselenyl group 
is of decisive effect on the stereoselectivity of glycosylations of 2-deoxy-2-phenylselenyl 
thioglycosides.60 In the coupling of mannoside 162 and guloside 166 with glucopyranoside 
174, disaccharides 165 and 169 were obtained with excellent α- and β-selectivity, 
respectively (Scheme 19). The 2-deoxy-2-phenylselenyl glucoside 170 provided a 1:1 
mixture of diastereomers (173). The stereochemical outcomes of the condensations were 
rationalized to arise from the intermediate oxacarbenium ions involved.64 The mannosyl 4H3 
ion 163 places the phenylselenyl group in a favorable axial position, and does not suffer 
from any sterically demanding interactions. Nucleophilic attack on this ion leads to the 
formation of the α-product 165. Similarly, nucleophilic attack on gulose oxacarbenium ion 
168 with an axial C2-SePh, is favored over the pathway involving ion 167, leading to the 
selective formation of β-disaccharide 169. The axial SePh halfchair conformer in the 
glucose case (i.e. ion 172) on the other hand experiences two 1,3-diaxial interactions in the 
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ground state of the oxacarbenium ion. The nucleophillic attack on this oxacarbenium ion 
leads to two additional 1,3-diaxial interactions of the nucleophile and the substituents on C-
3 and C-5. Thus, in this case product formation also arises from the oxacarbenium ion 
having its C-2 phenylselenyl group in an equatorial position, and an anomeric mixture is 
formed.   
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Oxacarbenium ions with 1-3 diaxial interactions. Reagents and conditions: toluene/dioxane (1:3), 
acceptor (174), NIS, 0 °C, TfOH. 
To conclude, the mechanism of glycosylation reactions is highly complex and can follow 
several pathways involving various reactive intermediates. Over the years, different 
strategies have been devised for stereoselective glycosylations, exploiting the reactivity of 
particular reactive species. For example, anomeric halides and triflates have been used in 
stereoselective SN2 like condensations and stereoselective SN1 type glycosylations have 
been achieved building on the stereopreference of the intermediate oxacarbenium ions. 
Nonetheless the stereoselective installation of a cis-glycosidic bond still presents a 
challenge and requires the careful tuning of reaction parameters, including the protecting 
group pattern, leaving group, activator, solvent and temperature. The reliability with which 
a trans glycosidic linkage can be installed, has not yet been realized for the construction of 
the cis glycosidic bond. Mechanistic studies on the formation of the glycosidic bond are a 
valuable approach to tune the stereochemistry of glycosylations. 
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Chapter 2 
NIS/TFA: a General Method for Hydrolyzing Thioglycosides1 
Introduction 
Thioglycosides are versatile building blocks in synthetic carbohydrate chemistry. Installing 
an aryl- or alkylthio functionality at the anomeric centre of most common monosaccharides 
is easily accomplished starting from the corresponding peracylated sugars.2,3 Anomeric thio 
functionalities are compatible with many protective group manipulations inherent to 
carbohydrate synthesis practice, thereby allowing their introduction at an early stage of an 
synthetic route towards oligosaccharides. Thioglycosides can be activated by a number of 
reagent systems, the most prominent of which are the N-iodosuccinimide/ 
trifluoromethanesulfonic acid (NIS/TfOH)4 and the sulfoxide (both 1-
benzenesulfinylpiperidine and diphenylsulfoxide)/triflic anhydride reagent systems.5,6 As 
such, thioglycosides are often employed as carbohydrate donors in oligosaccharide and 
glycoconjugate synthesis.7 A further advantageous property of thioglycosides, enabling 
their use in chemoselective glycosylation strategies, is their relative inertness towards 
activating systems other than those directed to anomeric thio functions.8 
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A relative shortcoming of anomeric thio functionalities is the difficulty often encountered 
in their removal. The numerous reported procedures for the hydrolysis of thioglycosides 
include heavy metal salts, N-bromosuccinimide (NBS) or NIS in wet acetone,9,10,11 AgNO3 
in wet acetone,12,13 NBS/NaHCO3 (aq) or CaCO3 (aq) in THF,6a NBS/HCl,14  
nBu4NIO4/TrB(C6H5)4, nBu4NIO4/trifluoromethanesulfonic acid (TfOH), 
nBu4NIO4/HClO4,15 (NH4)6Mo7O24.4H2O-H2O2 with HClO4/NH4Br,16 V2O5-H2O2/NH4Br,17 
chloramine-T18 and NIS/TfOH19 among others. The experience is that none of these 
methods is fail-safe in their application on different thioglycosides. This is unfortunate, 
because it limits the use of thio functionalities as anomeric protecting groups. Based on 
their excellent glycosylation properties, one would think that thioglycosides are easily 
hydrolysable by executing a standard thioglycoside mediated glycosylation protocol, but 
with H2O as acceptor instead of an acceptor glycoside. This chapter describes a study 
performed on the NIS mediated hydrolysis under acidic conditions of a set of diversely 
functionalized thioglycosides.  
Results and discussion 
In an initial set of experiments, 1-thio mannopyranoside 1 was treated with 1 equivalent 
NIS in wet methylene chloride (DCM / H2O = 10:1) in the presence of either a catalytic 
amount of TfOH or an equimolar amount of trifluoroacetic acid (TFA) (Scheme 1). 
Scheme 1 
O
BnO
SPh
O
O
Ph
O
BnO OH
O
O
Pha or b
OBn
OBn
1 2  
Hydrolysis of 1-thio mannopyranoside (1). Reagents and conditions: a) NIS, TfOH (cat), DCM / H2O 
= 10:1, 0 °C, 30 min, traces of 2;  b) NIS, TFA (stoichiometric), DCM / H2O = 10:1, 0 °C, 30 min, 
75% of 2. 
Both reaction mixtures were stirred for 30 minutes at 0 °C and subsequently quenched by 
the addition of aqueous sodium thiosulfate. The protocol involving triflic acid proved to be 
unproductive: next to trace amounts of the desired hydrolysis product both self-
condensation products and benzylidene cleavage products were formed, as detected by 
LCMS. In contrast, the NIS/TFA conditions afforded the target mannose derivative 2 in 
75% yield (Table 1, entry 1). The outcome of these two experiments led to several 
observations. First, the conditions involving catalytic triflic acid are too acidic for the 
benzylidene protective group to withstand. Second, the occurrence of self-condensation in 
the TfOH experiment, but not in the TFA experiment, indicates the existence of two 
separate reaction pathways for the two processes. It should be noted here that apart from the 
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nature and equivalents of acid used, the reaction conditions (concentration, excess of water, 
temperature, running time) were identical in both experiments. One possible explanation for 
the observed difference in product formation is the involvement of the anomeric 
trifluoroacetate as intermediate in the second experiment.  
The outcome of the NIS/TFA mediated hydrolysis of a diverse set of thioglycosides is 
presented in Table 1. Invariably, productive yields (70-90%) were obtained irrespective of 
the nature of the starting thioglycoside concerning its substitution pattern and the nature of 
the protective groups. Most reactions went to completion within 30 minutes at 0 °C, as 
monitored by TLC. In some instances a somewhat prolonged reaction time was required, as 
indicated in the table. Important to notice is the number of different protective groups that 
are compatible with the hydrolysis conditions, ranging from acid labile (benzylidene, silyl 
ether, p-methoxybenzyl, isopropylidene) to base-labile ester functionalities and including 
standard amine protective groups (azide, phthaloyl). Moreover, the nature of the parent 
glycoside (glucose, mannose, galactose, rhamnose) including deoxysugars and uronic acid 
derivatives appear to have no effect on the outcome of the anomeric deprotection. In the 
case of thiomannuronic acid (Table 1, entry 13), a prolonged quenching time had to be 
employed. In the first attempt, the corresponding anomeric trifluoroacetate was isolated as 
the main product. This result is of interest in itself, as it points towards the occurrence of 
anomeric trifluoroacetates as important reaction intermediates. The last entry involving the 
anomeric deblocking of a thiodisaccharide (Table 1, entry 14) holds promise for the future 
use of thio functionalities as temporary anomeric protective groups in the construction of 
oligosaccharides. 
Table 1 
entry thioglycoside hemiacetal time (min) yield (%) 
1 
O
BnO
SPh
O
O
Ph OBn
1  
O
BnO
OBnO
O
Ph
OH
2  
30 75 
2 O
BnO
BnO
BnO
OBn
SPh
3  
O
BnO
BnO
BnO
OBn
OH
4  
30 90 
3 O
AcO
AcO
AcO
OAc
SPh
5  
O
AcO
AcO
AcO
OAc
OH
6  
30 88 
4 O
OBzBzO
BzO
OBz
SEt
7  
O
OBzBzO
BzO
OBz
OH
8  
60 92 
5 O
AcO
NPht
SPh
N3
9  
O
AcO
NPht
N3
OH
10  
15 79 
Hydrolysis of thioglycosides. Reagents and conditions:  NIS/TFA (stoichiometric), DCM/H2O (10/1) 
0.1 M, at 0 °C. 
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entry thioglycoside hemiacetal Time (min) 
Yield 
(%) 
6 
O
LevO SPh
O
O
Ph
NPht11  
O
LevO
O
O
Ph
NPht
OH
12  
120 85 
7 
O
PMBO
OBnO
O
Ph
SPh13  
O
PMBO
OBnO
O
Ph
OH
14  
30 80 
8 
O
BnO
OBn
SPh
O
O
PhOMe
15  
O
BnO
OBn
O
O
OH
PhOMe
16  
20 70 
9 O
OBz
TBDMSO
OBz
SEt
AcO
17  
O
OBz
TBDMSO
OBz
OH
AcO
18  
40 85 
10 
O
O
O
AcO
SPh
19
 
O
O
O
AcO
OH
20  
30 83 
11 
O
OAcCl
AcO
AcO SPh
21  
O
OAcCl
AcO
AcO
OH
22  
30 86 
12 O
BnOOC
AcO
BzO
OBz
SPh
23  
O
BnOOC
AcO
BzO
OBz
OH
24  
60 82 
13 
O
MeOOC
AcO
BnO
OBn
25 SPh  
O
MeOOC
AcO
BnO OH
OBn
26  
30 74 
14 
O
BzO
BzO
BzO
OBz
O
O
BnO OBn
OBn
SEt
27
 
O
BzO
BzO
BzO
OBz
O
O
BnO OBn
OBn
OH
28
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Hydrolysis of thioglycosides. Reagents and conditions:  NIS/TFA (stoichiometric), DCM/H2O (10/1) 
0.1 M, at 0 °C. 
Having established the use of the NIS/TFA combination of reagents in the hydrolysis of a 
number of thioglycosides, the hypothesis was examined whether the NIS/TFA combination 
could effectuate an efficient glycosylation of thioglycoside donors.20 Accordingly, in a pilot 
experiment 1-thio galactopyranoside (7) was treated with equimolar amounts of NIS and 
TFA at 0 °C and acceptor glycoside methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside was 
added. After workup, only traces of disaccharide were be obtained. Instead, acceptor and 
hydrolyzed donor were isolated, indicating that NIS/TFA is not a useful alternative 
thioglycoside activating system for oligosaccharide synthesis purposes. 
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In conclusion, this chapter presents an efficient and generally applicable protocol for the 
hydrolysis of thioglycosides, which complements existing literature procedures.9-19 
Experimental 
General: All chemicals (Acros, Fluka, Merck, Schleicher & Schue) were used as received. Column 
chromatography was performed on Merck silica gel 60 (0.040-0.063 mm). TLC analysis was 
conducted on HPTLC aluminum sheets (Merck, silica gel 60, F245). Compounds were visualized by 
UV absorption (245 nm), by spraying with 20% H2SO4 in ethanol or with a solution of 
(NH4)6Mo7O24·4H2O 25 g/L, (NH4)4Ce(SO4)4·2H2O 10 g/L, 10% H2SO4 in H2O followed by charring 
at +/- 140 °C. 1H and 13C NMR spectra were recorded with a Bruker AV 400 (400 and 100 MHz 
respectively), AV 500 (500 and 125 MHz respectively) or a Bruker DMX 600 (600 and 150 MHz 
respectively). NMR spectra were recorded in CDCl3 with chemical shift (δ) relative to 
tetramethylsilane unless stated otherwise. High resolution mass spectra were recorded on a LTQ-
orbitrap (thermo electron). IR spectra were recorded on a Shimadzu FTIR-8300 and are reported in 
cm-1. 
Procedure NIS/TMSOTf: To a vigorously stirred solution of mannose 1 (270 mg, 0.50 mmol) in 
DCM (5 ml) and H2O (0.5 ml) was added at 0 °C NIS (112 mg, 0.50 mmol) and TMSOTf (4 μl, 0.05 
mmol). After 30 min. TLC analysis showed complete consumption of starting material to lower 
running spots, the reaction was quenched Et3N, then washed with sat. aq. The organic layer was dried 
over MgSO4 and concentrated in vacuo. Purification by column chromatography yielded only trace 
amounts of the corresponding 1-hydroxy glycosides (detected by LCMS). 
General procedure NIS/TFA: To a vigorously stirred solution of thioglycoside (0.50 mmol) in 
DCM (5 ml) and H2O (0.5 ml) was added at 0 °C NIS (112 mg, 0.50 mmol) and TFA (39 μl, 0.50 
mmol). After TLC analysis showed complete consumption of starting material, the reaction was 
quenched with sat. aq. Na2S2O3 (unless noted otherwise) and washed with sat. aq. NaHCO3. The 
organic layer was dried over MgSO4 and concentrated in vacuo. Purification by column 
chromatography yielded the corresponding 1-hydroxy glycosides. 
2,3-Di-O-benzyl-4,6-O-benzylidene-D-mannopyranose (2).21 The 
reaction mixture was quenched after 30 minutes. Column chromatography 
yielded the title compound 2 (0.166 g, 75%) as a colorless oil. IR (neat): 
1028, 1093, 1373, 2870; 1H NMR (500 MHz, CDCl3): δ = 3.09 (d, 1H, J = 3.6 Hz, OH), 3.79 (bs, 1H, 
H-2), 3.85 (d, 1H, J = 10.1 Hz, H-6), 3.99 (m, 2H, H-5, H-3), 4.22 (m, 2H, H-4, H-6), 4.64 (d, 1H, J = 
12.2 Hz, CH2 Bn), 4.68 (d, 1H, J = 12.2 Hz, CH2 Bn), 4.78 (d, 1H, J = 12.1 Hz, CH2 Bn), 4.81 (d, 1H, 
J = 12.1 Hz, CH2 Bn), 5.12 (d, 1H, J = 2.1 Hz, H-1), 5.63 (s, 1H, CH benzylidene), 7.24-7.50 (m, 
15H, H Arom); 13C NMR (125 MHz): δ = 64.2 (C-5), 68.8 (C-6), 73.1 (CH2 Bn), 73.5 (CH2 Bn), 75.8 
(C-3), 76.7 (C-2), 79.1 (C-4), 94.1 (C-1), 101.4 (CH benzylidene), 126.0-129.1 (CH Arom), 137.5, 
138.1, 138.5 (Cq Bn, Cq benzylidene); HRMS: C27H28O6 + Na+ requires 471.17781, found 471.17779. 
2,3,4,6-Tetra-O-benzyl-D-glucopyranose (4).22 The reaction mixture was 
quenched after 30 minutes by addition of Et3N after which sat. aq. Na2S2O3 
O
BnO
OBnO
O
Ph
OH
O
BnO
BnO
BnO
OBn
OH
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was added. Column chromatography yielded the title compound 4 (0.243 g, 90%) as a white solid. IR 
(neat): 1026, 1045, 1074, 1085, 1145, 1356, 1452, 1497; 1H NMR (500 MHz, CDCl3): δ = 3.26 (bs, 
1H, OH), 3.54–3.70 (m, 4H, H-6, H-6, H-2), 3.98 (t, 1H, J = 9.3 Hz, H-3), 4.03 (d, 1H, J = 8.4 Hz, H-
5), 4.46-4.50 (m, 2H, CH2 Bn), 4.58 (d, 1H, J = 12.2 Hz, CH2 Bn), 4.68 (d, 1H, J = 11.9 Hz, CH2 Bn), 
4.75 (d, 1H, J = 11.8 Hz, CH2 Bn), 4.80 (m, 2H, CH2 Bn), 4.95 (d, 1H, J = 10.9 Hz, CH2 Bn), 5.21 (d, 
1H, J = 3.4 Hz, H-1), 7.26-7.36 (m, 20H, H Arom Bn); 13C NMR (125 MHz): δ = 68.5 (C-6), 70.2 (C-
5), 73.2 (CH2 Bn), 73.4 (CH2 Bn), 75.0 (CH2 Bn), 75.7 (CH2 Bn), 77.7 (C-4), 79.9 (C-2), 81.7 (C-3), 
91.3 (C-1), 127.6-128.5 (CH Bn), 137.8 (Cq Bn), 138.1 (Cq Bn), 138.6 (Cq Bn); HRMS: C34H36O6 + 
Na+  requires 563.24041, found 563.24251. 
2,3,4,6-Tetra-O-acetyl-D-glucopyranose (6).23 The reaction mixture was 
quenched after 30 minutes. Column chromatography yielded the title 
compound 6 (0.153 g, 88%) as a colorless oil. IR (neat): 1032, 1213, 1367, 
1740; 1H NMR (500 MHz, CDCl3): δ = 2.03 (s, 3H, CH3 Ac), 2.04 (s, 3H, CH3 Ac), 2.09 (s, 3H, CH3 
Ac), 2.10 (s, 3H, CH3 Ac), 4.15 (t, 1H, J = 11.5 Hz, H-6), 4.26 (m, 2H, H-5, H-6), 4.89 (dd, 1H, J = 
3.0 Hz, 9.5 Hz, H-2), 5.09 (m, 1H, H-4), 5.46 (d, 1H, J = 2.5 Hz, H-1), 5.54 (t, 1H, J = 9.5 Hz, H-3); 
13C NMR (125 MHz): δ = 20.6 (CH3 Ac), 20.7 (CH3 Ac), 20.8 (CH3 Ac), 20.9 (CH3 Ac), 61.9 (C-6), 
67.1 (C-5), 68.4 (C-4), 69.7 (C-3), 73.0 (C-2), 90.0 (C-1), 169.6 (C=O Ac), 170.2 (C=O Ac), 170.7 
(C=O Ac), 170.9 (C=O Ac); HRMS: C14H20O10 + Na+  requires 371.09487, found 371.09519. 
2,3,4,6-Tetra-O-benzoyl-D-galactopyranose (8).24 The reaction mixture was 
quenched after 60 minutes. Column chromatography yielded the title compound 
8 (0.274 g, 92%) as a colorless oil. IR (neat): 1026, 1069, 1093, 1263, 1724; 1H 
NMR (500 MHz, CDCl3): δ = 3.63 (s, 1H, OH), 4.38 (m, 1H, H-6), 4.61 (m, 1H, 
H-6), 4.87 (t, 1H, J = 6.6 Hz, H-5), 5.71 (dd, 1H, J = 3.0 Hz, 10.0 Hz, H-2), 5.85 (s, 1H, H-1), 6.08 
(m, 2H, H-3, H-4), 7.22-8.15 (m, 20H, H Arom); 13C NMR (125 MHz): δ = 62.4 (C-6), 66.8 (C-5), 
68.0 (C-4), 69.2 (C-2), 69.5 (C-3), 91.1 (C-1), 128.2-128.6 (CH Arom), 129.1-129.4 (Cq Bz), 129.7-
129.9 (CH Arom), 133.1-133.6 (CH Arom), 165.6 (C=O Bz), 166.1 (C=O Bz); HRMS: C34H28O10 + 
Na+  requires 619.15747, found 619.15892. 
3-O-Acetyl-4-azido-2,4,6-tri-deoxy-2-phthalimido-D-galactopyranose (10). 
The reaction mixture was quenched after 15 minutes. Column chromatography 
yielded the title compound 10 (0.142 g, 79%) as a colorless oil. IR (neat): 1044, 
1242, 1383, 1708, 2108; 1H NMR (500 MHz, CDCl3): δ = 1.37 (d, 3H, J = 11 
Hz, CH3 C-6), 1.98 (s, 3H, CH3 Ac), 3.97 (d, 1H, J = 6 Hz, H-5), 3.99 (d, 1H, J = 4 Hz, H-4), 4.49 
(dd, 1H, J = 9 Hz, 11 Hz, H-2), 5.38 (d, 1H, J = 9 Hz, H-1), 5.89 (dd, 1H, J = 3 Hz, 11 Hz, H-3), 
7.72-7.87 (m, 4H, H Arom); 13C NMR (125 MHz): δ = 17.4 (C-6), 20.3 (CH3 Ac), 53.0 (C-2), 63.2 
(C-4), 69.3 (C-5), 70.3 (C-3), 92.3 (C-1), 123.5 (CH Phth), 123.6 (CH Phth), 131.3 (Cq Phth), 131.4 
(Cq Phth), 134.3 (CH Phth), 134.4 (CH Phth), 168.0 (C=O Phth), 168.3 (C=O Phth), 170.1 (C=O Ac); 
HRMS: C16H16O6 + H+ requires 361.11426, found 361.15307. 
4,6-O- Benzylidene -2-deoxy -3-O- levulinoyl- 2- phthalimido -D-
glucopyranose (12). The reaction mixture was quenched after 120 
minutes. Column chromatography yielded the title compound 12 (0.210 g, 
85%) as a white solid. IR (neat): 1076, 1386, 1716; HRMS: 1H NMR (500 
MHz, CDCl3): δ = 1.86 (s, 3H, CH3 Lev), 2.35-2.56 (m, 4H, CH2 Lev), 3.81 (m, 3H, H-6, H-5, H-4), 
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4.25 (dd, 1H, J = 8.5 Hz, 10.0 Hz, H-2), 4.25 (dd, 1H, J = 4.0 Hz, 10.0 Hz, H-6), 5.54 (s, 1H, CH 
benzylidene), 5.63 (d, 1H, J = 8.5 Hz, H-1), 5.93 (t, 1H, J = 10.0 Hz, H-3), 7.35 (m, 3H, H Arom), 
7.45 (m, 2H, H Arom), 7.67 (m, 2H, H Arom), 7.81 (bs, 2H, H Arom); 13C NMR (125 MHz): δ = 27.7 
(CH2 Lev), 29.3 (CH3 Lev), 37.6 (CH2 Lev), 56.5 (C-2), 66.3 (C-5), 68.5 (C-6), 69.5 (C-3), 79.2 (C-
4), 93.1 (C-1), 101.4 (CH benzylidene), 123.4-136.8 (CH Arom), 168.1 (C=O Phth), 171.9 (C=O 
Lev), 206.0 (C=O Lev); C26H25O9N + Na+ requires 518.14215, found 518.14428. 
2-O-Benzyl -4,6- O- benzylidene -3-O- paramethoxybenzyl -D-
mannopyranose (14). The reaction mixture was quenched after 30 
minutes. Column chromatography yielded the title compound 14 (0.191 g, 
80%) as a colorless oil. IR (neat): 1026, 1090, 1512, 1612; 1H NMR (500 MHz, CDCl3): δ = 3.45 (d, 
1H, J = 3.5 Hz, OH), 3.75 (s, 3H, CH3 OMe), 3.77 (m, 1H, H-2), 3.82 (t, 1H, J = 10.5 Hz, H-6), 3.97 
(dd, 2H, J = 3.0 Hz, 10.5 Hz, H-5, H-3), 4.19 (m, 2H, H-4, H-6),  4.56 (d, 1H, J = 12 Hz, CH2 Bn), 
4.65 (d, 1H, J = 12 Hz, CH2 Bn), 4.71 (d, 1H, J = 12 Hz, CH2 Bn), 4.74 (d, 1H, J = 12 Hz, CH2 Bn), 
5.07 (s, 1H, H-1), 5.61 (s, 1H, CH benzylidene), 6.82 (d, 2H, J = 8.5 Hz, H Arom), 7.29 (m, 12H, H 
Arom); 13C NMR (125 MHz): δ = 55.1 (CH3 PMB), 64.1 (C-5), 68.8 (C-6), 72.6 (CH2 Bn), 73.4 (CH2 
Bn), 75.4 (C-3), 76.5 (C-2), 79.0 (C-4), 93.9 (C-1), 101.4 (CH benzylidene), 113.6 (CH Arom PMB), 
126.0-129.5 (CH Arom), 130.6 (Cq Arom), 137.6 (Cq Arom), 138.0 (Cq Arom), 159.0 (Cq PMB); 
HRMS: C28H30O7 + Na+ requires 501.18837, found 501.18893. 
2,3-Di-O-benzyl-4,6-O-paramethoxybenzylidene-D-galactopyranose (16). The 
reaction mixture was quenched after 20 minutes. Column chromatography 
yielded the title compound 16 (0.168 g, 70%) as a colorless oil. IR (neat): 1028, 
1051, 1093, 1248, 1517, 1614; 1H NMR (500 MHz, CDCl3): δ = 2.90 (bs, 1H, 
OH), 3.73 (s, 3 H, CH3 pOMePhCH), 3.76 (d, 1H, J = 1.0 Hz, H-5), 3.88 (dd, 
1H, J = 4.5 Hz, 12.5 Hz, H-3), 3.92 (dd, 1H, J = 2.5 Hz, 16.5 Hz, H-6), 3.98 (dd, 
1H, J = 4.5 Hz, 12.5 Hz, H-2), 4.13 (m, 2H, H-4, H-6),  4.62 (d, 1H, J = 14.5 Hz, CH2 Bn), 4.69 (d, 
2H, J = 5 Hz, CH2 Bn), 4.71 (d, 1H, J = 14.5 Hz, CH2 Bn), 5.29 (d, 1H, J = 4.5 Hz, H-1), 5.37 (s, 1H, 
CH pOMePhCH), 6.79 (d, 2H, J = 6.0 Hz, H Arom pOMePhCH), 7.19-7.22 (m, 14H, H Arom); 13C 
NMR (125 MHz): δ =55.3 (CH3 pOMePhCH), 62.8 (C-5), 69.4 (C-6), 71.7 (CH2 Bn), 73.9 (CH2 Bn), 
74.3 (C-4), 75.7 (C-2,3), 92.3 (C-1), 101.0 (CH pOMePhCH), 113.5 (CH pOMePhCH), 127.7-128.4 
(CH Arom), 130.4 (Cq pOMePhCH), 138.3 (Cq Bn), 138.5 (Cq Bn), 160.0 (Cq pOMePhCH). 
4-O-Acetyl-2,6-di-O-benzoyl-3-O-tert-butyldimethylsilyl-D-
galactopyranose (18). The reaction mixture was quenched after 40 minutes. 
Column chromatography yielded the title compound 18 (0.231 g, 85%) as a 
colorless oil. IR (neat): 1112, 1270, 1451, 1723; 1H NMR (500 MHz, 
CDCl3): δ = 0.02 (s, 3H, CH3 Me TBDMS), 0.13 (s, 3H, CH3 Me TBDMS), 0.76 (s, 9H, CH3  tBu 
TBDMS), 2.19 (s, 3H, CH3 Ac), 3.40 (s, 1H, OH), 4.33 (m, 1H, H-6), 4.46 (m, 2H, H-3, H-6), 4.60 (t, 
1H, J = 6 Hz, H-5), 5.39 (d, 1H, J = 7.5 Hz, H-2), 5.51 (s, 1H, H-4), 5.89 (s, 1H, H-1), 7.46 (m, 4H, H 
Arom), 7.58 (m, 2H, H Arom), 8.08 (m, 4H, H Arom); 13C NMR (125 MHz): δ = -5.0 (CH3 Me 
TBDMS), -4.8 (CH3 Me TBDMS), 17.7 (CH3 Ac), 25.3 (CH3  tBu TBDMS), 62.9 (C-6), 66.6 (C-3), 
67.0 (C-5), 71.0 (C-4), 71.7 (C-2), 91.1 (C-1), 128.3-133.4 (CH Arom), 166.0 (C=O Bz), 166.2 (C=O 
Bz), 170.3 (C=O Ac); HRMS: C28H36O9Si + Na+ requires 567.20208, found 567.20453. 
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4-O-Acetyl-2,3-O-Isopropylidene-L-rhamnopyranoside (20).25 The reaction 
mixture was quenched after 30 minutes. Column chromatography yielded the 
title compound 20 (0.102 g, 83%) as a white solid. IR (neat): 1045, 1130, 1221, 
1375, 1740; 1H NMR (500 MHz, CDCl3): δ = 1.16 (d, 3H, J = 6.3 Hz, H-6), 
1.36 (s, 3H, CH3 isoprop), 1.57 (s, 3H, CH3 isoprop), 2.11 (s, 3H, CH3 Ac), 3.21 
(d, 1H, J = 2.9 Hz, OH), 3.97 (dq, 1H, H-5, J = 6.3 Hz, 10.0 Hz, H-5), 4.18 (d, 1H, J = 5.4 Hz, H-2), 
4.22 (dd, 1H, J = 5.4 Hz, 7.7 Hz, H-3), 4.87 (dd, 1H, J = 7.7 Hz, 10.0 Hz H-4), 5.42 (d, 1H, J = 2.2 
Hz, H-2); 13C NMR (125 MHz): δ = 17.0 (C-6), 21.0 (CH3 Ac), 26.4 (CH3 isoprop), 27.6 (CH3 
isoprop), 64.2 (C-5), 74.4 (C-4), 75.5 (C-3), 76.1 (C-2), 91.8 (C-1), 109.8 (Cq isoprop), 170.2 (C=O 
Ac). 
3,4-di-O-Acetyl-2-O-chloroacetyl-L-rhamnopyranoside (22). The reaction 
mixture was quenched after 30 minutes. Column chromatography yielded the 
title compound 22 (0.139 g, 86%) as a colorless oil. IR (neat): 1049, 1219, 
1371, 1740; 1H NMR (500 MHz, CDCl3): δ = 1.22 (d, 3H, J = 5.8 Hz, H-6), 2.00 (s, 3H, CH3 Ac), 
2.06 (s, 3H, CH3 Ac), 3.21 (s, 1H, OH), 4.18 (m, 3H, H-5, CH2Cl ClAc), 5.11 (t, 1H, J = 9.5 Hz, H-4), 
5.20 (s, 1H, H-1), 5.36 (s, 1H, H-2), 5.39 (m, 1H, H-3); 13C NMR (125 MHz): δ = 17.4 (C-6), 20.7 
(CH3 Ac), 20.8 (CH3 Ac), 40.7 (CH2Cl ClAc), 66.4 (C-5), 68.6 (C-3), 70.9 (C-4), 71.9 (C-2), 91.8 (C-
1), 166.8 (C=O ClAc), 170.0 (C=O Ac). 
Benzyl (4-O-acetyl-2,3-di-O-benzoyl-D-glucopyranoside) uronate (24). The 
reaction mixture was quenched after 60 minutes. Column chromatography 
yielded the title compound 24 (0.220 g, 82%) as a colorless oil. IR (neat): 906, 
1261, 1450, 1674, 1724; 1H NMR (500 MHz, CDCl3): δ = 1.68 (s, 3H, CH3 
Ac), 4.09 (d, 1H, J = 2.5 Hz, OH), 4.76 (d, 1H, J = 10 Hz, H-5), 5.11 (d, 1H, J = 12 Hz, CH2 Bn), 
5.17 (d, 1H, J = 12 Hz, CH2 Bn), 4.60 (dd, 1H, J = 3.5 Hz, 10 Hz, H-2), 5.46 (t, 1H, J = 9.5 Hz, H-4), 
5.78 (s, 1H, H-1), 6.04 (t, 1H, J = 10 Hz, H-3), 7.36 (m, 9H, H Arom), 7.49 (m, 2H, H Arom), 7.94 
(m, 4H, H Arom); 13C NMR (125 MHz): δ = 20.2 (CH3 Ac), 67.9 (CH2 Bn), 68.3 (C-5), 69.3 (C-4), 
69.6 (C-3), 71.6 (C-2), 90.4 (C-1), 128.4-134.6 (CH Arom), 165.6 (C=O Bz), 165.7 (C=O Bz), 168.0, 
169.6 (C=O Ac, COOBn). 
Methyl (4-O-acetyl-2,3-di-O-benzyl-D-mannopyranoside) uronate (26). The 
reaction mixture was quenched after 30 minutes by addition of Et3N after 
which sat. aq.  Na2S2O3 was added. Column chromatography yielded the title 
compound 26 (0.189 g, 88%) as a colorless oil. IR (neat, cm-1): 1042, 1118, 1229, 1371, 1744; 1H 
NMR (600 MHz, CDCl3): δ = 2.01 (s, 3H, CH3 Ac), 3.60 (s, 3H, CH3 COOMe), 3.65 (bs, 1H, H-2), 
3.89 (dd, 1H, J = 6.6 Hz, 2.9 Hz, H-3), 4.55 (d, 1H, J = 12.0 Hz, CH2 Bn), 4.61 (d, 1H,  J = 12.0 Hz, 
CH2 Bn), 4.63 (d, 1H, J = 12.2 Hz, CH2 Bn), 4.73 (d, 1H, J = 12.2 Hz, CH2 Bn), 5.51–5.56 (m, 2H, J 
= 6.6 Hz, H-1, H-4), 7.23–7.49 (m, 10H, H Arom); 13C NMR (125 MHz, CDCl3) δ = 20.7 (CH3 Ac), 
52.3 (CH3 COOMe), 69.3 (C-4), 72.3 (C-5), 76.7 (C-2), 77.2 (C-3), 92.4 (C-1), 127.5–128.4 (CH 
Arom), 137.6 (Cq Bn), 137.9 (Cq Bn), 169.2, 169.8 (C=O Ac, C=O COOMe); HRMS: C23H26O8 + 
Na+ requires 453.15199, found 453.15220. 
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2,3,4-Tri-O-benzyl-6-O-(2,3,4,6-tetra-O-benzoyl-β-D-
glucopyranosyl)-D-glucopyranose (28).26 The reaction mixture 
was quenched after 30 minutes. Column chromatography yielded 
the title compound 28 (0.361 g, 70%) as a colorless oil. IR (neat): 
1068, 1265, 1730, 2341, 2360; 1H NMR (400 MHz, CDCl3): δ 
=2.59 (d, 1H, J = 2.4 Hz, OH), 3.43 (m, 2H, H-2, H-4), 3.81 (dd, 1H, J = 4.5 Hz, 11 Hz, H-6), 3.89 (t, 
1H, J = 9.5 Hz, H-3), 4.00 (dd, 1H, J = 2.8 Hz, 10 Hz, H-5), 4.23 (m, 2H, H-6, CH2 Bn), 4.40 (m, 2H, 
H-6’, CH2 Bn), 4.53 (d, 1H, J = 11.2 Hz, CH2 Bn), 4.69 (m, 3H, H-6’, CH2 Bn), 4.80 (d, 1H, J = 8.0 
Hz, H-1’), 4.87 (m, 2H, H-5’, CH2 Bn), 5.09 (d, 1H, J = 3.5 Hz, H-1), 5.61 (dd, 1H, J = 3.6 Hz, 10.4 
Hz, H-3’), 5.83 (dd, 1H, J = 2.4 Hz, 8 Hz, H-2’), 5.97 (d, 1H, J = 3.2 Hz, H-4’), 7.09-8.09 (m, 35H, H 
Arom); 13C NMR (100 MHz): δ =61.9 (C-6’), 68.1 (C-5’), 68.7 (C-6), 69.8, 70.0 (C-4’, C-5), 71.3 (C-
2’), 71.6 (C-3’), 73.2 (CH2 Bn), 74.7 (CH2 Bn), 75.5 (CH2 Bn), 77.3 (C-4), 79.9 (C-2), 81.5 (C-3), 
91.1 (C-1’), 102.1 (C-1), 127.5-128.3 (CH Arom), 128.3-129.3 (Cq  Arom), 129.6-130.0 (CH Arom), 
133.3-133.5 (CH Arom), 137.9-138.6 (Cq  Arom), 165.0 (C=O Bz), 165.5 (C=O Bz), 165.6 (C=O Bz), 
166.0 (C=O Bz). 
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Chapter 3 
Synthesis of Hyaluronic Acid Oligomers using Ph2SO/Tf2O 
Mediated Glycosylations1 
Introduction 
Hyaluronan (HA, 1, Figure 1) is a linear glycosaminoglycan polymer having the β-1,3-
linked 2-acetamido-2-deoxy-D-glucose-β-(1,4)-D-glucuronic acid disaccharide2 as repeating 
unit. HA has the simplest primary structure amongst the class of glycosaminoglycans, and 
is involved in a wide variety of biological processes, such as cell-migration, proliferation, 
adhesion, recognition,3 tumor invasion4 and tumor inhibition.5 Recently, evidence has 
accumulated that specific activities of HA are related to the length of its carbohydrate 
chain. For instance, whereas high molecular mass HA polymers are immunosuppressive,6 
small HA oligosaccharides can induce complete and irreversible maturation of human 
dendritic cells through the Toll-like receptor 4 (TLR-4), thereby activate the innate immune 
system.7 In addition, macrophages treated with HA oligomers, generated by degradation 
with different types of glycosidases produced different levels of interleukin-12 production, 
indicating that the nature of the monosaccharide at the reducing end of the HA oligomer 
(being either N-acetyl glucosamine or glucuronic acid) is of importance for biological 
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activity.8 For the understanding of the role of HA at a molecular level, the development of 
an efficient synthetic approach to sufficient quantities of well-defined oligomers and 
derivatives thereof is crucial. 
Figure 1  
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Repeating unit of hyaluronan oligosaccharides. 
Since the pioneering work of Jeanloz9 in 1964, several research groups have studied the 
synthesis of HA oligomers.10 Compared to other glycosaminoglycan family members such 
as heparin sulfate, HA has received little attention from the synthetic carbohydrate 
community. In this chapter the synthesis of a HA trimer, tetramer and pentamer, each with 
a glucuronic acid moiety as the reducing end sugar is described. 
Results and discussion  
The synthetic strategy presented here, is based on the finding of Codée et al.11 that donor 1-
hydroxysugars can be chemoselectively condensed with acceptor 1-thioglycosides under 
the agency of Gin’s activator system for dehydrative glycosylations (diphenylsulfoxide / 
trifluoromethanesulfonic anhydride),12 resulting in the formation of 1-thiodisaccharides 
amenable for elongation at both reducing end and non-reducing end.13 The reducing 
glucuronide in the target HA oligomers is masked as the 3-azido-1-propanol glycoside, with 
the dual advantage of locking the anomeric configuration and enabling functionalization of 
the azide moiety for conjugation studies. 
The syntheses of functionalized monosaccharides 4, 5, 6 and 7 that were required for 
executing the selected strategy are summarized in Scheme 1. Partially protected 1-
phenylthioglucuronide 2, prepared following a previously reported procedure,14 was 
transformed into the corresponding 4-O-levulinoyl derivative 3. Glycosylation with 3-
azidopropanol (Ph2SO, Tf2O) followed by deblocking of the 4’-hydroxyl function gave 
reducing end building block 4. The procedure described in Chapter 2 was used to hydrolyze 
the thioacetal funtion in 3 providing 1-hydroxy donor 5.15 Partially protected glucosamine 
derivative 6 was prepared as described by Blatter and Jacquinet,16 and levulinoylated to 
give donor thioglycoside 7. 
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Synthesis of monomer HA building blocks. Reagents and conditions: a) Lev2O, dioxane, pyridine 
(86%); b) Ph2SO, DCM, -60 °C, then Tf2O, 15 min., then HO(CH2)3N3, -60 °C to rT; ii. Pyridine, 
AcOH, hydrazine, (64% over 2 steps); c) TFA, NIS, DCM, H2O (82%); d) Lev2O, dioxane, pyridine 
(87%). 
The synthesis of the fully protected HA trimer 9 is depicted in Scheme 2 and commenced 
with the Ph2SO/Tf2O/TTBP mediated condensation of donor glycoside 5 and acceptor 
glycoside 6 to give 8 in 56% yield. Thiodisaccharide 8 was condensed with acceptor 
glucuronide 4 under the same conditions to provide trisaccharide 9 (47%). Deprotection of 
the levulinoyl group in 9 afforded trisaccharide 10 (hydrazine, pyridine/AcOH). It is of 
interest to note that replacement of the N-trichloroacetyl group in glucosamine acceptor 6 
by either a N-acetyl or N-phthaloyl protective group resulted in a dramatic drop in coupling 
efficiency.  
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Sequential glycosylation strategy. Reagents and conditions: a) Ph2SO, TTBP, DCM, -60 °C, then 
Tf2O, to -40 °C then add acceptor 6, -40 °C to 0 °C (56%); b) Ph2SO, TTBP, DCM, -60 °C, Tf2O, 10 
min, then add acceptor 4, to 0 °C (47%); c) Pyridine, AcOH, hydrazine (96%). 
At this stage, the efficiency in preparing trisaccharide 9 following a one-pot procedure was 
investigated.17 Accordingly, the reaction mixture containing disaccharide 8, formed after 
Tf2O/Ph2SO mediated condensation of 1-hydroxydonor 5 with thioglycoside 6, was cooled 
and activated with an additional equivalent of Tf2O and TTBP (0.95 equiv. with respect to 
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Tf2O) for 10 minutes, followed by addition of acceptor glycoside 4 (1 equiv.). Following 
this protocol (Scheme 3), trisaccharide 9 could be prepared, but the yield (12%) proved to 
be considerably lower than the overall yield (26%) of the two separate glycosylation steps. 
Scheme 3 
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One pot glycosylation strategy towards trisaccharide 9. 
The difficulty of this reaction sequence is that base (TTBP) has to be introduced in both 
condensation steps in order to avoid acid mediated (due to in situ formation of TfOH) 
cleavage of the benzylidene group in the glucosamine derivative. However, the amount of 
base should be such that orthoester formation during the dehydrative glycosylation and 
oxazolidine formation upon activation of the thioglucosamine donor is avoided. The 
efficiency of the one-pot procedure could not be enhanced by varying the amount of TTBP. 
On the basis of these results, it was concluded that trisaccharide 9 is best prepared via two 
individual glycosylation steps, and that the optimal amount of based used in both steps is 
0.95 equivalents with respect to Tf2O. 
Scheme 4 
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HA tetramer and pentamer synthesis. Reagents and conditions: a) Ph2SO, TTBP, DCM, -60 °C, then 
Tf2O, 10 min., then 10, to -15 °C (11 62%, 12 48%). 
Fully protected HA tetramer 11 and pentamer 12 were prepared starting from trimer 10 as 
follows (Scheme 4). Activation of thioglucosamine 7 using the protocol described above 
(Ph2SO, Tf2O, TTBP) followed by addition of acceptor trisaccharide 10 led to the formation 
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of fully protected HA tetramer 11. Quenching the reaction at -15 °C improved the yield 
considerably with respect to quenching at 0 °C, and tetramer 11 was isolated in 62% yield. 
In a similar fashion, but with phenylthiodisaccharide 8 as the donor, fully protected 
pentasaccharide 12 (42% yield) was prepared.  
Finally, the fully deprotected target tri-, tetra- and pentamers 13, 14 and 15 were obtained 
(Scheme 5) by acid cleavage of the benzylidene group followed by saponification of the 
ester and amide functionalities under the agency of KOH, N-acetylation in MeOH with 
Ac2O and purification by gel filtration. 
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HA deprotection. Reagents and conditions: a) i. MeOH, p-TsOH; ii. H2O, THF, KOH; iii. Ac2O, 
MeOH (13 58%, 14 54%, 15 48%). 
In conclusion, HA oligomers that are suitably functionalized for future biological studies 
can be conveniently prepared by making use of thioglycosides and 1-hydroxyglycosides, in 
combination with the Ph2SO/Tf2O/TTBP activating system. The yields in the glycosidic 
bond formations are moderate, and the combination of the presence of acid-labile 
benzylidene protective groups and the propensity of orthoester formation makes that the 
glycosylations have to be monitored with care, especially with respect to the amount of 
base used. However, the general strategy is convenient, in that useful quantities can be 
prepared from readily available building blocks. By making use of glucuronic acid building 
blocks, post-glycosylation manipulations can be kept to a minimum. The compounds will 
prove to be useful in the assessment of the biological properties of HA oligomers, such as 
their TLR-4 mediated immunostimulatory activity. 
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Experimental Section 
General: Dichloromethane was refluxed with P2O5 and distilled before use. Trifluoromethanesulfonic 
anhydride was distilled from P2O5. Traces of water in the donor and acceptor glycosides, 
diphenylsulfoxide and TTBP were removed by co-evaporation with toluene. All other chemicals 
(Acros, Fluka, Merck, Schleicher & Schue) were used as received. Column chromatography was 
performed on Merck silica gel 60 (0.040-0.063 mm). TLC analysis was conducted on HPTLC 
aluminum sheets (Merck, silica gel 60, F245). Compounds were visualized by UV absorption (245 
nm), by spraying with 20% H2SO4 in ethanol or with a solution of (NH4)6Mo7O24·4H2O 25 g/L, 
(NH4)4Ce(SO4)4·2H2O 10 g/L, 10% H2SO4 in H2O followed by charring at +/- 140 °C. 1H and 13C 
NMR spectra were recorded with a Bruker AV 400 (400 and 100 MHz respectively), AV 500 (500 
and 125 MHz respectively) or a Bruker DMX 600 (600 and 150 MHz respectively). NMR spectra 
were recorded in CDCl3 with chemical shift (δ) relative to tetramethylsilane unless stated otherwise. 
Optical rotations were measured on a Propol automatic polarimeter. High resolution mass spectra 
were recorded on a LTQ-orbitrap (thermo electron). IR spectra were recorded on a Shimadzu FTIR-
8300 and are reported in cm-1. 
Methyl (phenyl 2,3-di-O-benzoyl-4-O-levulinoyl-1-thio-β-D-
glucopyranoside) uronate (3). To a solution of 2 (3.81 g, 7.49 mmol) in 
pyridine (75 ml) was added a solution of Lev2O in dioxane (0.5 M, 37.5 ml, 
18.7 mmol). After 18 h the mixture was diluted with EtOAc (200 ml), washed 
with 1M HCl (aq), NaHCO3 (aq), and brine. The organic layer was dried over MgSO4 and 
concentrated in vacuo. Purification by column chromatography yielded 3 as a colorless oil (3.91 g, 
86%). [α]D22: +63 (c = 1, CHCl3); IR (neat): 716, 1068, 1263, 1710, 2930 cm-1; 1H NMR (400 MHz, 
CDCl3): δ = 2.04 (s, 3H, CH3 Lev), 2.37-2.58 (m, 4H, 2 x CH2 Lev), 3.81 (s, 3H, CH3 COOMe), 4.23 
(d, 1H, J = 10.0 Hz, H-5), 4.97 (d, 1H, J = 10.0 Hz, H-1), 5.41 (m, 2H, H-2, H-4), 5.71 (t, 1H, J = 
10.0 Hz, H-3),7.29-7.55 (m, 11H, H Arom), 7.87 (d, 2H, J = 7.2 Hz, H Arom), 7.93 (d, 2H, J = 7.2 
Hz, H Arom); 13C NMR (100 MHz, CDCl3) δ = 27.7 (CH2 Lev), 29.5 (CH3 Lev), 37.6 (CH2 Lev), 
53.0 (CH3 COOMe), 69.5, 70.0 (C-2, C-4), 73.5 (C-3), 76.4 (C-5), 86.6 (C-1), 128.4-128.7 (CH 
Arom), 129.0 (CH Arom), 129.8-130.0 (CH Arom), 131.3 (Cq Arom), 133.4-133.5 (CH Arom), 164.9, 
165.6, 166.9, 171.1 (C=O Bz, COOMe, C=O Lev), 205.5 (C=O Lev); HRMS: C32H30O10S + H+ 
requires 607.16324, found 607.16324. 
3-azidopropyl (methyl (2,3-di-O-benzoyl-β-D-glucopyranoside) uronate) 
(4). A mixture of 3 (1.21 g, 2.00 mmol) and Ph2SO (0.485 g, 2.40 mmol) 
were co-evaporated with toluene two times to remove traces of water, 
dissolved in DCM (40 ml) and further dried by stirring over molsieves 3Å for 15 min. At -60 °C Tf2O 
(0.40 ml, 2.4 mmol) was added. After 15 min. a solution of 3-azidopropanol (0.608 g, 6.00 mmol) in 
DCM (15 ml) was slowly added and the reaction mixture was allowed to warm to 0 °C. Dry Et3N 
(1.39 ml, 10 mmol) was added and the reaction was washed with NaHCO3 (aq). The organic layer 
was dried over MgSO4 and concentrated in vacuo. This crude concentrate was then dissolved in a 
mixture of pyridine (16 ml) and AcOH (4 ml), after which hydrazine monohydrate (0.48 ml, 10 
mmol) was added. The mixture was stirred for 15 min. and diluted with EtOAc (50 ml), washed with 
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1M HCl (aq), NaHCO3 (aq), and brine. The organic layer was dried over MgSO4 and concentrated in 
vacuo. Purification by column chromatography yielded 4 as a colorless oil (0.639 g, 64%). [α]D22: +56 
(c = 1, CHCl3); IR (neat): 709, 1067, 1252, 1717, 2103, 2930 cm-1; 1H NMR (400 MHz, CDCl3): δ = 
1.78 (m, 2H, CH2 C3H6N3), 3.25 (m, 2H, CH2 C3H6N3), 3.37 (d, 1H, J = 2.4 Hz, OH), 3.63 (m, 1H, 
CH2 C3H6N3), 3.87 (s, 3H, CH3 COOMe), 4.02 (m, 1H, CH2 C3H6N3), 4.10 (m, 1H, H-3), 4.10 (dt, 
1H, J = 2.4 Hz, 9.2 Hz, H-4), 4.75 (d, 1H, J = 7.6 Hz, H-1), 5.43 (dd, 1H, J = 8.0 Hz, 9.6 Hz, H-2), 
5.54 (dd, 1H, J = 9.2 Hz, 9.6 Hz, H-5), 7.39 (m, 4H, H Arom), 7.51 (m, 2H, H Arom), 7.97 (m, 4H, H 
Arom); 13C NMR (100 MHz, CDCl3) δ = 28.9 (CH2 C3H6N3), 47.8 (CH2 C3H6N3), 53.0 (CH3 
COOMe), 66.9 (CH2 C3H6N3), 70.6 (C-4), 71.2 (C-2), 74.6 (C-5), 74.9 (C-3), 101.4 (C-1), 128.4 (CH 
Arom), 128.4 (Cq Bz), 128.9 (Cq Bz), 129.7 (CH Arom), 129.9 (CH Arom), 133.4 (CH Arom), 165.1, 
166.6, 169.1 (C=O Bz, COOMe); HRMS: C24H25N3O9 + Na+ requires 522.14830, found 522.14827. 
Methyl (2,3-di-O-benzoyl-4-O-levulinoyl-D-glucopyranose) uronate (5). To 
a vigorously stirred solution of 3 (0.30 g, 0.50 mmol) in CH2Cl2 (5 ml) and 
H2O (0.5 ml) was added at 0 °C NIS (112 mg, 0.50 mmol) and TFA (39 μl, 
0.50 mmol). After TLC analysis showed complete consumption of starting material, the reaction was 
quenched with Na2S2O3 (aq) and washed with NaHCO3 (aq). The organic layer was dried over 
MgSO4 and concentrated in vacuo. Purification by column chromatography yielded 5 as a colorless 
oil (0.21 g, 82%). Spectral data of the major anomer α. IR (neat): 711, 1264, 1722, 2343, 2361, 2927, 
3440 cm-1; 1H NMR (400 MHz, CDCl3): δ = 2.03 (s, 3H, CH3 Lev), 2.40 (m, 1H, CH2 Lev), 2.60 (m, 
3H, CH2 Lev), 3.74 (s, 3H, CH3 COOMe), 4.75 (d, 1H, J = 10.0 Hz, H-5), 5.08 (d, 1H, J = 4.4 Hz, 
OH), 5.24 (dd, 1H, J = 3.2 Hz, 10 Hz, H-2), 5.43 (dd, 1H, J = 10.0 Hz, 9.6 Hz, H-4), 5.78 (d, 1H, J = 
3.6 Hz, H-1), 6.06 (dd, 1H, J = 10.0 Hz, 9.6 Hz, H-3), 7.33 (m, 4H, H Arom) , 7.48 (m, 2H, H Arom), 
7.94 (m, 4H, H Arom); 13C NMR (100 MHz, CDCl3) δ = 27.6 (CH2 Lev), 29.3 (CH3 Lev), 37.5 (CH2 
Lev), 52.8 (CH3 COOMe), 67.9 (C-5), 69.5 (C-3, C-4), 71.6 (C-2), 90.2 (C-1), 128.2 (CH Arom), 
128.7 (Cq Bz), 129.6 (CH Arom), 133.3 (CH Arom), 165.6, 165.8, 168.6, 171.3 (C=O Bz, C=O 
COOMe, C=O Lev), 206.2 (C=O Lev); HRMS: C26H26O11 + H+ requires 515.15479, found 
515.15500. 
Phenyl 4,6-O-benzylidene-2-deoxy-3-O-levulinoyl-2-
trichloroacetamido-1-thio-β-D-glucopyranoside (7). To a solution of 6 
(0.505 g, 1.00 mmol) in pyridine (10 ml) was added a solution of Lev2O in 
dioxane (0.5 M, 5.0 ml, 2.5 mmol). After 18 h the mixture was diluted with EtOAc, washed with 1M 
HCl (aq), NaHCO3 (aq), and brine. The organic layer was dried over MgSO4 and concentrated in 
vacuo. Purification by column chromatography yielded 7 as a off-white solid (0.523 g, 87%). [α]D22: -
47 (c = 1, CHCl3); IR (neat): 750, 824, 1081, 1534, 1688, 2882, 3312 cm-1; 1H NMR (400 MHz, 
CDCl3): δ = 2.08 (s, 3H, CH3 Lev), 2.54 (m, 2H, CH2 Lev), 2.67 (m, 2H, CH2 Lev), 3.52 (dd, 1H, J = 
9.6 Hz, 4.8 Hz, H-5), 3.69 (m, 2H, m, H-4, H-6), 4.04 (dd, 1H, J = 10.0 Hz, 9.6 Hz, H-2), 4.11 (dd, 
1H, J = 10.0 Hz, 4.8 Hz, H-6), 4.92 (d, 1H, J = 10.4 Hz, H-1), 5.50 (m, 2H, H-3, CHPh), 7.23 (d, 1H, 
J = 9.6 Hz, NH), 7.24 (m, 6H, H Arom), 7.46 (m, 4H, H Arom); 13C NMR (100 MHz, CDCl3) δ = 
28.0 (CH2 Lev), 29.6 (CH3 Lev), 37.9 (CH2 Lev), 55.0 (C-2), 68.2 (C-6), 70.6 (C-5), 72.4 (C-3), 78.3 
(C-4), 87.1 (C-1), 92.3 (CCl3), 101.1 (CHPh), 126.0-129.1 (CH Arom), 132.0 (Cq SPh), 132.8 (CH 
Arom), 136.8 (Cq CHPh), 161.8, 173.1 (C=O TCA, C=O Lev), 205.6 (C=O Lev); HRMS: C26H26Cl3-
NO7S + Na+ requires 624.03878, found 624.03870. 
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Phenyl (4,6-O-benzylidene-2-deoxy-2-trichloroacetamido-3-
O-(methyl (2,3-di-O-benzoyl-4-O-levulinoyl-β-D-
glucopyranosyl) uronate)-1-thio-β-D-glucopyranoside (8). A 
mixture of 1-hydroxy donor 5 (0.514 g, 1.00 mmol), Ph2SO 
(0.485 g, 2.40 mmol) and TTBP (0.248 g, 1.00 mmol) was co-evaporated with toluene two times to 
remove traces of water, dissolved in DCM (20 ml) and further dried by stirring over molsieves 3Å for 
15 min. At -60 °C Tf2O (0.177 ml, 1.05 mmol) was added and the temperature was raised to -40 °C. 
After 1 h. a solution of acceptor 6 (0.505 g, 1.00 mmol) in DCM (20 ml) was slowly added and the 
reaction mixture was allowed to warm to 0 °C. Dry Et3N (1.35 ml, 10 mmol) was added and the 
reaction was washed with NaHCO3 (aq), the organic layer was dried over MgSO4 and concentrated in 
vacuo. Purification by column chromatography yielded 8 as a white solid (0.314 g, 56%). IR (neat): 
709, 1090, 1271, 1718, 2360, 2930, 3334 cm-1; 1H NMR (400 MHz, CDCl3): δ = 2.01 (s, 3H, CH3 
Lev), 2.34 (m, 1H, CH2 Lev), 2.50 (m, 3H, CH2 Lev), 3.45 (m, 1H, H-2), 3.62 (dt, 1H, J = 4.8 Hz, 9.6 
Hz, H-5), 3.66 (s, 3H, CH3 COOMe), 3.81 (m, 3H, H-4, H-5’, H-6), 4.35 (dd, 1H, J = 5.2 Hz, 10.8 
Hz, H-6), 4.69 (t, 1H, J = 9.2 Hz, H-3), 5.02 (d, 1H, J = 7.6 Hz, H-1’), 5.37 (m, 2H, H-2’, H-4’), 5.44 
(d, 1H, J = 10.4 Hz, H-1), 5.51 (s, 1H, CHPh), 5.54 (t, 1H, J = 9.6 Hz, H-3’), 6.98 (d, 1H, J = 6.8 Hz, 
NH), 7.29-7.43 (m, 16H, H Arom), 7.83 (m, 4H, H Arom); 13C NMR (100 MHz, CDCl3) δ = 27.6 
(CH2 Lev), 29.6 (CH3 Lev), 37.5 (CH2 Lev), 52.9 (CH3 COOMe), 57.4 (C-2), 68.6 (C-6), 69.3 (C-2’), 
70.5 (C-5), 71.9 (C-4’), 72.0 (C-5’), 72.5 (C-3’), 77.0 (C-3), 79.7 (C-4), 84.1 (C-1), 99.3 (C-1’), 101.5 
(CHPh), 126.0 (CH Arom), 128.4-128.7 (CH Arom), 128.8 (Cq Arom),129.2-129.9 (CH Arom), 131.1 
(Cq Arom), 133.4-133.5 (CH Arom), 136.9 (Cq Arom), 161.7, 164.9, 165.5, 167.0, 171.1 (C=O TCA, 
C=O Bz, C=O COOMe, C=O lev), 205.5 (C=O lev); HRMS: C47H44Cl3NO15S + NH4+ requires 
1017.18355, found 1017.18301. 
3-azidopropyl (methyl (2,3-di-O-benzoyl-4-
O-(4,6-O-benzylidene-2-deoxy-2-
trichloroacetamido-3-O-(methyl (2,3-di-O-
benzoyl-4-O-levulinoyl-β-D-glucopyranosyl) uronate)-β-D-glucopyranosyl)-β-D-glucopyranoside) 
uronate (9). A mixture of 1-thio donor 8 (0.314 g, 0.314 mmol), Ph2SO (0.070 g, 0.345 mmol) and 
TTBP (0.078 g, 0.314 mmol) was co-evaporated with toluene two times to remove traces of water, 
dissolved in DCM (6 ml) and further dried by stirring over molsieves 3Å  for 15 min. At -60 °C Tf2O 
(55 µl, 0.329 mmol) was added and after 15 min. at -60 °C a solution of acceptor 4 (0.191 g, 0.377 
mmol) in DCM (3 ml) was slowly added and the reaction mixture was allowed to warm to 0 °C. Dry 
Et3N (0.44 ml, 3.14 mmol) was added and the reaction was washed with NaHCO3 (aq), the organic 
layer was dried over MgSO4 and concentrated in vacuo. Purification by column chromatography 
yielded 9 as a colorless oil (0.204 g, 47%). [α]D22 +31 (c = 1, CHCl3); IR (neat): 709, 1027, 1045, 
1267, 1726, 2099, 2361, 2927, 3338 cm-1; 1H NMR (400 MHz, CDCl3): δ = 1.75 (m, 2H, CH2 
C3H6N3), 2.01 (s, 3H, CH3 Lev), 2.32 (m, 1H, CH2 Lev), 2.51 (m, 3H, CH2 Lev, H-6’), 3.26 (m, 2H, 
CH2 C3H6N3), 3.32 (dt, 1H, J = 4.8 Hz, 9.6 Hz, H-5’), 3.37 (q, 1H, J = 9.6 Hz, H-2’), 3.46 (t, 1H, J = 
9.0 Hz, H-4’), 3.59 (m, 1H, CH2 C3H6N3), 3.63 (s, 3H, CH3 COOMe), 3.69 (dd, 1H, J = 4.8 Hz, 
10.8Hz, H-6’), 3.79 (s, 3H, CH3 COOMe), 3.79 (d, 1H, J = 9.6 Hz, H-5’’), 3.94 (m, 1H, CH2 
C3H6N3), 4.04 (d, 1H, J = 9.6 Hz, H-5), 4.34 (t, 1H, J = 9.0 Hz, H-4), 4.40 (t, 1H, J = 9.6 Hz, H-3’), 
4.70 (d, 1H, J = 7.2 Hz, H-1’’), 4.93 (d, 1H, J = 7.8 Hz, H-1), 5.11 (d, 1H, J = 8.4 Hz, H-1’), 5.14 (s, 
1H, CHPh), 5.34 (m, 3H, H-2, H-2’’, H-3’’), 5.49 (t, 1H, J = 9.6 Hz, H-4’’), 5.57 (t, 1H, J = 9.6 Hz, 
H-3), 6.74 (d, 1H, J = 7.8 Hz, NH), 7.31-7.58 (m, 17H, CH Arom), 7.81 (d, 2H, J = 7.2 Hz, H Arom), 
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7.85 (d, 2H, J = 7.2 Hz, H Arom), 7.93 (d, 2H, J = 7.2 Hz, H Arom), 7.99 (d, 2H, J = 7.2 Hz, H 
Arom); 13C NMR (100 MHz, CDCl3) δ = 27.6 (CH2 Lev), 28.9 (CH2 C3H6N3), 29.6 (CH3 Lev), 37.6 
(CH2 Lev), 47.8 (CH2 C3H6N3), 52.8 (CH3 COOMe), 53.2 (CH3 COOMe), 58.4 (C-2’), 65.9 (C-5’), 
66.9 (CH2 C3H6N3), 67.7 (C-6’), 69.4 (C-3’’), 71.5, 71.9 (C-2, C-2’’), 72.1 (C-5’’), 72.4 (C-3), 72.6 
(C-4’’), 74.0 (C-5), 75.8 (C-4), 76.4 (C-3’), 79.6 (C-4’), 98.5 (C-1’), 99.6 (C-1), 101.2 (CHPh), 101.4 
(C-1’’), 126.1 (CH Arom), 128.3-128.9 (CH Arom), 128.9-129.2 (Cq Arom), 129.8-130.0 (CH Arom), 
133.3-133.4 (CH Arom), 136.9 (Cq Arom), 161.4, 164.9, 165.2, 165.3, 165.6, 167.0, 168.3, 171.1 
(C=O TCA, C=O Bz, C=O COOMe, C=O lev), 205.7 (C=O Lev); HRMS: C65H63Cl3N4O24 + H+ 
requires 1389.29706, found 1389.29504. 
3-azidopropyl (methyl (2,3-di-O-benzoyl-4-
O-(4,6-O-benzylidene-2-deoxy-2-
trichloroacetamido-3-O-(methyl (2,3-di-O-
benzoyl-β-D-glucopyranosyl) uronate)-β-D-
glucopyranosyl)-β-D-glucopyranoside) uronate) (10). HA-trimer (9) (204 mg, 0.147 mmol) was 
dissolved in a mixture of pyridine (2.35 ml) and AcOH (0.58 ml), after which hydrazine monohydrate 
(0.036 ml, 0.735 mmol) was added. The mixture was stirred for 15 min. and diluted with EtOAc (20 
ml), washed with 1M HCl (aq), NaHCO3 (aq), and brine. The organic layer was dried over MgSO4 
and concentrated in vacuo. Purification by column chromatography yielded 10 as a white solid (182 
mg, 96%). IR (neat): 705, 1027, 1091, 1264, 1711, 1734, 2098, 2343, 2360, 2890, 3374, 3503 cm-1; 
1H NMR (400 MHz, CDCl3): δ = 1.76 (m, 2H, CH2 C3H6N3), 2.56 (t, 1H, J = 10.4 Hz, H-6’), 3.16 (d, 
1H, J = 3.2 Hz, OH), 3.28 (m, 2H, CH2 C3H6N3), 3.34 (dd, 1H, J = 4.8 Hz, 9.6 Hz, H-5’), 3.42 (m, 
2H, H-4’ H-2’), 3.59 (m, 1H, CH2 C3H6N3), 3.71 (m, 2H, H-6’, H-5’’), 3.73 (s, 3H, CH3 COOMe), 
3.79 (s, 3H, CH3 COOMe), 3.94 (m, 1H, CH2 C3H6N3), 4.05 (d, 1H, J = 9.2 Hz, H-5), 4.09 (dd, 1H, J 
= 3.2 Hz, 9.2 Hz, H-4’’), 4.34 (t, 1H, J = 9.2 Hz, H-4), 4.38 (t, 1H, J = 9.2 Hz, H-3’), 4.70 (d, 1H, J = 
7.2 Hz, H-1’’), 4.93 (d, 1H, J = 7.2 Hz, H-1), 5.10 (d, 1H, J = 8.4 Hz, H-1’), 5.18 (s, 1H, CHPh), 5.34 
(m, 3H, H-2, H-2’’, H-3’’), 5.58 (t, 1H, J = 9.2 Hz, H-3), 6.72 (d, 1H, J = 8.0 Hz, NH), 7.31-7.58 (m, 
17H, H Arom), 7.88 (m, 4H, H Arom), 7.93 (m, 2H, H Arom), 7.99 (m, 2H, H Arom); 13C NMR (100 
MHz, CDCl3) δ = 28.9 (CH2 C3H6N3), 47.8 (CH2 C3H6N3), 52.7 (CH3 COOMe), 53.2 (CH3 COOMe), 
58.3 (C-2’), 65.9 (C-5’), 66.9 (CH2 C3H6N3), 67.7 (C-6’), 70.2 (C-4’’), 71.5, 71.7 (C-2, C-2’’), 72.5 
(C-3), 74.0 (C-5), 74.1 (C-5’’), 75.1 (C-3’’), 75.9 (C-4), 76.2 (C-3’), 79.5 (C-4’), 98.8 (C-1’), 99.5 
(C-1’’), 101.2 (C-1), 101.4 (CHPh), 125.9 (CH Arom), 128.3-128.4 (CH Arom), 128.9-129.2 (Cq 
Arom), 129.7-130.0 (CH Arom), 133.3-133.4 (CH Arom), 137.0 (Cq Arom), 161.4, 165.0, 165.1, 
165.2, 166.4, 168.4, 169.0 (C=O TCA, C=O Bz, C=O COOMe); HRMS: C60H57Cl3N4O22 + NH4+ 
requires 1308.28683, found 1308.28478. 
3-azidopropyl (methyl 
(2,3-di-O-benzoyl-4-O-
(4,6-O-benzylidene-2-
deoxy-2-
trichloroacetamido-3-O-(methyl (2,3-di-O-benzoyl-4-O-(4,6-O-benzylidene-2-deoxy-3-O-
levulinoyl-2-trichloroacetamido-β-D-glucopyranosyl)-β-D-glucopyranosyl) uronate)-β-D-
glucopyranosyl)-β-D-glucopyranoside) uronate) (11). A mixture of 1-thio donor 7 (0.081 g, 0.135 
mmol), Ph2SO (0.030 g, 0.148 mmol) and TTBP (0.034 g, 0.135 mmol) was co-evaporated with 
toluene two times to remove traces of water, dissolved in DCM (2.7 ml) and further dried by stirring 
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over molsieves 3Å  for 15 min. At -60 °C Tf2O (24 µl, 0.141 mmol) was added and after 15 min. at -
60 °C a solution of trisaccharide acceptor 10 (0.145 g, 0.112 mmol) in DCM (1.1 ml) was slowly 
added and the reaction mixture was allowed to warm to -15 °C. Dry Et3N (0.2 ml, 1.3 mmol) was 
added and the reaction was washed with NaHCO3 (aq). The organic layer was dried over MgSO4 and 
concentrated in vacuo. Purification by column chromatography yielded 11 as a colorless oil (0.124 g, 
62%). IR (neat): 708, 1027, 1070, 1265, 1718, 2100, 2342, 2360, 2926 cm-1; 1H NMR (400 MHz, 
CDCl3): δ = 1.75 (m, 2H, CH2 C3H6N3), 2.10 (s, 3H, CH3 Lev), 2.45 (t, 1H, J = 10.4 Hz, H-6’’’), 2.54 
(m, 3H, CH2 Lev, H-6’), 2.66 (m, 2H, CH2 Lev), 3.23 (m, 2H, CH2 C3H6N3), 3.29 (m, 2H, H-5’, H-
5’’’), 3.39 (m, 2H, H-4’, H-4’’’), 3.46 (m, 2H, H-2’, H-6’’’), 3.61 (m, 1H, CH2 C3H6N3), 3.65 (s, 3H, 
CH3 COOMe), 3.69 (dd, 1H, J = 4.4 Hz, 10.4 Hz, H-6’), 3.81 (s, 3H, CH3 COOMe), 3.87 (m, 2H, H-
2’’’, H-5), 3.94 (m, 1H, CH2 C3H6N3), 4.05 (d, 1H, J = 9.2 Hz, H-5’’), 4.16 (t, 1H, J = 9.2 Hz, H-4), 
4.32 (t, 1H, J = 9.6 Hz, H-3’), 4.33 (t, 1H, J = 9.6 Hz, H-4’’), 4.71 (d, 1H, J = 7.2 Hz, H-1’’), 4.87 (d, 
1H, J = 8.4 Hz, H-1’’’), 4.96 (d, 1H, J = 6.8 Hz, H-1), 5.06 (d, 1H, J = 8.0 Hz, H-1’), 5.14 (s, 1H, 
CHPh), 5.18 (s, 1H, CHPh), 5.22 (t, 1H, J = 10.0 Hz, H-3’’’), 5.26 (t, 1H, J = 6.8 Hz, H-2), 5.57 (dd, 
1H, J = 7.6 Hz, 9.6 Hz, H-2’’), 5.48 (t, 1H, J = 9.6 Hz, H-3), 5.58 (t, 1H, J = 9.6 Hz, H-3’’), 6.71 (d, 
1H, J = 8.0 Hz, NH), 6.88 (d, 1H, J = 9.2 Hz, NH), 7.31-7.58 (m, 22H, CH Arom), 7.85 (d, 2H, J = 
7.6 Hz, H Arom), 7.91 (m, 4H, H Arom), 7.99 (d, 2H, J = 7.2 Hz, H Arom); 13C NMR (100 MHz, 
CDCl3) δ = 28.0 (CH2 Lev), 28.8 (CH2 C3H6N3), 29.7 (CH3 Lev), 37.9 (CH2 Lev), 47.8 (CH2 
C3H6N3), 52.8 (CH3 COOMe), 53.2 (CH3 COOMe), 56.1 (C-2’’’), 58.1 (C-2’), 65.9 (C-5’), 66.1 (C-
5’’’), 66.9 (CH2 C3H6N3), 67.4 (C-6’’’), 68.0 (C-6’), 71.4 (C-2’’), 71.7 (C-3’’), 72.2 (C-3), 72.3 (C-
2), 72.4 (C-3’’), 73.4 (C-5), 73.9 (C-5’’), 76.0 (C-3’), 76.1 (C-4’’), 77.0 (C-4), 78.0 (C-4’’’), 79.1 (C-
4’), 92.3 (Cq TCA), 99.0 (C-1’), 99.6 (C-1), 100.8 (CHPh), 101.0 (CHPh), 101.0 (C-1’’’), 101.4 (C-
1’’), 125.7-126.1 (CH Arom), 128.2-128.4 (CH Arom), 128.9-129.2 (Cq Arom), 129.6-129.9 (CH 
Arom), 133.2-133.4 (CH Arom), 136.7 (Cq Arom), 137.0 (Cq Arom), 161.4, 161.6,  164.9-165.1, 
168.5, 168.9, 172.3 (C=O TCA, C=O Bz, C=O COOMe, C=O lev), 205.8 (C=O Lev); HRMS: 
C80H77Cl6N5O29 + H+ requires 1782.29081, found 1782.29053. 
3-azidopropyl 
(methyl (2,3-
di-O-benzoyl-
4-O-(4,6-O-
benzylidene-2-deoxy-2-trichloroacetamido-3-O-(methyl (2,3-di-O-benzoyl-4-O-(4,6-O-
benzylidene-2-deoxy-2-trichloroacetamido-3-O-(methyl (2,3-di-O-benzoyl-4-O-levulinoyl-β-D-
glucopyranosyl) uronate)-β-D-glucopyranosyl)-β-D-glucopyranosyl) uronate)-β-D-
glucopyranosyl)-β-D-glucopyranoside) uronate) (12). A mixture of 1-thio donor 8 (0.164 g, 0.164 
mmol), Ph2SO (0.036 g, 0.177 mmol) and TTBP (0.039 g, 0.157 mmol) was co-evaporated with 
toluene two times to remove traces of water, dissolved in DCM (3.3 ml) and further dried by stirring 
over molsieves 3Å  for 15 min. At -60 °C Tf2O (29 µl, 0.171 mmol) was added and after 15 min. at -
60 °C a solution of trisaccharide acceptor 10 (0.143 g, 0.110 mmol) in DCM (1.1 ml) was slowly 
added and the reaction mixture was allowed to warm to -15 °C. Dry Et3N (0.25 ml, 1.6 mmol) was 
added and the reaction was washed with NaHCO3 (aq), the organic layer was dried over MgSO4 and 
concentrated in vacuo. Purification by column chromatography yielded 12 as a colorless oil (0.116 g, 
48%). IR (neat): 709, 1027, 1069, 1267, 1728, 2100, 2342, 2360, 2926 cm-1; 1H NMR (400 MHz, 
CDCl3): δ = 1H NMR (400 MHz, CDCl3): δ = 1.75 (m, 2H, CH2 C3H6N3), 2.01 (s, 3H, CH3 Lev), 2.45 
(t, 1H, J = 6.8 Hz, H-6’ or H-6’’’), 2.45 (t, 1H, J = 6.4 Hz, H-6’ or H-6’’’), 2.35 (m, 1H, CH2 Lev), 
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2.51 (m, 3H, CH2 Lev), 3.25 (m, 5H, CH2 C3H6N3, H-5’, H-5’’’, H-2’’’ ), 3.39 (m, 3H, H-2’, H-4’, H-
4’’’), 3.59 (m, 1H, CH2 C3H6N3), 3.62 (s, 3H, CH3 COOMe), 3.63 (s, 3H, CH3 COOMe), 3.67 (m, 
2H, H-6’, H-6’’’), 3.78 (m, 2H, H-5, H-5’’’’), 3.80 (s, 3H, CH3 COOMe), 3.85 (m, 1H, CH2 C3H6N3), 
4.05 (d, 1H, J = 9.6 Hz, H-5’’), 4.30 (m, 3H, H-3’’’, H-4, H-4’’), 4.43 (t, 1H, J = 9.2 Hz, H-3’), 4.71 
(d, 1H, J = 7.2 Hz, H-1), 4.90 (d, 1H, J = 8.0 Hz, H-1’’ or H-1’’’’), 4.92 (d, 1H, J = 8.0 Hz, H-1’’ or 
H-1’’’’), 5.04 (d, 1H, J = 8.0 Hz, H-1’), 5.08 (d, 1H, J = 8.4 Hz, H-1’’’), 5.10 (s, 1H, CHPh), 5.17 (s, 
1H, CHPh), 5.22 (dd, 1H, J = 6.8 Hz, 9.6 Hz, H-2’’’’), 5.34 (m, 3H, H-2, H-2’’, H-4’’’’), 5.39 (t, 1H, 
J = 9.2 Hz, H-3’’’’), 5.48 (t, 1H, J = 9.2 Hz, H-3), 5.57 (t, 1H, J = 9.2 Hz, H-3’’), 6.66 (d, 1H, J = 7.2 
Hz, NH), 6.72 (d, 1H, J = 8.0 Hz, NH), 7.27-7.57 (m, 28H, H Arom), 7.78-7.98 (m, 12H, H Arom); 
13C NMR (100 MHz, CDCl3) δ = 27.6 (CH2 Lev), 28.9 (CH2 C3H6N3), 29.6 (CH3 Lev), 37.5 (CH2 
Lev), 47.8 (CH2 C3H6N3), 52.8 (CH3 COOMe), 52.9 (CH3 COOMe), 53.2 (CH3 COOMe). 58.1 (C-
2’), 58.5 (C-2’’’), 65.8, 65.9 (C-5’, C-5’’’), 66.9 (CH2 C3H6N3), 67.6 (C-6’ and C-6’’’), 69.3, 71.4, 
71.9, 72.1, 72.2, 72.4, 72.6 (C-2, C-2’’,C-2’’’’, C-3, C-3’’, C-3’’’’), 73.8, 74.0 (C-5, C-5’’, C-5’’’’), 
75.4, 76.0, 76.2 (C-3’, C-3’’’, C-4, C-4’’, C-4’’’’), 79.3, 79.5 (C-4’, C-4’’’), 92.3 (Cq TCA), 98.4 (C-
1’’’), 99.0 (C-1’), 99.5 (C-1’’), 99.8 (C-1’’’’), 100.8 (CHPh), 101.1 (CHPh), 101.4 (C-1), 125.8-126.2 
(CH Arom), 128.3-128.4 (CH Arom), 128.7-129.4 (Cq Arom), 129.7-123.0 (CH Arom), 133.3-133.3 
(CH Arom), 136.9 (Cq Arom), 137.0 (Cq Arom), 161.4, 161.4, 164.8-165.5, 166.9, 168.1, 168.5, 171.1 
(C=O TCA, C=O Bz, C=O COOMe, C=O lev), 205.6 (C=O Lev); HRMS: C101H95Cl6N5O37 + NH4+ + 
Na+ requires 1110.20338, found 1110.20361. 
3-azidopropyl (4-O-(2-deoxy-2-acetamido-
3-O-(β-D-glucopyranuronic acid)-β-D-
glucopyranosyl)-β-D-glucopyranuronic acid 
(13). Trisaccharide 9 (44 mg, 0.032 mmol) was dissolved in MeOH (5 ml) and a catalytic amount of 
p-toluene sulfonic acid was added. The reaction mixture was stirred for 15 h were it was quenched 
with Et3N (0.1 ml) and concentrated in vacuo. The remaining syrup was taken up in a mixture of THF 
and H2O (6 ml, 1/1 v/v) and a 0.5 M solution of KOH in H2O (0.64 ml, 0.32 mmol) was added 
stepwise (1 equiv.) over a period of 48 h. The reaction mixture was stirred for 4 days after which it 
was quenched with Amberlite H+, concentrated in vacuo and desalted by gel filtration. The resulting 
sugar was then taken up in MeOH (5 ml) and Ac2O (0.25 ml). After 2 hours this mixture was co-
evaporated three times with MeOH and toluene (1/1 v/v) and concentrated in vacuo. Purification by 
gel filtration (LH-20) and lyophilization yielded 13 as a white solid (12 mg, 58%). 1H NMR (600 
MHz, D2O): δ =  1.83 (m, 2H, CH2 C3H6N3), 1.97 (s, 3H, CH3 NHAc), 3.26 (m, 2H, H-2, H-2’’), 3.85 
(t, 2H, J = 7.2 Hz, CH2 C3H6N3), 3.43-3.44 (m, 2H), 3.47-3.54 (m, 2H), 3.63-3.74 (m, 7H), 3.79 (t, 
1H, J = 8.4 Hz, H-2’), 3.86 (d, 1H, J = 10.8 Hz, H-6’), 3.91 (m, 1H, CH2 C3H6N3), 4.40 (m, 2H, H-1, 
H-1’’), 4.51 (d, 1H, J = 8.4 Hz, H-1’); 13C NMR (150 MHz, D2O) δ = 23.4 (CH3 NHAc), 29.2 (CH2 
C3H6N3), 48.8 (CH2 C3H6N3), 55.2 (C-2’), 61.5 (C-6’), 68.5 (CH2 C3H6N3), 69.4, 72.7, 73.6, 73.7, 
74.8, 76.2, 76.3, 76.9, 77.6, 81.1, 83.9 (C-2, C-2’’, C-3, C-3’, C-3’’, C-4, C-4’, C-4’’, C-5, C-5’, C-
5’’), 101.6 (C-1’), 103.4 (C-1’’), 104.0 (C-1), 175.2, 175.9, 176.5 (C=O COOH, C=O NHAc); 
HRMS: C23H36N4O18 + H+ requires 657.20974, found 657.20997. 
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3-azidopropyl (4-O-(2-deoxy-2-
acetamido-3-O-(4-O-(2-deoxy-
2-acetamido-β-D-
glucopyranosyl)-β-D- glucopyranuronic acid)-β-D-glucopyranosyl)-β-D- glucopyranuronic acid 
(14). Tetrasaccharide 11 (80 mg, 0.045 mmol) was dissolved in MeOH (5 ml) and a catalytic amount 
of p-toluene sulfonic acid was added. The reaction mixture was stirred for 15 h where it was 
quenched with Et3N (0.1 ml) and concentrated in vacuo. The remaining syrup was taken up in a 
mixture of THF and H2O (9 ml, 1/1 v/v) and a 0.5 M solution of KOH in H2O (1 ml, 0.5 mmol) was 
added stepwise (1 equiv.) over a period of 48 h. The reaction mixture was stirred for 7 days after 
which it was quenched with Amberlite H+, concentrated in vacuo and desalted by gel filtration. The 
resulting sugar was then taken up in MeOH (9 ml) and Ac2O (0.25 ml). After 2 hours this mixture 
was co-evaporated three times with toluene and concentrated in vacuo. Purification by gel filtration 
(LH-20) and lyophilization yielded 14 as a white solid (21 mg, 54%). 1H NMR (600 MHz, D2O): δ = 
1.83 (m, 2H, CH2 C3H6N3), 1.96 (s, 3H, CH3 NHAc), 1.99 (s, 3H, CH3 NHAc), 3.25-3.30 (m, 2H, H-
2, H-2’’), 3.37-3.40 (m, 4H), 3.43-3.48 (m, 2H), 3.50-3.54 (m, 2H), 3.62-3.72 (m, 10H), 3.77-3.80 
(m, 1H), 3.85-3.87 (m, 2H, H-6’, H-6’’’), 3.91 (m, 1H, CH2 C3H6N3), 4.40 (m, 2H, H-1, H-1’’), 4.47 
(d, 1H, J = 8.4 Hz, H-1’ or H-1’’’), 4.50 (d, 1H, J = 8.4 Hz, H-1’ or H-1’’’); 13C NMR (150 MHz, D2-
O) δ = 23.3 (CH3 NHAc), 23.4 (CH3 NHAc), 29.2 (CH2 C3H6N3), 48.8 (CH2 C3H6N3), 55.2, 56.3, 
61.4 (C-2’, C-2’’’, C-6’, C-‘’’), 68.5 (CH2 C3H6N3), 69.4, 70.6, 73.4, 73.7, 74.5, 74.7, 76.3, 76.8, 
77.2, 77.6, 80.7, 81.1, 83.4 (C-2, C-2’’, C-3, C-3’, C-3’’, C-3’’’, C-4, C-4’, C-4’’, C-4’’’, C-5, C-5’, 
C-5’’, C-5’’’), 101.6 (C-1’ and C-1’’’), 103.4 (C-1 or C-1’’), 104.1 (C-1 or C-1’’), 175.1, 175.2, 
175.8, 175.9 (C=O COOH, C=O NHAc);  HRMS: C31H49N5O23 + H+ requires 860.28911, found 
860.28932. 
3-azidopropyl (4-
O-(2-deoxy-2-
acetamido-3-O-(4-
O-(2-deoxy-2-
acetamido-3-O-(β-D-glucopyranonic acid)-β-D-glucopyranosyl)-β-D- glucopyranuronic acid)-β-D-
glucopyranosyl)-β-D- glucopyranuronic acid (15). Pentasaccharide 12 (53 mg, 0.024 mmol) was 
dissolved in MeOH (5 ml) and a catalytic amount of p-toluene sulfonic acid was added. The reaction 
mixture was stirred for 15 h where it was quenched with Et3N (0.1 ml) and concentrated in vacuo. 
The remaining syrup was taken up in a mixture of THF and H2O (8 ml, 1/1 v/v) and a 0.5 M solution 
of KOH in H2O (0.72 ml, 0.36 mmol) was added stepwise (1 equiv.) over a period of 64 h. The 
reaction mixture was stirred for 12 days after which it was quenched with Amberlite H+, concentrated 
in vacuo and desalted by gel filtration. The resulting sugar was then taken up in MeOH (5 ml) and 
Ac2O (0.25 ml). After 2 hours this mixture was co-evaporated three times with toluene and 
concentrated in vacuo. Purification by gel filtration (LH-20) and lyophilization yielded 15 as a white 
solid (12 mg, 48%). 1H NMR (600 MHz, D2O): δ = 1.84 (m, 2H, CH2 C3H6N3), 1.96 (s, 3H, CH3 
NHAc), 1.97 (s, 3H, CH3 NHAc), 3.25-3.30 (m, 2H, H-2, H-2’’, H-2’’’’), 3.85 (m, 2H, CH2 C3H6N3), 
3.43-3.45 (m, 4H), 3.46-3.50 (m, 2H), 3.51-3.54 (m, 2H), 3.61-3.73 (m, 10H), 3.78 (m, 2H, H-2’, H-
2’’’), 3.85 (m, 2H, H-6’, H-6’’’), 3.91 (m, 1H, CH2 C3H6N3), 4.40 (m, 3H, H-1, H-1’’, H-1’’’’), 4.50 
(m, 2H, H-1’, H-1’’’); 13C NMR (150 MHz, D2O) δ = 23.4 (CH3 NHAc), 29.2 (CH2 C3H6N3), 48.8 
(CH2 C3H6N3), 55.2 (C-2’, C-2’’’), 61.4 (C-6’, C-6’’’), 68.4 (CH2 C3H6N3), 69.4, 69.5, 72.7, 73.4, 
73.7, 74.5, 74.8, 76.2, 76.3, 76.3, 76.7, 77.3, 77.7, 80.8, 81.1, 83.5, 84.0 (C-2, C-2’’, C-2’’’’, C-3, C-
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3’, C-3’’, C-3’’’, C-3’’’’, C-4, C-4’, C-4’’, C-4’’’, C-4’’’’, C-5, C-5’, C-5’’, C-5’’’, C-5’’’’), 101.5, 
101.6 (C-1’, C-1’’’), 103.4, 104.0, 104.2 (C-1, C-1’’, C-1’’’’), 175.1, 175.9, 176.5 (C=O COOH, 
C=O NHAc); HRMS: C37H57N5O29 + H+ requires 1036.32120, found 1036.32094.  
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Chapter 4 
Synthesis of Hyaluronic Acid Oligomers using 
Chemoselective and One-Pot Strategies1  
Introduction 
Inspection of the primary structure of hyaluronan (HA) indicates that a straightforward 
synthetic route to HA oligomers comprises the elongation of the growing carbohydrate 
chain with a suitably protected disaccharide building block (Scheme 1).2 Chapter 3 
describes the synthesis of a HA tri- and pentamer, having a glucuronic acid moiety at the 
reducing end,3 using the glucuronate (GlcA)-glucosamine (GlcN) thio-disaccharide 
building block 2 (Scheme 1) in combination with the Ph2SO/Tf2O activating system.4,5 This 
chapter presents the synthesis of complementary HA oligomers having a glucosamine 
reducing end. These HA-fragments, ranging in size from three to seven residues, were 
synthesized using GlcN-GlcA building block 3 (Scheme 1), chemoselective and one-pot 
glycosylation procedures were implemented. 
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Scheme 1 
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Retrosynthetic analysis of hyaluronan oligomers using building block 2 (Chapter 3) or building block 
3 (this Chapter). 
Results and discussion  
In Chapter 3 it became clear that the acid sensitivity of the benzylidene acetal in 
disaccharide donor 2 required careful tuning of the amount of base (tri-tert-
butylpyrimidine, TTBP6) in the glycosylation reactions used.2 Glycosylations with an 
insufficient amount of base gave unwanted cleavage of the benzylidene group, whereas 
excess of base led to the formation of orthoester/oxazoline side-products. In order to 
circumvent this drawback the more acid stabile di-tert-butylsilylidene (DTBS) group was 
selected as a more suitable option to protect the C4-OH and C6-OH of the glucosamine 
moiety. To compare the effectiveness of silylidene and benzylidene acetals in the 
glycosylation procedure described in Chapter 3, the syntheses of HA trimer 10 having a 
silylidene group was undertaken and compaired to the previous results from Chapter 3 
(Scheme 2). In reactions with the benzylidene protected glucosamine 5 0.95 equiv. of base 
was used, while in the otherwise similar glycosylations with silylidene protected 
glucosamine 6 (for the synthesis of building block 6, see Scheme 3) the base was omitted.  
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Comparative study using glucosamine building blocks 5 and 6. Reagents and conditions: a) Ph2SO, 
TTBP, DCM, -60 °C, then Tf2O, -45 °C 1h., then 5, -45 °C to 0 °C (56%); b) Ph2SO, DCM, -60 °C, 
then Tf2O, -45 °C 1h., then 6, -45 °C to 0 °C (75%); c) Ph2SO, TTBP, DCM, -60 °C, then Tf2O, 15 
min., then 8, -60 °C to rT (47%); d) Ph2SO, DCM, -60 °C, Tf2O, 15 min., then 8, -60 °C to rT (78%). 
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It turned out that the silylidene protected disaccharide dimer 7 could be obtained in 75% 
yield compared to the benzylidene protected dimer 2 which yielded 56% product. The 
difference in yield was even more pronounced in the glycosylation reactions towards 
trimers 9 47% and 10 78%. Having established the superiority of the silylidene group over 
the benzylidene group, the synthesis of key building block 3 was investigated. Both 
chemoselective and orthogonal glycosylation strategies were projected, requiring the 
availability of 1-thio glucuronate ester acceptor 19 and 1-thio, 1-OH, or 1-trifluoroimidate 
glucosamine donors 13, 14 or 18 (Table 1). The synthesis of the glucosamine building 
blocks 13, 14 and 18 started with the introduction of the trichloroacetyl group on the amino 
function of glucosamine 11 using trichloroacetylchloride and triethylamine in methanol 
(Scheme 3).7 The resulting N-TCA glucosamine intermediate was next transformed into 1-
thio glucosamine 6 in four steps as described by Blatter and Jacquinet.8 Introduction of the 
di-tert-butylsilylene function yielding 6 was followed by levulinoylation of the C3-OH to 
give glucosamine donor 13. Hydrolysis of the thioacetal funtion in 13, using the NIS/TFA 
protocol described in Chapter 2, then provided 1-hydroxy donor 14.9 1-Trifluoroimidate 18 
was prepared from 15 in three consecutive reactions. Thus, regioselective silylation of the 
C6-OH and C4-OH in 15 using di-tert-butylsilyl bistriflate in DMF at -30 °C quantitatively 
yielded 4,6-O-di-tert-butylsilylidene glucosamine 16. This diol was regioselectively 
transformed into the anomeric 1-trifluoroimidate 17 by treatment with ClC(=NPh)CF3 and 
Cs2CO3 in acetone.10,11 Levulinoylation of the remaining 3-OH furnished the completely 
protected imidate donor 18 in 67% yield from 11. Glucuronate ester 19 was synthesized as 
described by van den Bos et al.12 
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Synthesis of  the monomer HA building blocks 13, 14 and 18. Reagents and conditions: a) 
tBu2Si(OTf)2, DMF, -20 °C (90%); b) Pyridine, AcOH, hydrazine (quant.); c) TFA, NIS, DCM, H2O 
(84%); d) Cl3CC(=O)Cl, MeOH, Et3N (46%); e) tBu2Si(OTf)2, DMF, -20 °C (95%); f) 
CF3C(=NPh)Cl, CsCO3, acetone (71%); g) Lev2O, dioxane, pyridine (94%). 
The 1-thio (13), 1-hydroxy (14) and 1-imidate (18) donors were glycosidated with 
glucuronate 19. The results are summarized in Table 1. The condensation of 1-
thioglucosamine 13 with 19 proceeded rapidly using the Ph2SO/Tf2O activator system3 and 
yielded disaccharide 3 in 70% (entry 1). No activation of the glucuronate ester 19 or 
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thiodisaccharide 3 was found during this glycosylation indicating the reactivity difference 
of the donor (13) and acceptor/product (19/3).13 The Ph2SO/Tf2O mediated dehydrative 
condensation of glucosamine 14 and thioacceptor 19 proceeded slowly to give dimer 3 
(63% yield). The BSP/Tf2O11 reagent combination in this dehydrative condensation is less 
productive (56%) than the Ph2SO/Tf2O system. Finally, imidate donor 18 reacted smoothly 
with acceptor 19 using catalytic amounts of TMSOTf or TfOH to yield disaccharide 3 in 
78% and 79% yield respectively (entries 4 and 5). Thus, all three donor-acceptor 
combinations provided dimer 3 in satisfactory yields, with imidate 18 performing best. 
Given the fact that imidate 18 is synthesized in only 4 steps from glucosamine 11 we tried 
to improve the yield of the imidate coupling by increasing the amount of donor glycoside. 
When 1.5 equivalents of 18 were used in the triflic acid mediated glycosylation of 19, 
dimer 3 was obtained in 90% yield. 
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Entry Donor  Equiv. donor Activator, conditions Yield 
1 13, R = SPh 1.2 Ph2SO/Tf2O, -60 °C to 0 °C 70% 
2 14, R = OH 1.2 Ph2SO /Tf2O, -60 °C to 0 °C 63% 
3 14, R = OH 1.2 BSP/Tf2O, -60 °C to 0 °C 56% 
4 18, R = OC(=NPh)CF3 1.2 TMSOTf, 0 °C 78% 
5 18, R = OC(=NPh)CF3 1.2 TfOH, 0 °C 79% 
6 18, R = OC(=NPh)CF3 1.5 TfOH, 0 °C 90% 
Glycosylations of 13, 14, and 18 with acceptor 19. 
With the optimal leaving group determined, the stage was set to assemble the HA-
oligosaccharides as depicted in Scheme 4 22, 24 and 26. First, the reducing end 
glucosamine 21 was synthesized by coupling 1-thio glucosamine 13 or imidate 18 with 
azidopropanol and subsequent delevulinoylation. This reducing-end building block was 
condensed with dimer 3 using the Ph2SO/Tf2O activator system. Although pre-activation of 
the thiodisaccharide proceeded smoothly, the ensuing reaction with acceptor 21 did not go 
to completion and trisaccharide 22 was isolated in 46% yield.14 Poor yields with uronate 
ester donors in glycosylations were observed before,3a and previously an increase of the 
coupling efficiency was reached by changing from Ph2SO/Tf2O to the related BSP/Tf2O 
reagent system. Also in the present case this change in activator system significantly 
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improved the outcome of the glycosylation and HA trimer 22 was obtained in 75% yield. 
NIS/TfOH as activator species was examined as well, since this could provide an 
opportunity for a one-pot synthesis of trisaccharide 22, combining imidate chemistry with 
iodonium ion activation of the thiodisaccharide. Under the agency of NIS/TfOH dimer 3 
and glucosamine 21 were condensed to give trisaccharide 22 in 75% yield. Next, a one-pot 
procedure was investigated.15 Imidate 18 and 1-thio glucuronate 19 were combined and 
treated with a catalytic amount of TfOH to produce the 1-thio disaccharide. Acceptor 21 
and NIS were added to this mixture at 0 °C, leading to the formation of trisaccharide 22 in 
72% yield. 
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Assembly of the protected HA-oligomers 22, 24 and 26. Reagents and conditions: a) Ph2SO, DCM, -
60 °C, then Tf2O, 15 min., then HO(CH2)3N3, -60 °C to rT (94%); b) DCM, HO(CH2)3N3, 0 °C, 
TfOH (99%); c) Pyridine, AcOH, Hydrazine (85%); d) 3, Ph2SO, DCM, -60 °C, then Tf2O, 15 min., 
then 21, -60 °C to 0 °C (46%); e) 3, BSP, DCM, -60 °C, then Tf2O, 15 min., then 21, -60 °C to 0 °C 
(75%); f) 3, 21, DCM, NIS, 0 °C, then TfOH (75%); g) 18, 19, DCM, 0 °C, TfOH, to rT, then 0 °C, 
21, NIS (72%); h) Pyridine, AcOH, hydrazine (94%); i) 3, 23, DCM, NIS, 0 °C, then TfOH (98%); j) 
Pyridine, AcOH, hydrazine (91%); k) 3, 25, DCM, NIS, 0 °C, then TfOH (61%). 
The C3’’-OLev in 22 was removed and the resulting alcohol 23 was condensed with dimer 
3. To this end 1-thiodisaccharide 3 was activated by BSP/Tf2O and treated with acceptor 
23. It was observed that while the activated disaccharide decomposed over time, only trace 
amounts of glycosylation product was formed, resulting in the recovery of unreacted 
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acceptor. The NIS-TfOH glycosylation protocol does not require pre-activation of the 
donor glycoside at low temperature. In addition, iodonium activated glycosylations are 
more easily executed at higher concentration than pre-activation based sulfonium promoted 
coupling reactions. Thus, donor 3, acceptor 23 and NIS were dissolved in dichloromethane 
(0.1M in acceptor) and cooled to 0 °C before addition of a catalytic amount of TfOH. This 
time, complete consumption of trisaccharide 23 was observed and pentamer 24 was 
obtained in 98% yield. Delevulinoylation of 24 gave alcohol 25 which was elongated in a 
subsequent NIS/TfOH mediated glycosylation with building block 3. This reaction was 
difficult to monitor, because of the similar polarities of the reaction partners and product, as 
well as the rather viscous nature of the reaction mixture. Heptamer 26 was nonetheless 
obtained in 61% yield. 
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Deprotection of the HA oligomers 28, 30 and 32. Reagents and conditions: a) i. Et3N/3HF, THF; ii. 
KOH, THF, H2O, 27 (48%) 29 (42%) 31 (59%); b) i. Ac2O, MeOH; ii. H2O, LiOH (0.5M), 28 (99%), 
30 (74%), 32 (78%). 
The synthesis of the HA-fragments was completed by global deprotection of oligomers 22, 
24 and 26 as depicted in Scheme 5. The silylidene groups were removed with Et3N/3HF, 
and subsequent saponification of the ester and amide functionalities under the agency of 
KOH yielded the zwitterionic tri-, penta-, and heptamer 27, 29, and 31. Finally, N-
acetylation with Ac2O in MeOH and basic treatment in H2O provided the anionic HA-
fragments 28, 30 and 32. 
In conclusion, this Chapter describes the highly efficient synthesis of a set of HA 
oligosaccharides combining chemoselective and one-pot glycosylation strategies. It is clear 
that the 4,6-silylidene function is a valuable alternative to the benzylidene functionality, 
previously employed in HA syntheses (Chapter 3), since the former is completely stable 
under the (Lewis)-acidic reaction conditions used. The synthesis of the oligomers builds on 
the chemoselective condensation of glucosamine N-phenyltrifluoroimidate 18 and S-phenyl 
glucuronate ester 19, which are both accessed using short, high yielding synthetic routes. 
Monomers 18 and 19 are condensed to give the key 1-thio disaccharide building block 3 or 
combined in a one-pot glycosylation sequence with azidopropanol glucosamine 21 to 
produce the reducing end trimer 22. For the synthesis of the higher HA-oligomers iodonium 
ion activation of dimer building block 3 proved to be more effective than the sulfonium 
based activator systems.16 
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Experimental  
General: Dichloromethane was refluxed with P2O5 and distilled before use. Trifluoromethanesulfonic 
anhydride was distilled from P2O5. Traces of water in the donor and acceptor glycosides, 
diphenylsulfoxide and TTBP were removed by co-evaporation with toluene. All other chemicals 
(Acros, Fluka, Merck, Schleicher & Schue) were used as received. Column chromatography was 
performed on Merck silica gel 60 (0.040-0.063 mm). Size exclusion was performed on Sephadex 
LH20 (eluent MeOH/DCM = 1/1). Gel filtration was performed on Sephadex HW40 (0.15 M 
Et3NHOAc in H2O). TLC analysis was conducted on HPTLC aluminum sheets (Merck, silica gel 60, 
F245). Compounds were visualized by UV absorption (245 nm), by spraying with 20% H2SO4 in 
ethanol or with a solution of (NH4)6Mo7O24·4H2O 25 g/L, (NH4)4Ce(SO4)4·2H2O 10 g/L, 10% H2SO4 
in H2O followed by charring at +/- 140 °C. 1H and 13C NMR spectra were recorded with a Bruker AV 
400 (400 and 100 MHz respectively), AV 500 (500 and 125 MHz respectively) or a Bruker DMX 600 
(600 and 150 MHz respectively). NMR spectra were recorded in CDCl3 with chemical shift (δ) 
relative to tetramethylsilane unless stated otherwise. Optical rotations were measured on a Propol 
automatic polarimeter. High resolution mass spectra were recorded on a LTQ-orbitrap (thermo 
electron). IR spectra were recorded on a Shimadzu FTIR-8300 and are reported in cm-1. 
Phenyl (4,6-O-di-tert-butylsilylidene-2-deoxy-2-
trichloroacetamido-3-O-(methyl (2,3-di-O-benzoyl-4-
O-levulinoyl-β-D-glucopyranosyl) uronate)-1-thio-β-D-
glucopyranoside (7). A mixture of 1-hydroxy donor 4 (0.591 g, 1.15 mmol) and diphenyl sulfoxide 
(0.465 g, 2.30 mmol) was co-evaporated with toluene two times to remove traces of water, dissolved 
in DCM (11.5 ml) and stirred over activated molsieves 3Å for 30 min. At -60 °C triflic anhydride 
(0.202 ml, 1.19 mmol) was added and the temperature was raised to -40 °C. After 1 h. a solution of 
acceptor 6 (0.534 g, 0.958 mmol) in DCM (10 ml) was slowly added and the reaction mixture was 
allowed to warm to 0 °C. Dry Et3N (0.66 ml) was added and the reaction was washed with NaHCO3 
(aq), the organic layer was dried over MgSO4 and concentrated in vacuo. Purification by column 
chromatography yielded 7 as a white foam (0.761 g, 75%). [α]D22 = +16 (c = 0.1, DCM); 1H NMR 
(400 MHz, CDCl3): δ = 0.88 (s, 9H, tBu), 1.02 (s, 9H, tBu), 1.99 (s, 3H, CH3 Lev), 2.34-2.42 (m, 2H, 
CH2 Lev), 2.47-2.61 (m, 2H, CH2 Lev), 3.39-3.52 (m, 2H, H-2, H-5), 3.76 (s, 3H, CH3 COOMe), 
3.88-3.97 (m, 2H, H-4, H-6), 4.17-4.21 (m, 2H, H-6, H-5’),  4.43 (t, 1H, J = 9.6 Hz, H-3), 5.19 (d, 
1H, J = 7.2 Hz, H-1’), 5.32 (d, 1H, J = 10.4 Hz, H-1), 5.41 (t, 1H, J = 9.2 Hz, H-2’), 5.47 (t, 1H, J = 
9.6 Hz, H-4’), 5.63 (t, 1H, J = 9.2 Hz, H-3’), 7.18 (d, 1H, J = 7.2 Hz, NH), 7.24-7.49 (m, 11H, H 
Arom), 7.87-7.89 (m, 4H, H Arom); 13C NMR (100 MHz): δ =19.6 (Cq tBu), 22.4 (Cq tBu), 26.6 (CH3 
tBu), 27.2 (CH3 tBu), 27.5 (CH2 Lev), 29.4 (CH3 Lev), 37.5 (CH2 Lev), 52.8 (CH3 COOMe), 57.3 (C-
2), 65.9 (C-6), 69.2 (C-4’), 72.0 (C-3’), 72.1 (C-2’), 72.4 (C-5’), 74.3 (C-4), 74.8 (C-5’), 78.8 (C-3), 
85.0 (C-1), 92.2 (Cq CCl3), 98.5 (C-1’), 128.2-129.6 (CH Arom, Cq Arom), 131.5 (Cq Arom), 133.0-
133.3 (CH Arom), 161.5 (C=O TCA), 164.8 (C=O Bz), 165.4 (C=O Bz), 167.0 (C=O COOMe) 171.0 
(C=O COO Lev), 205.5 (C=O CO Lev); HRMS: C48H56Cl3NO15SSi + H+ requires 1074.2098, found 
1074.2106. 
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3-Azidopropyl (methyl (2,3-di-O-benzoyl-4-
O-(4,6-O-di-tert-butylsilylidene-2-deoxy-2-
trichloroacetamido-3-O-(methyl (2,3-di-O-
benzoyl-4-O-levulinoyl-β-D-glucopyranosyl) 
uronate)-β-D-glucopyranosyl)-β-D-glucopyranoside) uronate (10).  A mixture of 1-thio donor 7 
(0.353 g, 0.335 mmol) and diphenyl sulfoxide (0.081 g, 0.40 mmol) was co-evaporated with toluene 
two times to remove traces of water, dissolved in DCM (7 ml) and stirred over activated molsieves 
3Å for 30 min. At -60 °C triflic anhydride (62 µl, 0.369 mmol) was added and after 15 min. at -60 °C 
a solution of acceptor 8 (0.20 g, 0.40 mmol) in DCM (4 ml) was slowly added and the reaction 
mixture was allowed to warm to 0 °C. Dry Et3N (0.22 ml) was added and the reaction was washed 
with NaHCO3 (aq), the organic layer was dried over MgSO4 and concentrated in vacuo. Purification 
by column chromatography yielded 10 as a white foam (0.377 g, 78%). [α]D22 = +5 (c = 0.1, DCM); 
1H NMR (400 MHz, CDCl3): δ = 0.83 (s, 9H, tBu), 0.89 (s, 9H, tBu), 1.79-1.86 (m, 2H, CH2 
C3H6N3), 2.03 (s, 3H, CH3 Lev), 2.39-2.47 (m, 2H, CH2 Lev), 2.49-2.62 (m, 3H, C-6’, CH2 Lev), 
3.17-3.26 (m, 4H, H-2’, H-5’, CH2 C3H6N3), 3.52 (t, 1H, J = 9.2 Hz, H-4’), 3.56-3.60 (m, 2H, H-6’, 
CH2 C3H6N3), 3.77 (s, 3H, CH3 COOMe), 3.81  (s, 3H, CH3 COOMe), 3.92-3.97 (m, 1H, CH2 
C3H6N3), 4.05-4.15 (m, 2H, H-5, H-5’’),  4.23 (t, 1H, J = 9.6 Hz, H-3’), 4.32 (t, 1H, J = 9.2 Hz, H-4), 
4.71 (d, 1H, J = 7.6 Hz, H-1), 5.06 (d, 1H, J = 8.0 Hz, H-1’), 5.09 (d, 1H, J = 7.2 Hz, H-1’’), 5.33-
5.37 (m, 2H, H-2, H-2’’), 5.47 (t, 1H, J = 9.2 Hz, H-4’’), 5.52-5.59 (m, 2H, H-3, H-3’’), 6.91 (d, 1H, 
J = 7.6 Hz, NH), 7.32-7.40 (m, 8H, H Arom), 7.48-7.51 (m, 4H, H Arom), 7.85-7.93 (m, 8H, H 
Arom); 13C NMR (100 MHz): δ =19.5 (Cq tBu), 22.3 (Cq tBu), 26.6 (CH3 tBu), 27.2 (CH3 tBu), 27.6 
(CH2 Lev), 28.7 (CH2 C3H6N3), 29.4 (CH3 Lev), 37.5 (CH2 Lev), 47.6 (CH2 C3H6N3), 52.8 (CH3 
COOMe), 53.1 (CH3 COOMe), 58.7 (C-2’), 65.0 (C-6’), 66.7 (CH2 C3H6N3), 69.2 (C-4’’),70.0 (C-5’), 
71.2, 72.2, 72.3, 72.4 (C-2, C-3, C-2’’, C-3’’), 72.7 (C-5’’), 73.9 (C-5), 74.7 (C-4’), 75.1 (C-4), 77.5 
(C-3’), 92.4 (Cq CCl3), 98.1 (C-1’), 99.0 (C-1’’), 101.2 (C-1), 128.2-128.9 (CH Arom, Cq Arom), 
129.5-129.8 (CH Arom), 133.0-133.3 (CH Arom), 161.4 (C=O TCA), 164.9 (C=O Bz), 165.0 (C=O 
Bz), 165.2 (C=O Bz), 165.4 (C=O Bz), 167.0 (C=O COOMe), 168.1 (C=O COOMe), 171.0 (C=O 
COO Lev), 205.5 (C=O CO Lev); HRMS: C66H75Cl3N4O24SSi + H+ requires 1441.3679, found 
1441.3698. 
Phenyl 4,6-O-di-tert-butylsilylidene-2-deoxy-2-trichloroacetamido-β-
thio-D-glucopyranoside (6). To a solution of phenyl 2-deoxy-2-
trichloroacetamido-β-thio-D-glucopyranoside (12) (6.95 g, 16.8 mmol) in 
DMF (80 ml) at -30 °C was added di-tert-butylsilylidene bistriflate (5.42 ml, 16.8 mmol). The 
reaction was warmed to -10 °C in 1 hour after which pyridine (4.0 ml, 50 mmol) was added and 
subsequently the reaction was diluted with Et2O and washed with H2O. The organic layer was dried 
over MgSO4 and concentrated in vacuo, purification by column chromatography (PE, EtOAc) yielded 
6 as a white amorphous solid (8.44 g, 90%). [α] D22 = -18 (c = 0.1, DCM);  IR (neat): 818, 1063, 1528, 
1687, 2359, 2887, 2931, 3335 cm-1; 1H NMR (400 MHz, CDCl3): δ = 0.94 (s, 9H, tBu), 1.04 (s, 9H, 
tBu), 2.99 (d, 1H, J = 2.0 Hz, OH), 3.48 (dt, 1H, J = 5.2 Hz, 9.6 Hz, H-5), 3.69-3.76 (m, 2H, H-2, H-
4), 3.91 (t, 1H, J = 10.0 Hz, H-6), 3.99 (dt, 1H, J = 1.6 Hz, 8.4 Hz, H-3), 4.19 (dd, 1H, J = 4.8 Hz, 5.2 
Hz, H-6), 5.11 (d, 1H, J = 10.4 Hz), 7.28-7.33 (m, 4H, NH, H Arom), 7.45-7.48 (m, 2H, H Arom); 13C 
NMR (100 MHz): δ = 19.8 (Cq tBu), 22.5 (Cq tBu), 26.8 (CH3 tBu), 27.3 (CH3 tBu), 56.4 (C-2), 65.9 
(C-6), 74.2 (C-5), 74.3 (C-3), 77.3 (C-4), 86.1 (C-1), 92.3 (Cq CCl3), 128.2 (CH Arom), 128.9 (CH 
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Arom), 132.0 (Cq Arom), 132.9 (CH Arom), 162.0 (C=O TCA); HRMS: C22H32Cl3NO5SSi + H+ 
requires 556.0909, found 556.0907. 
Phenyl 4,6-O-di-tert-butylsilylidene-2-deoxy-4-O-levulinoyl-2-
trichloroacetamido-β-thio-D-glucopyranoside (13). To a solution of 6 
(8.44 g, 15.2 mmol) in DCM (40 ml) at 0 oC was added LevOH (3.87 g, 
33.3 mmol), DIC (2.58 ml, 16.7 mmol) and a catalytic amount of DMAP. The mixture was stirred for 
four hours and allowed to warm to rT. Filtration over celite and purification by column 
chromatography (PE, EtOAc) yielded 13 as a white amorphous solid (10.19 g, quant.). [α]D22 = -26 (c 
= 0.1, DCM); IR (neat): 825, 1070, 1166, 1525, 1701, 2341, 2360, 2860, 2933, 3315 cm-1; 1H NMR 
(400 MHz, CDCl3): δ = 0.95 (s, 9H, tBu), 1.04 (s, 9H, tBu), 2.15 (s, 3H, CH3 Lev), 2.57-2.61 (m, 2H, 
CH2 Lev), 2.70-2.73 (m, 2H, CH2 Lev), 3.54 (dt, 1H, J = 5.2 Hz, 10.0 Hz, H-5), 3.88-3.98 (m, 3H, H-
2, H-4, H-6), 4.24 (dd, 1H, J = 4.8 Hz, 5.2 Hz, H-6), 4.92 (d, 1H, J = 10.4 Hz, H-1), 5.18 (dd, 1H, J = 
9.2 Hz, 9.2 Hz, H-3), 6.88 (d, 1H, J = 9.2 Hz, NH), 7.31-7.34 (m, 3H, H Arom), 7.46-7.48 (m, 2H, H 
Arom); 13C NMR (100 MHz): δ =19.8 (Cq tBu), 22.6 (Cq tBu), 26.8 (CH3 tBu), 27.3 (CH3 tBu), 28.0 
(CH2 Lev), 29.7 (CH3 Lev), 38.0 (CH2 Lev), 54.7 (C-2), 66.0 (C-6), 74.6, (C-5), 74.9 (C-4), 75.1 (C-
3), 87.3 (C-1), 92.3 (Cq CCl3), 128.5 (CH Arom), 129.1 (CH Arom), 132.0 (Cq Arom), 133.0 (CH 
Arom), 161.7 (C=O TCA), 172.5 (C=O COO Lev), 205.8 (C=O CO Lev); HRMS: C27H38Cl3NO5SSi 
+ H+ requires 654.1277, found 654.1278. 
4,6-O-Di-tert-butylsilylidene-2-deoxy-4-O-levulinoyl-2- 
trichloroacetamido-α/β-D-glucopyranose (14). To a solution of 13 
(0.655 g, 1.00 mmol) in DCM (10 ml) and H2O (1 ml) at 0 oC was added 
NIS (0.225 g, 1.00 mmol) and TFA (77 μl, 1.0 mmol). After 30 min a 
second equivalent of NIS (0.225 g, 1.00 mmol) was added and the reaction was stirred for an 
additional 30 min. The reaction was quenched by addition of Et3N and washed with Na2S2O3. The 
organic layer was dried over MgSO4 and concentrated in vacuo, purification by column 
chromatography (PE, EtOAc) yielded 14 as a colorless oil (0.838 g, 84%). IR (neat): 765, 817, 1064, 
1092, 1533, 1701, 1747, 2337, 2931 cm-1; NMR assignment of major isomer (α) 1H NMR (400 MHz, 
CDCl3): δ =  0.98 (s, 9H, tBu), 1.05 (s, 9H, tBu), 2.17 (s, 3H, CH3 Lev), 2.60-2.64 (m, 2H, CH2 Lev), 
2.72-2.75 (m, 2H, CH2 Lev), 3.34 (bs, 1H, OH), 3.89 (d, 1H, J = 9.6 Hz, H-6), 3.93 (t, 1H, J = 9.2 Hz, 
H-4), 4.06 (t, 1H, J = 4.8 Hz, H-5), 4.08-4.18 (m, 2H, H-2, H-6), 5.29 (dd, 1H, J = 9.2 Hz, 10.4 Hz, 
H-3), 5.32 (d, 1H, J = 3.2 Hz, H-1), 7.06 (d, 1H, J = 8.8 Hz, NH); 13C NMR (100 MHz): δ = 19.9 (Cq 
tBu), 22.7 (Cq tBu), 26.8 (CH3 tBu), 27.3 (CH3 tBu), 28.1 (CH2 Lev), 29.8 (CH3 Lev), 38.0 (CH2 
Lev), 54.0 (C-2), 66.4 (C-6), 66.8, (C-5), 72.5 (C-3), 74.9 (C-4), 87.3 (C-1), 91.3 (C-1), 162.1 (C=O 
TCA), 173.0 (C=O COO Lev), 205.9 (C=O CO Lev); HRMS: C21H34Cl3NO8Si + H+ requires 
562.1192, found 562.1192. 
2-Deoxy-2-trichloroacetamido-D-glucopyranose (15). To a mixture of D-
glucosamine-HCl (53.9 g, 250 mmol) in MeOH (625 ml) and Et3N (70 ml, 500 
mmol) was added dropwise at 0 °C TCACl (28 ml, 250 mmol). After 5 day’s 
the mixture was filtered and concentrated in vacuo. Purification by column chromatography (EtOAc, 
MeOH) yielded 15 as an off-white solid (37.8 g, 46%). Analytical data were identical to those 
described in literature previously.17 HRMS: C8H12Cl3NO6 + H+ requires 323.9803, found 323.9803. 
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4,6-O-Di-tert-butylsilylidene-2-deoxy-2-trichloroacetamido-D-
glucopyranose (16). To a solution of 15 (13.9 g, 43.0 mmol) in DMF 
(215 ml) at -30 oC was added di-tert-butylsilylidene bistriflate (13.6 ml, 
42.0 mmol). The reaction was warmed to -10 °C in 1 hour after which 
pyridine (10.9 ml, 129 mmol) was added and subsequently the reaction was diluted with Et2O and 
washed with H2O. The organic layer was dried over MgSO4 and concentrated in vacuo to afford 16 as 
white amorphous solid (18.5 g, 95%). IR (neat):765, 817, 1064, 1092, 1533, 1683, 2337, 2931 cm-1; 
NMR assignment of major isomer (α), 1H NMR (400 MHz, CDCl3): δ = 0.99, (s, 9H, tBu), 1.06 (s, 
9H, tBu), 3.30 (bs, 1H, OH), 3.74-3.82 (m, 1H), 3.87-3.94 (m, 2H), 3.96-4.13 (m, 3H, H-2, H-6), 5.34 
(d, 1H, J = 3.2 Hz, H-1), 6.98 (d, 1H, J = 8.4 Hz, NH); 13C NMR (100 MHz): δ = 19.7 (Cq tBu), 22.7 
(Cq tBu), 26.9 (CH3 tBu), 27.4 (CH3 tBu), 54.4 (C-2), 66.3 (C-6), 66.4 (C-5), 71.9 (C-3), 77.7 (C-4), 
91.7 (C-1), 162.3 (C=O TCA). HRMS: C16H28Cl3NO6Si + H+ requires 464.0824, found 464.0823. 
 (N-Phenyl)-2,2,2-trifluoroacetimidate 4,6-O-di-tert-
butylsilylidene-2-deoxy-2-trichloroacetamido-α-D-glucopyranoside 
(17). To a solution of 16 (10.4 g, 22.4 mmol) in acetone (80 ml) at 0 
oC was added Cs2CO3 (8.0 g, 24.6 mmol) and ClC(=NPh)CF3 (6.8 ml, 
44.8 mmol). The reaction was warmed to rT, when TLC analysis 
showed complete consumption of starting material the mixture was filtered over celite and 
concentrated in vacuo. Purification by column chromatography (PE, EtOAc) yielded 17 as a colorless 
oil (10.11 g, 71%). NMR assignment of major isomer (α), 1H NMR (400 MHz, CDCl3): δ = 1.01 (s, 
9H, tBu), 1.07 (s, 9H, tBu), 2.84 (bs, 1H, OH), 3.84-3.93 (m, 3H, H-4, H-5, H-6), 3.98 (t, 1H, J = 8.8 
Hz, H-3), 4.16-4.20 (m, 2H, H-2, H-6), 6.40 (bs, 1H, H-1), 6.78 (d, 2H, J = 7.6 Hz, H Arom), 6.84 (d, 
1H, J = 7.2 Hz, NH), 7.11 (t, 1H, J = 7.2 Hz, H Arom), 7.27 (m, 2H, H Arom); 13C NMR (100 MHz): 
δ = 19.9 (Cq tBu), 22.7 (Cq tBu), 26.8 (CH3 tBu), 27.3 (CH3 tBu), 54.3 (C-2), 66.0 (C-6), 68.5 (C-5), 
71.3 (C-3), 77.0 (C-4), 92.0 (Cq CCl3), 93.0 (C-1), 119.2 (CH Arom), 124.7 (CH Arom), 128.8 (CH 
Arom), 142.8 (Cq Arom), 162.2 (C=O TCA); HRMS: C24H32Cl3F3N2O6Si + H+ requires 635.1120, 
found 635.1120. 
 (N-Phenyl)-2,2,2-trifluoroacetimidate 4,6-O-di-tert-butylsilylidene-
2-deoxy-4-O-levulinoyl-2-trichloroacetamido-α-D-glucopyranoside 
(18). Imidate 17 (6.64 g, 10.0 mmol) was dissolved in DCM (40 ml) 
and after cooling to 0 oC LevOH (3.28 g, 28.3 mmol), DIC (2.2 ml, 
14.2 mmol) and a catalytic amount of DMAP were added. The mixture 
was stirred for four hours and allowed to warm to rT. Filtration over celite and purification by column 
chromatography (PE, Et2O) yielded 18 as a colorless oil (6.90 g, 94%). NMR assignment of major 
isomer (α), 1H NMR (400 MHz, CDCl3): δ = 0.99 (s, 9H, tBu), 1.07 (s, 9H, tBu), 2.13 (s, 3H, CH3 
Lev), 2.62-2.65 (m, 2H, CH2 Lev), 2.70-2.75 (m, 2H, CH2 Lev), 3.88-3.99 (m, 2H, H-5, H-6), 3.98 (t, 
1H, J = 9.2 Hz, H-4), 4.14-4.19 (m, 1H, H-6), 4.26-4.28 (m, 1H, H-2), 5.27 (t, 1H, J = 10.0 Hz, H-3), 
6.43 (bs, 1H, H-1), 6.78 (d, 2H, J = 8.0 Hz, H Arom), 7.11 (t, 1H, J = 7.6 Hz, H Arom), 6.84 (d, 1H, J 
= 7.6 Hz, NH), 7.27 (t, 2H, J = 7.6 Hz, H Arom); 13C NMR (100 MHz): δ = 19.7 (Cq tBu), 22.4 (Cq 
tBu), 26.6 (CH3 tBu), 27.1 (CH3 tBu), 27.7 (CH2 Lev), 29.4 (CH3 Lev), 37.7 (CH2 Lev), 53.5 (C-2), 
65.9 (C-6), 68.8 (C-5), 71.8 (C-3), 73.8 (C-4), 91.6 (Cq CCl3), 92.6 (C-1), 119.4 (CH Arom), 124.6 
(CH Arom), 129.0 (CH Arom), 142.5 (Cq Arom), 162.0 (C=O TCA), 173.5 (C=O COO Lev), 205.2 
(C=O CO Lev); HRMS: C29H38Cl3F3N2O8Si + Na+ requires 755.1307, found 755.1310. 
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Methyl (phenyl 2,3-di-O-benzoyl-4-O-(4,6-O-di-tert-
butylsilylidene-2-deoxy-3-O-levulinoyl-2-
trichloroacetamido-β-D-glucopyranoside)-β-D-
glucopyranosyl) uronate) (3). Method A: A mixture of 
1-thio donor 13 (0.157 g, 0.24 mmol) and diphenyl sulfoxide (0.057 g, 0.28 mmol) was co-evaporated 
with toluene two times to remove traces of water, dissolved in DCM (5 ml) and stirred over activated 
molsieves 3Å for 30 min. At -60 °C triflic anhydride (40 µl, 0.24 mmol) was added and after 15 min. 
at -60 °C a solution of acceptor 19 (0.102 g, 0.2 mmol) in DCM (2 ml) was slowly added and the 
reaction mixture was allowed to warm to 0 °C in 3 h. Dry Et3N (0.13 ml) was added and the reaction 
mixture was diluted with DCM and washed with NaHCO3 (aq). The water layer was extracted twice 
with DCM, the collected organic layers were dried over MgSO4 and concentrated in vacuo. 
Purification by column chromatography (PE, EtOAc) yielded 3 as a white foam (0.147 g, 70%). 
Method B: A mixture of 1-hydroxy donor 14 (0.135 g, 0.24 mmol) and diphenyl sulfoxide (0.097 g, 
0.48 mmol) was co-evaporated with toluene two times to remove traces of water, dissolved in DCM 
(5.6 ml) and stirred over activated molsieves 3Å for 30 min. At -60 °C triflic anhydride (42 μl, 0.25 
mmol) was added and the temperature was raised to -40 °C. After 1 h. a solution of acceptor 19 
(0.102 g, 0.2 mmol) in DCM (2 ml) was slowly added and the reaction mixture was allowed to warm 
to 0 °C in 2 h. Dry Et3N (0.13 ml) was added and the reaction mixture was diluted with DCM and 
washed with NaHCO3 (aq). The water layer was extracted twice with DCM, the collected organic 
layers were dried over MgSO4 and concentrated in vacuo. Purification by column chromatography 
(PE, EtOAc) yielded 3 as a white foam (0.126 g, 63%). 
Method C: A mixture of 1-hydroxy donor 14 (0.135 g, 0.24 mmol) and 1-(benzenesulfinyl)piperidine 
(0.10 g, 0.48 mmol) was co-evaporated with toluene two times to remove traces of water, dissolved in 
DCM (5.6 ml) and stirred over activated molsieves 3Å for 30 min. At -60 °C triflic anhydride (42 µl, 
0.25 mmol) was added and the temperature was raised to -40 °C. After 1 h. a solution of acceptor 19 
(0.102 g, 0.2 mmol) in DCM (2 ml) was slowly added and the reaction mixture was allowed to warm 
to 0 °C in 2 h. Dry Et3N (0.13 ml) was added and the reaction mixture was diluted with DCM and 
washed with NaHCO3 (aq). The water layer was extracted twice with DCM, the collected organic 
layers were dried over MgSO4 and concentrated in vacuo. Purification by column chromatography 
(PE, EtOAc) yielded 3 as a white foam (0.118 g, 56%). 
Method D: Imidate donor 15 (0.176 g, 0.24 mmol) and acceptor 19 (0.102 g, 0.20 mmol) in DCM (4 
ml) were stirred over activated molsieves 3Å for 30 min. The mixture was cooled to 0 °C before a 
catalytic amount of triflic acid (1 µl, 0.01 mmol) was added. The mixture was allowed to warm to rT. 
After TLC analysis showed complete consumption of starting material (1 h) the reaction was 
quenched with Et3N. The reaction mixture was diluted with DCM and washed with NaHCO3 (aq). 
The water layer was extracted twice with DCM, the collected organic layers were dried over MgSO4 
and concentrated in vacuo. Purification by column chromatography (PE, EtOAc) yielded 3 as a white 
foam (0.164 g, 78%). [α]D22 = -18 (c = 0.1, DCM); IR (neat): 826, 1074, 1533, 1697, 2098, 2341, 
2361, 2860, 2933, 3315 cm-1; 1H NMR (400 MHz, CDCl3): δ = 0.878 (s, 18H, 2 x tBu), 2.14 (s, 3H, 
CH3 Lev), 2.52-2.59 (m, 3H, H-6’, CH2 Lev), 2.64-2.70 (m, 2H, CH2 Lev), 3.24 (dt, 1H, J = 4.8 Hz, 
10.0 Hz, H-5’), 3.45 (dd, 1H, J = 4.8 Hz, 5.6 Hz, H-6’), 3.55 (t, 1H, J = 9.2 Hz, H-4’),  3.80-3.86 (m, 
4H, H-2’, CH3 COOMe), 4.14 (d, 1H, J = 10.0 Hz, H-5), 4.24 (t, 1H, J = 9.6 Hz, H-4), 4.92 (d, 1H, J 
= 8.4 Hz, H-1’), 4.97-5.04 (m, 2H, H-1, H-3’), 5.38 (t, 1H, J = 10.0 Hz, H-2), 5.65 (t, 1H, J = 9.2 Hz, 
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H-3), 6.84 (d, 1H, J = 9.2 Hz, NH), 7.28-7.53 (m, 11H, H Arom), 7.90-7.94 (m, 4H, H Arom); 13C 
NMR (100 MHz): δ =19.6 (Cq tBu), 22.3 (Cq tBu), 26.6 (CH3 tBu), 27.2 (CH3 tBu), 27.9 (CH2 Lev), 
29.6 (CH3 Lev), 37.9 (CH2 Lev), 53.1 (CH3 COOMe), 55.6 (C-2’), 64.7 (C-6’), 69.5 (C-2),  70.4, (C-
5’), 73.6 (C-3), 74.1 (C-3’), 74.3 (C-4’), 76.3 (C-4), 76.9 (C-5), 86.7 (C-1), 92.3 (Cq CCl3), 100.3 (C-
1’), 128.3-129.6 (CH Arom), 129.8 (Cq Arom), 131.5 (Cq Arom), 132.6-133.3 (CH Arom), 161.5 
(C=O TCA), 164.9 (C=O Bz), 165.0 (C=O Bz), 168.4 (C=O COOMe) 172.5 (C=O COO Lev), 205.8 
(C=O CO Lev); HRMS: C48H56Cl3NO15SSi + Na+ requires 1074.2098, found 1074.2112. 
3-Azidopropyl (4,6-O-di-tert-butylsilylidene-2-deoxy-3-O-
levulinoyl-2-trichloroacetamido-β-D-glucopyranoside (20). Method 
A: A mixture of thio donor 13 (0.655 g, 1.0 mmol) and diphenyl 
sulfoxide (0.233 g, 1.1 mmol) was co-evaporated with toluene two 
times to remove traces of water, dissolved in DCM (20 ml) and stirred over activated molsieves 3Å 
for 30 min. The mixture was cooled to -78 °C before triflic anhydride (0.176 µl, 1.05 mmol) was 
added. The mixture was stirred for 10 min. at -78 °C followed by addition of 3-azidopropanol (0.303 
g, 3.0 mmol) in DCM (6 ml). The reaction mixture was allowed to warm to 0 °C in 4 h and Et3N (0.15 
ml) was added. The reaction mixture was diluted with DCM and washed with NaHCO3 (aq). The 
water layer was extracted twice with DCM after which the collected organic layers were dried over 
MgSO4 and concentrated in vacuo. Purification by column chromatography (PE, EtOAc) yielded 20 
as a white amorphous solid (0.606 g, 94%). 
Method B: Imidate donor 18 (0.176 g, 0.24 mmol) and 3-azidopropanol (0.073 g, 0.72 mmol) in 
DCM (4.8 ml) were stirred over activated molsieves 3Å for 30 min. The mixture was cooled to 0 °C 
before a catalytic amount of triflic acid (1 µl, 0.01 mmol) was added, then the mixture was allowed to 
warm to rT. After TLC analysis showed complete consumption of starting material (1 h) the reaction 
was quenched with Et3N. The reaction mixture was diluted with DCM and washed with NaHCO3 
(aq). The water layer was extracted twice with DCM, the collected organic layers were dried over 
MgSO4 and concentrated in vacuo. Purification by column chromatography (PE, EtOAc) yielded 20 
as a white amorphous solid (0.143 g, 99%). [α]D22 = -30 (c = 0.1, DCM); IR (neat): 827, 1078, 1558, 
1699, 1716, 2098, 2341, 2361, 2860, 2933 cm-1; 1H NMR (400 MHz, CDCl3): δ = 0.96 (s, 9H, tBu), 
1.05 (s, 9H, tBu), 1.76-1.84 (m, 2H, CH2 C3H6N3), 2.15 (s, 3H, CH3 Lev), 2.58-2.61 (m, 2H, CH2 
Lev), 2.71-2.75 (m, 2H, CH2 Lev), 3.36 (t, 2H, J = 6.8 Hz, CH2 C3H6N3), 3.48-3.60 (m, 2H, H-5, CH2 
C3H6N3), 3.89-4.02 (m, 4H, H-2, H-4, H-6, CH2 C3H6N3), 4.20 (dd, 1H, J = 4.8 Hz, 5.2 Hz, H-6), 
4.80 (d, 1H, J = 8.4 Hz, H-1), 5.28 (t, 1H, J = 10.0 Hz, H-3), 7.72 (d, 1H, J = 8.8 Hz, NH); 13C NMR 
(100 MHz): δ =19.5 (Cq tBu), 22.3 (Cq tBu), 26.5 (CH3 tBu), 27.0 (CH3 tBu), 27.8 (CH2 Lev), 28.6 
(CH2 C3H6N3), 29.4 (CH3 Lev), 37.7 (CH2 Lev), 47.5 (CH2 C3H6N3), 55.4 (C-2), 65.8 (C-6), 66.1 
(CH2 C3H6N3), 70.3, (C-5), 73.5 (C-3), 74.7 (C-4), 92.2 (Cq CCl3), 100.7 (C-1), 162.0 (C=O TCA), 
171.8 (C=O COO Lev), 205.8 (C=O CO Lev); HRMS: C24H39Cl3N4O8Si + H+ requires 645.1676, 
found 645.1677. 
3-Azidopropyl (4,6-O-di-tert-butylsilylidene-2-deoxy-2-
trichloroacetamido-β-D-glucopyranoside (21). Glucosamine 20 
(0.579 g, 0.896 mmol) was dissolved in a mixture of pyridine (4 ml) 
and AcOH (1 ml), after which hydrazine monohydrate (0.22 ml, 4.5 
mmol) was added. The mixture was stirred for 15 min. and diluted with EtOAc (20 ml), washed with 
1M HCl (aq), NaHCO3 (aq), and brine. The organic layer was dried over MgSO4 and concentrated in 
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vacuo. Purification by column chromatography (PE, EtOAc) yielded 21 as a white amorphous solid 
(0.765 g, 85%). ; IR (neat): 826, 1074, 1533, 1697, 2098, 2341, 2360, 2860, 2933, 3315 cm-1; 1H 
NMR (400 MHz, CDCl3): δ = 0.99 (s, 9H, tBu), 1.06 (s, 9H, tBu), 1.79-1.86 (m, 2H, CH2 C3H6N3), 
3.02 (s, 1H, OH), 3.37 (t, 2H, J = 6.8 Hz, CH2 C3H6N3), 3.44-3.60 (m, 3H, H-2, H-5, CH2 C3H6N3), 
3.70 (t, 1H, J = 9.2 Hz, H-4), 3.89-3.94 (m, 2H, H-6, CH2 C3H6N3), 4.02 (t, 1H, J = 9.6 Hz, H-3), 4.19 
(dd, 1H, J = 4.8 Hz, 5.2 Hz, H-6), 4.88 (d, 1H, J = 8.4 Hz, H-1), 7.11 (d, 1H, J = 6.7 Hz, NH); 13C 
NMR (100 MHz): δ = 19.8 (Cq tBu), 22.6 (Cq tBu), 26.8 (CH3 tBu), 27.3 (CH3 tBu), 28.9 (CH2 
C3H6N3), 47.9 (CH2 C3H6N3), 58.1 (C-2), 65.9 (C-6), 66.5 (CH2 C3H6N3), 70.2, (C-5), 72.6 (C-3), 
77.7 (C-4), 92.4 (Cq CCl3), 99.8 (C-1), 162.1 (C=O TCA); HRMS: C19H33Cl3N4O6Si + H+ requires 
547.1308, found 547.1306. 
3-Azidopropyl (4,6-O-di-tert-
butylsilylidene-2-deoxy-2-
trichloroacetamido-3-O-(methyl (2,3-
di-O-benzoyl-4-O-(4,6-O-di-tert-
butylsilylidene-2-deoxy-3-O-levulinoyl-2-trichloroacetamido-β-D-glucopyranosyl)-β-D-
glucopyranosyl) uronate)-β-D-glucopyranoside (22). Method A: Thio dimer 3 (0.211 g, 0.2 mmol) 
and diphenyl sulfoxide (0.045 g, 0.22 mmol) were co-evaporated with toluene two times to remove 
traces of water, dissolved in DCM (4 ml) and stirred over activated molsieves 3Å for 30 min. At -60 
°C triflic anhydride (37 µl, 0.22 mmol) was added and after 15 min. at -60 °C a solution of acceptor 
21 (0.132 g, 0.24 mmol) in DCM (2.4 ml) was slowly added and the reaction mixture was allowed to 
warm to 0 °C in 3 h. Dry Et3N was added and the reaction was washed with NaHCO3 (aq), the 
organic layer was dried over MgSO4 and concentrated in vacuo. Purification by size exclusion and 
column chromatography (PE, EtOAc) yielded 22 as a off white foam (0.137 g, 46%). 
Method B: Thio dimer 3 (0.90 g, 0.86 mmol) and 1-(benzenesulfinyl)piperidine (0.198 g, 0.946 
mmol) were co-evaporated with toluene two times to remove traces of water, dissolved in DCM (17 
ml) and stirred over activated molsieves 3Å for 30 min. At -60 °C triflic anhydride (0.152 ml, 0.903 
mmol) was added and after 15 min. at -60 °C a solution of acceptor 21 (0.564 g, 1.03 mmol) in DCM 
(10 ml) was slowly added and the reaction mixture was allowed to warm to 0 °C in 3 h. Dry Et3N 
(0.57 ml) was added and the reaction was washed with NaHCO3 (aq), the organic layer was dried 
over MgSO4 and concentrated in vacuo. Purification by size exclusion and column chromatography 
(PE, EtOAc) yielded 22 as a off white foam (0.956 g, 75%). 
Method C: Thio dimer 3 (0.211 g, 0.2 mmol) and acceptor 21 (0.132 g, 0.24 mmol) were co-
evaporated with toluene two times to remove traces of water and dissolved in DCM (4 ml). NIS 
(0.054 g, 0.24 mmol) was added and the mixture was stirred over activated molsieves 3Å for 30 min. 
The mixture was cooled to 0 °C before a catalytic amount of triflic acid (1 µl, 0.01 mmol) was added. 
After TLC analysis showed complete consumption of thio dimer (1.5 h) the reaction was quenched 
with Et3N. The reaction mixture was diluted with DCM and washed with Na2S2O3 (aq) and NaHCO3 
(aq). The water layers were extracted twice with DCM and the collected organic layers were dried 
over MgSO4 and concentrated in vacuo. Purification by size exclusion and column chromatography 
(PE, EtOAc) yielded 22 as an off white foam (0.221 g, 75%). 
Method D (1-pot procedure): Imidate donor 18 (1.36 g, 1.80 mmol) and acceptor 19 (0.610 g, 1.20 
mmol) in DCM (18 ml) were stirred over activated molsieves 3Å for 30 min. The mixture was cooled 
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to 0 °C before a catalytic amount of triflic acid (8 µl, 0.09 mmol) was added, then the mixture was 
allowed to warm to rT. After TLC analysis showed complete consumption of thio acceptor (1 h) the 
mixture was cooled to 0 °C. Then and a mixture of glucosamine acceptor 21 (0.99 g, 1.60 mmol) and 
NIS (0.32 g, 1.44 mmol) (dried over activated molecular sieves) in DCM (18 ml) was added. After 2 
h at 0 °C TLC analysis showed complete consumption of thio dimer and the reaction was quenched 
with Et3N. The reaction mixture was diluted with DCM and washed with NaHCO3 (aq). The water 
layer was extracted twice with DCM, the collected organic layers were dried over MgSO4 and 
concentrated in vacuo. Purification by size exclusion and column chromatography (PE, EtOAc) 
yielded 22 as an off white foam (1.29 g, 72%). [α]D22 = -26 (c = 0.1, DCM); IR (neat): 827, 1070, 
1521, 1716, 2098, 2341, 2359, 2860, 2933 cm-1; 1H NMR (400 MHz, CDCl3): δ = 0.84 (s, 9H, tBu), 
0.88 (s, 9H, tBu), 0.90 (s, 9H, tBu), 1.03 (s, 9H, tBu), 1.79-1.82 (m, 2H, CH2 C3H6N3), 2.14 (s, 3H, 
CH3 Lev), 2.54-2.57 (m, 2H, CH2 Lev), 2.67-2.71 (m, 3H, H-6’’, CH2 Lev), 3.28 (dd, 1H, J = 4.8 Hz, 
9.6 Hz H-5’’), 3.34 (t, 2H, J = 6.4 Hz, CH2 C3H6N3), 3.46 (dd, 1H, J = 4.8 Hz, 9.6 Hz, H-5), 3.54-
3.62 (m, 4H, H-2, H-4’’, H-6’’, CH2 C3H6N3), 3.84 (s, 3H, CH3 COOMe), 3.87-3.91 (m, 4H, H-4, H-
6, H-2’’, CH2 C3H6N3), 4.16-4.19 (m, 2H, H-6, H-5’), 4.70 (t, 1H, J = 9.2 Hz, H-3), 4.33 (t, 1H, J = 
9.2 Hz, H-4’), 4.81 (d, 1H, J = 8.0 Hz, H-1), 4.97 (d, 1H, J = 8.4 Hz, H-1’’), 5.02 (t, 1H, J = 9.6 Hz, 
H-3’’), 5.21 (dd, 1H, J = 4.4 Hz, 8.8 Hz, H-2’), 5.39 (d, 1H, J = 4.4 Hz, H-1’) 5.62 (t, 1H, J = 9.2 Hz, 
H-3’), 6.91 (d, 1H, J = 8.8 Hz, NH), 7.01 (d, 1H, J = 8.4 Hz, NH), 7.34-7.43 (m, 4H, H Arom), 7.49-
7.54 (m, 2H, H Arom), 7.91-7.93 (m, 4H, H Arom); 13C NMR (100 MHz): δ = 19.6 (Cq tBu), 19.7 (Cq 
tBu), 22.3 (Cq tBu), 22.5 (Cq tBu), 26.6 (CH3 tBu), 26.6 (CH3 tBu), 27.1 (2 x CH3 tBu), 27.8 (CH2 
Lev), 28.8 (CH2 C3H6N3), 29.6 (CH3 Lev), 37.9 (CH2 Lev), 47.7 (CH2 C3H6N3), 52.9 (CH3 COOMe), 
55.5 (C-2’’), 57.3 (C-2), 64.9 (C-6’’), 65.9 (C-6), 66.4 (CH2 C3H6N3), 70.2 (C-5), 70.5 (C-5’’), 71.3 
(C-3’), 74.0, 74.2, 74.3, 74.4 (C2’, C-5’, C-3’’, C-4’’), 76.0 (C-4), 76.5 (C-4’), 77.8 (C-3), 92.3 (Cq 
CCl3), 92.5 (Cq CCl3), 99.6 (C-1’), 99.9 (C-1), 100.9 (C-1’’), 128.2-128.7 (CH Arom, Cq Arom), 
129.5-129.8 (CH Arom, Cq Arom), 133.0-133.4 (CH Arom), 161.5 (C=O TCA), 161.7 (C=O TCA), 
165.0 (C=O Bz), 165.6 (C=O Bz), 170.2 (C=O COOMe), 172.0 (C=O COO Lev), 205.9 (C=O CO 
Lev); HRMS: C61H83Cl6N5O21Si2 + H+ requires 1488.3323, found 1488.3330. 
3-Azidopropyl (4,6-O-di-tert-
butylsilylidene-2-deoxy-2-
trichloroacetamido-3-O-(methyl (2,3-
di-O-benzoyl-4-O-(4,6-O-di-tert-butylsilylidene-2-deoxy-2-trichloroacetamido-β-D-
glucopyranosyl)-β-D-glucopyranosyl) uronate) -β-D-glucopyranoside (23). Trimer 22 (1.08 g, 0.72 
mmol) was dissolved in a mixture of pyridine (6.4 ml) and AcOH (1.6 ml), after which hydrazine 
monohydrate (0.18 ml, 3.6 mmol) was added. The mixture was stirred for 15 min. and diluted with 
EtOAc (20 ml), washed with 1M HCl (aq), NaHCO3 (aq), and brine. The organic layer was dried over 
MgSO4 and concentrated in vacuo. Purification by column chromatography (PE, EtOAc) yielded 23 
as a white foam (0.942 g, 94%). [α]D22 = -26 (c = 0.1, DCM); IR (neat): 827, 1072, 1527, 1724, 2100, 
2860, 2933 cm-1; 1H NMR (400 MHz, CDCl3): δ = 0.85 (s, 9H, tBu), 0.90 (s, 18H, tBu), 1.03 (s, 9H, 
tBu), 1.78-1.80 (m, 2H, CH2 C3H6N3), 2.65 (t, 1H, J = 12.0 Hz, H-6’’), 2.93 (bs, 1H, OH), 3.22 (dd, 
1H, J = 4.8 Hz, 9.6 Hz H-5’’), 3.31-3.40 (m, 3H, H-3’’, CH2 C3H6N3), 3.45-3.58 (m, 5H, H-2, H-5, 
H-2’’, H-6’’, CH2 C3H6N3), 3.74 (t, 1H, J = 9.6 Hz, H-4’’), 3.84 (s, 3H, CH3 COOMe), 3.86-3.97 (m, 
3H, H-4, H-6, CH2 C3H6N3), 4.11-4.20 (m, 2H, H-6, H-5’), 4.26-4.36 (m, 2H, H-3, H-4’), 4.82 (d, 1H, 
J = 8.4 Hz, H-1), 4.98 (d, 1H, J = 8.4 Hz, H-1’’), 5.24 (dd, 1H, J = 4.4 Hz, 8.8 Hz, H-2’), 5.36 (d, 1H, 
J = 4.4 Hz, H-1’) 5.61 (t, 1H, J = 9.2 Hz, H-3’), 6.97 (d, 1H, J = 8.0 Hz, NH), 7.04 (d, 1H, J = 7.6 Hz, 
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NH), 7.34-7.42 (m, 4H, H Arom), 7.49-7.55 (m, 2H, H Arom), 7.91-7.93 (m, 4H, H Arom); 13C NMR 
(100 MHz): δ = 19.7 (Cq tBu), 19.8 (Cq tBu), 22.4 (Cq tBu), 22.7 (Cq tBu), 26.6 (CH3 tBu), 26.8 (CH3 
tBu), 27.2 (CH3 tBu), 27.3 (CH3 tBu), 28.9 (CH2 C3H6N3), 47.8 (CH2 C3H6N3), 53.0 (CH3 COOMe), 
57.6 (C-2’’), 57.9 (C-2), 65.0 (C-6’’), 66.0 (C-6), 66.5 (CH2 C3H6N3), 70.1 (C-5’’), 70.3 (C-5), 71.5 
(C-3’), 73.9 (C-2’), 74.1 (C-5’), 74.4 (C-4’’), 76.0 (C-4), 76.2 (C-4’), 77.3 (C-3’’), 77.9 (C-3), 92.5 
(Cq CCl3), 92.6 (Cq CCl3), 99.8 (C-1’), 99.9 (C-1’’), 100.0 (C-1), 128.3-128.8 (CH Arom, Cq Arom), 
129.6-129.8 (CH Arom, Cq Arom), 133.0-133.4 (CH Arom), 161.8 (C=O TCA), 162.2 (C=O TCA), 
165.2 (C=O Bz), 165.7 (C=O Bz), 170.2 (C=O COOMe); HRMS: C56H77Cl6N5O19Si2 + H+ requires 
1390.2955, found 1390.2975. 
3-
azidoprop
yl (4,6-O-
di-tert-
butylsilylidene-2-deoxy-2-trichloroacetamido-3-O-(methyl (2,3-di-O-benzoyl-4-O-(4,6-O-di-tert-
butylsilylidene-2-deoxy-2-trichloroacetamido-3-O-(methyl (2,3-di-O-benzoyl-4-O-(4,6-O-di-tert-
butylsilylidene-2-deoxy-3-O-levulinoyl-2-trichloroacetamido-β-D-glucopyranosyl)-β-D-
glucopyranosyl)uronate)-β-D-glucopyranosyl)-β-D-glucopyranosyl)uronate)-β-D-
glucopyranoside (24). Thio dimer 3 (1.132 g, 1.074 mmol) and trimer acceptor 23 (0.998 g, 0.716 
mmol) were co-evaporated with toluene two times to remove traces of water then dissolved in DCM 
(10 ml). NIS (0.242 g, 1.074 mmol) was added and the mixture was stirred over activated molsieves 
3Å for 30 min. The mixture was cooled to 0 °C before a catalytic amount of triflic acid (4 µl, 0.05 
mmol) was added, then the mixture was allowed to warm to rT. After TLC analysis showed complete 
consumption of starting material (2 h) the reaction was quenched with Et3N. The reaction mixture was 
diluted with DCM and washed with NaHCO3 (aq). The water layer was extracted twice with DCM 
and the collected organic layers were dried over MgSO4 and concentrated in vacuo. Purification by 
size exclusion and column chromatography (PE, EtOAc) yielded 24 as a white foam (1.64 g, 98%). 
IR (neat): 825, 1069, 1527, 1724, 2099, 2860, 2933 cm-1; 1H NMR (400 MHz, CDCl3): δ = 0.77 (s, 
9H, tBu), 0.85 (s, 9H, tBu), 0.89 (s, 27H, tBu), 1.03 (s, 9H, tBu), 1.78-1.80 (m, 2H, CH2 C3H6N3), 
2.13 (s, 3H, CH3 Lev), 2.54-2.57 (m, 2H, CH2 Lev), 2.67-2.71 (m, 4H, H-6’’’’, H-6’’), 3.19-3.21 (m, 
1H), 3.29-3.34 (m, 3H), 3.38-3.44 (m, 2H), 3.45-3.63 (m, 9H), 3.81 (s, 3H, CH3 COOMe), 3.83 (s, 
3H, CH3 COOMe), 3.86-3.96 (m, 5H), 4.06-4.19 (m, 5H), 4.26-4.37 (m, 3H), 4.82 (d, 1H, J = 8.0 
Hz), 4.96-5.04 (m, 3H), 5.09-5.12 (m, 1H), 5.22-5.25 (m, 1H), 5.31-5.38 (m, 2H), 5.54-5.59 (m, 2H), 
6.87-6.95 (m, 3H, NH), 7.35-7.42 (m, 8H, H Arom), 7.48-7.55 (m, 4H, H Arom), 7.88-7.92 (m, 8H, H 
Arom); 13C NMR (100 MHz): δ = 19.5 (Cq tBu), 19.7 (Cq tBu), 22.4 (Cq tBu), 22.6 (Cq tBu), 26.6-
26.7 (CH3 tBu), 27.1-27.2 (CH3 tBu), 28.0 (CH2 Lev), 28.9 (CH2 C3H6N3), 29.6 (CH3 Lev), 38.1 (CH2 
Lev), 47.9 (CH2 C3H6N3), 52.8 (CH3 COOMe), 53.0 (CH3 COOMe), 55.6, 58.2, 58.7 (C-2, C-2’’, C-
2’’’’), 65.1, 65.2, 66.1, (C-6, C-6’’, C-6’’’’), 66.6 (CH2 C3H6N3), 69.9, 70.4, 70.6, 71.3, 71.6, 73.8, 
74.4, 74.4, 74.7, 74.8, 75.8, 75.9, 77.9, 78.3, (C-3, C-4, C-5, C-2’, C-3’, C-4’, C-5’, C-3’’, C-4’’, C-
5’’, C-2’’’, C-3’’’, C-4’’’, C-5’’’, C-3’’’’, C-4’’’’, C-5’’’’), 92.5 (Cq CCl3), 92.5 (Cq CCl3), 92.7 (Cq 
CCl3), 99.5, 99.7, 99.9, 99.9, 101.1 (C-1, C-1’, C-1’’, C-1’’’, C-1’’’’), 128.2-128.9 (CH Arom, Cq 
Arom), 129.5-130.0 (CH Arom, Cq Arom), 132.9-133.5 (CH Arom), 161.4 (C=O TCA), 161.6 (C=O 
TCA), 161.8 (C=O TCA), 165.1 (C=O Bz), 165.2 (C=O Bz), 165.6 (C=O Bz), 165.7 (C=O Bz), 169.7 
(C=O COOMe), 170.7 (C=O COOMe), 172.1 (C=O COO Lev),  205  (C=O CO Lev); HRMS: 
C98H127Cl9N6O34Si3 + 2H+ requires 1166.2522, found 1166.2526. 
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azidopro
pyl (4,6-
O-di-
tert-
butylsilylidene-2-deoxy-2-trichloroacetamido-3-O-(methyl (2,3-di-O-benzoyl-4-O-(4,6-O-di-tert-
butylsilylidene-2-deoxy-2-trichloroacetamido-3-O-(methyl (2,3-di-O-benzoyl-4-O-(4,6-O-di-tert-
butylsilylidene-2-deoxy-2-trichloroacetamido-β-D-glucopyranosyl)-β-D-glucopyranosyl) 
uronate)-β-D-glucopyranosyl)-β-D-glucopyranosyl) uronate) -β-D-glucopyranoside (25). Pentamer 
24 (1.635 g, 0.70 mmol) was dissolved in a mixture of pyridine (8 ml) and AcOH (2 ml), after which 
hydrazine monohydrate (35 µl, 3.58 mmol) was added. The mixture was stirred for 30 min. and 
diluted with EtOAc (20 ml), washed with 1M HCl (aq), NaHCO3 (aq), and brine. The organic layer 
was dried over MgSO4 and concentrated in vacuo. Purification by column chromatography (PE, 
EtOAc) yielded 25 as a white foam (1.42 g, 91%). IR (neat): 828, 1072, 1527, 1719, 2098, 2829, 
2933 cm-1; 1H NMR (400 MHz, CDCl3): δ = 0.78 (s, 9H, tBu), 0.86 (s, 9H, tBu), 0.89 (m, 18H, tBu), 
0.91 (s, 9H, tBu), 1.04 (s, 9H, tBu), 1.78-1.80 (m, 2H, CH2 C3H6N3), 2.65-2.67 (m, 2H, H-6’’’’, H-
6’’), 2.93 (bs, OH), 3.20-3.25 (m, 2H), 3.33 (t, 2H, J = 6.8 Hz, CH2 C3H6N3), 3.37-3.70 (m, 11H), 
3.78-3.79 (m, 1H), 3.82 (s, 3H, CH3 COOMe), 3.83 (s, 3H, CH3 COOMe), 3.86-3.97 (m, 5H), 4.06-
4.19 (m, 5H), 4.26-4.41 (m, 4H), 4.82 (d, 1H, J = 8.0 Hz), 4.96-5.04 (m, 3H), 5.09-5.12 (m, 1H), 
5.22-5.25 (m, 1H), 5.33-5.41 (m, 2H), 5.53-5.60 (m, 2H), 6.88-6.93 (m, 2H, NH), 7.14 (d, 1H, J = 7.6 
Hz, NH), 7.33-7.42 (m, 8H, H Arom), 7.48-7.54 (m, 4H, H Arom), 7.88-7.92 (m, 8H, H Arom); 13C 
NMR (100 MHz): δ = 19.5 (Cq tBu), 19.6 (Cq tBu), 22.4 (Cq tBu), 22.5 (Cq tBu), 26.6-26.8 (CH3 tBu), 
27.0-27.3 (CH3 tBu), 28.9 (CH2 C3H6N3), 47.8 (CH2 C3H6N3), 52.7 (CH3 COOMe), 52.9 (CH3 
COOMe), 57.1, 57.7, 57.7 (C-2, C-2’’, C-2’’’’), 65.1, 65.1, 66.0, (C-6, C-6’’, C-6’’’’), 66.5 (CH2 
C3H6N3), 69.8, 70.1, 70.3, 71.3, 71.5, 73.7, 74.3, 74.4, 74.7, 74.9, 75.8, 75.9, 76.3, 77.0, 77.8, 78.4, 
(C-3, C-4, C-5, C-2’, C-3’, C-4’, C-5’, C-3’’, C-4’’, C-5’’, C-2’’’, C-3’’’, C-4’’’, C-5’’’, C-3’’’’, C-
4’’’’, C-5’’’’), 92.5 (Cq CCl3), 92.6 (Cq CCl3), 92.6 (Cq CCl3), 99.5, 99.6, 99.8, 99.8, 100.3 (C-1, C-
1’, C-1’’, C-1’’’, C-1’’’’), 128.2-128.9 (CH Arom, Cq Arom), 129.5-129.9 (CH Arom, Cq Arom), 
132.7-133.4 (CH Arom), 161.4 (C=O TCA), 161.7 (C=O TCA), 162.3 (C=O TCA), 165.0 (C=O Bz), 
165.2 (C=O Bz), 165.6 (C=O Bz), 165.7 (C=O Bz), 169.7 (C=O COOMe), 170.9 (C=O COOMe); 
HRMS: C93H121Cl9N6O32Si3 + 2K+ requires 1136.2117, found 1136.2108. 
azidopropyl (4,6-O-di-tert-butylsilylidene-2-deoxy-2-trichloroacetamido-3-O-(methyl (2,3-di-O-
benzoyl-4-O-(4,6-O-di-tert-butylsilylidene-2-deoxy-2-trichloroacetamido-3-O-(methyl (2,3-di-O-
benzoyl-4-O-(4,6-O-di-tert-butylsilylidene-2-deoxy-2-trichloroacetamido-3-O-(methyl (2,3-di-O-
benzoyl-4-O-(4,6-O-di-tert-butylsilylidene-2-deoxy-3-O-levulinoyl-2-trichloroacetamido-β-D-
glucopyranosyl)-β-D-glucopyranosyl) uronate)-β-D-glucopyranosyl)-β-D-glucopyranosyl) 
uronate)-β-D-glucopyranosyl)-β-D-glucopyranosyl) uronate) -β-D-glucopyranoside (26). Thio 
dimer 3 (0.542 g, 0.515 mmol) and pentamer acceptor 25 (0.922 g, 0.412 mmol) were co-evaporated 
with toluene two times to remove traces of water then dissolved in DCM (4.1 ml). NIS (0.116 g, 
0.515 mmol) was added and the mixture was stirred over activated molsieves 3Å for 30 min. The 
mixture was cooled to 0 °C before a catalytic amount of triflic acid (2 µl, 0.025 mmol) was added, 
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then the mixture was allowed to warm to rT. TLC analysis proved difficult to analyze due to the 
viscosity of the mixture as well as the similar polarities of donor and acceptor, after 4 h the reaction 
was quenched with Et3N. The reaction mixture was diluted with DCM and washed with NaHCO3 
(aq). The water layer was extracted twice with DCM and the collected organic layers were dried over 
MgSO4 and concentrated in vacuo. Purification by size exclusion and column chromatography (PE, 
EtOAc) yielded 26 as a white foam (0.76 g, 61%). IR (neat): 826, 1028, 1068, 1707, 2098, 2860, 
2934 cm-1; 1H NMR (400 MHz, CDCl3): δ = 0.73 (s, 9H, tBu), 0.74 (s, 9H, tBu), 0.85 (s, 9H, tBu), 
0.89 (s, 36H, tBu), 1.03 (s, 9H, tBu), 1.78-1.81 (m, 2H, CH2 C3H6N3), 2.13 (s, 3H, CH3 Lev), 2.54-
2.57 (m, 2H, CH2 Lev), 2.64-2.71 (m, 5H, H-6’’, H-6’’’’, H-6’’’’’’), 3.19-3.22 (m, 2H), 3.23-3.35 (m, 
3H), 3.38-3.63 (m, 12H), 3.81 (s, 6H, CH3 COOMe), 3.83 (s, 3H, CH3 COOMe), 3.85-3.96 (m, 5H), 
4.07-4.18 (m, 7H), 4.28-4.36 (m, 4H), 4.82 (d, 1H, J = 8.0 Hz), 4.96-5.04 (m, 4H), 5.09-5.13 (m, 2H), 
5.22-5.25 (m, 1H), 5.31-5.39 (m, 3H), 5.51-5.59 (m, 3H), 6.88-6.98 (m, 4H, NH), 7.33-7.42 (m, 12H, 
H Arom), 7.48-7.55 (m, 6H, H Arom), 7.87-7.93 (m, 12H, H Arom); 13C NMR (100 MHz): δ = 19.6 
(Cq tBu), 19.7 ( Cq tBu), 22.4 (Cq tBu), 22.6 (Cq tBu), 26.6-26.7 (CH3 tBu), 27.1-27.2 (CH3 tBu), 28.0 
(CH2 Lev), 28.9 (CH2 C3H6N3), 29.6 (CH3 Lev), 38.1 (CH2 Lev), 47.9 (CH2 C3H6N3), 52.8 (CH3 
COOMe), 52.8 (CH3 COOMe), 53.0 (CH3 COOMe), 55.6, 57.0, 57.3, 57.8 (C-2, C-2’’, C-2’’’’, C-
2’’’’’’), 65.1, 65.1, 65.2, 66.1, (C-6, C-6’’, C-6’’’’, C-6’’’’’’), 66.6 (CH2 C3H6N3), 69.9, 70.4, 70.6, 
71.4, 71.5, 71.6, 73.8, 74.4, 74.4, 74.4, 74.7, 74.8, 75.8, 75.9, 77.8, 78.2, (C-3, C-4, C-5, C-2’, C-3’, 
C-4’, C-5’, C-3’’, C-4’’, C-5’’, C-2’’’, C-3’’’, C-4’’’, C-5’’’, C-3’’’’, C-4’’’’, C-5’’’’, C-2’’’’’, C-
3’’’’’, C-4’’’’’, C-5’’’’’, C-3’’’’’’, C-4’’’’’’, C-5’’’’’’), 92.5 (Cq CCl3), 99.5, 99.6, 99.9, 100.0, 101.2 
(C-1, C-1’, C-1’’, C-1’’’, C-1’’’’, C-1’’’’’, C-1’’’’’’), 128.3-128.9 (CH Arom, Cq Arom), 129.5-130.0 
(CH Arom, Cq Arom), 133.0-133.5 (CH Arom), 161.4 (C=O TCA), 161.4 (C=O TCA), 161.6 (C=O 
TCA), 161.8 (C=O TCA), 165.1 (C=O Bz), 165.1 (C=O Bz), 165.2 (C=O Bz), 165.6 (C=O Bz), 165.7 
(C=O Bz), 165.7 (C=O Bz), 169.7 (C=O COOMe), 170.3 (C=O COOMe), 170.8 (C=O COOMe), 
172.1 (C=O COO Lev); HRMS: C135H171Cl12N7O47Si4 + 2H+ requires 1587.8349, found 1587.8345. 
3-azidopropyl (2-deoxy-2-amino-3-O-(4-O-(2-
deoxy-2-amino-β-D-glucopyranosyl)-β-D-
glucopyranosyl) uronate) -β-D-glucopyranoside 
(27). Fully protected trimer 22 (0.173 g, 0.116 
mmol) was dissolved in THF (2.3 ml) and Et3N/ 3HF (0.11 ml, 0.696 mmol) was added. After 2 hour 
the mixture was diluted with EtOAc and washed with NaHCO3 (aq). The water layer was extracted 
twice with EtOAc and the collected organic layers were dried over MgSO4 and concentrated in vacuo. 
The resulting syrup was then dissolved in THF (2 ml) and H2O (2 ml) and a 0.5 M solution of KOH in 
H2O (1.62 ml, 0.812 mmol) was added stepwise (per 1 equiv.) over a period of 10 h. The reaction 
mixture was stirred for 4 days after which it was quenched with AcOH and concentrated in vacuo. 
The remaining solid was subsequently purified by gel filtration and lyophilized 3 times yielding 27 as 
a white amorphous solid (28 mg, 48%). 1H NMR (600 MHz, CDCl3): δ = 1.87-1.92 (m, 2H, CH2 
C3H6N3), 3.04 (dd, 1H, J = 8.4, 10.2 Hz, H-2 or H-2’’), 3.08 (t, 1H, J = 9Hz, H-2 or H-2’’), 3.43 (t, 
2H, J = 6.6Hz, CH2 C3H6N3), 3.45-3.50 (m, 4H), 3.61-3.67 (m, 4H), 3.69-3.76 (m, 4H), 3.79-3.82 (m, 
1H, H-5’), 3.88-3.93 (m, 3H), 3.97-4.01 (m, 1H, CH2 C3H6N3), 4.63 (d, 1H, J = 8.4 Hz, H-1 or H-1’ 
or H-1’’) , 4.67 (d, 1H, J = 8.4 Hz, H-1 or H-1’ or H-1’’) , 4.74 (d, 1H, J = 8.4 Hz, H-1 or H-1’ or H-
1’’); 13C NMR (150 MHz): δ = 28.2 (CH2 C3H6N3), 48.0 (CH2 C3H6N3), 55.1, 55.7 (C-2, C-2’’), 60.3, 
60.4 (C-6, C-6’’), 67.6 (CH2 C3H6N3), 68.0, 69.4, 72.2, 72.7, 74.1, 74.6, 75.8, 76.3, 79.9 (C-3, C-4, C-
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5, C-2’, C-3’, C-4’, C-3’’, C-4’’, C-5’’), 82.8 (C-5’), 98.9, 99.8, 101.9 (C-1, C-1’, C-1’’), 174.9 
(COOH); HRMS: C21H37N5O15 + H+ requires 600.2359, found 600.2378. 
3-azidopropyl (2-deoxy-2-acetamido-3-O-(4-O-
(2-deoxy-2-acetamido-β-D-glucopyranosyl)-β-D-
glucopyranosyl) uronate) -β-D-glucopyranoside 
(28). Zwitterionic HA-trisaccharide 27 (17 mg, 
0.028 mmol) was dissolved in MeOH (5 ml) and Ac2O (0.5 ml) was added. After 4 hours this mixture 
was co-evaporated three times with toluene and concentrated in vacuo. When NMR-revealed an 
additional methylester signal, the residue was dissolved in H2O and LiOH (0.1 ml, 0.5 M) was added. 
The mixture was stirred for 2 hour and quenched with AcOH till neutral and concentrated in vacuo. 
The remaining solid was subsequently purified by gel filtration and lyophilized 3 times yielding 28 as 
a white amorphous solid (19 mg, 99%). 1H NMR (400 MHz, CDCl3): δ = 1.79-1.84 (m, 2H, CH2 
C3H6N3), 2.01 (s, 3H, CH3 Ac), 2.03 (s, 3H, CH3 Ac), 3.32-3.36 (m, 3H), 3.40-3.57 (m, 7H), 3.62-
3.75 (m, 7H), 3.78-3.83 (m, 1H), 3.88-3.98 (m, 3H), 4.45 (d, 1H, J = 6.7 Hz, H-1 or H-1’ or H-1’’) , 
4.50 (d, 1H, J = 8.4 Hz, H-1 or H-1’ or H-1’’), 4.51 (d, 1H, J = 8.4 Hz, H-1 or H-1’ or H-1’’); 13C 
NMR (100 MHz): δ = 22.2 (CH3 Ac), 22.4 (CH3 Ac), 28.1 (CH2 C3H6N3), 47.7 (CH2 C3H6N3), 54.5, 
55.3 (C-2, C-2’’), 60.5, 60.6 (C-6, C-6’’), 67.1 (CH2 C3H6N3), 68.5, 69.6, 72.4, 73.5, 73.8, 75.3, 75.8, 
76.3, 79.8, 82.2 (C-3, C-4, C-5, C-2’, C-3’, C-4’, C-3’’, C-4’’, C-5’, C-5’’), 100.7, 100.9, 103.1 (C-1, 
C-1’, C-1’’), 174.2, 174.6, 174.8 (C=O Ac, COOH); HRMS: C25H41N5O17 + H+ requires 684.2570, 
found 684.2573. 
azidopropyl (2-deoxy-2-
amino-3-O-(4-O-(2-
deoxy-2-amino-3-O-(4-
O-(2-deoxy-2-amido-β-
D-glucopyranosyl)-β-D-glucopyranosyl) uronate)-β-D-glucopyranosyl)-β-D-glucopyranosyl) 
uronate)-β-D-glucopyranoside (29). Fully protected HA pentamer 24 (0.289 g, 0.124 mmol) was 
dissolved in THF (3 ml) and Et3N/3HF (0.121 ml, 0.741 mmol) was added. After 6 hour the mixture 
was diluted with EtOAc and was washed with NaHCO3 (aq). The water layer was extracted twice 
with EtOAc the collected organic layers were dried over MgSO4 and concentrated in vacuo. The 
resulting syrup was then dissolved in THF (3 ml) and H2O (3 ml) and a 0.5 M solution of KOH in 
H2O (2.73 ml, 1.36 mmol) was added stepwise (per 1 equiv.) over a period of 72h. The reaction 
mixture was stirred for 4 days after which it was quenched with AcOH, concentrated in vacuo. The 
remaining solid was subsequently purified by gel filtration and lyophilized 3 times yielding 29 as a 
white amorphous solid (51 mg, 42%). 1H NMR (600 MHz, CDCl3): δ = 1.86-1.91 (m, 2H, CH2 
C3H6N3), 3.01-3.06 (m, 2H, H-2 or H-2’’ or H-2’’’’), 3.14-3.18 (m, 1H, H-2 or H-2’’ or H-2’’’’), 
3.41-3.50 (m, 8H), 3.60 (t, 1H, J = 9 Hz), 3.63-3.67 (m, 4H), 3.69-3.78 (m, 7H), 3.86-3.93 (m, 6H), 
3.96-4.00 (m, 1H, CH2 C3H6N3), 4.59 (d, 1H, J = 8.4 Hz, H-1 or H-1’ or H-1’’ or H-1’’’ or H-1’’’’), 
4.65 (d, 1H, J = 8.4 Hz, H-1 or H-1’ or H-1’’ or H-1’’’ or H-1’’’’), 4.66 (d, 1H, J = 8.4 Hz, H-1 or H-
1’ or H-1’’ or H-1’’’ or H-1’’’’), 4.70 (d, 1H, J = 9.0 Hz, H-1 or H-1’ or H-1’’ or H-1’’’ or H-1’’’’), 
4.73 (d, 1H, J = 8.4 Hz, H-1 or H-1’ or H-1’’ or H-1’’’ or H-1’’’’); 13C NMR (150 MHz): δ = 28.2 
(CH2 C3H6N3), 48.0 (CH2 C3H6N3), 55.0, 55.2, 55.7 (C-2, C-2’’, C-2’’’’), 60.3, 60.3, 60.4 (C-6, C-6’’, 
C-6’’’’), 67.6 (CH2 C3H6N3), 67.8, 68.0, 69.5, 72.2, 72.6, 72.7, 74.1, 74.5, 74.7, 75.8, 75.9, 76.2, 80.0, 
80.1 (C-3, C-4, C-5, C-2’, C-3’, C-4’, C-3’’, C-4’’, C-5’’, C-2’’’, C-3’’’, C-4’’’, C-3’’’’, C-4’’’’, C-
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5’’’’), 82.4, 83.3 (C-5’, C-5’’’), 99.1, 99.5, 100.2, 101.8, 102.1 (C-1, C-1’, C-1’’, C-1’’’, C-1’’’’), 
174.8, 174.8 (COOH); HRMS: C33H56N6O28 + H+ requires 937.3368, found 937.3376. 
azidopropyl (2-
deoxy-2-
acetamido-3-O-(4-
O-(2-deoxy-2-
acetamido-3-O-(4-O-(2-deoxy-2-acetamido-β-D-glucopyranosyl)-β-D-glucopyranosyl) uronate)-
β-D-glucopyranosyl)-β-D-glucopyranosyl) uronate)-β-D-glucopyranoside (30). Zwitterionic HA-
pentasaccharide 29 (12 mg, 0.013 mmol) was dissolved in MeOH (5 ml) and Ac2O (0.5 ml) was 
added. After 4 hours this mixture was co-evaporated three times with toluene and concentrated in 
vacuo. When NMR-revealed additional methyl ester signals, the residue was dissolved in H2O and 
LiOH (0.1 ml, 0.5 M) was added. The mixture was stirred for 2 hour and quenched with AcOH till 
neutral and concentrated in vacuo. The remaining solid was subsequently purified by gel filtration and 
lyophilized 3 times yielding 30 as a white amorphous solid (10 mg, 74%). 1H NMR (400 MHz, 
CDCl3): δ = 1.84-1.88 (m, 2H, CH2 C3H6N3), 2.05 (s, 6H, CH3 Ac), 2.07 (s, 3H, CH3 Ac), 3.37-3.40 
(m, 4H), 3.47-3.62 (m, 10H), 3.69-3.86 (m, 14H), 3.92-4.12 (m, 4H), 4.48 (d, 1H, J = 7.6 Hz, H-1 or 
H-1’ or H-1’’ or H-1’’’ or H-1’’’’), 4.49 (d, 1H, J = 8.0 Hz, H-1 or H-1’ or H-1’’ or H-1’’’ or H-
1’’’’), 4.54 (d, 1H, J = 8.4 Hz, H-1 or H-1’ or H-1’’ or H-1’’’ or H-1’’’’), 4.55 (d, 1H, J = 9.6 Hz, H-1 
or H-1’ or H-1’’ or H-1’’’ or H-1’’’’), 4.57 (d, 1H, J = 8.8 Hz, H-1 or H-1’ or H-1’’ or H-1’’’ or H-
1’’’’); 13C NMR (100 MHz): δ = 22.2 (CH3 Ac), 22.4 (CH3 Ac), 22.5 (CH3 Ac), 28.1 (CH2 C3H6N3), 
47.8 (CH2 C3H6N3), 54.3, 54.6, 55.4 (C-2, C-2’’, C-2’’’’), 60.5, 60.5, 60.7 (C-6, C-6’’, C-6’’’’), 67.2 
(CH2 C3H6N3), 68.4, 68.6, 69.7, 72.5, 72.5, 73.6, 73.9, 75.4, 75.9, 76.3, 76.4, 79.8, 80.0, 82.2, 82.6 
(C-3, C-4, C-5, C-2’, C-3’, C-4’, C-3’’, C-4’’, C-5’’, C-2’’’, C-3’’’, C-4’’’, C-3’’’’, C-4’’’’, C-5’’’’), 
100.6, 100.7, 101.0, 103.1, 103.1 (C-1, C-1’, C-1’’, C-1’’’, C-1’’’’), 174.1, 174.2, 174.6, 174.9, 174.9 
(C=O Ac, COOH); HRMS: C39H62N6O28 + H+ requires 1063.3685, found 1063.3694. 
azidopropyl (2-deoxy-2-amino-3-O-(4-O-(2-deoxy-2-amino-3-O-(4-O-(2-deoxy-2-amino-3-O-(4-
O-(2-deoxy-2-amino-β-D-glucopyranosyl)-β-D-glucopyranosyl) uronate)-β-D-glucopyranosyl)-β-
D-glucopyranosyl) uronate)-β-D-glucopyranosyl)-β-D-glucopyranosyl) uronate) -β-D-
glucopyranoside (31). Fully protected HA heptamer 26 (0.261 g, 0.082 mmol) was dissolved in THF 
(1.6 ml) and Et3N/ 3HF (0.107 ml, 0.656 mmol) was added. After 2 hour the mixture was diluted with 
EtOAc and was washed with NaHCO3 (aq). The water layer was extracted twice with EtOAc the 
collected organic layers were dried over MgSO4 and concentrated in vacuo. The resulting syrup was 
then dissolved in THF (1.6 ml) and H2O (1.6 ml) and a 0.5 M solution of KOH in H2O (0.164 ml, 
1.23 mmol) was added stepwise (per 1 equiv.) over a period of 10 h. The reaction mixture was stirred 
for 4 days after which it was quenched with AcOH, concentrated in vacuo. The remaining solid was 
subsequently purified by gel filtration and lyophilized 3 times yielding 31 as a white amorphous solid 
(64 mg, 59%). 1H NMR (600 MHz, CDCl3): δ = 1.86-1.90 (m, 2H, CH2 C3H6N3), 2.93 (t, 1H, J = 9.6 
Hz, H-2 or H-2’’ or H-2’’’’ or H-2’’’’’’), 2.98 (t, 1H, J = 10.2 Hz, H-2 or H-2’’ or H-2’’’’ or H-
2’’’’’’), 3.08 (t, 2H, J = 9.6 Hz, H-2 or H-2’’ or H-2’’’’ or H-2’’’’’’), 3.41-3.49 (m, 11H), 3.55 (t, 1H, 
J = 9.6 Hz), 3.59-3.80 (m, 18H), 3.87-3.91 (m, 7H), 3.96-3.99 (m, 1H, CH2 C3H6N3), 4.50 (d, 1H, J = 
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8.4 Hz, H-1 or H-1’ or H-1’’ or H-1’’’ or H-1’’’’ or H-1’’’’’, or h-1’’’’’’), 4.62-4.63 (M, 4H, H-1 or 
H-1’ or H-1’’ or H-1’’’ or H-1’’’’ or H-1’’’’’, or h-1’’’’’’), 4.64 (d, 1H, J = 8.4 Hz, H-1 or H-1’ or H-
1’’ or H-1’’’ or H-1’’’’ or H-1’’’’’, or h-1’’’’’’), 4.68 (d, 1H, J = 8.4 Hz, H-1 or H-1’ or H-1’’ or H-
1’’’ or H-1’’’’ or H-1’’’’’, or h-1’’’’’’); 13C NMR (150 MHz): δ = 28.2 (CH2 C3H6N3), 48.0 (CH2 
C3H6N3), 55.3, 55.3, 55.5, 55.8 (C-2, C-2’’, C-2’’’’, C-2’’’’’’), 60.3, 60.3, 60.4 (C-6, C-6’’, C-6’’’’, 
C-6’’’’’’), 67.5 (CH2 C3H6N3), 67.9, 67.9, 68.1, 69.5, 72.6, 72.8, 74.2, 74.2, 74.7, 74.9, 75.0, 75.8, 
75.8, 76.2, 80.1, 80.2 (C-3, C-4, C-5, C-2’, C-3’, C-4’, C-3’’, C-4’’, C-5’’, C-2’’’, C-3’’’, C-4’’’, C-
3’’’’, C-4’’’’, C-5’’’’,C-2’’’’’, C-3’’’’’, C-4’’’’’, C-3’’’’’’, C-4’’’’’’, C-5’’’’’’), 83.4, 83.5, 84.7 (C-
5’, C-5’’’, C-5’’’’’), 99.6, 99.6, 100.3, 101.2, 102.2, 102.2, 102.5 (C-1, C-1’, C-1’’, C-1’’’, C-1’’’’, 
C-1’’’’’, C-1’’’’’’), 174.7, 174.7, 174.8 (COOH); HRMS: C45H75N7O35 + H+ requires 1274.4377, 
found 1274.4395. 
xazidopropyl (2-deoxy-2-acetamido-3-O-(4-O-(2-deoxy-2-acetamido-3-O-(4-O-(2-deoxy-2-
acetamido-3-O-(4-O-(2-deoxy-2-acetamido-β-D-glucopyranosyl)-β-D-glucopyranosyl) uronate)-
β-D-glucopyranosyl)-β-D-glucopyranosyl) uronate)-β-D-glucopyranosyl)-β-D-glucopyranosyl) 
uronate) -β-D-glucopyranoside (32). Zwitterionic HA-heptasaccharide 31 (11 mg, 0.0089 mmol) 
was dissolved in MeOH (5 ml) and Ac2O (0.5 ml) was added. After 4 hours this mixture was co-
evaporated three times with toluene and concentrated in vacuo. When NMR-revealed additional 
methyl ester signals, the residue was dissolved in H2O and LiOH (0.1 ml, 0.5 M) was added. The 
mixture was stirred for 2 hour and quenched with AcOH till neutral and concentrated in vacuo. The 
remaining solid was subsequently purified by gel filtration and lyophilized 3 times yielding 32 as a 
white amorphous solid (10 mg, 78%). 1H NMR (400 MHz, CDCl3): δ = 1.80-1.84 (m, 2H, CH2 
C3H6N3), 2.00 (s, 6H, CH3 Ac), 2.01 (s, 6H, CH3 Ac), 2.03 (s, 3H, CH3 Ac), 3.30-3.37 (m, 5H), 3.43-
3.58 (m, 13H), 3.60-3.72 (m, 17H), 3.74-3.84 (m, 3H), 3.88-3.95 (m, 4H), 3.96-3.98 (m, 1H), 4.43-
4.54 (m, 7H, H-1, H-1’, H-1’’, H-1’’’, H-1’’’’, H-1’’’’’, H-1’’’’’’); 13C NMR (100 MHz): δ = 22.2 
(CH3 Ac), 22.4 (CH3 Ac), 22.4 (CH3 Ac), 28.0 (CH2 C3H6N3), 47.7 (CH2 C3H6N3), 54.3, 54.3, 54.5, 
55.3 (C-2, C-2’’, C-2’’’’, C-2’’’’’’), 60.5, 60.6 (C-6, C-6’’, C-6’’’’, C-6’’’’’’), 67.1 (CH2 C3H6N3), 
68.4, 68.5, 69.6, 72.4, 73.5, 73.8, 75.3, 75.8, 76.2, 76.4, 79.7, 79.9 (C-3, C-4, C-5, C-2’, C-3’, C-4’, 
C-3’’, C-4’’, C-5’’, C-2’’’, C-3’’’, C-4’’’, C-3’’’’, C-4’’’’, C-5’’’’,C-2’’’’’, C-3’’’’’, C-4’’’’’, C-
3’’’’’’, C-4’’’’’’, C-5’’’’’’), 82.1, 82.5 (C-5’, C-5’’’, C-5’’’’’), 100.6, 100.9, 103.1 (C-1, C-1’, C-1’’, 
C-1’’’, C-1’’’’, C-1’’’’’, C-1’’’’’’), 174.1, 174.2, 174.6, 174.8, 174.9 (C=O Ac, COOH); HRMS: 
C53H83N7O39 + H+ requires 1442.4799, found 1442.4819. 
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Chapter 5 
Stereoselective Synthesis of L-Guluronic Acid Alginates1 
Introduction 
Alginates are naturally occurring polysaccharides composed of 1,2-cis-linked L-guluronic 
and D-mannuronic acid residues that are arranged in homopolymer (polyguluronate and 
polymannuronate) or heteropolymer (a mixed sequence of these residues) sections (Figure 
1). Alginate polymers, isolated from marine brown algae (Phaeophyta),2 are used for food, 
textile and pharmaceutical purposes.3 Bacteria, such as Pseudomonas aeruginosa also 
produce alginates as exopolysaccharides, and alginate oligomers appear to have cytokine-
inducing activities by binding to Toll-like receptors (TLRs) 2 and 4.4 With the objective to 
evaluate the immunomodulating properties of carbohydrate structures, attention is directed 
to the development of synthetic routes towards well-defined alginate fragments. 
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Alginate oligosaccharide consisting of D-mannuronic acid and L-guluronic acid 
In this framework, the synthesis of 1,4-β-linked D-mannuronic acid oligomers have recently 
been reported using 1-S-phenyl mannuronic acid pyranosides.5 The study described in this 
chapter focuses on the development of a synthetic route to the corresponding 1,4-α-linked 
L-guluronic acid oligomers. Analogously to other acidic oligosaccharides,6 the carboxylate 
function in L-guluronic acid oligomers can be introduced at the monosaccharide stage by 
the use of suitably protected L-guluronate ester building blocks or at the oligomer level by 
selective deprotection and oxidation of the incorporated orthogonally protected L-gulose 
residues. Which route of synthesis is more efficient relies on the glycosylation properties of 
L-guluronate ester and L-gulose donors, respectively. Up to now, L-gulose donors have only 
been employed in the total synthesis of bleomycin,7 and L-guluronate ester donors are 
completely unexplored. The present Chapter describes an evaluation of the glycosylating 
properties of gulose and guluronate ester donors and the first synthesis of a guluronic acid 
trimer. It is revealed that gulopyranose has a very high tendency to form 1,2-cis-linkages 
(α-linkages) without the need to incorporate stereodirecting groups, as is the case for most 
other pyranosides. 
Results and Discussion 
L-Gulose and L-guluronic acid are C5-epimers of D-mannose and mannuronic acid, 
respectively, and not commercially available. Therefore the first aim was to develop a 
scalable route for the synthesis of L-gulopyranose, modified with an anomeric thio function 
for ensuing glycosylations. A practical approach was found in the use of L-gulonic acid γ-
lactone (1), which is commercially available at reasonable cost. The transformation of this 
lactone into S-phenyl-β-L-gulopyranose 6 is depicted in Scheme 1 and starts with protection 
of the four hydroxyls by treatment of 1 with dimethoxy propane in the presence of H2SO4. 
The lactone was reduced using DIBAL-H in toluene (2),8 and acidic hydrolysis of both 
acetonides delivered the hygroscopic L-gulose (3), which was immediately acetylated to 
give per-acetyl gulose 4. Lewis acid mediated introduction of the anomeric thiophenol 
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resulted in an inseparable α/β mixture of thioglycosides. Alternatively, transformation of 4 
into the anomeric bromide and ensuing treatment with PhSH under phase transfer 
conditions9 gave thioguloside 5 as a single anomer, which was deacetylated to furnish S-
phenyl-β-L-gulopyranose 6. The sequence of reactions for the preparations of 6 required 
only one chromatographic purification and can be performed on a 500 mmol scale (100 g). 
Standard protecting group manipulations on 6 delivered gulose donor 7 and guluronate 
ester 9.10  
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Synthesis of S-phenyl-β-L-gulopyranose 7 and 9. Reagents and conditions: a) i. Acetone, 
dimethoxypropane, H2SO4; ii. Toluene, DIBAL-H, 0 °C, 84% (over 2 steps); b) 20% TFA in H2O, 
quant.; c) Pyridine, Ac2O, 72%; d) i. AcOH, HBr; ii. EtOAc, Bu4NHSO4, Na2CO3, PhSH, H2O, 66% 
(over 2 steps); e) MeOH, NaOMe (cat), 97%; f) DMF, BnBr, NaH, 0 °C to rT, 89%; g) i. Pyridine, 
TrCl; ii. DMF, BnBr, NaH, 0 °C to rT; iii. MeOH, pTsOH (cat) 88% (over 3 steps); h) i. DCM, H2O, 
TEMPO, BIAB; ii. DMF, K2CO3, MeI, 72% (over 2 steps). 
The glycosylating properties of these donors were examined by condensation with 
acceptors 10, 11 and 12.11 Each donor was activated with diphenyl sulfoxide (Ph2SO) and 
triflic anhydride (Tf2O) in the presence of tri-tert-butylpyrimidine (TTBP) in DCM at -78 
°C (donor 7) or -45 °C (donor 9). After complete activation the temperature was adjusted to 
-78 °C, and then 1.5 equiv. of the acceptor was added and the reaction mixture was allowed 
to warm to 0 °C. As recorded in Table 1, condensation of primary acceptor 10 with gulose 
7 gave almost exclusively the α-product, while the reaction of guluronate ester donor 9 with 
10 proceeded with slightly lower anomeric stereoselectivity. Gulosylation of the secondary 
acceptors 11 and 12 proceeded with high α-selectivity for both the gulose and guluronate 
ester. Apparently, both gulose and guluronate ester have an unusually strong preference for 
the formation of α-glycosidic bonds. 
Chapter 5 
78 
Table 1 
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Entry Donor Acceptor Yield %, (α/β) Product 
1 7a 10 71% (13/1) 13 
2 7a 11 91% (10/1) 14 
3 7a 12 73% (α only) 15 
4 9b 10 73% (3/1) 16 
5 9b 11 94% (α only) 17 
6 9b 12 79% (10/1) 18 
Glycosylations of S-phenyl-β-L-gulopyranose donors 7[a] and 9[b]. Reagents and conditions: a) Ph2SO, 
TTBP, DCM, -78 °C, Tf2O 10 min, nucleophile, to 0 °C; b) Ph2SO, TTBP, DCM, -45 °C, Tf2O 10 
min, then -78 °C, nucleophile, to 0 °C. 
To explore the effect of different protecting groups on the α-selectivity and to find the most 
convenient building block for the synthesis of guluronic acid alginates, guluronate ester 
(22) and three differently protected gulose donors (19, 24, and 25) were investigated. The 
conformationally constrained 4,6-O-benzylidene gulose 19 and 4,6-O-di-tert-
butylsilylidene (DTBS) gulose 25 were selected on the basis of the reputation of the acetal 
protective group to influence the stereochemical outcome of glycosylations.12,13 The gulosyl 
donor 24 and the guluronyl ester donor (22), having a selectively removable levulinoyl 
ester at the OH-4 position, were selected to allow elongation of alginate oligomers with 
minimal protective group manipulations. All four donor building blocks were assembled 
from phenyl S-phenyl-β-L-gulopyranose 6 as depicted in Scheme 2. Installment of the 4,6-
O-benzylidene acetal on 6 and subsequent benzylation yielded 4,6-O-benzylidene protected 
gulosyl donor 19. Guluronyl ester donor 22 was prepared by acidic cleavage of the 
benzylidene acetal of 19, regio- and chemoselective oxidation of the primary hydroxyl in 
diol 20 by 2,2,6,6-tetramethyl-1-piperidinyloxy (TEMPO)/ [bis(acetoxy)iodo]benzene 
(BAIB), methylation of the carboxylic acid with TMSCH2N2 and levulinoylation of the C4-
OH in 21. Protection of C6-OH of diol 20 with a tert-butyldimethylsilyl group and 
levulinoylation of the remaining alcohol furnished donor 24. Treatment of tetraol 6 with di-
tert-butylsilyl bistriflate in pyridine at -20 °C followed by benzylation of the crude product 
afforded di-O-tert-butylsilylidene gulose 25 (Scheme 2). 
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Scheme 2 
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Synthesis of gulose building blocks 19, 22, 24, and 25. Reagents and conditions: a) i. MeCN, 
PhCH(OMe)2, pTsOH (cat); ii. DMF, BnBr, NaH, 0 °C to rT, 70% (over 2 steps); b) MeOH, pTsOH 
(cat), quant.; c) i. DCM, H2O, TEMPO, BIAB; ii. Et2O, TMSCH2N2, 49% (over 2 steps); d) Pyridine, 
dioxane, Lev2O, 95%; e) DMF, TBDMSCl, imidazole, 0 °C to rT, 90%; f) Pyridine, dioxane, Lev2O, 
94%; g) i. Pyridine, (tBu)2Si(OTf)2, -20 °C to rT; ii. DMF, BnBr, NaH, 0 °C to rT, 88% (over 2 
steps). 
Having the thioglycoside donors 19, 22, 24, and 25 in hand, the first focus was to establish 
the glycosylating properties of thioguluronate ester 22 (Table 2). For comparative reasons 
22 was condensed with model acceptors 10 and 11. In line with the glycosylations of 
compound 9, levulinoyl donor 22 gave moderate α-selectivity when primary alcohol 10 was 
used and completely α-selective when secondary acceptor 11 was employed (entries 1 and 
2). Next, donor 22 was coupled with 3-azidopropanol (26) and 3-azidopropyl methyl (2,3-
O-benzyl-α-L-gulopyranoside) uronate 27. In contrast to the gulosylations described above, 
the β-product prevailed in the condensation with 22 and the more reactive primary alcohol 
26 (entry 3). The di-uronate 30 was formed in low yield from 22 and 27, again with α-
selectivity (entry 4). The gulosyl donors 19, 24 and 25 all provided predominantly the 1,2-
cis linked products. Thus, the presence of the C5 carboxylic acid ester does not contribute 
favourably in forming the α-gulosidic linkage. Since the DTBS protected donor 25 showed 
the best α-selectivity of the three thiogulosides examined, this compound was employed for 
the synthesis of a guluronic alginate trimer (Scheme 3). 
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Entry Donor Acceptor Yield %, (α/β) Product 
1 22a 10 66% (3/1) 29 
2 22a 11 64% (α) 30 
3 22a 26 77% (1/3) 31 
4 22a 27 34% (3/1) 32 
5 24b 26 86% (3/1) 33 
6 24b 28 48% (6/1) 34 
7 19b 26 88% (3/1) 35 
8 19b 28 45% (6/1) 36 
9 25b 26 75% (5/1) 37 
10 25b 28 48% (10/1) 38 
Glycosylations of orthogonally protected β-S-phenyl-L-gulose donors. Reagents and conditions: a) 
Ph2SO, TTBP, DCM, -45 °C, Tf2O 10 min, then -78 °C, nucleophile, to 0 °C; b) Ph2SO, TTBP, 
DCM, -78 °C, Tf2O 10 min, nucleophile, to 0 °C. 
It is clear that the guluronate ester (27) and gulose (28) C4-OH  are poor nucleophiles 
leading to moderate yields in the gulosylations (Table 2, entries 4, 6, 8 and 10). These 
moderate yields were attribute to a reactivity mismatch of the coupling partners,14 since in 
the condensation reactions all donor guloside was consumed while some of the acceptor 
remained untouched. Other promotor systems were investigated to modulate the reactivity 
of the activated donor species. NIS/TMSOTf mediated glycosylations resulted in the same 
stereoselectivity while the yield was not improved and IDCP15 did not give any productive 
couplings.  Next, a dehydrative condensation strategy, as originally devised by Gin and co-
workers16 was explored. This type of glycosylations is well suited for inreactive 
nucleophiles, since the activated sulfoxonium species is relatively stable and survives 
longer at higher temperatures.17 Therefore thiogulose 25 was hydrolyzed using the 
procedure described in Chapter 2 (NIS/TFA),18 to give hemiacetal donor 39 (Scheme 3). 
This lactol was activated by Ph2SO/Tf2O and coupled with gulose 28 to provide 
disaccharide 38 in a slightly improved yield (55%). Importantly, the excellent α-
stereoselectivity of DTBS-protected gulose 25 was maintained and thus shown to be 
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independent of the activation method. Changing the donor/acceptor ratio (1.2:1 to 2:1) 
further increased the yield to 84%. Next, the C4’-OH function of 38 was liberated in two 
steps and subsequently elongated by glycosylation using 2 equivalents of 39. Trimer 42 was 
obtained as a single diastereomer, albeit in a moderate 42% yield. Introduction of the 
carboxylate functions was achieved by first desilylation of dimer 38 and trimer 42 and 
subsequent TEMPO/BAIB mediated oxidation. The primary alcohols 40 and 43 were 
smoothly transformed into the corresponding aldehydes, but that ensuing oxidation to the 
acid stage was troublesome. Addition of tBuOH to homogenize the biphasic (DCM/H2O) 
reaction mixture enhanced the rate of aldehyde hydration, thereby allowing the efficient 
oxidation of the lipophilic substrates.19 Hydrogenolysis completed the synthesis and the di- 
and triacid 44 and 45 were isolated in 90% and 85% yield respectively over the two final 
steps. 
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Synthesis of the alginate di and trisaccharide 44 and 45. Reagents and conditions: a) DCM, NIS, TFA, 
95%; b) Ph2SO, TTBP, -60 °C, Tf2O, 28, -60 °C to rT, 84% (α/β= 10:1); c) THF, TBAF, 87%; d) 
DMF, TBDMSCl, imidazole, 78%; e) 37, Ph2SO, TTBP, -60 °C, Tf2O, then 41, -60 °C to rT, 42% 
(α); f) THF, TBAF, 83%; g) i. DCM, tBuOH, H2O, TEMPO, BAIB; ii. tBuOH, Pd/C, H2, 44 90%, 45 
85% (over 2 steps). 
Finally, it is appropriate to comment on the unusually high α-selectivity displayed by the 
gulopyranosides described in this chapter. In most pyranosides, an alkoxide aglycon prefers 
to adopt an axial position as dictated by the anomeric effect.20 In gulose however, the 
anomeric effect will be largely offset by the 1,3-diaxial interaction of the α-oriented 
aglycon and the C3-substituent.21 It is therefore not likely that the anomeric effect is at the 
basis of the observed selectivities. Anomeric triflates have convincingly been demonstrated 
to be intermediates in sulfonium mediated glycosylations as practiced here.22 In most cases 
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the anomeric α-triflates serve as a reservoir for the actual glycosylation species, being a 
close ion pair (CIP) or a solvent separated ion pair (SSIP). In the gulosylations at hand, it is 
difficult to predict which anomeric triflate will be the most stable, because also in this case 
the anomeric effect is counterbalanced by steric interactions and both the α- and β-triflate 
may exist in solution. It is unlikely that the α-stereoselectivity in gulosylations arises from 
the selective SN2-type displacement on the β-triflate or β-CIP. Rather, the high α-selectivity 
can originate from an SN1 reaction and the conformational preferences of the intermediate 
solvent separated oxacarbenium ion. As already postulated by Lemieux and Huber in 1954 
(see Chapter 1) the relative stabilities of the oxacarbenium conformers can influence the 
stereochemical outcome of glycosylation reactions.23 Recently the conformational 
restriction of oxacarbenium ions was exploited in the stereoselective synthesis of β-
arabinofuranoses.24 Computational25 and experimental26 data validated that substituents on 
the pyranose ring influence the stability of the oxacarbenium intermediate and thereby 
affect the outcome of a glycosylation reaction. It was shown that electronegative 
substituents at C-3 and C-4 prefer to adopt a pseudo-axial orientation, thereby minimizing 
their electron withdrawing capacity on the oxacarbenium ion. Substituents at C-2 and C-5 
prefer to adopt a pseudo-equatorial orientation, because of hyperconjugative effects for the 
former27 and steric reasons for the latter.25 When these findings are applied to the two likely 
halfchair conformations of the L-gulose oxacarbenium ion intermediate, it becomes clear 
that all substituents occupy their preferred orientation in the 3H4 conformer (Figure 2). 
Contrary, in the 4H3 conformer all substituents are in disfavored positions. An incoming 
nucleophile will approach the oxacarbenium ion following a pseudo axial trajectory, with a 
preference for the diastereotopic face that leads to the more favorable chair-like product.28 
If no prohibitive steric interactions evolve in the transition state leading to the coupled 
product, the L-gulose oxacarbenium ion will react from the 3H4 conformer to form the α-
product (1,2-cis).  
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Oxacarbenium ion model of L-gulose and L-guluronate ester.  
The protecting group pattern on the gulosides has a marginal effect on the stereochemical 
outcome of the condensation reactions. Although the cyclic protecting groups in 19 and 25 
restrict the conformational freedom of the gulopyranoses they do not a priori rule out either 
of the two half chair oxacarbenium ion conformers, since they can be accommodated in 
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both constellations. Participation of the C4-acyl group in 24, as has been suggested in α-
galactosylations,29 does not play a decisive role in the gulosylations described here. In 
comparison with the gulose donors the stereoselectivity of the guluronate esters is 
somewhat decreased. The counter-productive effect of the carboxylic ester can be the result 
of the preference of this group to adopt an axial position (Chapter 1 and 6)5b in the 
oxacarbenium ion, thereby shifting the ratio of the two half chair intermediates and the 
stereochemical outcome of the glycosylations. 
In closing, in this Chapter the glycosylation properties of gulopyranosides are mapped out 
and it is shown that gulose has an intrinsic preference for the formation of α-glycosidic 
bonds. It is postulated that this glycosylation behaviour originates from nucleophilic attack 
at the oxacarbenium ion, which adopts the most favourable 3H4 conformation. Building on 
these results a guluronic acid alginate trisaccharide was assembled for the first time. Insight 
into the influence of the stereochemistry of substituents on the pyranoside ring on the 
stereochemical outcome on a glycosylation will be discussed in Chapter 6. 
Experimental 
General: Dichloromethane was refluxed with P2O5 and distilled before use. Trifluoromethanesulfonic 
anhydride was distilled from P2O5. Traces of water in the donor and acceptor glycosides, 
diphenylsulfoxide and TTBP were removed by co-evaporation with toluene. All other chemicals 
(Acros, Fluka, Merck, Schleicher & Schue) were used as received. Column chromatography was 
performed on Merck silica gel 60 (0.040-0.063 mm). TLC analysis was conducted on HPTLC 
aluminum sheets (Merck, silica gel 60, F245). Compounds were visualized by UV absorption (245 
nm), by spraying with 20% H2SO4 in ethanol or with a solution of (NH4)6Mo7O24·4H2O 25 g/L, 
(NH4)4Ce(SO4)4·2H2O 10 g/L, 10% H2SO4 in H2O followed by charring at +/- 140 °C. 1H and 13C 
NMR spectra were recorded with a Bruker AV 400 (400 and 100 MHz respectively), AV 500 (500 
and 125 MHz respectively) or a Bruker DMX 600 (600 and 150 MHz respectively). NMR spectra 
were recorded in CDCl3 with chemical shift (δ) relative to tetramethylsilane unless stated otherwise. 
Optical rotations were measured on a Propol automatic polarimeter. High resolution mass spectra 
were recorded on a LTQ-orbitrap (thermo electron). IR spectra were recorded on a Shimadzu FTIR-
8300 and are reported in cm-1. 
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2,3-5,6-di-O-isopropylidene-L-gulofuranose (2): To a suspension of L-gulonic acid 
γ-lactone (1) (40.0 g, 225 mmol) and 2,2-dimethoxypropane (71 mL, 788 mmol) in 
acetone (800 mL) was added H2SO4 (5 drops). The mixture was stirred overnight and 
quenched with Et3N until neutral pH. The acetone was removed in vacuo, the residue 
was taken up in Et2O and washed twice with H2O. The organic layer was dried over 
MgSO4 and concentrated in vacuo. The residue was dissolved in toluene (2.0 L) and 
at 0 °C DIBAL-H (137 mL, 1.7 M solution in toluene) was slowly added. After 20 
minutes the mixture was quenched with EtOAc (20 mL), under vigorous stirring 2 M 
NaOH (215 mL) was added and the mixture was filtered over Hyflo Gel. The aqueous layer was 
extracted twice with EtOAc, the combined organic layers dried over MgSO4 and concentrated in 
vacuo to afford 2 as white solid (49 g, 84%). IR (neat): 1091, 1263, 1380, 1454, 2986, 3445 cm-1; 1H 
NMR (400 MHz, CDCl3): δ = 1.29 (s, 3H, CH3 isoprop), 1.39 (s, 3H, CH3 isoprop), 1.45 (s, 6H, 2 x 
CH3 isoprop), 3.44 (d, 1H, J = 2.0 Hz, OH), 3.74 (dd, 1H, J = 7.2 Hz, 8.4 Hz, H-6), 4.13 (dd, 1H, J = 
3.6 Hz, 8.4 Hz, H-4), 4.21 (dd, 1H, J = 6.4 Hz, 8.4 Hz, H-6), 4.37 (dd, 1H, J = 6.8 Hz, 8.4 Hz, H-5), 
4.63 (d, 1H, J = 5.6 Hz, H-2), 4.70 (dd, 1H, J = 3.8 Hz, 5.8 Hz, H-3), 5.46 (d, 1H, J = 2.0 Hz, H-1) ; 
13C NMR (100 MHz): δ = 24.7 (CH3 isoprop), 25.4 (CH3 isoprop), 25.9 (CH3 isoprop), 26.7 (CH3 
isoprop), 66.0 (C-6), 75.5 (C-5), 79.8 (C-3), 82.1 (C-4), 85.6 (C-2), 101.3 (C-1), 109.7 (Cq isoprop), 
112.8 (Cq isoprop); HRMS: C12H20O6 + H+ requires 261.1333, found 261.1313. 
L-gulose (3): To a mixture of H2O (870 mL) and TFA (174 mL) at 0 °C was 
added 2 (75.5 g, 290 mmol), after which the mixture was allowed to warm to 
rT. After stirring for 5 h approximately half of the volume was evaporated in 
vacuo. The solution was diluted with H2O (500 mL) and evaporated to half the 
volume. This process was repeated twice and the remaining TFA was quenched with Et3N until 
neutral, it was concentrated in vacuo to obtain 3 as a colorless oil (52.2 g, quantitative). 1H NMR (500 
MHz, D2O): δ = 3.65 (dd, 1H, J = 3.3 Hz, 8.3 Hz, H-2), 3.74-3.79 (m, 2H, H-6, H-6), 3.83 (d, 1H, J = 
3.5 Hz, H-4), 4.02 (t, 1H, J = 6.0 Hz, H-5), 4.09 (t, 1H, J = 3.3 Hz, H-3), 4.90 (d, 1H, J = 8.0 Hz, H-
1); 13C NMR (125 MHz): δ = 60.56 (C-6), 68.64-73.66 (C-2, C-3, C-4, C-5), 93.39 (C-1); HRMS: 
C6H12O6 + Na+ requires 203.05261, found 203.05262. 
Penta-O-Acetyl-L-gulopyranose (4): Gulose (3) (52.2 g, 290 mmol) was 
dissolved in pyridine (1 L) and cooled to 0 °C. After addition of Ac2O (200 
mL) the mixture was allowed to stir overnight at room temperature. The 
reaction was quenched with MeOH and concentrated in vacuo. The mixture was diluted with EtOAc, 
washed with 1M HCl (aq), NaHCO3 (aq) and brine. The organic layer was dried over MgSO4 and 
concentrated in vacuo yielding 4 as a dark yellow oil (96.6 g, 72%). IR (neat): 1065, 1207, 1369, 
1744 cm-1; 1H NMR major anomer (400 MHz, CDCl3): δ = 2.05-2.17 (5 x s, 15H, 5 x CH3 acetyl), 
4.11 (m, 1H, H-6), 4.17 (m, 1H, H-6), 4.37 (m, 1H, H-5), 5.00 (dd, 1H, J = 1.2 Hz, 4.0 Hz, H-4), 5.12 
(dd, 1H, J = 3.6 Hz, 8.6 Hz, H-2), 5.44 (t, 1H, J = 3.6 Hz, H-3), 6.00 (d, 1H, J = 8.4 Hz, H-1); 13C 
NMR (100 MHz): δ = 20.5-20.9 (CH3 acetyl), 61.5 (C-6), 67.2 (C-3), 67.3 (C-2), 67.5 (C-4), 71.3 (C-
5), 89.9 (C-1), 168.9-170.4 (CO); HRMS: C16H22O11 + Na+ requires 413.10543, found 413.10544. 
Phenyl 2,3,4,6-tetra-O-acetyl-1-thio-β-L-gulopyranoside (5): Per acetyl 
gulose (4) (83.8 g, 215 mmol) was dissolved in AcOH (86 mL) and cooled to 
0 °C. Slowly HBr/AcOH (33%, 102 mL) was added and the mixture was 
stirred at 0 °C for 2h. The reaction was then poured in ice water and extracted twice with EtOAc (2 x 
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250 mL). The organic layers were carefully washed with NaHCO3 (aq) and added to a solution of 
Bu4NHSO4 (730 g, 215 mmol), Na2CO3 (286 g, 1.00 mol) and PhSH (26.4 mL, 258 mmol) in H2O 
(1000 mL). When TLC analysis showed complete consumption of starting material the layers were 
separated and the organic layer was washed with 1M NaOH and brine. The organic layer was dried 
over MgSO4 and concentrated in vacuo. Column chromatography yielded 5 as a slightly yellow oil 
(62.5 g, 66%). [α]D22: -20.6 (c = 1, CHCl3); IR (neat): 1026, 1059, 1209, 1369, 1736 cm-1; 1H NMR 
(600 MHz, CDCl3): δ = 2.01-2.22 (m, 12H, CH3 acetyl), 4.145-4.25 (m, 3H, H-5, H-6, H-6), 4.98 (dd, 
1H, J = 0.8 Hz, 4.0 Hz H-4), 5.05 (m, 2H, H-1, H-2), 5.37 (dd, 1H, J = 2.0 Hz, 3.2 Hz, H-3), 7.26-
7.33 (m, 3H, H Arom SPh), 7.50-7.54 (m, 2H, H Arom SPh); 13C NMR (150 MHz): δ = 20.6-21.0 
(CH3 acetyl), 62.0 (C-6), 66.3 (C-2), 66.8 (C-3), 67.8 (C-4), 72.7 (C-5), 83.0 (C-1), 127.4-132.4 (CH 
Arom), 132.6 (Cq SPh), 168.8-170.4 (CO); HRMS: C20H24O9S + Na+ requires 463.10332, found 
463.10311. 
Phenyl 1-thio-β-L-gulopyranoside (6): 5 (62.5 g, 142 mmol) was dissolved 
in MeOH (750 mL) and a catalytic amount of NaOMe was added. The 
reaction was stirred overnight, quenched with Amberlite H+ and concentrated 
in vacuo. Crystallization from acetone yieled 6 as white crystals (37.5 g, 
97%). [α]D22: +48.6 (c = 1, CHCl3); IR (neat): 974, 1034, 1051, 1412, 3234, 3440 cm-1; 1H NMR (400 
MHz, MeOD): δ = 3.67-3.79 (m, 4H, H-2, H-4, H-6, H-6), 3.92 (t, 1H, J = 5.8 Hz, H-4), 3.97 (t, 1H, J 
= 3.6 Hz, H-3), 5.02 (d, 1H, J = 10.4 Hz, H-1), 7.19-7.29 (m, 3H, H Arom), 7.53-7.56 (m, 2H, H 
Arom); 13C NMR (150 MHz): δ = 62.7 (C-6), 68.1 (C-2), 71.2 (C-5), 72.6 (C-4), 77.3 (C-3), 87.3 (C-
1), 127.8, 129.8, 131.9 (CH Arom), 136.3 (Cq SPh); HRMS: C12H16O5S + Na+ requires 295.06107, 
found 295.06130. 
Phenyl-2,3,4,6-tetra-O-benzyl-1-thio-β-L-gulopyranoside (7): Thiogulose 
(6) (1.54 g, 5.66 mmol) was dissolved in DMF (56 mL) and cooled to 0 °C. 
Respectively, BnBr (3.2 mL, 27 mmol) and NaH (1.08 g, 27 mmol, 60% 
dispersion in oil) were added. After stirring o.n. the mixture was quenched 
with MeOH and concentrated in vacuo. The residue was taken up in Et2O and washed three times 
with H2O, the organic layer was dried over MgSO4 and concentrated in vacuo. Column 
chromatography yielded 7 as colorless oil (3.19 g, 89%). [α]D22: + 9.17 (c = 0.024, DCM). IR (neat): 
741, 1001, 1028, 1076, 1101, 1207, 1360, 1439, 1454, 1497, 2866, 3032, 3061. 1H NMR (400 MHz): 
δ = 3.51 (m, 1H, H-4), 3.57-3.67 (m, 2H, H-6), 3.71 (t, 1H, J = 3.2 Hz, H-3), 3.75 (dd, 1H, J = 2.8 Hz, 
10 Hz, H-2), 4.13 (t, 1H, J = 6.4 Hz, H-5), 4.26 (d, 1H, J = 12 Hz, CH2 Bn), 4.31 (d, 1H, J = 12 Hz, 
CH2 Bn), 4.37 (d, 1H, J = 10.8 Hz, CH2 Bn), 4.40 (d, 1H, J = 8.8 Hz, CH2 Bn), 4.47-4.52 (m, 2H, CH2 
Bn), 4.59 (d, 1H, J = 11.6 Hz, CH2 Bn), 4.66 (d, 1H, J = 12 Hz, CH2 Bn), 5.23 (d, 1H, J = 10 Hz, H-
1), 7.08-7.10 (m, 2H, H Arom), 7.12-7.35 (m, 21 H, H Arom), 7.51-7.60 (m, 2H, H Arom). 13C NMR 
(100 MHz): δ = 69.0 (C-6), 72.4 (CH2 Bn), 72.8 (CH2 Bn), 73.1 (C-3), 73.2 (CH2 Bn), 73.4 (CH2 Bn), 
74.4 (C-5), 74.8 (C-2), 74.9 (C-4), 84.3 (C-1), 126.8-128.6 (CH Arom), 131.4 (CH Arom), 138.2 (Cq 
Bn); HRMS: C40H40O5S + Na+ requires 655.24887, found 655.24860. 
Phenyl-2,3,4-tri-O-benzyl-1-thio-β-L-gulopyranoside (8): 6 (5.45 g, 20 
mmol) was dissolved in pyridine (100 mL), then trityl chloride (8.36 g, 30 
mmol) was added and the reaction was stirred for 3 day’s. The reaction was 
quenched with MeOH and concentrated in vacuo. The mixture was diluted 
with EtOAc, washed with 1M HCl (aq), NaHCO3 (aq) and brine. The organic layer was dried over 
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MgSO4 and concentrated in vacuo. The residue was dissolved in DMF (100 mL) and cooled to 0 °C. 
Respectively, BnBr (8.55 mL, 72 mmol) and NaH (2.88 g, 72 mmol, 60% dispersion in oil) were 
added. After stirring o.n. the mixture was quenched with MeOH and concentrated in vacuo. The 
residue was taken up in Et2O and washed three times with H2O, the organic layer was dried over 
MgSO4 and concentrated in vacuo. The residue was dissolved in DCM (50 mL) MeOH (200 mL) 
after which a catalytic amount of pTsOH was added. The reaction mixture was stirred o.n. The 
reaction mixture was neutralized with Et3N concentrated in vacuo. Column chromatography yielded 8 
as colorless oil (9.58 g, 88%). [α]D22: + 11.8 (c = 0.024, DCM). IR (neat): 739, 922, 1001, 1026, 1042, 
1074, 1207, 1358, 1439, 1454, 1477, 1497, 2878, 3030, 3063. 1H NMR (400 MHz): δ = 3.40 (m, 1H, 
H-3), 3.45-3.53 (m, 1H, H-6), 3.76 (m, 2H, H-2, H-4), 3.80-3.85 (m, 1H, H-6), 3.94-3.97 (m, 1H, H-
5), 4.22 (d, 1H, J = 12 Hz, CH2 Bn), 4.29 (d, 1H, J = 12 Hz, CH2 Bn), 4.40 (d, 1H, J = 12 Hz, CH2 
Bn), 4.49 (d, 1H, J = 12 Hz, CH2 Bn), 4.61 (d, 1H, J = 11.6 Hz, CH2 Bn), 4.71 (d, 1H, J = 12 Hz, CH2 
Bn), 5.23 (d, 1H, J = 9.6 Hz, H-1), 7.07-7.10 (m, 2H, H Arom), 7.23-7.36 (m, 16H, H Arom), 7.55-
7.57 (m, 2H, H Arom). 13C NMR (100 MHz): δ = 62.5 (C-6), 72.1 (CH2 Bn), 72.7 (C-2 or C-4), 72.9 
(CH2 Bn), 73.4 (CH2 Bn), 74.9 (C-2 or C-4), 75.2 (C-3), 75.8 (C-5), 84.0 (C-1), 127.0-128.8 (CH 
Arom), 131.6 (CH Arom), 134.0 (Cq Bn), 137.5 (Cq Bn), 137.8 (Cq Bn), 138.1 (Cq Bn). HRMS: 
C33H34O5S + H+ requires 543.21997, found 543.22015. 
Methyl (phenyl 2,3,4-tri-O-benzyl-1-thio-β-D-gulopyranosyluronate) (9): 
8 (1.95 g, 3.6 mmol) was taken up in DCM (24 mL) and H2O (12 mL). To 
this mixture were added TEMPO (0.115 g, 0.74 mmol) and BAIB (2.89 g, 
9.0 mmol). The mixture was stirred vigorously until TLC-analysis showed 
complete conversion of the starting material. 50 mL Na2S2O3 (aq) was added and the resulting 
mixture was stirred for 15 min. The layers were separated and the aqueous phase acidified with 1M 
HCl and extracted three times with DCM. The combined organic layers were dried over MgSO4 and 
concentrated in vacuo. The residue was taken up in DMF (20 mL) after which K2CO3 (2.49 g, 18 
mmol) and MeI (0.56 mL, 9.0 mmol) were added. After 2 hours the mixture diluted with Et2O (50 
mL) and washed three times with H2O, the organic layer was dried over MgSO4 and concentrated in 
vacuo. Purification by column chromatography yielded 9 as a white solid. (1.48 g, 72%). [α]D22: + 
17.0. IR (neat): 731, 897, 814, 939, 1026, 1074, 1126, 1209, 1265, 1304, 1358, 1420, 1439, 1454, 
1477, 1497, 1734, 1765, 2876. 1H NMR (400 MHz): δ = 3.72-3.75 (m, 4H, H-3, CH3 CO2Me), 3.83 
(dd, 1H, J = 3.2 Hz, J = 10 Hz, H-2), 3.91 (dd, 1H, J = 3.6 Hz, J = 1.6 Hz, H-4), 4.31 (d, 1H, J = 12 
Hz, CH2 Bn), 4.39 (d, 1H, J = 12 Hz, CH2 Bn), 4.41 (d, 1H, J = 12 Hz, CH2 Bn), 4.56 (d, 1H, J = 12 
Hz, CH2 Bn), 4.60 (s, 1H, H-5), 4.61 (d, 1H, J = 12 Hz, CH2 Bn), 4.71 (d, 1H, J = 12.4 Hz, CH2 Bn), 
5.23 (d, 1H, J = 10 Hz, H-1). 13C NMR (100 MHz): δ = 52.1 (CH3 CO2Me), 72.5 (CH2 Bn), 72.7 
(CH2 Bn), 72.7 (C-3), 72.2 (CH2 Bn), 73.9 (C-2), 74.7 (C-5), 76.2 (C-4),84.4 (C-1), 127.2-128.6 (C 
Arom), 132.4 (C Arom), 133.7 (Cq Bn), 137.4 (Cq Bn), 137.7 (Cq Bn), 137.8 (Cq Bn), 169.1 
(COOMe). HRMS: C34H34O6S + NH4+ requires 588.24144, found 588.24210. 
Methyl 2,3,4-tri-O-benzyl-6-O-(2,3,4,6-tetra-O-benzyl-α/β-L-
gulopyranoside) -α-D-glucopyranoside (13): A solution of 
donor 7 (0.127 g, 0.2 mmol), diphenyl sulfoxide (0.045 g, 0.22 
mmol) and tri-tert-butylpyrimidine (0.124 g, 0.5 mmol) in DCM 
(4 ml) was stirred over activated MS 3Å for 30 min. The mixture was cooled to -78 °C before triflic 
anhydride (37 µl, 0.22 mmol) was added. The mixture was stirred for 10 min. at -78 °C followed by 
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addition of acceptor 10 (0.139 g, 0.3 mmol) in DCM (3 ml). Stirring was continued and the reaction 
mixture was allowed to warm to 0 °C and Et3N (0.15 ml) was added. The reaction mixture was 
diluted with DCM and washed with NaHCO3 (aq). The water layer was extracted twice with DCM, 
the collected organic layers were dried over MgSO4 and concentrated in vacuo. Purification by size 
exclusion and column chromatography yielded 13 as a colorless oil (71%, 0.140 g, α/β = 13/1). IR 
(neat): 733, 820, 908, 1026, 1047, 1069, 1194, 1207, 1310, 1327, 1360, 1454, 1497, 2870, 3030, 
3063. Determination of α/β ratio by 1H NMR: 3.25 (s, 3H, OCH3 α), 3.33 (s, 0.22 H, OCH3 β). α 
isomer: 1H NMR (400 MHz): δ = 3.25 (s, 3H, OCH3), 3.38 (dd, 1H, J = 3.6 Hz, J = 9.6 Hz, H-2), 
3.53-3.62 (m, 2H, H-6’), 3.63-3.85 (m, 6H, H-3’, H-4, H-6, H-5, H-2’, H-4’),  3.96 (t, 1H, J = 9.2 Hz, 
H-3), 4.01 (d, 1H, J = 10 Hz, H-6’), 4.33-4.55 (m, 9H, H-5’, CH2 Bn), 4.57 (d, 1H, J = 3.6 Hz, H-1), 
4.68 (d, 1H, J = 12.4 Hz, CH2 Bn), 4.71 (d, 1H, J = 12.4 Hz, CH2 Bn), 4.80 (d, 1H, J = 10.8 Hz, CH2 
Bn), 4.83 (d, 1H, J = 12 Hz, CH2 Bn), 4.93 (d, 1H, J =10.8 Hz, CH2 Bn), 4.98 (d, 1H, J = 3.2 Hz, H-
1’). 13C NMR (100 MHz): δ = 54.8 (OCH3), 65.5 (C-5), 67.2 (C-6’), 68.8 (C-6), 70.1 (C-4’), 71.1 
(CH2 Bn), 72.7 (C-2’), 72.7 (CH2 Bn), 72.8 (CH2 Bn), 73.0 (CH2 Bn), 73.1 (CH2 Bn), 74.2 (C-5’), 74.8 
(CH2 Bn), 75.5 (CH2 Bn), 75.6 (C-3’), 77.9 (C-4’), 80.2 (C-2), 82.0 (C-3), 97.7 (C-1’), 97.8 (C-1), 
127.1-128.3 (CH Arom), 138.1 (Cq Bn), 138.3 (Cq Bn), 138.4 (Cq Ph), 138.5 (Cq Bn), 138.8 (Cq Bn), 
139.1 (Cq Bn), 139.4 (Cq Bn). HRMS: C62H66O11 + NH4+ requires 1004.49434, found 1004.49579. 
Methyl 2,3,6-tri-O-benzyl-4-O-(2,3,4,6-tetra-O-benzyl-α/β-L-
gulopyranoside) -α-D-glucopyranoside (14): As described for 
the synthesis of 13 using acceptor 11 (0.139 g, 0.3 mmol). 
Purification by size exclusion and column chromatography 
yielded 14 as a colorless oil (91%, 0.179 g, α/β = 10/1). IR (neat): 732, 909, 1027, 1454, 2866, 3030. 
Determination of α/β ratio by 1H NMR: 5.11 (d, 1H, J = 4.0 Hz, H-1’ α), 5.38 (d, 0.09H, J = 8.0 Hz, 
H-1’ β); α isomer: 1H NMR (400 MHz): δ = 3.34 (s, 3H, CH3 OMe), 3.45 (m, 1H), 3.51 (dd, 1H, J = 
3.6 Hz, 8.8 Hz), 3.60 (m, 1H), 3.68 (t, 1H, J = 3.2 Hz), 3.73 (m, 1H, H-2’), 3.76-3.89 (m, 4H), 4.09 
(d, 1H, J = 11.6 Hz, CH2 Bn), 4.15 (d, 1H, J = 11.6 Hz, CH2 Bn), 4.26-4.40 (m, 7H), 4.51-4.56 (m, 
3H, H-1), 4.66 (d, 1H, J = 8.8 Hz, CH2 Bn), 4.68 (d, 1H, J = 8.8 Hz, CH2 Bn), 4.88 (d, 1H, J = 11.2 
Hz, CH2 Bn), 4.95 (d, 1H, J = 11.2 Hz, CH2 Bn), 5.11 (d, 1H, J = 4.0 Hz, H-1’), 7.08-7.30 (m, 35H, 
CH Arom); 13C NMR (100 MHz): δ = 54.9 (CH3 OMe), 65.3, 68.1, 68.9, 70.1, 71.3, 72.6, 72.7, 72.8, 
72.9, 73.0, 73.1, 73.3, 73.9, 74.5, 75.8, 80.3, 80.5, 97.6 (C-1’), 97.8 (C-1), 126.8-128.7 (CH Arom), 
137.9-139.5 (Cq Bn); ESI-MS: 987.5 (M+H+). 
p-Methoxyphenyl-2-O-benzyl-(2,3,4,6-tetra-O-benzyl-α-L-
gulopyranoside)-4,6-benzylidene-β-D-galactopyranoside (15): 
As described for the synthesis of 13 using acceptor 12 (0.139 g, 
0.3 mmol). Purification by size exclusion and column 
chromatography yielded 15 as a colorless oil (73%, 0.144 g). IR 
(neat): 731, 824, 872, 910, 997, 1026, 1065, 1080, 1173, 1217, 
1265, 1308, 1367, 1454, 1506, 2866, 3030. Determination of α/β 
ratio by 1H NMR: δ = 5.47 (s, 0.07 H, CH benzylidene β), 5.55 
(s, 1H, CH benzylidene α). α anomer: 1H NMR (400 MHz): δ = 3.28 (s, 1H, H-6), 3.43 (dd, 1H, J = 
10 Hz, H-6), 3.57-3.60 (m, 1H, H-4’), 3.62 (t, 1H, J = 10 Hz, H-5’), 3.68 (dd, 1H, J = 10 Hz, J = 3.6 
Hz, H-3), 3.71 (s, 1H, H-6’), 3.86 (m, 1H, H-2’), 3.90 (m, 1H, H-3’), 4.03-4.10 (m, 2H, H-2, H-6), 
4.30-4.49 (m, 6H, CH2 Bn), 4.58-4.63 (m, 2H, H-4, CH2 Bn), 4.71-4.72 (m, 1H, H-5), 4.76 (d, 1H, J = 
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11.2 Hz, CH2 Bn), 4.87-4.90 (m, 2H, H-1, CH2 Bn), 5.23 (d, 1H, J = 3.6 Hz, H-1’), 5.55 (s, 1H, CH 
benzylidene), 6.74-6.76 (m, 2H, H Arom), 6.99-7.01 (m, 2H, H Arom), 7.12-7.31 (m, 35H, H Arom), 
7.38-7.40 (m, 3H, H Arom), 7.50-7.52 (m, 2H, H Arom). 13C NMR (100 MHz): δ = 55.5 (OCH3 
pMP), 66.6 (C-5), 68.5 (C-6), 70.9 (C-6’), 70.9 (C-4), 72.0 (C-3’), 72.5 (CH2 Bn), 72.8 (CH2 Bn), 
73.8 (CH2 Bn), 74.3 (C-2’), 75.1 (C-5’), 75.1 (CH2 Bn), 76.8 (C-4’), 77.0 (C-2), 82.8 (C-3), 99.5 (CH 
benzylidene), 100.7 (C-1’), 102.7 (C-1), 114.2 (CpMP), 118.9 (CpMP), 125.2-128.3 (CH Arom), 137.7 
(Cq Bn), 138.9 (Cq Bn), 138.1 (Cq Bn), 138.3 (Cq Bn), 138.9 (Cq Bn), 139.0 (Cq Bn), 151.6 (Cq Bn), 
155.0 (Cq Bn). HRMS: C61H62O12 + NH4+ requires 1004.45795, found 1004.45946. 
Methyl 2,3,4-tri-O-benzyl-6-O-(methyl (2,3,4-tri-O-benzyl-α/β-L-
gulopyranosyl)uronate) -α-D-glucopyranoside (16): A solution of 
donor 7 (0.114 g, 0.2 mmol), diphenyl sulfoxide (0.045 g, 0.22 mmol) 
and tri-tert-butylpyrimidine (0.124 g, 0.5 mmol) in DCM (4 ml) was 
stirred over activated MS 3Å for 30 min. The mixture was cooled to -
60 °C before triflic anhydride (37 µl, 0.22 mmol) was added. The 
mixture was warmed to -45 °C then cooled to -78 °C followed by 
addition of acceptor 10 (0.139 g, 0.3 mmol) in DCM (3 ml). Stirring was continued and the reaction 
mixture was allowed to warm to 0 °C and Et3N (0.15 ml) was added. The reaction mixture was 
diluted with DCM and washed with NaHCO3 (aq). The water layer was extracted twice with DCM, 
the collected organic layers were dried over MgSO4 and concentrated in vacuo. Purification by size 
exclusion and column chromatography yielded 16 as a colorless oil (115 mg, 73%, α/β = 3/1). IR 
(neat): 731, 808, 910, 1026, 1047, 1070, 1207, 1265, 1304, 1358, 1439, 1454, 1497, 1732, 1765, 
2876, 3030. Determination of α/β ratio by 1H NMR (400 MHz):  δ = 3.60 (s, 1.15H, CH3 CO2Me β), 
3.64 (s, 3.62 H, CH3 CO2Me α), 4.96 (d, 0.33 H, J = 8 Hz, H-1’β), 5.08 (d, 1H, J = 3.6 Hz, H-1). 13C 
NMR (100 MHz): δ = 97.8 (C-1α), 98.0 (C-1’α), 100.6 (C-1’β). HRMS: C56H60O12 + NH4+ requires 
942.44230, found 942.44351. 
Methyl 2,3,6-tri-O-benzyl-4-O-(methyl (2,3,4-tri-O-benzyl-α-
L-gulopyranosyl)uronate) -α-D-glucopyranoside (17): As 
described for the synthesis of 16 using acceptor 11 (0.139 g, 0.3 
mmol). Purification by size exclusion and column 
chromatography yielded 17 as a colorless oil (189 mg, 94%). IR 
(neat): 533, 732, 910, 1027, 1208, 1554, 1797, 1734, 1764, 2892, 3031. 1H NMR (400 MHz): δ = 
3.31 (s, 3H, CH3 CO2Me), 3.42 (s, 3H, CH3 OMe), 3.63 (dd, 1H, J = 3.6 Hz, 8.8 Hz, H-2), 3.72-3.75 
(m, 2H, H-6, H-3’), 3.85-3.97 (m, 5H, H-3, H-5, H-6, H-2’, H-4’), 4.35 (s, 2H, CH2 Bn), 4.40-4.53 
(m, 4H, CH2 Bn), 4.57 (d, 1H, J = 12 Hz, CH2 Bn), 4.63 (d, 1H, J = 3.6 Hz, H-1), 4.69 (d, 1H, J = 12 
Hz, CH2 Bn), 4.83 (d, 1H, J = 12 Hz, CH2 Bn) 4.99 (m, 2H, H-5’, CH2 Bn), 5.26 (d, 1H, J = 3.6 Hz, 
H-1’), 7.16-7.40 (m, 30H, H Arom); 13C NMR (100 MHz): δ = 51.4 (CH3 COOMe), 54.9 (CH3 
OMe), 67.6 (C-5’), 68.3 (C-6), 70.2, 71.5, 72.2, 72.6, 72.9, 73.1, 73.2, 73.3, 74.2, 75.0, 76.6, 76.7, 
77.3, 79.8, 80.1, 97.4 (C-1’), 97.8 (C-1), 126.5-128.3 (CH Bn), 137.5-139.2 (Cq Bn), 169.6 
(COOMe); ESI-MS: 925.4 (M+H+). 
O
OBn
OBn
MeOOC
OBn
BnO
O
OBnO
OBn
OMe
O
OBn
OBn
MeOOC
OBn
O O
BnO
BnO
BnO
OMe
Stereoselective Synthesis of L-Guluronic Acid Alginates 
89 
p-Methoxyphenyl-2-O-benzyl-3-O-(methyl (2,3,4-tri-O-
benzyl-α/β-L-gulopyranosyl)uronate)-4,6-benzylidene-β-D-
galactopyranoside (18): As described for the synthesis of 13 
using acceptor 12 (0.139 g, 0.3 mmol). Purification by size 
exclusion and column chromatography yielded 18 as a colorless 
oil (124 mg, 79%, α/β = 10/1). IR (neat): 731, 826, 908, 997, 
1026 1065, 1078, 1175, 1217, 1265, 1306, 1366, 1439, 1454, 
1506, 175, 2870, 3030. Determination of α/β ratio by 1H NMR (400 MHz): δ = 5.21 (d, 0.11 H, J = 
8Hz, H-1’β), 5.34 (d, 1H, J = 3.6 Hz, H-1’α). 13C NMR (100 MHz): δ = 100.2 (C-1’α), 102.6 (C-1α). 
HRMS: C55H56O13 + Na+ requires 947.36131, found 947.36190. 
Phenyl 2,3-di-O-benzyl-4,6-O-benzylidene-1-thio-β-L-gulopyranoside (19): 6 
(10.88 g, 40.0 mmol) was dissolved in MeCN (400 mL), then benzaldehyde 
dimethylacetal (6.32 mL, 42.0 mmol) and a catalytic amount of p-TsOH were 
added. After stirring for 15h, the mixture was quenched with Et3N until neutral 
pH and concentrated in vacuo. The residue was dissolved in DMF (200 mL) and 
cooled to 0 °C. Respectively, BnBr (11.4 mL, 96 mmol) and NaH (3.84 g, 96 mmol, 60% dispersion 
in oil) were added. After stirring o.n. the mixture was quenched with MeOH and concentrated in 
vacuo. The residue was taken up in Et2O and washed three times with H2O, the organic layer was 
dried over MgSO4 and concentrated in vacuo. Column chromatography yielded 19 (15.12 g, 70%) as 
a colorless oil. [α]D22: +39.2 (c = 1, CHCl3); IR (neat): 995, 1080, 1394, 1454, 2870, 3032 cm-1; 1H 
NMR (400 MHz, CDCl3): δ = 3.81 (dd, 1H, J = 2.8 Hz, 10.0 Hz, H-2), 3.83 (s, 1H, H-5), 3.92 (t, 1H, 
J = 3.2 Hz), 3.97 (dd, 1H, J = 1.6 Hz, 12.4 Hz, H-6), 4.05 (d, 1H, J = 3.6 Hz, H-4), 4.33 (d, 1H, J = 
12.8 Hz, H-6), 4.36 (d, 1H, J = 11.6 Hz, CH2 Bn), 4.47 (d, 1H, J = 11.2 Hz, CH2 Bn), 4.63 (d, 1H, J = 
12.0 Hz, CH2 Bn), 4.79 (d, 1H, J = 12.0 Hz, CH2 Bn), 5.27 (d, 1H, J = 9.6 Hz, H-1), 5.47 (s, 1H, CH 
benzylidene), 7.15-7.72 (m, 20H, H Arom); 13C NMR (100 MHz): δ = 67.5 (C-5), 69.5 (C-6), 72.5 
(CH2 Bn), 73.6 (CH2 Bn), 74.0 (C-2), 74.3 (C-3), 75.0 (C-4), 83.1 (C-1), 100.9 (CHPh), 126.4-132.7 
(CH Arom), 133.0 (Cq SPh), 137.8, 137.9, 138.1 (Cq Bn, Cq benzylidene); HRMS: C33H32O5S + H+ 
requires 541.20432, found 541.20440. 
Phenyl 2,3-O-benzyl-1-thio-β-L-gulopyranoside (20): A solution of 3 (10.8 g, 
20 mmol) in MeOH (200 mL) and a catalytic amount of p-TsOH was stirred 
overnight at room temperature. After quenching the mixture with Et3N till neutral 
pH it was concentrated in vacuo. Purification of the residue by column 
chromatography afforded 20 (9.05 g, quantitative) as a colorless oil. [α]D22: +27.6 (c = 1, CHCl3); IR 
(neat): 956, 1026, 1454, 2889, 3402 cm-1; 1H NMR (400 MHz, CDCl3): δ = 2.38 (bs, 1H, 6-OH), 3.45 
(d, 1H, J = 3.6 Hz, 4’-OH), 3.81 (dd, 1H, J = 2.8 Hz, 10.0 Hz, H-2), 3.85-3.98 (m, 5H, H-3, H-4, H-5, 
H-6, H-6), 4.55 (d, 1H, J = 11.6 Hz, CH2 Bn), 4.60 (d, 1H, J = 12.0 Hz, CH2 Bn), 4.64 (d, 1H, J = 
11.6 Hz, CH2 Bn), 4.77 (d, 1H, J = 12.0 Hz, CH2 Bn), 5.28 (d, 1H, J = 10.0 Hz, H-1), 7.24-7.38 (m, 
13H, H Arom), 7.52-7.54 (m, 2H, H Arom); 13C NMR (100 MHz): δ = 64.0 (C-6), 70.8 (C-5), 72.7 
(CH2 Bn), 73.5 (CH2 Bn), 74.2 (C-4), 75.0 (C-2), 75.5 (C-3), 84.7 (C-1), 127.2-131.5 (CH Arom), 
133.8 (Cq SPh), 137.9 (Cq Bn), 138.2 (Cq Bn); HRMS: C26H28O5S + H+ requires 453.17302, found 
453.17296. 
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Methyl (phenyl-2,3-O-benzyl-1-thio-β-L-guluronate) (21): 20 (0.538 g, 
1.18 mmol) was taken up in DCM (10 mL) and H2O (4 mL). To this mixture 
were added TEMPO (0.038 g, 0.24 mmol) and BAIB (0.955 g, 2.96 mmol). 
The mixture was stirred vigorously until TLC-analysis showed complete conversion of the starting 
material. 50 mL Na2S2O3 (aq) was added and the resulting mixture was stirred for 15 min. The layers 
were separated and the aqueous phase acidified with 1M HCl and extracted three times with DCM. 
The combined organic layers were dried over MgSO4 and concentrated in vacuo. The resulting syrup 
was then dissolved in Et2O (20 mL) and cooled to 0 °C, after which TMSdiazomethane (0.5 M in 
Et2O) was added until the solution became bright yellow, AcOH was added until the yellow color 
disappeared. The mixture was concentrated in vacuo. Purification by column chromatography yielded 
21 (0.280 g, 49%) as a colourless oil. [α]D22: -98.8 (c = 1, CHCl3); IR (neat): 1069, 1118, 1744, 2855, 
2920, 3445 cm-1; 1H NMR (400 MHz, CDCl3): δ = 2.76 (bs, 1H, 4’-OH), 3.73-3.74 (m, 1H, H-2), 
3.75 (s, 3H, CH3 CO2Me), 3.95 (t, 1H, J = 3.4 Hz, H-3), 4.16 (bs, 1H, H-4), 4.51 (d, 1H, J = 11.2 Hz, 
CH2 Bn), 4.58-4.64 (m, 3H, CH2 Bn, H-5), 4.75 (d, 1H, J = 12.0 Hz, CH2 Bn), 5.21 (d, 1H, J = 10.0 
Hz), 7.24-7.62 (m, 15H, H Arom); 13C NMR (100 MHz): δ =  52.4 (CH3 CO2Me), 69.4 (C-4), 72.7 
(CH2 Bn), 73.4 (CH2 Bn), 74.3 (C-2), 74.9 (C-3), 75.1 (C-5), 85.1 (C-1), 127.5-132.3 (CH Arom), 
133.3 (Cq Bn), 137.7 (Cq Bn), 137.9 (Cq Bn), 169.4 (COOMe); HRMS: C27H28O6S + Na+ requires 
503.1499, found 503.1488. 
Methyl (phenyl-2,3-O-benzyl-4-O-levulinoyl-1-thio-β-L-guluronate)(22): 
To a solution of 21 (0.96 g, 2.00 mmol) in pyridine (20 mL) was added a 
solution of Lev2O in dioxane (0.5 M, 8.0 mL, 4.0 mmol). After 16 h the 
mixture was diluted with EtOAc, washed with 1M HCl (aq), NaHCO3 (aq) and brine. The organic 
layer was dried over MgSO4 and concentrated in vacuo. Purification by column chromatography 
yielded 22 (1.10 g, 95%) as a colorless oil. [α]D22: -105.6 (c = 1, CHCl3); IR (neat): 1026, 1064, 1111, 
1250, 1713, 1740, 2873 cm-1; 1H NMR (600 MHz, CDCl3): δ = 2.16 (s, 3H, CH3 Lev), 2.45-2.48 (m, 
2H, CH2 Lev), 2.64-2.73 (m, 2H, CH2 Lev), 3.60 (dd, 1H, J = 3.0 Hz, 10.2 Hz, H-2), 3.76 (s, 3H, CH3 
CO2Me), 3.93 (t, 1H, J = 3.3 Hz, H-3), 4.47-4.76 (m, 5H, CH2 Bn, H-5), 5.21 (d, 1H, J = 10.2 Hz, H-
1), 5.29 (dd, 1H, J = 1.5 Hz, 3.9 Hz, H-4), 7.26-7.66 (m, 15H, H Arom); 13C NMR (150 MHz): δ = 
27.9 (CH2 Lev), 29.7 (CH3 Lev), 37.7 (CH2 Lev), 52.3 (CH3 CO2Me), 70.2 (C-4), 72.4 (CH2 Bn), 
72.5 (C-3), 73.2 (C-5), 73.4 (CH2 Bn), 73.7 (C-2), 84.6 (C-1), 127.5-132.6 (CH Arom), 133.4 (Cq 
SPh), 137.5 (Cq Bn), 137.6 (Cq Bn), 167.9 (COOMe), 171.3 (COO Lev), 206.0 (CO Lev); HRMS: 
C32H34O8S + Na+ requires 601.1867, found 601.1843.  
Phenyl 2,3-O-benzyl-6-O-tert-butyldimethylsilyl-1-thio-β-L-
gulopyranoside (23): A solution of 20 (0.869 g, 1.92 mmol) in DMF (10 
mL) was cooled to 0 °C. Respectively, imidazole (0.136 g, 2.00 mmol) and 
TBDMSCl (0.301 g, 2.00 mmol) were added and the mixture was warmed to rT. After stirring for 4h, 
the mixture was quenched with MeOH and concentrated in vacuo. The residue was taken up in Et2O 
and washed three times with H2O, the organic layer was dried over MgSO4 and concentrated in 
vacuo. Column chromatography yielded 23 (0.978 g, 90%) as a colorless oil. [α]D22: +32.4 (c = 1, 
CHCl3); IR (neat): 833, 1026, 1103, 1254, 2855, 2928, 3456 cm-1; 1H NMR (600 MHz, CDCl3): δ = 
0.08 (s, 3H, CH3), 0.11 (s, 3H, CH3), 0.91 (s, 9H, tBu), 3.79 (dd, 1H, J = 3.0 Hz, 10.2 Hz, H-2), 3.82 
(bs, 1H, OH), 3.87-3.91 (m, 3H, H-3, H-5, H-6), 3.97 (dd, 1H, J = 3.6 Hz, 10.8 Hz, H-6), 4.00 (bs, 
1H, H-4), 4.46 (d, 1H, J = 11.4 Hz, CH2 Bn), 4.55 (d, 1H, J = 11.4 Hz, CH2 Bn), 4.57 (d, 1H, J = 12.0 
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Hz, CH2 Bn), 4.74 (d, 1H, J = 12.0 Hz, CH2 Bn), 5.18 (d, 1H, J = 10.2 Hz, H-1), 7.23-7.59 (m, 15H, 
H Arom); 13C NMR (150 MHz): δ = -5.7 (CH3), -5.5 (CH3), 18 (Cq TBDMS), 25.8 (tBu), 65.2 (C-6), 
70.8 (C-4), 72.7 (CH2 Bn), 73.5 (CH2 Bn), 73.9 (C-5), 74.7 (C-2), 75.6 (C-3), 84.6 (C-1), 127.2-132.3 
(CH Arom), 133.8 (Cq SPh), 138.1 (Cq Bn), 138.4 (Cq Bn); ESI-MS: 567.3 (M+H+).  
Phenyl 2,3-O-benzyl-6-O-tert-butyldimethylsilyl-4-O-levulinoyl-1-thio-β-
L-gulopyranoside (24): To a solution of 23 (0.978 g, 1.73 mmol) in 
pyridine (10 mL) was added a solution of Lev2O in dioxane (0.5 M, 6.92 
mL, 3.46 mmol). After 16 h the mixture was diluted with EtOAc, washed 
with 1M HCl (aq), NaHCO3 (aq) and brine. The organic layer was dried over MgSO4 and 
concentrated in vacuo. Purification by column chromatography yielded 24 (1.08 g, 94%) as a 
colorless oil. [α]D22: +35.6 (c = 1, CHCl3); IR (neat): 1026, 1096, 1362, 1717, 1740, 2858, 2928 cm-1; 
1H NMR (400 MHz, CDCl3): δ = -0.01 (s, 3H, CH3 TBDMS), -0.01 (s, 3H, CH3 TBDMS), 0.83 (s, 
9H, tBu TBDMS), 2.13 (s, 3H, CH3 Lev), 2.45-2.48 (m, 2H, CH2 Lev), 2.64-2.67 (m, 2H, CH2 Lev), 
3.55-3.60 (m, 2H, H-2, H-6), 3.68 (dd, 1H, J = 6.4 Hz, 10.0 Hz, H-6), 3.90 (t, 1H, J = 3.6 Hz, H-3), 
4.10 (t, 1H, J = 6.8 Hz, H-5), 4.48 (d, 1H, J = 11.6 Hz, CH2 Bn), 4.56 (d, 1H, J = 11.6 Hz, CH2 Bn), 
4.64 (d, 1H, J = 12.0 Hz, CH2 Bn), 4.69 (d, 1H, J = 12.0 Hz, CH2 Bn), 5.06 (d, 1H, J = 3.6 Hz, H-4), 
5.23 (d, 1H, J = 10.0 Hz, H-1), 7.18-7.54 (m, 15H, H Arom); 13C NMR (100 MHz): δ = -5.7 (CH3 
TBDMS), -5.5 (CH3 TBDMS), 18 (Cq TBDMS), 25.7 (tBu TBDMS), 27.9 (CH2 Lev), 29.7 (CH3 
Lev), 37.8 (CH2 Lev), 61.0 (C-6), 68.7 (C-4), 72.2 (CH2 Bn), 72.7 (C-3) 73.1 (CH2 Bn), 74.4, 74.5 
(C-2, C-5), 84.4 (C-1), 126.9-131.2 (CH Arom), 134.2 (Cq SPh), 137.7 (Cq Bn), 137.8 (Cq Bn), 171.6 
(COO Lev), 205.9 (CO Lev); HRMS: C37H48O7SSi + H+  requires 665.29628, found 665.29699. 
Phenyl 2,3-di-O-benzyl-4,6-O-di-tert-butylsilylidene-1-thio-β-L-
gulopyranoside (25): To a solution of 6 (2.72 g, 10.0 mmol) in pyridine 
(100 mL) was added at -20 °C (tBu)2Si(OTf)2 (3.24 mL, 10.0 mmol) after 
which the reaction was warmed to rT. The reaction mixture was quenched 
with MeOH and concentrated in vacuo, taken up in EtOAc, washed with 1M 
HCl (aq), NaHCO3 (aq), and brine. The organic layer was dried over MgSO4 and concentrated in 
vacuo. The residue was dissolved in DMF (50 mL) and cooled to 0 °C. Respectively, BnBr (2.87 mL, 
24.0 mmol) and NaH (0.96 g, 24.0 mmol, 60% dispersion in oil) were added. After stirring for 15h, 
the mixture was quenched with MeOH and concentrated in vacuo. The residue was taken up in Et2O 
and washed three times with H2O, the organic layer was dried over MgSO4 and concentrated in 
vacuo. Column chromatography yielded 25 (5.20 g, 88%) as a colorless oil. [α]D22: +26.6 (c = 1, 
CHCl3); IR (neat): 853, 937, 1088, 1474, 2858, 2932 cm-1; 1H NMR (600 MHz, CDCl3):  δ = 1.00 (s, 
9H, tBu), 1.04 (s, 9H, tBu), 3.74 (bs, 1H, H-5), 3.87-3.89 (m, 2H, H-2, H-3), 4.11 (dd, 1H, J = 2.4 Hz, 
12.6 Hz, H-6), 4.15-4.18 (m, 2H, H-4, H-6), 4.59 (d, 1H, J = 12.0 Hz, CH2 Bn), 4.66 (d, 1H, J = 11.4 
Hz, CH2 Bn), 4.75 (d, 1H, J = 11.4 Hz, CH2 Bn), 4.84 (d, 1H, J = 12.0 Hz, CH2 Bn), 5.27 (d, 1H, J = 
9.6 Hz, H-1), 7.18-7.54 (m, 15H, H Arom); 13C NMR (150 MHz): δ = 20.4 (Cq tBu), 23.2 (Cq tBu), 
27.5 (CH3 tBu), 67.2 (C-6), 72.0 (C-4), 72.1 (C-5), 72.7 (CH2 Bn), 73.7 (CH2 Bn), 75.2 (C-2), 76.3 
(C-3), 84.9 (C-1), 126.9-134.7 (CH Arom), 134.7 (Cq SPh), 137.8 (Cq Bn), 138.4 (Cq Bn); HRMS: 
C34H44O5SSi + H+ requires 593.27515, found 593.27527. 
3-Azidopropyl (methyl (2,3-O-benzyl-α-L-gulopyranoside) uronate) 
(27): To a solution of 29 (178 g, 0.31 mmol) in pyridine/AcOH (4/1, 3.5 
mL) was added hydrazine (76 μl, 1.6 mmol). The mixture was stirred for 
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10 min and then diluted with EtOAc, washed with 1M HCl, water, and NaHCO3 (aq). The organic 
layer was dried over MgSO4 and concentrated in vacuo. Column chromatography afforded 27 (116 
mg, 80%), as a colorless oil. IR (neat): 1034, 1088, 1450, 2095, 2870, 2924 cm-1; 1H NMR (400 
MHz, CDCl3): δ = 1.81-1.96 (m, 2H, CH2 C3H6N3), 2.39 (d, 1H, J = 5.6 Hz, 4’-OH), 3.35-3.38 (m, 
2H, CH2 C3H6N3), 3.47-3.53 (m, 1H, CH2 C3H6N3), 3.78 (s, 3H, CH3 CO2Me), 3.82-3.88 (m, 2H, H-
2, C3H6N3), 3.90 (t, 1H, J = 3.4 Hz, H-3), 4.19 (bs, 1H, H-4), 4.57-4.67 (m, 3H, CH2 Bn), 4.79 (d, 1H, 
J = 1.2 Hz, H-5), 4.87 (d, 1H, J = 12.0 Hz, CH2 Bn), 4.95 (d, 1H, J = 3.6 Hz, H-1), 7.25-7.38 (m, 
10H, H Arom); 13C NMR (100 MHz): δ = 28.9 (CH2 C3H6N3), 48.2 (CH2 C3H6N3), 52.4 (CH3 
CO2Me), 65.5 (CH2 C3H6N3), 67.7 (C-5), 69.8 (C-4), 71.8 (CH2 Bn), 72.9 (C-2), 73.1 (CH2 Bn), 75.4 
(C-3), 98.1 (C-1), 127.6-128.4 (CH Arom), 137.9 (Cq Bn), 138.6 (Cq Bn), 170.5 (COOMe); HRMS: 
C24H29N3O7 + H+ requires 472.2078, found 472.2081. 
3-Azidopropyl 2,3-O-benzyl-6-O-tert-butyldimethylsilyl-α-L-
gulopyranoside (28): A solution of 35 (0.576 g, 0.988 mmol) in THF (10 
mL) was cooled to 0 °C. TBAF (3 mL, 3 mmol, 1 M in THF) was added. 
After 4 h the mixture was diluted with EtOAc, and washed with water and 
brine. The organic layer was dried over MgSO4 and concentrated in vacuo. The residue was taken up 
in DMF (5.0 mL) was cooled to 0 °C. Imidazole (0.073 g, 1.08 mmol) and TBDMSCl (0.162 g, 1.08 
mmol) were added and the mixture was warmed to rT. After stirring for 4h, the mixture was quenched 
with MeOH and concentrated in vacuo. The residue was taken up in Et2O and washed three times 
with H2O, the organic layer was dried over MgSO4 and concentrated in vacuo. Column 
chromatography yielded 28 (0.414 g, 75%) as a colorless oil. [α]D22: -23.0 (c = 1, CHCl3); IR (neat): 
1042, 1107, 2095, 2858, 2928 cm-1; 1H NMR (500 MHz, CDCl3): δ = 0.09 (s, 6H, CH3 TBDMS), 
0.89 (s, 9H, tBu TBDMS), 1.78-1.98 (m, 2H, CH2 C3H6N3), 3.37 (t, 2H, J = 6.5 Hz, 2H, CH2 
C3H6N3), 3.44-3.48 (m, 1H, CH2 C3H6N3), 3.76-3.83 (m, 2H, OH, CH2 C3H6N3), 3.86-3.87 (m, 1H, 
H-5), 3.91-3.92 (m, 3H, H-2, H-6, H-6), 4.03-4.05 (m, 2H, H-3, H-4), 4.57-4.66 (m, 3H, CH2 Bn), 
4.86-4.89 (m, 2H, H-1, CH2 Bn), 7.24-7.37 (m, 10H, H Arom); 13C NMR (125 MHz): δ = -5.7 (CH3 
TBDMS), -5.6 (CH3 TBDMS), 18.1 (Cq tBu TBDMS), 25.7 (CH3 tBu TBDMS), 28.9 (CH2 C3H6N3), 
48.3 (CH2 C3H6N3), 64.5 (CH2 C3H6N3), 65.1 (C-3), 65.5 (C-6), 70.9 (C-4), 71.4 (CH2 Bn), 72.9 (CH2 
Bn), 73.5 (C-2), 75.5 (C-5), 97.9 (C-1), 127.3-128.3 (CH Arom), 138.3 (Cq Bn), 139.0 (Cq Bn); 
HRMS: C29H43N3O6Si + H+ requires 558.29939, found 558.29985. 
Methyl 2,3,4-tri-O-benzyl-6-O-(methyl (2,3-di-O-benzyl-4-O-
levulinoyl-α/β-L-gulopyranosyl)uronate) -α-D-glucopyranoside 
(29): As described for the synthesis of 13 using donor 22 (0.061 g, 
0.105 mmol) and acceptor 10 (0.073 g, 0.158 mmol). Purification by 
size exclusion and column chromatography yielded 29 as a colorless 
oil (0.064 g, 66%, α/β = 3/1). Determination of α/β ratio by 1H NMR 
(400 MHz): δ = 3.27 (s, 3H, OMe), 3.33 (s, 0.33H, OMe), 4.99 (d, 0.33H, J = 8.4 Hz, H-1’β), 5.05 
(bs, 1H, H-1’α). 13C NMR (100 MHz): δ = 55.0 (CH3 OMe αα), 55.0 (CH3 OMe βα), 97.9 (C-1’α), 
100.6 (C-1’β). 
Methyl 2,3,6-tri-O-benzyl-4-O-(methyl (2,3-di-O-benzyl-4-O-
levulinoyl-α-L-gulopyranosyl)uronate) -α-D-glucopyranoside 
(30): As described for the synthesis of 13 using donor 22 (0.065 
g, 0.112 mmol) and acceptor 11 (0.078 g, 0.168 mmol). 
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Purification by size exclusion and column chromatography yielded 30 as a colorless oil (0.066 g, 
64%). 1H NMR (400 MHz, CDCl3): δ =  2.14 (s, 3H, CH3 Lev), 2.38-2.48 (m, 2H, CH2 Lev), 2.59-
2.72 (m, 2H, CH2 Lev), 3.25 (s, 3H, CH3 CO2Me), 3.36 (s, 3H, CH3 OMe), 3.57-3.58 (m, 1H, H-2), 
3.63 (bs, 1H, H-2’), 3.65 (bs, 1H, H-4), 3.88-3.91 (m, 5H, H-3, H-5, H-6, H-6, H-3’), 4.39-4.52 (m, 
5H, CH2 Bn), 4.57 (bs, 1H, H-1), 4.62 (m, 3H, CH2 Bn), 5.01 (s, 1H, H-5’), 5.16 (bs, 1H, H-1’), 5.19 
(s, 1H, H-4’), 7.11-7.43 (m, 25H, H Arom); 13C NMR (100 MHz): δ = 27.9 (CH2 Lev), 29.7 (CH3 
Lev), 37.7 (CH2 Lev), 51.8 (CH3 CO2Me), 55.0 (CH3 OMe), 66.0 (C-5’), 68.2 (C-6), 70.2, 70.7 (C-
4’), 71.2 (CH2 Bn), 71.8 (C-3’), 72.5 (C-2’), 73.8 (CH2 Bn), 73.3 (CH2 Bn), 74.2 (CH2 Bn), 74.9, 79.7, 
80.3 (C-2), 97.4 (C-1’), 97.9 (C-1), 126.5-128.4 (CH Arom), 137.5-139.2 (Cq Arom), 168.7 (CO2Me), 
171.5 (CO Lev), 206.1 (COO Lev). 
3-Azidopropyl (methyl (2,3-di-O-benzyl-4-O-levulinoyl-α-L-
gulopyranoside) uronate) (31): A solution of 22 (0.116 g, 0.20 mmol), 
diphenyl sulfoxide (0.049 g, 0.24 mmol) and tri-tert-butylpyrimidine 
(0.129 g, 0.52 mmol) in DCM (4 mL) was stirred over activated MS 3Å 
for 30 min. The mixture was cooled to -60 °C before triflic anhydride (40 
μl, 0.24 mmol) was added then warmed to -45 °C. The mixture was stirred for 10 min. at -45 °C 
followed by addition of azidopropanol (0.061 g, 0.6 mmol) in DCM (1.5 mL). Stirring was continued 
and the reaction mixture was allowed to warm to 0 °C and Et3N (0.14 mL) was added. The reaction 
mixture was diluted with DCM and washed with NaHCO3 (aq). The water layer was extracted twice 
with DCM and the collected organic layers were dried over MgSO4 and concentrated in vacuo. 
Purification by column chromatography yielded 31 (0.098 g, 86%, α/β = 1:3) as a colorless oil, 
anomers could be separated on column, spectral data for the α anomer  are given. IR (neat): 1141, 
1744, 2095, 2870, 2924 cm-1; 1H NMR (400 MHz, CDCl3): δ = 1.80-1.96 (m, 2H, C3H6N3), 2.17 (s, 
3H, CH3 Lev), 2.45-2.49 (m, 2H, CH2 Lev), 2.66-2.73 (CH2 Lev), 3.33-3.37 (m, 2H, C3H6N3), 3.48-
3.53 (m, 1H, C3H6N3), 3.70 (t, 1H, J = 3.8 Hz, H-2), 3.71 (s, 3H, CO2Me), 3.81-3.86 (m, 1H, 
C3H6N3), 3.92 (t, 1H, J = 3.4 Hz, H-3), 4.52 (d, 1H, J = 12.4 Hz, CH2 Bn), 4.62 (d, 1H, J = 12.4 Hz, 
CH2 Bn), 4.72 (d, 1H, J = 12.0, CH2 Bn), 4.82-4.86 (m, 2H, H-5, CH2 Bn), 4.95 (d, 1H, J = 4.0 Hz, 
H-1), 5.32 (dd, 1H, J = 1.6 Hz, 3.2 Hz, H-4), 7.26-7.41 (m, 10H, H Arom); 13C NMR (100 MHz): δ = 
28.0 (CH2 Lev), 28.9 (CH2 C3H6N3), 29.7 (CH3 Lev), 37.8 (CH2 Lev), 48.2 (CH2 C3H6N3), 52.4 (CH3 
CO2Me), 65.4 (C-5), 70.8 (C-4), 71.5 (CH2 Bn), 72.5, 72.5 (C-2, C-3), 73.1 (CH2 Bn), 97.9 (C-1), 
127.6-128.4 (CH Arom), 137.8 (Cq Bn), 138.3 (Cq Bn), 169.1 (COOMe), 171.4 (COO Lev), 206.0 
(CO Lev); HRMS: C29H35N3O9 + H+ requires 570.2446, found 570.2447. 
3-Azidopropyl (methyl (2,3-di-O-benzyl-4-O-(methyl (2,3-di-O-
benzyl-4-O-levulinoyl-α-L-gulopyranosyl)uronate) -α-L-
gulopyranoside) uronate) (32): A solution of 22 (0.116 g, 0.20 
mmol), diphenyl sulfoxide (0.049 g, 0.24 mmol) and tri-tert-
butylpyrimidine (0.129 g, 0.52 mmol) in DCM (4 mL) was stirred 
over activated MS 3Å for 30 min. The mixture was cooled to -60 
°C before triflic anhydride (40 μl, 0.24 mmol) was added then 
warmed to -45 °C. The mixture was stirred for 10 min. at -45 °C followed by addition of 27 (0.078 g, 
0.166 mmol) in DCM (1.6 mL). Stirring was continued and the reaction mixture was allowed to warm 
to 0 °C and Et3N (0.14 mL) was added. The reaction mixture was diluted with DCM and washed with 
NaHCO3 (aq). The water layer was extracted twice with DCM and the collected organic layers were 
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dried over MgSO4 and concentrated in vacuo. Purification by size exclusion and column 
chromatography yielded 32 (0.053 g, 34%, α/β = 3:1) as a colorless oil, anomers could be separated 
on column, spectral data for the α anomer are given. [α]D22: -64.4 (c = 1, CH2Cl2); I IR (neat): 1038, 
1142, 1454, 1744, 2095, 2870, 2924 cm-1; 1H NMR (600 MHz, CDCl3): δ = 1.81-1.94 (m, 2H, CH2 
C3H6N3), 2.17 (s, 3H, CH3 Lev), 2.45-2.48 (m, 2H, CH2 Lev), 2.67-2.72 (m, 2H, CH2 Lev), 3.32-3.38 
(m, 2H, CH2 C3H6N3), 3.52-3.55 (m, 1H, CH2 C3H6N3), 3.56 (s, 3H, CH3 CO2Me), 3.66 (t, 1H, J = 
3.3 Hz, H-2’), 3.70-3.72 (m, 4H, H-2, CH3 CO2Me), 3.86-3.90 (m, 3H, H-3, H-3’, CH2 C3H6N3), 4.18 
(d, 1H, J = 12.6 Hz, CH2 Bn), 4.27 (m, 1H, H-4), 4.30 (d, 1H, J = 12.0 Hz, CH2 Bn), 4.47 (d, 1H, J = 
12.0 Hz, CH2 Bn), 4.56 (d, 1H, J = 12.0 Hz, CH2 Bn), 4.59-4.61 (m, 3H, H-5’, CH2 Bn), 4.78-4.81 
(m, 3H, H-5, CH2 Bn), 4.97 (d, 1H, J = 3.6 Hz, H-1), 5.17 (d, 1H, J = 3.6 Hz, H-1’), 5.27 (dd, 1H, J = 
1.8 Hz, 4.2 Hz, H-4’), 7.09-7.42 (m, 20H, H Arom); 13C NMR (150 MHz): δ = 27.9 (CH2 Lev), 28.9 
(CH2 C3H6N3), 29.7 (CH3 Lev), 37.8 (CH2 Lev), 48.2 (CH2 C3H6N3), 52.1 (CH3 CO2Me), 52.4 (CH3 
CO2Me), 65.3 (CH2 C3H6N3), 66.8 (C-5’), 67.1 (C-5), 70.9 (C-4’), 71.4 (CH2 Bn), 71.6 (CH2 Bn), 
71.7 (C-3’), 72.8 (CH2 Bn), 73.0 (CH2 Bn), 73.1 (C-2’), 73.5 (C-2), 75.1 (C-3), 77.7 (C-4), 97.6 (C-
1), 99.7 (C-1’), 127.4-128.3 (CH Arom), 137.7 (Cq Bn), 137.9 (Cq Bn), 138.5 (Cq Bn), 138.6 (Cq Bn), 
168.5, 169.9, 171.4 (COOMe, COO Lev), 206.10 (CO Lev); HRMS: C50H57N3O15 + Na+ requires 
962.36955, found 962.36819. 
3-Azidopropyl 2,3-O-benzyl-6-O-tert-butyldimethylsilyl-4-O-levulinoyl-
α/β-L-gulopyranoside (33): A solution of donor 24 (0.133 g, 0.2 mmol), 
diphenyl sulfoxide (0.045 g, 0.22 mmol) and tri-tert-butylpyrimidine (0.124 
g, 0.5 mmol) in DCM (4 ml) was stirred over activated MS 3Å for 30 min. 
The mixture was cooled to -70 °C before triflic anhydride (37 µl, 0.22 
mmol) was added. The mixture was stirred for 10 min. at -70 °C followed by addition of 
azidopropanol (0.061 g, 0.6 mmol) in DCM (1.5 mL). Stirring was continued and the reaction mixture 
was allowed to warm to 0 °C and Et3N (0.15 ml) was added. The reaction mixture was diluted with 
DCM and washed with NaHCO3 (aq). The water layer was extracted twice with DCM, the collected 
organic layers were dried over MgSO4 and concentrated in vacuo. Purification by column 
chromatography yielded 33 (0.098 g, 86%, α/β = 3/1) as a colorless oil, anomers could not be 
separated on column. IR (neat): 1026, 1096, 1717, 1740, 2095, 2858, 2928 cm-1; 1H NMR (600 MHz, 
CDCl3): δ = -0.01-0.01 (m, 7.8H, CH3 TBDMS), 0.83 (s, 9H, tBu TBDMS), 0.84 (s, 3H, tBu 
TBDMS), 1.78-1.93 (m, 2.6H, CH2 C3H6N3), 2.13 (s, 1H, CH3 Lev), 2.14 (s, 3H, CH3 Lev), 2.47-2.49 
(m, 2.6H, CH2 Lev), 2.61-2.73 (m, 2.6H, CH2 Lev), 3.32-3.40 (m, 4H), 3.43-3.47 (m, 1.3H, CH2 
C3H6N3), 3.51 (dd, 1H, J = 6.6 Hz, 9.6 Hz), 3.57-3.62 (m, 2.9H), 3.65-3.70 (m, 1.6H), 3.77-3.81 (m, 
1H, CH2 C3H6N3), 3.84-3.87 (m, 1.3H), 3.93-3.96 (m, 0.3H, CH2 C3H6N3), 4.06 (t, 0.3H, J = 6.6 Hz), 
4.24 (t, 1H, J = 7.2 Hz), 4.50-4.79 (m, 7.1H, H-1 α, CH2 Bn), 4.81 (d, 0.3H, J = 7.8 Hz, H-1 β), 5.01 
(d, 0.3H, J = 1.6 Hz, H-4), 5.06 (d, 1H, J = 1.6 Hz, H-4), 7.23-7.62 (m, 13H, H Arom); 13C NMR 
(150 MHz): δ = -5.6 (CH3 TBDMS), -5.5 (CH3 TBDMS), 18.2 (Cq TBDMS), 25.8 (tBu TBDMS), 
26.7, 26.8, 28.0, 29.0, 29.3, 29.8, 31.5, 37.9, 48.5, 59.8, 60.9, 61.4, 64.8, 66.0, 66.5, 68.7, 69.2, 71.2, 
72.2, 72.6, 72.9, 73.0, 73.3, 74.7, 76.2, 97.4 (C-1α), 100.9 (C-1 β), 124.8-135.6 (CH Arom), 138.1 (Cq 
Bn), 138.1 (Cq Bn), 138.6 (Cq Bn), 138.6 (Cq Bn), 171.8 (COO lev), 171.9 (COO lev), 206.1 (CO 
Lev), 206.2 (CO Lev); HRMS: C34H49N3O8Si + Na+ requires 678.31811, found 678.31810. 
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3-Azidopropyl (2,3-O-benzyl-6-O-tert-butyldimethylsilyl-4-O-
(2,3-O-benzyl-6-O-tert-butyldimethylsilyl-4-O-levulinoyl-α-L-
gulopyranosyl) -α-L-gulopyranoside (34): A solution of donor 24 
(0.133 g, 0.2 mmol), diphenyl sulfoxide (0.045 g, 0.22 mmol) and 
tri-tert-butylpyrimidine (0.124 g, 0.5 mmol) in DCM (4 ml) was 
stirred over activated MS 3Å for 30 min. The mixture was cooled to 
-70 °C before triflic anhydride (37 µl, 0.22 mmol) was added. The 
mixture was stirred for 10 min. at -70 °C followed by addition of acceptor 28 (0.093 g, 0.166 mmol) 
in DCM (1.6 ml). Stirring was continued and the reaction mixture was allowed to warm to 0 °C and 
Et3N (0.15 ml) was added. The reaction mixture was diluted with DCM and washed with NaHCO3 
(aq). The water layer was extracted twice with DCM, the collected organic layers were dried over 
MgSO4 and concentrated in vacuo. Purification by size exclusion and column chromatography 
yielded 34 as a colorless oil (48%, 0.089 g, α/β = 6/1), anomers could be separated on column, 
spectral data for the α anomer are given. [α]D22: -88.0 (c = 0.1, CHCl3); IR (neat): 1003, 1092, 1454, 
1744, 2095, 2858, 2928, cm-1; 1H NMR (400 MHz, CDCl3): δ = -0.03 (s, 3, CH3 TBDMS), -0.01 (s, 
3, CH3 TBDMS), 0.00 (s, 3, CH3 TBDMS),  0.01 (s, 3, CH3 TBDMS), 0.83 (s, 9H, tBu TBDMS), 
0.87 (s, 9H, tBu TBDMS), 1.83-1.92 (m, 2H, CH2 C3H6N3), 2.18 (s, 3H, CH3 Lev), 2.45-2.53 (m, 2H, 
CH2 Lev), 2.67-2.73 (CH2 Lev), 3.34-3.38 (m, 2H, CH2 C3H6N3), 3.42-3.53 (m, 3H, C-6, C-6, CH2 
C3H6N3), 3.60 (t, 1H, J = 3.6 Hz, H-2’), 3.70-3.82 (m, 3H, H-2, H-6’, CH2 C3H6N3), 3.88-3.99 (m, 
4H, H-3, H-4, H-3’, H-6’), 4.13 (t, J = 7.2 Hz, H-5’), 4.19 (t, J = 6.8 Hz, H-5), 4.23 (d, 1H, J = 12.4 
Hz, CH2 Bn), 4.30 (d, 1H, J = 12.4 Hz, CH2 Bn), 4.53 (d, 1H, J = 12.4 Hz, CH2 Bn), 4.59 (d, 1H, J = 
11.6 Hz, CH2 Bn), 4.64-4.677 (m, 2H, CH2 Bn), 4.87 (d, 1H, J = 3.6 Hz, H-1), 4.81 (d, 1H, J = 11.6 
Hz, CH2 Bn), 4.86 (d, 1H, J = 12.4 Hz, CH2 Bn), 5.07-5.09 (m, 2H, H-1’, H-4’), 7.16-7.38 (m, 20H, 
H Arom); 13C NMR (100 MHz): δ = -5.5 (CH3 TBDMS), -5.4 (CH3 TBDMS), -5.3 (CH3 TBDMS), 
18.1 (Cq tBu TBDMS), 18.3 (Cq tBu TBDMS), 25.9 (tBu TBDMS), 28.1 (CH2 Lev), 29.2 (CH2 
C3H6N3), 29.8 (CH3 Lev), 37.9 (CH2 Lev), 48.6 (CH2 C3H6N3), 61.0, 61.1 (C-6, C-6’), 64.8 (CH2 
C3H6N3), 66.2 (C-5), 67.0 (C-5’), 69.8 (C-4’), 71.1 (CH2 Bn), 71.2 (CH2 Bn), 72.0 (C-3’), 72.5 (CH2 
Bn), 72.8 (CH2 Bn), 74.3 (C-2’), 74.3 (C-2), 74.7 (C-3), 75.8 (C-4), 97.5 (C-1), 99.6 (C-1’), 127.2-
128.4 (CH Arom), 138.2 (Cq Bn) , 138.3 (Cq Bn) , 139.1 (Cq Bn) , 139.2 (Cq Bn), 171.8 (COO Lev), 
206.1 (CO Lev); HRMS: C60H85N3O13Si2 + Na+ requires 1134.55131, found 1134.55163. 
3-Azidopropyl 2,3-di-O-benzyl-4,6-O-benzylidene-α/β-L-gulopyranoside 
(35): As described for the synthesis of 33 using donor 19 (0.108 g, 0.20 
mmol). Purification by column chromatography yielded 35 (0.094 g, 88%, α/β 
= 3/1.) as a colorless oil, anomers could not be separated on column. IR (neat): 
1088, 1109, 2095, 2874 cm-1; 1H NMR (400 MHz, CDCl3): δ = 1.84-1.96 (m, 
2.6H, CH2 C3H6N3), 3.36-3.39 (m, 2.6H, CH2 C3H6N3), 3.45-3.50 (m, 1H, 
CH2 C3H6N3), 3.60-3.66 (m, 0.3H, CH2 C3H6N3), 3.72 (dd, 0.3H, J = 2.8 Hz, 8.0 Hz, H-2 β), 3.77 (s, 
0.3H), 3.82-3.88 (m, 1H, CH2 C3H6N3), 3.91-3.97 (m, 3.6H), 4.00-4.05 (m, 2H), 4.10 (d, 1H, J = 2.4 
Hz), 4.23 (d, 1H, J = 12.4 Hz, CH2 Bn), 4.28 (d, 0.3H, J = 12.4 Hz, CH2 Bn), 4.57-4.69 (m, 3.9H, CH-
2 Bn), 4.83-4.88 (m, 0.6H, CH2 Bn), 4.92 (d, 1H, J = 12.0 Hz, CH2 Bn), 4.94 (d, 0.3H, J = 8.4 Hz, H-1 
β), 4.98 (d, 1H, J = 4.0 Hz, H-1 α), 5.48 (s, 0.3H, CH Benzylidene), 5.50 (s, 1H, CH Benzylidene), 
7.23-7.65 (m, 19.5H, H Arom); 13C NMR (100 MHz): δ = 29.0 (CH2 C3H6N3), 29.3 (CH2 C3H6N3), 
48.3 (CH2 C3H6N3), 48.4 (CH2 C3H6N3), 59.8, 64.7, 65.5, 66.2, 69.4, 69.7, 71.6, 73.2, 73.5, 73.7, 
73.9, 74.2, 75.3, 75.6, 76.4, 76.6, 97.8 (C-1 α), 100.7 (C-1 β), 101.0 (CHPh), 124.7-131.0 (CH Arom), 
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137.7 (Cq Bn), 138.1 (Cq Bn), 138.8 (Cq Bn); HRMS: C30H33N3O6 + H+ requires 532.24212, found 
532.24421. 
3-Azidopropyl (2,3-O-benzyl-6-O-tert-butyldimethylsilyl-4-O-(2,3-
di-O-benzyl-4,6-O-benzylidene-α-L-gulopyranosyl) -α-L-
gulopyranoside (36): As described for the synthesis of 34 using donor 
19 (0.108 g, 0.20 mmol). Purification by size exclusion and column 
chromatography yielded 36 as a colorless oil (45%, 0.074 g, α/β = 6/1), 
anomers could be separated on column, spectral data for the α anomer 
are given. [α]D22: -78.0 (c = 0.5, CHCl3); IR (neat): 1088, 1109, 2095, 
2874 cm-1; 1H NMR (400 MHz, CDCl3): δ = -0.04 (s, 3, CH3 TBDMS), 
0.01 (s, 3, CH3 TBDMS), 0.86 (s, 9H, tBu TBDMS), 1.86-2.01 (m, 2H, 
CH2 C3H6N3),  3.11 (bs, 1H, H-4’), 3.35-3.44 (m, 2H, CH2 C3H6N3), 3.55-3.58 (m, 1 H, CH2 C3H6N3), 
3.63 (t, 1H, J = 3.6 Hz, H-3’), 3.69-3.76 (m, 4H, H-2, H-6, H-6’, H-6’), 3.84-3.95 (m, 4H, H-3, H-2’, 
H-5’, CH2 C3H6N3), 3.95-3.99 (m, 2H, H-4, H-6), 4.13 (d, 1H, J = 7.2 Hz, H-5), 4.45 (d, 1H, J = 12.8 
Hz, CH2 Bn), 4.54 (d, 1H, J = 12.0 Hz, CH2 Bn), 4.59 (d, 1H, J = 10.8 Hz, CH2 Bn), 4.67-4.76 (m, 
3H, CH2 Bn), 4.91 (d, 1H, J = 3.6 Hz, H-1), 5.00 (d, 1H, J = 11.2 Hz, CH2 Bn),  5.19 (d, 1H, J = 3.6 
Hz, H-1’), 5.02 (d, 1H, J = 10.8 Hz, CH2 Bn), 5.45 (s, 1H, CH benzylidene), 6.94-7.48 (m, 25H, H 
Arom); 13C NMR (100 MHz): δ = -5.4 (CH3 TBDMS), -5.3 (CH3 TBDMS), 18.2 (Cq tBu TBDMS), 
25.8 (tBu TBDMS), 29.2 (CH2 C3H6N3), 48.6 (CH2 C3H6N3), 60.1 (C-4’), 61.1 (C-6), 64.8 (CH2 
C3H6N3), 66.8 (C-5), 69.5 (C-6’), 71.5 (CH2 Bn), 71.5 (CH2 Bn), 72.2 (CH2 Bn), 73.3 (CH2 Bn), 73.4 
(C-2), 73.8 (C-4), 75.1 (C-3), 75.3 (C-5’), 75.5 (C-3’), 76.1 (C-2’), 97.0 (C-1), 99.9 (C-1’), 100.9 (CH 
Benzylidene), 126.2-129.1 (CH Arom), 137.7-139.5 (Cq Arom); HRMS: C56H69N3O11Si + Na+ 
requires 1010.45936, found 1010.46006. 
3-Azidopropyl 2,3-di-O-benzyl-4,6-O-di-tert-butylsilylidene-α-L-
gulopyranoside (37): As described for the synthesis of 33 using donor 25 
(0.118 g, 0.20 mmol). Purification column chromatography yielded 37 
(0.088 g, 75%, α/β = 5/1) as a colorless oil, anomers could be separated 
on column, spectral data for the α anomer are given. [α]D22: -57.6 (c = 1, 
CHCl3); IR (neat): 1089, 1138, 2095, 2858, 2931 cm-1; 1H NMR (400 
MHz, CDCl3): δ = 0.91 (s, 9H, tBu), 0.98 (s, 9H, tBu), 1.82-1.85 (m, 1H, CH2 C3H6N3), 1.91-1.94 (m, 
1H, CH2 C3H6N3), 3.37 (t, 2H, J = 6.8 Hz, CH2 C3H6N3), 3.44-3.49 (m, 1H, CH2 C3H6N3), 3.78-82 
(m, 1H, CH2 C3H6N3), 3.83-3.88 (m, 2H, H-2, H-3), 3.93 (bs, 1H, H-5), 4.09 (dd, 1H, J = 1.6 Hz, 12.4 
Hz, H-6), 4.18-4.19 (m, 2H, H-4, H-6), 4.58-4.62 (m, 2H, CH2 Bn), 4.67 (d, 1H, J = 12.4 Hz, CH2 
Bn), 4.80 (d, 1H, J = 3.6 Hz, H-1), 4.96 (d, 1H, J = 12.0 Hz, CH2 Bn), 7.26-7.39 (m, 10H, H Arom); 
13C NMR (100 MHz): δ = 20.4 (Cq tBu), 23.3 (Cq tBu), 27.2 (CH3 tBu), 27.6 (CH3 tBu), 29.0 (CH2 
C3H6N3), 48.4 (CH2 C3H6N3), 64.1 (C-5), 64.6 (CH2 C3H6N3), 67.2 (C-6), 71.3 (CH2 Bn), 72.4 (C-4), 
72.6 (C-2), 73.3 (CH2 Bn), 76.1 (C-3), 97.8 (C-1), 127.5-128.4 (CH Arom), 138.0 (Cq Bn), 139.1 (Cq 
Bn); HRMS: C31H45N3O6Si + H+ requires 584.31504, found 584.31479. 
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3-Azidopropyl (2,3-O-benzyl-6-O-tert-butyldimethylsilyl-4-O-
(2,3-di-O-benzyl-4,6-O-di-tert-butylsilylidene-α-L-
gulopyranosyl)-α-L-gulopyranoside (38): Compound 38 was 
synthesized via two pathways, 1: As described for the synthesis of 
34 using donor 25 (0.118 g, 0.20 mmol). Purification by size 
exclusion and column chromatography yielded 38 (0.083 g, 48%, 
α/β = 10/1) as a colorless oil. 2: A solution of hemiacetal 39 (0.235 
g, 0.47 mmol), diphenyl sulfoxide (0.237 g, 1.17 mmol) and tri-
tert-butylpyrimidine (0.233 g, 0.939 mmol) in DCM (10 mL) was stirred over activated MS 3Å for 30 
min. The mixture was cooled to -60 °C before triflic anhydride (83 µL, 0.493 mmol) was added. The 
mixture was warmed to -40 °C and stirred for 1 h followed by addition of acceptor 28 (0.131 g, 0.234 
mmol) in DCM (2.5 mL). Stirring was continued and the reaction mixture was allowed to warm to rT, 
after which Et3N (5 equiv.) was added. The reaction mixture was diluted with DCM and washed with 
NaHCO3 (aq). The water layer was extracted twice with DCM, the collected organic layers were dried 
over MgSO4 and concentrated in vacuo. Purification by size exclusion and column chromatography 
yielded 38 (0.205 g, 84%, α/β = 10/1) as a colorless oil, anomers could be separated on column, 
spectral data for the α anomer are given. [α]D22: -75.0 (c = 1, CHCl3); IR (neat): 1084, 1138, 1454, 
1474, 2095, 2859, 2932 cm-1; 1H NMR (400 MHz, CDCl3): δ = -0.03 (s, 3, CH3 TBDMS), 0.01 (s, 3, 
CH3 TBDMS), 0.86 (s, 9H, tBu Silylidene), 0.91 (s, 9H, tBu Silylidene), 1.03 (s, 9H, tBu TBDMS), 
1.84-1.97 (m, 2H, CH2 C3H6N3),  3.29-3.40 (m, 3H, H-4’, CH2 C3H6N3), 3.50-3.52 (m, 1 H, CH2 
C3H6N3), 3.60 (t, 1H, J = 3.6 Hz, H-3), 3.67 (t, 1H, J = 3.6 Hz, H-2), 3.71 (dd, 1H, J = 1.2 Hz, 12.4 
Hz, H-6’), 3.76-3.81 (m, 3H, H-4, H-6, H-5’), 3.82-3.86 (m, 3H, H-2’, H-6’, CH2 C3H6N3), 3.89-3.95 
(m, 2H, H-6, CH2 Bn), 4.09-4.13 (m, 2H, H-5, H-3’), 4.37 (d, 1H, J = 12.4 Hz, CH2 Bn), 4.55-4.59 
(m, 2H, CH2 Bn), 4.69 (d, 1H, J = 12.0 Hz, CH2 Bn), 4.77 (d, 1H, J = 12.0 Hz, CH2 Bn), 4.87 (d, 1H, 
J = 3.6 Hz, H-1) 4.98 (d, 1H, J = 3.6 Hz, H-1’), 5.02 (d, 1H, J = 10.8 Hz, CH2 Bn), 6.96-7.48 (m, 
20H, H Arom); 13C NMR (100 MHz): δ = -5.4 (CH3 TBDMS), -5.3 (CH3 TBDMS), 18.2 (Cq tBu 
TBDMS), 20.4 (Cq tBu Silylidene), 23.3 (Cq tBu Silylidene), 25.9 (tBu TBDMS), 27.2 (CH3 tBu 
Silylidene), 27.6 (CH3 tBu Silylidene), 29.2 (CH2 C3H6N3), 48.6 (CH2 C3H6N3), 61.4 (C-6), 64.5 (C-
4’), 64.7 (CH2 C3H6N3), 66.9 (C-6’), 67.1 (C-5), 71.2 (CH2 Bn), 71.5 (CH2 Bn), 72.9 (CH2 Bn), 73.1 
(C-3’), 73.2 (CH2 Bn), 73.8 (C-2’), 73.9 (C-2), 75.5 (C-4), 75.6 (C-5’), 76.1 (C-3), 97.0 (C-1), 99.7 
(C-1’), 127.3-128.5 (CH Arom), 138.1 (Cq Bn), 138.5 (Cq Bn), 139.0 (Cq Bn), 139.7 (Cq Bn); HRMS: 
C57H81N3O11Si2 + Na+ requires 1062.53018, found 1062.53082. 
2,3-di-O-benzyl-4,6-O-di-tert-butylsilylidene-α/β-L-gulopyranoside (39): 
To a solution of 25 (0.638 g, 1.08 mmol) in CH2Cl2 (10 mL) was added at 0 
°C NIS (0.243 g, 1.08 mmol) and TFA (83 μl, 1.08 mmol). After TLC 
analysis showed complete consumption of starting material, the reaction was 
quenched with Et3N, then sat. aq. Na2S2O3 was added and the mixture was 
stirred for 30 min. The water layer was extracted twice with DCM and the combined organic layers 
were dried over MgSO4 and concentrated in vacuo. Purification by column chromatography yielded 
39 (0.514 g, 95%, α/β = 3/1) as a colorless oil. IR (neat): 826, 1045, 1084, 1138, 1474, 1736, 2858, 
2932, 3472 cm-1; 1H NMR (400 MHz, CDCl3): δ = 0.91 (s, 3H, tBu), 0.99 (s, 9H, tBu), 3.48 (d, 0.3H, 
J = 5.2 Hz, OH β), 3.65 (dd, 0.3H, J = 2.8 Hz, 8.0Hz, H-2 β), 3.80 (bs, 0.3H), 3.88-3.89 (m, 1H, H-2 
α), 3.98 (m, 1.3H), 4.13-4.23 (m, 3H), 4.57-4.71 (m, 2.6H, CH2 Bn), 4.80 (d, 0.3H, J = 12.0 Hz, CH2 
Bn), 4.85 (d, 1H, J = 11.6 Hz, CH2 Bn), 5.16 (dd, 0.3H, J = 5.2 Hz, 2.6 Hz, H-1 β), 5.22 (m, 1 H, H-1 
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α), 7.21-7.37 (m, 10.6H, H Arom); 13C NMR (100 MHz): δ = 20.3 (Cq tBu), 20.4 (Cq tBu), 23.2 (Cq 
tBu), 27.1 (CH3 tBu), 27.3 (CH3 tBu), 27.4 (CH3 tBu), 27.8 (CH3 tBu), 62.3, 67.0, 67.1, 70.2, 70.5, 
70.6, 71.6, 72.0, 72.7, 73.6, 74.6, 76.9, 77.6, 78.2, 92.9, 94.8 (C-1, α/β), 127.5-128.5 (CH Arom), 
137.2 (Cq Bn), 137.5 (Cq Bn), 138.3 (Cq Bn), 138.5 (Cq Bn); HRMS: C28H40O6Si + H+ requires 
501.26669, found 501.26671. 
3-Azidopropyl (2,3-O-benzyl-4-O-(2,3-O-benzyl-α-L-
gulopyranosyl) -α-L-gulopyranoside (40): A solution of 38 (0.233 g, 
0.244 mmol) in THF (2.5 mL) was cooled to 0 °C. TBAF (0.74 mL, 
0.74 mmol, 1 M in THF) was added. After 4 h the mixture was diluted 
with EtOAc, and washed with water and brine. The organic layer was 
dried over MgSO4 and concentrated in vacuo. Purification by column 
chromatography yielded 40 (0.153 g, 87%) as a colorless oil. [α]D22: -
73.2 (c = 1, CHCl3); IR (neat): 1069, 1109, 1454, 2095, 2878 cm-1; 1H NMR (400 MHz, CDCl3): δ = 
1.81-2.01 (m, 2H, CH2 C3H6N3), 3.37-3.43 (m, 3H, H-6, CH2 C3H6N3), 3.49-3.54 (m, 1H, CH2 
C3H6N3), 3.58 (dd, 1H, J = 2.8 Hz, 12 Hz, H-6), 3.70 (bs, 1H, OH), 3.77-3.77 (m, 5H), 3.83-3.88 (m, 
5H), 4.12 (bs, 1H), 4.18 (d, 1H, J = 12.6 Hz, CH2 Bn), 4.27 (m, 1H, H-4), 4.33 (d, 1H, J = 12.0 Hz, 
CH2 Bn), 4.37 (d, 1H, J = 12.4 Hz, CH2 Bn), 4.43 (d, 1H, J = 12.0 Hz, CH2 Bn), 4.54-4.61 (m, 3H, 
CH2 Bn), 4.65 (d, 1H, J = 12.0 Hz, CH2 Bn), 4.80 (d, 1H, J = 2.4 Hz, H-1), 4.85 (d, 1H, J = 12.0 Hz, 
CH2 Bn), 4.98 (d, 1H, J = 3.6 Hz, H-1’), 7.17-7.41 (m, 20H, Harom); 13C NMR (100 MHz): δ = 29.0 
(CH2 C3H6N3), 48.4 (CH2 C3H6N3), 62.6, 64.3 (C-6, C-6’), 64.8 (CH2 C3H6N3), 65.8, 65.9, 70.8, 71.3, 
71.4, 72.7, 72.7, 72.9, 73.3, 73.6, 74.6, 80.4, 97.1 (C-1), 99.8 (C-1’), 127.3-129.1 (CH Arom), 137.4 
(Cq Bn), 138.2 (Cq Bn), 138.3 (Cq Bn), 138.7 (Cq Bn); ESI-MS: 786.4 (M+H+). 
3-Azidopropyl (2,3-O-benzyl-6-O-tert-butyldimethylsilyl-4-O-
(2,3-O-benzyl-6-O-tert-butyldimethylsilyl-α-L-gulopyranosyl) -α-
L-gulopyranoside (41): A solution of 40 (0.278 g, 0.35 mmol) in 
DMF (5 mL) was cooled to 0 °C. Imidazole (0.049 g, 0.725 mmol) 
and TBDMSCl (0.109 g, 0.725 mmol) were added respectively and 
the mixture was warmed to rT. After stirring for 4h, the mixture was 
quenched with MeOH and concentrated in vacuo. The residue was 
taken up in Et2O and washed three times with H2O, the organic layer 
was dried over MgSO4 and concentrated in vacuo. Column chromatography yielded 41 (0.273 g, 
78%) as a colorless oil. [α]D22: -60.2 (c = 1, CHCl3); IR (neat): 1003, 1092, 1454, 2095, 2858, 2928 
cm-1; 1H NMR (400 MHz, CDCl3): δ = -0.01 (s, 3, CH3), 0.02 (s, 3, CH3), 0.11 (s, 3, CH3),  0.12 (s, 3, 
CH3), 0.89 (s, 9H, tBu), 0.93 (s, 9H, tBu), 1.88-1.99 (m, 2H, CH2 C3H6N3), 3.32-3.46 (m, 2H, CH2 
C3H6N3), 3.53-3.57 (m, 1H, CH2 C3H6N3), 3.60-3.66 (m, 3H, H-5’, H-6’, H-6’), 3.70 (t, 1H, J = 3.2 
Hz, H-3), 3.74-3.78 (m, 2H, H-2, H-6), 3.83-3.87 (m, 1H, CH2 C3H6N3), 3.88-4.04 (m, 5H, H-4, H-6, 
H-2’, H-4’, CH2 Bn), 4.09 (s, 1H, H-3’), 4.16 (t, 1H, J = 6.8 Hz, H-5), 4.42 (d, 1H, J = 12.4 Hz, CH2 
Bn), 4.58-4.62 (m, 2H, CH2 Bn), 4.65 (d, 1H, J = 12.0 Hz, CH2 Bn), 4.73 (d, 1H, J = 12.0 Hz, CH2 
Bn), 4.80 (d, 1H, J = 12.0 Hz, CH2 Bn),  4.87 (d, 1H, J = 3.6 Hz, H-1), 5.00 (d, 1H, J = 11.2 Hz, CH2 
Bn), 5.15 (d, 1H, J = 3.6 Hz, H-1’), 7.04-7.49 (m, 20H, H Arom); 13C NMR (100 MHz): δ = -5.6 
(CH3), -5.5 (CH3), -5.4 (CH3), 18.0 (Cq tBu), 18.2 (Cq tBu), 25.8 (tBu), 29.1 (CH2 C3H6N3), 48.5 
(CH2 C3H6N3), 61.1 (C-6), 64.6 (CH2 C3H6N3), 65.3 (C-5’), 65.6 (C-6’), 67.0 (C-5), 71.4 (CH2 Bn), 
71.5 (CH2 Bn), 72.5 (CH2 Bn), 73.1 (CH2 Bn), 72.1, 74.1, 74.9, 75.1, 75.2 (C-2, C-4, C-2’, C-3’, C-
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4’), 76.1 (C-3), 97.0 (C-1), 99.9 (C-1’), 127.0-128.3 (CH Arom), 138.4 (Cq Bn), 138.5 (Cq Bn), 139.0 
(Cq Bn), 139.6 (Cq Bn); HRMS: C55H79N3O11Si2 + Na+ requires 1036.51453, found 1036.51517. 
3-Azidopropyl (2,3-O-benzyl-6-O-tert-
butyldimethylsilyl-4-O-(2,3-O-benzyl-6-O-tert-
butyldimethylsilyl-4-O-(2,3-di-O-benzyl-4,6-O-di-tert-
butylsilylidene-α-L-gulopyranosyl) -α-L-
gulopyranosyl) -α-L-gulopyranoside (42): A solution of 
39 (0.162 g, 0.324 mmol), diphenyl sulfoxide (0.164 g, 
0.81 mmol) and tri-tert-butylpyrimidine (0.504 g, 0.125 
mmol) in DCM (6 mL) was stirred over activated MS 3Å 
for 30 min. The mixture was cooled to -60 °C before 
triflic anhydride (57μl, 0.340 mmol) was added. The 
mixture was allowed to warm to -40 °C and stirred for 1 
h followed by addition of acceptor 41 (0.164 g, 0.162 mmol) in DCM (1.6 mL). Stirring was 
continued and the reaction mixture was allowed to warm to 10 °C, then Et3N (0.1 mL) was added. 
The reaction mixture was diluted with DCM and washed with NaHCO3 (aq). The water layer was 
extracted twice with DCM and the collected organic layers were dried over MgSO4 and concentrated 
in vacuo. Purification by column chromatography yielded 42 (0.102 g, 42%) as a colorless oil. [α]D22: 
-75.8 (c = 1, CHCl3); IR (neat): 1084, 1138, 1454, 1474, 2095, 2859, 2932 cm-1; 1H NMR (400 MHz, 
CDCl3): δ = -0.02 (s, 3, CH3), -0.01 (s, 3, CH3), 0.01 (s, 3, CH3),  0.06 (s, 3, CH3), 0.87 (s, 9H, tBu), 
0.93 (s, 9H, tBu), 0.96 (s, 9H, tBu), 1.08 (s, 9H, tBu), 1.88-1.93 (m, 2H, CH2 C3H6N3), 3.32-3.37 (m, 
2H, CH2 C3H6N3), 3.39-3.45 (m, 2H), 3.69-3.86 (m, 8H), 3.89-3.98 (m, 7H), 4.03 (t, 1H, J = 9.6 Hz), 
4.09-4.20 (m, 5H), 4.28 (d, 1H, J = 12.4 Hz, CH2 Bn), 4.45 (d, 1H, J = 12.4 Hz, CH2 Bn), 4.59-4.66 
(m, 3H, CH2 Bn), 4.70 (d, 1H, J = 4.0 Hz, H-1), 4.73 (d, 1H, J = 12.0 Hz, CH2 Bn), 4.79 (d, 1H, J = 
12.4 Hz, CH2 Bn), 4.96 (d, 1H, J = 12.0 Hz, CH2 Bn), 5.03 (d, 1H, J = 12.0 Hz, CH2 Bn), 5.08 (d, 1H, 
J = 11.2 Hz, CH2 Bn), 5.11 (d, 1H, J = 2.8 Hz) , 5.16 (d, 1H, J = 2.4 Hz) (H-1’, H-1’’), 6.97-7.55 (m, 
30H, H Arom); 13C NMR (100 MHz): δ = -5.4 (CH3), -5.3 (CH3), -5.2 (CH3), 18.1 (Cq tBu), 18.2 (Cq 
tBu),  20.3 (Cq tBu), 23.3 (Cq tBu), 25.9 (tBu), 25.9 (tBu), 27.2 (CH3 tBu), 27.6 (CH3 tBu), 29.1 (CH2 
C3H6N3), 48.5 (CH2 C3H6N3), 61.0, 61.3 (C-6, C-6’), 64.5 (4’’), 64.6 (CH2 C3H6N3), 66.8 (C-6’’), 
67.6 (C-5, C-5’), 71.0 (CH2 Bn), 71.1 (CH2 Bn), 71.1 (CH2 Bn), 72.5 (CH2 Bn), 72.9 (CH2 Bn), 73.3 
(CH2 Bn), 73.0, 73.6, 74.9, 75.1, 75.4, 75.7, 75.8, 76.2, 97.2 (C-1), 99.3, 99.7 (C-1’, C-1’’), 127.0-
128.4 (CH Arom), 138.0 (Cq Bn), 138.4 (Cq Bn), 138.6 (Cq Bn), 139.5 (Cq Bn), 139.6 (Cq Bn), 138.7 
(Cq Bn); HRMS: C83H117N3O16Si3 + Na+ requires 1518.76338, found 1518.76503. 
3-Azidopropyl (2,3-O-benzyl-4-O-(2,3-O-benzyl-4-O-(2,3-
O-benzyl-a-L-gulopyranosyl)-α-L-gulopyranosyl)-α-L-
gulopyranoside (43): A solution of 42 (0.094 g, 0.063 
mmol) in THF (2 mL) was cooled to 0 °C. TBAF (0.28 mL, 
0.28 mmol, 1 M in THF) was added. After 4 h the mixture 
was diluted with EtOAc, and washed with water and brine. 
The organic layer was dried over MgSO4 and concentrated 
in vacuo. Purification by column chromatography yielded 
43 (0.067 g, 83%) as a colorless oil. IR (neat): 1069, 1109, 
1454, 2095, 2878 cm-1; 1H NMR (400 MHz, CDCl3): δ 1.88-
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1.96 (m, 2H, CH2 C3H6N3), 3.34-3.39 (m, 3H), 3.47-3.59 (m, 4H), 3.64-3.67 (m, 4H), 3.73-3.79 (m, 
4H), 3.82-3.87 (m, 7H), 3.97 (bs, 1H), 4.05 (bs, 1H), 4.14 (bs, 1H), 4.23 (d, 1H, J = 12.4 Hz, CH2 
Bn), 4.32 (d, 1H, J = 11.6 Hz, CH2 Bn), 4.34 (d, 1H, J = 10.8 Hz, CH2 Bn), 4.43 (d, 1H, J = 12.0 Hz, 
CH2 Bn), 4.49 (d, 1H, J = 12.4 Hz, CH2 Bn), 4.55 (d, 1H, J = 12.4 Hz, CH2 Bn), 4.57-4.68 (m, 5H, 
CH2 Bn), 4.70 (d, 1H, J = 3.2 Hz, H-1),  4.91 (d, 1H, J = 12.0 Hz, CH2 Bn), 4.95 (d, 1H, J = 3.6 Hz), 
4.97 (d, 1H, J = 3.6 Hz) (H-1’, H-1’’), 7.10-7.42 (m, 30H, H Arom); 13C NMR (100 MHz): δ = 29.1 
(CH2 C3H6N3), 48.4 (CH2 C3H6N3), 62.5, 62.8, 64.2, 64.7, 65.7, 66.0, 66.5, 70.7, 71.2, 71.3, 71.5, 
72.1, 72.6, 72.7, 72.7, 73.1, 73.2, 73.3, 74.0, 74.8, 79.7, 80.9, 97.3, 99.2, 99.9 (C-1, C-1’, C-1’’), 
127.4-128.5 (CH Arom), 137.4 (Cq Bn), 137.6 (Cq Bn), 138.2 (Cq Bn), 138.2 (Cq Bn), 138.3 (Cq Bn), 
139.0 (Cq Bn); ESI-MS: 1128.5 (M+Na+).  
3-Aminopropyl (4-O-(α-L-gulopyranosyl) uronate) -α-L-
gulopyranoside) uronic acid (44): 40 (0.243 g, 0.310 mmol) was 
taken up in DCM (2 mL), tBuOH (2 mL) and H2O (0.5 mL). To 
this mixture were added TEMPO (0.019 g, 0.124 mmol) and 
BAIB (0.496 g, 1.55 mmol). The mixture was stirred vigorously 
until TLC-analysis showed complete conversion of the starting 
material. 10 mL Na2S2O3 (aq) was added and the resulting mixture 
was stirred for 15 min. The layers were separated and the aqueous phase acidified with 1M HCl and 
extracted three times with DCM. The combined organic layers were dried over MgSO4 and 
concentrated in vacuo. The resulting syrup was then dissolved in tBuOH (2 mL) and H2O (2 mL) 
before a catalytic amount of Pd on charcoal is added. The reaction mixture is stirred overnight under 
an H2-atmosphere and filtered. Gel filtration (HW-40) afforded the desired disaccharide 44 (0.086 g, 
90%). 1H NMR (400 MHz, D2O): δ = 1.98-2.06 (m, 2H, CH2 C3H6N3), 3.14-3.23 (m, 2H, CH2 
C3H6N3), 3.65-3.71 (m, 1H, CH2 C3H6N3), 3.92-3.99 (m, 4H, H-2, H-2’, H-3’, CH2 C3H6N3), 4.09-
4.16 (m, 3H, H-3, H-4, H-4’), 4.41 (d, 1H, J = 1.2 Hz, H-5’), 4.47 (s, 1H, H-5), 4.96 (d, 1H, J = 3.6 
Hz), 5.02 (d, 1H, J = 4.0 Hz) (H-1, H-1’); 13C NMR (100 MHz): δ = 26.0 (CH2 C3H6N3), 39.0 (CH2 
C3H6N3), 64.5, 65.1 (C-2, C-2’), 66.7 (C-5), 67.8 (CH2 C3H6N3), 68.1 (C-5’), 69.1, 70.3 (C-3, C-3’), 
70.8 (C-4’), 80.5 (C-4), 98.4, 100.9 (C-1, C-1’), 175.7 (COOH), 176.1 (COOH); HRMS: C15H25NO13 
+ Na+ requires 450.12181, found 450.12170. 
3-Aminopropyl (4-O-(4-O-(α-L-gulopyranosyl) uronate) 
-α-L-gulopyranosyl) uronate) -α-L-gulopyranoside) 
uronic acid (45): 43 (0.039 g, 0.034 mmol) was taken up 
in DCM (1 mL), tBuOH (1 mL) and H2O (0.5 mL). To this 
mixture were added TEMPO (0.003 g, 0.021 mmol) and 
BAIB (0.082 g, 0.257 mmol). The mixture was stirred 
vigorously until TLC-analysis showed complete 
conversion of the starting material. 2 mL Na2S2O3 (aq) was 
added and the resulting mixture was stirred for 15 min. The 
layers were separated and the aqueous phase acidified with 
1M HCl and extracted three times with DCM. The combined organic layers were dried over MgSO4 
and concentrated in vacuo. The resulting syrup was then dissolved in tBuOH (1 mL) and H2O (1 mL) 
before a catalytic amount of Pd on charcoal is added. The reaction mixture is stirred overnight under 
an H2-atmosphere and filtered. Gel filtration (HW-40) afforded the desired trisaccharide (45) (0.018 
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g, 85%). 1H NMR (400 MHz, D2O): δ = 1.98-2.02 (m, 2H, CH2 C3H6N3), 3.14-3.19 (m, 2H, CH2 
C3H6N3), 3.65-3.71 (m, 1H, CH2 C3H6N3), 3.91-4.00 (m, 5H, H-2, H-2’, H-2’’, H-3’’, CH2 C3H6N3), 
4.04-4.07 (m, 2H, H-3, H-3’), 4.14 (bs, 3H, H-4, H-4’, H-4’’), 4.41 (s, 1H), 4.46 (s, 1H), 4.47 (s, 1H, 
H-5, H-5’, H-5’’), 4.96 (d, 1H, J = 4.0 Hz), 5.02 (d, 1H, J = 3.6 Hz), 5.06 (d, 1H, J = 4.0 Hz) (H-1, H-
1’, H-1’’); 13C NMR (100 MHz): δ = 26.2 (CH2 C3H6N3), 39.0 (CH2 C3H6N3), 64.6, 65.2, 65.2 (C-2, 
C-2’, C-2’’), 66.6, 67.3, 68.2 (C-5, C-5’, C-5’’), 67.8 (CH2 C3H6N3), 69.1, 69.2, 70.4 (C-3, C-3’, C-
3’’), 70.8 (C-4’’), 80.0, 80.5 (C-4, C-4’), 98.4, 100.7, 100.9 (C-1, C-1’, C-1’’), 175.5 (COOH), 175.6 
(COOH), 176.1 (COOH); HRMS: C21H33NO19 + Na+ requires 626.15390, found 626.15384. 
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Chapter 6 
Stereodirecting Effect of the Pyranosyl C-5 Substituent in 
Glycosylation Reactions 
Introduction 
Uronic acids, aldohexoses having their primary hydroxyl oxidized to a carboxylic acid, are 
widely spread constituents of naturally occurring polysaccharides.1 For instance, the 
biological important glycosaminoglycans are characterized by dimeric repeating units, in 
which one of the residues is either a D-glucuronic acid or a L-iduronic acid.2 Alginate 
(composed of D-mannuronic acid and L-guluronic acid residues)3 and pectin (D-galacturonic 
acid)4 are examples of the class of glycuronans that contain solely uronic acids. Recently 
the syntheses of β-1,4-D-mannuronic acid5 and α-1,4-L-guluronic acid6 oligomers as 
fragments of the alginate polymer were reported (see Chapter 5). In a sulfonium ion 
mediated preactivation glycosylation procedure7 the β-1,4-D-mannuronic acid linkages (4) 
were introduced with high stereoselectivity using a suitably protected thiomannuronate 
ester donor (for example 1, Scheme 1). In analogy with the thorough mechanistic studies of 
the group of Crich on the glycosylating properties of 4,6-O-benzylidene thiomannoside 
donors, this stereochemical outcome can be rationalized by an SN2-like attack of the 
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nucleophile on the putative axial α-triflate 2 or on the corresponding contact ion pair.8 The 
electron withdrawing capacity of the C-5 carboxylate1,9 destabilizes the (solvent separated) 
oxocarbenium ion 3a-b, resulting in a shift of the equilibrium to the side of the α-triflate 2.5 
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Glycosylations with mannuronate and guluronate ester donors. Reagents and conditions: a) BSP, 
TTBP, DCM, -60 °C to -45 °C, Tf2O 10 min, then -60 °C, nucleophile, to 0 °C. b) Ph2SO, TTBP, 
DCM, -60 °C to -45 °C, Tf2O 10 min, then -60 °C, nucleophile, to 0 °C. 
Application of the same type of glycosylation procedure to the suitably protected 
thioguluronic ester donor 5 (the C-5 epimer of D-mannose) gave the α-linked product (8),6 
albeit with reduced stereoselectivity and yield. The stereochemical outcome of the 
glycosylation of 5 can not be explained by invoking α-triflate 6 as the product forming 
intermediate, since SN2-like attack on the axial triflate 6 would result in the formation of the 
1,2-trans product. Puzzled by the effect of the C-5 carboxylate ester on the stereochemistry 
of these glycosylations, attention was attracted to the work of Woerpel and co-workers on 
the stereoselectivity of pyranosyl oxacarbenium ions in C-glycosylation reactions.10 From 
their work it is apparent that the relative stability of the 3H4 and 4H3 half-chair conformers11 
of the intermediate oxacarbenium ions12 is of prime importance for the stereochemical 
outcome of C-glycosylations.13 Provided that there are no prohibitive steric interactions in 
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the transition state, the isomeric ratio of the addition products reflects the relative ground-
state energies of the product forming oxacarbenium ions.14 The stability of the half-chair 
conformers is determined by the nature and the configuration of the substituents on the 
pyranose ring.12c,15 Alkyl groups at C-3 and C-4 prefer to adopt pseudo equatorial positions, 
whereas electron withdrawing substituents at these positions preferentially adopt an axial 
orientation. C-2 Alkoxy substituents again prefer an equatorial orientation.12c To establish 
the stereodirecting effect of the C-5 carboxylate ester Codée et al. studied the 
condensations of pyranoside 9 (Scheme 2) having a single carboxylate subtituent at C-5, 
and its “non-oxidized” counterpart 10 having a methyloxybenzyl group at this position.16 It 
turned out that the C-5 ester is 1,5-cis directing, while the C-5 methyloxybenzyl 
functionalized pyranoside gives little selectivity. The stereochemical outcome of these 
glycosylations can be explained by taking into consideration the half chair oxocarbenium 
ions 11 and 12 as product forming intermediates. Attack of an incoming nucleophile on 
these ions occurs along a pseudo axial trajectory with a facial selectivity which allows the 
formation of the lower energy chair product, as opposed to a twist boat product originating 
from attack from the other side of the oxacarbenium ion.14b The formation of the 1,2-cis-
product 13 arises from the 3H4 (11a) conformer, indicating that the C-5 carboxylate prefers 
to occupy an axial position in the oxacarbenium ion intermediate. 
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Stereoselectivity of C-5 functionalized pyranosides. Reagents and conditions: a) Ph2SO, TTBP, 
DCM, -78 °C, Tf2O, 5 min, then BnOH, -78 °C, 15 min. 
In the D-mannuronate ester 3H4 oxacarbenium ion (3a) the axial preference of the C-5 ester 
can be accommodated keeping all other substituents in their most favorable orientations 
(Scheme 1). The 3H4 conformer will therefore be substantially more stable than the 
corresponding 4H3 half-chair (3b), and nucleophilic attack on 3a leads to the formation of 
the 1,2-cis product. Thus, besides α-triflate 2 (Scheme 1), oxacarbenium ion 3a can also be 
at the basis of the selectivity displayed by mannuronate esters. In the L-guluronate case, the 
C-5 ester can only adopt its favorable axial position in the 4H3 half-chair (7b), in which all 
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other substituents are in disfavored positions (Scheme 1). In the alternative 3H4 conformer 
(7a), the C-2, C-3 and C-4 substituents are favorably oriented, however the C-5 ester is in 
the more destabilizing equatorial position. The effect of the C-5 ester does not outweigh the 
combined electronic effects of the substituents at C-2, C-3 and C-4,12c and therefore the 4H3 
half-chair (7b), which leads to 1,2-cis selective condensations, is preferred over its 3H4 
counterpart (7a). Because the guluronate ester oxacarbenium ion half chairs will be closer 
together in ground state energy the selectivity of glycosylations involving these 
intermediates is less pronounced. 
To investigate the magnitude of the stereodirecting effect of the C-5 substituent in 
glycosylations in more detail, a study towards the glycosylation properties of a set of 
thioglycosides having a carboxylate methyl ester, a methylene benzyl ether or a methyl 
group at C-5 is presented in this Chapter. To this end, D-manno, D-gulo, D-gluco and D-
galacto configured 1-thioglycosides, 1-thio uronic acids and 1-thio 6-deoxy thioglycosides 
were synthesized and glycosidated with both a primary and a secondary glycosyl acceptor. 
Results and discussion 
First, theoretical support was sought for the effect of ester, methylene ether17 and methyl 
functions at C-5 on the stability of the oxacarbenium ion half chairs (Figure 1). To this end 
the geometries of the C-5 functionalized pyranosyl half chair oxacarbenium ions were 
optimized and their relative energies calculated. Second order Möller-Plesset (MP2) 
geometry-optimizations18 were performed using the 6-311+G** basis set in Spartan 04.19 
The MP2 and MP3 gas phase energy calculations of the geometry-optimized conformers 
were performed using Gaussian 03.20 The effect of the solvent (dichloromethane) was taken 
into account by application of the Polarizable Continuum Model (PCM) at the MP2 level, 
which leveled the energy differences to some extent (vide infra). The results of the 
calculations are reported in Figure 1. Both the MP2 and MP3 calculations show that the 
methyl ester oxacarbenium ion 3H4 conformer (15), in which the ester occupies an axial 
position, is more stable than the corresponding equatorial ester oxacarbenium ion (17). The 
orientation of the ester is of importance: conformer 15, in which the ester carbonyl is 
pointing towards the ring oxygen, was calculated to be approximately 3.6 kcal/mol more 
stable than the equatorial conformer, whereas conformer 16, having the methoxy group 
oriented towards the oxacarbenium ion, is isoenergetic with the equatorial conformer.21,22 
The stability of 15 results from the donation of electron density from the carbonyl group to 
the electron depleted oxacarbenium ion function. The axial preference of the C-5 ester in 
conformer 15 is of similar magnitude as the axial preference of C-3 and C-4 alkoxy 
groups.12c The calculations show the axially oriented methyloxy methylene pyranosyl  
oxacarbenium 18 (with the alkoxy group situated above the ring)10e also to be the most 
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stable conformer, although the difference between the axial and equatorial conformer was 
significantly smaller when compared to the C-5 ester system. The axially (20) and 
equatorially (21) oriented C-5 methyl oxacarbenium ions differ in energy by approximately 
1 kcal/mol, in favor of the equatorial substituent. A similar value has previously been 
reported by Bowen and co-workers for the same system.12c 
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Calculated relative energies of C5-substituted pyranosyl oxacarbenium ions. The error in these 
calculations is approximately ± 1 kcal/mol. 
The trend17 revealed by the calculations is in line with the experimental results described 
above in Scheme 2. The C-5 ester prefers to adopt an axial position in the oxacarbenium 
intermediate, thereby stabilizing the 3H4 conformer relative to its 4H3 counterpart leading to 
the preferential formation of the 1,5-cis product. The slight preference of the 
methyloxybenzyl group in pyranoside 18 to occupy an axial position does not lead to the 
selective formation of the 1,5-cis product. In this case steric interactions between the 
incoming nucleophile and the C-5 substituent in the transition state counterbalance the 
ground state preferences of the half chair oxacarbenium ions. 
Next, the stereodirecting effect of three C-5 substituents (methyl ester, methyloxybenzyl 
and methyl) on the glycosylation properties of a set of epimeric perbenzylated D-
pyranosides was investigated. First, the mannose series was investigated. Phenyl 1-thio-β-
D-mannuronate ester 22, the corresponding D-mannose 23, and 6-deoxy-D-mannose (D-
rhamnose) 24 were condensed with both the primary alcohol 25 and the secondary alcohol 
26 using a diphenylsulfoxide (Ph2SO)-trifluoromethane sulphonic anhydride (Tf2O) 
activation procedure. The coupling conditions for all three donors were identical except for 
the activation temperature: mannuronate ester 22 was activated starting at -60 oC and 
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warming to -45 oC over a period of 15 minutes, before adding the acceptor at -78 oC and 
very slow warming to 0 oC, at which temperature the reaction was quenched. The more 
reactive mannose donor 23 and rhamnose donor 24 were pre-activated at -78 oC for 10 
minutes after which the acceptor was added at the same temperature. The results of these 
condensations are summarized in Table 1. 
Table 1 
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Acceptor 22: R = COOMea  23: R = CH2OBnb 24: R = CH3b 
25 27 α/β = 0/1 (77%) 28 α/β = 1/2 (71%) 29 α/β = 1 / 1.7 (71%) 
26 30 α/β = 0/1 (58%) 31 α/β = 1/1.5 (52%) 32 α/β = 1 / 1 (65%) 
Study of the C-5 substituent effect in the mannose series. Reagents and conditions: a) Ph2SO, TTBP, 
DCM, -60 °C to -45 °C, Tf2O 10 min, then -78 °C, nucleophile, to 0 °C; b) Ph2SO, TTBP, DCM, -78 
°C, Tf2O 10 min, nucleophile, to 0 °C. 
Mannuronate ester 22 yielded solely the β-linked products 27 and 30 independent of the 
nature of the acceptor. Tetrabenzyl mannose 23 showed a significant drop in selectivity, but 
maintained a slight preference for the formation of the β-product. The β-selectivity for the 
glycosylation involving the primary acceptor 25 was slightly better than for the secondary 
acceptor 26. Although the β-selectivity of donor 23 is not unprecedented,23 it stands in 
contrast to the perception that perbenzylated mannose donors are α-selective in 
glycosylation reactions.24,25 The condensations of D-rhamnose 24 showed a further decrease 
of β-product formation and also here the secondary acceptor gave more α-product. The 
anomeric ratios of the glycosylations in Table 1 follow the trend in the stability of the 
respective oxacarbonium ions (Scheme 3). In the 3H4 conformer of mannuronic ester (33a) 
all substituents are situated in a favorable position, explaining the nucleophilic attack on 
this conformer and the sole formation of the cis product. In mannose the difference in 
stability between the 3H4 conformer (34a) and its 4H3 counterpart (34b) is less pronounced. 
Because steric interactions in the transition state leading to the α-product are smaller than in 
the transition state which leads to the β-linked dimer,10d,e a Curtin-Hammett/Winstein-
Holness kinetic scenario,26 in which product formation arises from the higher energy 4H3 
conformer (34b), can account for the formation of the 1,2-trans-product in the anomeric 
mixture. Because the methyl group prefers an equatorial orientation in the oxacarbenium 
ion intermediate, the difference in stability between the 3H4 (35a) and 4H3 (35b) conformers 
of rhamnose is further minimized, and more product is formed from the 4H3 oxacarbenium 
ion. 
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Scheme 3 
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Mannosyl oxacarbenium ions. 
Execution of glycosylation reactions of 25 and 26 with D-gulose derivatives  36, 37 and 38 
shows an α-selectivity that increases slightly in going from the carboxylate methyl ester 36, 
to methylene benzyl ether 37, to 6-deoxy 38 (Table 2). For both tetrabenzyl (37) and the 6-
deoxy (38) gulose the α-selectivity is slightly diminished when secondary alcohol 26 is 
used instead of primary acceptor 25. Contrary, for the guluronic acid methyl ester (36) 
glycosylations this effect is reversed. 
Table 2 
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Acceptor 36: R = COOMea 37: R = CH2OBnb 38: R = CH3b 
25 39 α/β = 1/0.33 (86%) 40 α/β = 1/0.10(76%) 41 α/β = 1/0.08 (67%) 
26 42 α/β = 1/0.17 (63%) 43 α/β = 1/0.12 (70%) 44 α/β = 1/0.15 (70%) 
Study of the C-5 substituent effect in the gulose series. Reagents and conditions: a) Ph2SO, TTBP, 
DCM, -60 °C to -45 °C, Tf2O 10 min, then -78 °C, nucleophile, to 0 °C; b) Ph2SO, TTBP, DCM, -78 
°C, Tf2O 10 min, nucleophile, to 0 °C. 
The stereochemical outcome of the glycosylations in Table 2 can be rationalized with the 
oxacarbenium ions 45-47 (Scheme 4) as product forming intermediates. Although the 
degree of influence of the substituents on the stereoselectivity seems to be reduced, the 
trend based on the relative stabilities of the 3H4 and the 4H3 conformers, is again 
confirmed.27 All gulosylations may proceed by an axial attack of the nucleophile on the 4H3 
conformer, leading to the cis-product (Scheme 4). The 4H3 oxacarbenium ion of 6-
deoxygulose 47b has the substituents positioned in such a manner that they all contribute 
favorably to the stability of this conformer and the gulosylations of this donor are therefore 
the most cis selective. The stereoselectivity of gulose 37 and in particular guluronic ester 36 
is less pronounced, as in the 4H3 conformer (45b) the carboxylic ester does not occupy its 
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favored axial position (Scheme 4). The erosion in stereoselectivity caused by the 
unfavorable positioning of the C-5 substituent is considerably less in the gulose series than 
in the mannose series. This may be due to the difference in steric interactions that develop 
in the transition states of the nucleophilic additions to the respective oxacarbenium ions. 
Axial attack of a nucleophile on the mannose 3H4 oxacarbenium ions 33a-35a leads to 1,3-
diaxial interactions with both the C-3 and C-5 substituent,12c which are absent in the 
transition state of the 4H3 half chairs 33b-35b (Scheme 3). For gulose both half chair 
conformers give rise to one 1,3-diaxial interaction in the transition states and are therefore 
sterically equally demanding (Scheme 4). 
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Gulosyl oxacarbenium ions. 
The results reported above for mannuronic acid donor 22 and 6-deoxy gulose donor 38 
indicate that highly stereoselective glycosylations can be obtained when all the substituents 
occupy a favorable position in either the 3H4 or the 4H3 oxacabenium ion conformer. To 
further assess the effect of the substituent at C-5 on the stereochemical outcome of 
glycosylation reactions, three other epimers were examined. D-gluco, D-allo and D-galacto 
configured 1-thioglycosides and the corresponding 1-thio uronic acids were prepared and 
glycosidated with the same primary and secondary acceptor as used in the manno- and 
gulo- series. The results of these condensations are summarized in Table 3. Almost all of 
the condensations proceed with poor stereoselectivity. Furthermore, the nature of the 
acceptor appears to have a profound effect on the stereochemical outcome of the 
glycosylations. The low selectivities observed in the glucose (48 and 49) and galactose (60 
and 61) series are in contrast to the previously reported highly α-selective C-glycosylations 
of these epimers.23a,28 No clear effect of the C-5 substituent can be distilled from the data 
reported in Table 3.  
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donor acceptor R = COOMea R = CH2OBnb 
25 50 α/β = 1/1.4 (68%) 51 α/β = 1/1.4 (75%) 
Glucose (48, 49) 
26 52 α/β = 1/0.6 (86%) 53 α/β = 1/1.7 (89%) 
25 56 α/β = 1/0.4 (91%) 57 α/β = 1/0.5 (92%) 
Allose (54, 55) 
26 58 α/β = 1/0 (52%) 59 α/β = 1/0.6 (65%) 
25 62 α/β = 1/2.3 (49%) 63 α/β = 1/3 (67%) 
Galactose (60, 61) 
26 64 α/β = 1/0.4 (86%) 65 α/β = 1/0.1 (72%) 
Study of the C-5 substituent effect in the glucose, galactose, and allose series. Reagents and 
conditions: a) Ph2SO, TTBP, DCM, -60 °C to -45 °C, Tf2O 10 min, then -78 °C, nucleophile, to 0 °C; 
b) Ph2SO, TTBP, DCM, -78 °C, Tf2O 10 min, nucleophile, to 0 °C. 
Considering the structures of the half chair oxacarbenium ions involved in the 
condensations in Table 3 (Scheme 5), it can be seen that all of them have one or more 
substituents occupying an unfavorable position, making none of them highly favorable 
based on electronic grounds. In addition, destabilizing steric interactions are present in all 
oxacarbenium ions and in all product forming transition states, except in the 4H3 glucose 
half chair 67b. The stereochemical outcome of the glycosylations are thus a delicate 
balance between electronic and steric factors in both the ground state of the oxacarbenium 
ions and the resulting transition states. 
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Glucosyl, galactosyl and allosyl oxacarbenium ions. 
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In conclusion, the study described here investigated the stereodirecting capacity of glycosyl 
C-5 substituents in systems that were devoid of any other stereodirecting factors. In 
pyranosyl oxacarbenium ion intermediates possessing a half chair conformation, a C-5 ester 
prefers to occupy a pseudo axial position. In this orientation it can donate electron density 
through space to the electron depleted oxacarbenium ion, thereby stabilizing this 
intermediate. A C-5 methyloxyalkyl substituent is also capable of such an energetically 
favorable though space interaction, but the magnitude of this stabilization is significantly 
smaller than that of the C-5 ester functionality. A C-5 alkyl group prefers to adopt an 
equatorial position because of steric reasons. When the stereodirecting effect of the C-5 
substituent works in concert with the other functional groups on the pyranose ring, highly 
selective condensations are achieved. This is exemplified by the glycosidations of 
mannuronate ester 22 and 6-deoxy guloside 38. In systems having conflicting substituent 
preferences, steric factors in both the ground state of the oxacarbenium ion half chair and 
product forming transition states become important for the outcome of the reaction. The 
mechanistic insight described here can aid in the design of glycosylation strategies. 
Experimental 
General: Dichloromethane was refluxed with P2O5 and distilled before use. Trifluoromethanesulfonic 
anhydride was distilled from P2O5. Traces of water in the donor and acceptor glycosides, 
diphenylsulfoxide and TTBP were removed by co-evaporation with toluene. All other chemicals 
(Acros, Fluka, Merck, Schleicher & Schue) were used as received. Column chromatography was 
performed on Merck silica gel 60 (0.040-0.063 mm). TLC analysis was conducted on HPTLC 
aluminum sheets (Merck, silica gel 60, F245). Size exclusion chromatography was performed on 
sephadex™ LH-20. Compounds were visualized by UV absorption (245 nm), by spraying with 20% 
H2SO4 in ethanol or with a solution of (NH4)6Mo7O24·4H2O 25 g/L, (NH4)4Ce(SO4)4·2H2O 10 g/L, 
10% H2SO4 in H2O followed by charring at +/- 140 °C. 1H and 13C NMR spectra were recorded with a 
Bruker AV 400 (400 and 100 MHz respectively), AV 500 (500 and 125 MHz respectively) or a 
Bruker DMX 600 (600 and 150 MHz respectively). NMR spectra were recorded in CDCl3 with 
chemical shift (δ) relative to tetramethylsilane unless stated otherwise. Optical rotations were 
measured on a Propol automatic polarimeter. High resolution mass spectra were recorded on a LTQ-
orbitrap (thermo electron). IR spectra were recorded on a Shimadzu FTIR-8300 and are reported in 
cm-1. The α/β ratio was determined using 1H NMR and 13C-GATED NMR where applicable.  
Synthesis of Building Blocks: β-Thio-D-allose was synthesized as described by Gómez et al.29 β-
Thio-D-gulose was obtained as described in the previous Chapter using D-gulonolactone as starting 
material.5 To obtain the protected 1-thio glycosides the corresponding 1-thio tetraols  were benzylated 
using BnBr and NaH in DMF yielding 23, 37, 49, 55 and 61 (Scheme 7). The uronic acids and 6-
deoxy glycosides were synthesized by tritylating the C-6-OH and benzylating the remaining free 
hydroxyls by treatment with NaH and BnBr. The trityl group was then cleaved using pTsOH in 
methanol/DCM. Oxidation of the primary alcohol using the TEMPO/BAIB reagent combination and 
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ensuing methylation with MeI and K2CO3 in DMF gave the uronic acid methyl esters 22, 36, 48, 54 
and 60. Treatment of the C-6-OH glycosides with PPh3, iodine and imidazole in toluene at 70 °C and 
subsequent reduction of the iodine with LiAlH4 yielded rhamnose 24 and 6-deoxy-D-gulose 
(antiarose) 38 (Scheme 7). 
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Synthesis of β-S-phenyl -glycosides, -uronic acid esters and -6-deoxy glycosides. Reagents and 
conditions: a) DMF, BnBr, NaH, 0 °C to rT; b) i. Pyridine, TrCl; ii. DMF, BnBr, NaH, 0 °C to rT; iii. 
MeOH, pTsOH (cat).  iv. Toluene, PPh3, Imidazole, I2; v THF, LiAlH4; c) i. Pyridine, TrCl; ii. DMF, 
BnBr, NaH, 0 °C to rT; iii. MeOH, pTsOH (cat). iv. DCM, H2O, TEMPO, BAIB; v. DMF, K2CO3, 
MeI. 
General procedure for the synthesis of tetrabenzyl thioglycosides: To a solution of thioglycoside 
in DMF (0.2 M) was added at 0 °C BnBr (4.8 eq.) and NaH (4.8 eq.). The mixture was allowed to 
warm to rT and stirred for several hours until TLC analysis showed total conversion into a higher 
running spot. The reaction was quenched by addition of MeOH at 0 °C, washed with H2O and 
extracted three times with Et2O. The combined organic layers were dried over MgSO4, filtered, and 
concentrated in vacuo. Column chromatography afforded the title compounds. 
General procedure for TEMPO/BAIB oxidations: To a solution of thioglycoside in pyridine (0.2 
M) was added trityl chloride (1.5 eq.) and a catalytic amount of DMAP. The reaction mixture was 
stirred until TLC analysis showed total conversion (several days). The reaction mixture was quenched 
by addition of MeOH and extracted with EtOAc. The combined organic layers were washed with HCl 
(1 M) and NaHCO3 (aq., sat.), dried over MgSO4, filtered, and concentrated in vacuo. The obtained 
yellow residue was dissolved in DMF (0.2 M) and at 0 °C was added BnBr (3.6 eq.) and NaH (3.6 
eq.). The mixture was allowed to warm to rT and stirred for several hours until TLC analysis showed 
total conversion into a higher running spot. The reaction was quenched by addition of MeOH at 0 °C, 
washed with H2O and extracted three times with Et2O. The combined organic layers were dried over 
MgSO4, filtered, and concentrated in vacuo. The obtained residues were dissolved in MeOH/DCM 
(4/1, v/v, 0.1 M) and a catalytic amount of pTsOH was added. The reaction mixture were stirred until 
TLC analysis showed total cleavage of the trityl protective group and the reaction mixture was 
neutralized with Et3N and concentrated. Flash column chromatography yielded 6-OH thioglycoside 
which was dissolved in DCM/H2O (2/1, 0.2 M in DCM) after which BAIB (2.5 eq.) and TEMPO (0.2 
eq.) were added. After TLC analysis showed total conversion into a lower running spot. The reaction 
mixture was quenched by addition of Na2S2O3 (aq). The organic layer was isolated and the aqueous 
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layer was extracted twice with EtOAc. The combined organic layers were dried over MgSO4, filtered, 
concentrated, in vacuo. The resulting syrup was then dissolved in DMF (0.2 M), after which K2CO3 
(5 eq.) and MeI (3 eq.) were added. The mixture was stirred for several hours until TLC analysis 
showed total conversion into a higher running spot. The mixture was washed with H2O and extracted 
with Et2O. The combined organic layers were dried over MgSO4, filtered and concentrated in vacuo. 
Purification by column chromatography yielded the corresponding uronic acid esters. 
General procedure for the synthesis of 6-deoxy glycosides: To a solution of thioglycoside in 
pyridine (0.2 M) was added trityl chloride (1.5 eq.) and a catalytic amount of DMAP. The reaction 
mixture was stirred until TLC analysis showed total conversion (several days). The reaction mixture 
was quenched by addition of MeOH and extracted with EtOAc. The combined organic layers were 
washed with HCl (1 M) and NaHCO3 (aq., sat.), dried over MgSO4, filtered, and concentrated in 
vacuo. The obtained yellow residue was dissolved in DMF (0.2 M) and at 0 °C was added BnBr (3.6 
eq.) and NaH (3.6 eq.). The mixture was allowed to warm to rT and stirred for several hours until 
TLC analysis showed total conversion into a higher running spot. The reaction was quenched by 
addition of MeOH at 0 °C, washed with H2O and extracted three times with Et2O. The combined 
organic layers were dried over MgSO4, filtered, and concentrated in vacuo. The obtained residues 
were dissolved in MeOH/DCM (4/1, v/v, 0.1 M) and a catalytic amount of pTsOH was added. The 
reaction mixture were stirred until TLC analysis showed total cleavage of the trityl protective group 
and the reaction mixture was neutralized with Et3N and concentrated. Flash column chromatography 
yielded the 6-OH thioglycoside which was dissolved in Toluene (0.05 M) and degassed with argon 
for 1 h. Then PPh3 (1.5 eq.), imidazole (2 eq.) and I2 (1.4 eq.) were added. The mixture was then 
heated to 70 °C. After TLC analysis showed total conversion into a higher running spot, the reaction 
mixture was quenched by addition of Na2S2O3 (aq) and NaHCO2¬ (aq). The organic layer was 
isolated and the aqueous layer was extracted twice with EtOAc. The combined organic layers were 
dried over MgSO4, filtered, concentrated in vacuo. Purification by column chromatography yielded 
the corresponding 6-iodo compounds which were then dissolved in THF (0.2 M). At 0 °C LiAlH4 (2 
eq.) was added and the mixture was then heated to 70 °C. When TLC analysis showed total 
conversion of starting material the reaction was cooled to rT and quenched with EtOAc, filtered and 
concentrated in vacuo. Purification by column chromatography yielded the corresponding 6 deoxy 
glycosides. 
General procedure for glycosylations of thioglycosides and 6-deoxy thioglycosides: A solution of 
donor, diphenyl sulfoxide (1.1 eq) and tri-tert-butylpyrimidine (2.5 eq) in DCM (0.05 M) was stirred 
over activated MS 3Å for 30 min. The mixture was cooled to -78 °C before triflic anhydride (1.1) was 
added. The mixture was stirred for 10 min. at -78 °C followed by addition of acceptor (1.5 eq) in 
DCM (0.1 M). The reaction mixture was allowed to warm to 0 °C and Et3N (0.15 ml) was added. The 
reaction mixture was diluted with DCM and washed with NaHCO3 (aq). The aqueous layer was 
extracted twice with DCM and the collected organic layers were dried over MgSO4, filtered and 
concentrated in vacuo. Purification by size exclusion and column chromatography yielded the 
corresponding dimer. 
General procedure for glycosylations of thioglycuronates: A solution of donor, diphenyl sulfoxide 
(1.1 eq) and tri-tert-butylpyrimidine (2.5 eq) in DCM (0.05 M) was stirred over activated MS 3Å for 
30 min. The mixture was cooled to -60 °C before triflic anhydride (1.1 eq) was added. The mixture 
was warmed to -45 °C then cooled to -78 °C followed by addition of acceptor (1.5 eq) in DCM (0.1 
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M). Stirring was continued and the reaction mixture was allowed to warm to 0 °C and Et3N (0.15 ml) 
was added. The reaction mixture was diluted with DCM and washed with NaHCO3 (aq). The aqueous 
layer was extracted twice with DCM and the collected organic layers were dried over MgSO4, filtered 
and concentrated in vacuo. Purification by size exclusion and column chromatography yielded the 
corresponding dimer. 
Methyl (phenyl 2,3,4-tri-O-benzyl-1-thio-β-D-mannopyranosyluronate) 
(22): The title compound was prepared according to the general procedure 
for the synthesis of uronate esters starting from phenyl-1-thio-β-D-
mannopyranoside (2.54 g, 9.35 mmol) yielding 22 as a white solid (2.15 g, 40%). [α]D = -65 (c = 1, 
DCM);  IR (neat): 725, 829, 883, 1007, 1026, 1045, 1076, 1138, 1207, 1238, 1393, 1454, 1732, 2037, 
2191, 2341, 2361; 1H NMR (400 MHz): δ =  3.62 (dd, 1H, J = 9.6 Hz, J = 2.8 Hz, H-3), 3.72 (s, 3H, 
CO2CH3), 3.87 (d, 1H, J = 9.6 Hz, H-5), 4.14 (d, 1H, J = 2.0 Hz, H-2), 4.31 (t, 1H, J = 9.6 Hz, H-4), 
4.68-4.75 (m, 3H,  CH2 Bn), 4.78 (s, 1H, H-1), 4.85-4.88 (m, 2H,  CH2 Bn), 5.05 (d, 1H, J = 11.6 Hz, 
CH2 Bn), 7.24-7.37 (17 H, 1 H Arom), 7.45-7.49 (m, 3H,  H Arom); 13C NMR (100 MHz): δ =  52.5 
(CO2CH3), 72.8 (CH2 Bn), 75.2 (CH2 Bn), 75.3 (CH2 Bn), 75.6 (C-4), 77.3 (C-2), 78.9 (C-5), 83.4 (C-
3), 88.9 (C-1), 127.4-129.0 (CH Arom), 130.9 (CH Arom), 135.2 (Cq Ph), 137.9 (Cq Ph), 138.1 (Cq 
Ph), 168.3 (C=O, CO2CH3); 13C-GATED NMR (100 MHz): 88.94 (JC-1, H-1 = 152 Hz, C-1); HRMS: 
C34H34O6S + NH4+ requires: 588.2414, found 588.2428. 
Methyl 2,3,4-tri-O-benzyl-6-O-(methyl 2,3,4-tri-O-benzyl-β-D-
mannopyranosyluronate)-α-D-glucopyranoside (27): Donor 
22 (86 mg, 0.15 mmol) was condensed with acceptor 25 
according to the general procedure for glycosylations of 
thioglycuronates, yielding β-linked disaccharide 27 (80 mg, 58%) as a white solid. [α]D = + 9.4 (c = 
0.016, DCM); IR (neat): 729, 795, 860, 910, 1026, 1049, 1157, 1120, 1238, 1265, 1362, 1454, 1497, 
1605, 1747, 2862, 2924, 3032; 1H NMR (400 MHz): δ =  3.31 (s, 3H, C-1-OCH3), 3.39-3.43 (m, 3H, 
H-3’, H-4, H-6), 3.50 (d, 1H, J = 9.2 Hz, H-2), 3.70-3.77 (m, 6H, CO2CH3, H-5, H-5’, H-2’), 4.01 (t, 
1H, J = 8.8 Hz, H-3), 4.11-4.03 (m, 2H, H-1’, H-6), 4.21 (t, 1H, J = 9.2 Hz, H-4’), 4.47-4.56 (m, 4H,  
CH2 Bn, H-1), 4.66 (d, 1H, J = 11.6 Hz, CH2 Bn), 4.77-4.91 (m, 5H,  CH2 Bn), 4.96 (d, 1H, J = 10.0 
Hz, CH2 Bn), 5.02 (d, 1H, J = 10.8 Hz, CH2 Bn), 7.20-7.46 (m, 30 H,  HArom); 13C NMR (100 
MHz): δ =  52.4 (CO2CH3), 55.1 (C-1-OCH3), 68.6 (C-6), 69.7 (C-5), 71.7 (CH2 Bn), 73.3 (C-5’or C-
2’), 73.4 (CH2 Bn), 73.8 (CH2 Bn), 74.8 (CH2 Bn), 75.2 (CH2 Bn), 75.3 (C-5’or C-2’), 75.8 (CH2 Bn), 
75.8 (C-4’), 77.6 (C-3’or C-4), 79.9 (C-2), 81.3 (C-3’or C-4), 82.2 (C-3), 97.8 (C-1), 102.1 (C-1’), 
127.6-128.5 (CH Arom), 138.0 (Cq Ph), 138.1  (Cq Ph), 1383  (Cq Ph), 138.3  (Cq Ph), 138.5  (Cq Ph), 
138.88  (Cq Ph), 168.7 (C=O CO2Me); 13C-GATED NMR (100 MHz): δ =  97.8 (JC-1, H-1 = 167 Hz, C-
1), 102.1 (JC-1’, H-1’ = 155 Hz, C-1’); HRMS: C56H60O12 + Na+ requires: 947.39770, found 947.39853. 
para-Methoxyphenyl-2-O-benzyl-3-O-(Methyl 2,3,4-tri-O-
benzyl-β-D-mannopyranosyluronate)-4,6-benzylidene-β-
D-galactopyranoside (30): Donor 22 (86 mg, 0.15 mmol) 
was condensed with acceptor 26 according to the general 
procedure for glycosylations of thioglycuronates, yielding β-
linked disaccharide 30 (107 mg, 77%)as a white solid. [α]D = 
- 8.5 (c = 2, DCM); IR (neat): 729, 895, 1003, 1061 1096, 1219, 1265, 1366, 1508, 1747, 3055; 1H 
NMR: δ =  3.15 (d, 1H, J 9.2 Hz, H-3’), 3.53 (s, 1H, H-5), 3.62 (s, 1H, H-2’), 3.66-3.75 (m, 4H, H-5’, 
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CO2CH3), 3.77 (s, 3H, CO2CH3), 3.84 (dd, 1H, J = 2.8 Hz, 9.6 Hz, H-3), 4.05-4.10 (m, 2H, H-2, H-6), 
4.18 (t, 1H, J = 9.6 Hz, H-4’), 4.27 (d, 1H, J = 10.0 Hz, CH2 Bn), 4.34-4.37 (m, 3H, H-4, H-6, CH2 
Bn), 4.60 (d, 1H, J, 10.4 Hz, CH2 Bn), 4.70 (s, 1H, H-1’), 4.81-4.97 (m, 5H, H-1,  CH2 Bn), 5.61 (s, 
1H, CHPh benzylidene), 6.83 (d, 2H, J = 8 Hz,  H Arom), 7.05-7.07 (m, 3H,  H Arom), 7.16-7.40 (m, 
22H, H Arom), 7.51-7.70 (m, 2H,  H Arom); 13C NMR (100 MHz): δ =  52.3 (CO2CH3), 55.6 (OCH3 
pMP), 66.6 (C-5), 68.9 (C-6), 71.7 (C-2’), 71.7 (CH2 Bn), 73.3 (CH2 Bn), 75.2 (CH2 Bn), 75.6 (C-4’), 
75.8 (C-4, C-5), 77.7 (C-3), 79.1 (C-2), 82.0 (C-3’), 100.8 (CHPh benzylidene), 103.1 (C-1’, C-1), 
114.5 (CH Arom pMP), 118.8 (CH Arom pMP), 126.3-128.8 (CH Arom), 130.9 (Cq Ph), 151.4 (Cq 
Ph), 155.4 (Cq Ph), 168.7 (C=O CO2Me); 13C-GATED NMR (100 MHz): δ =  100.8 (JC-1, H-1 = 152 
Hz, C-1), 103.2 (JC-1’, H-1’ = 155 Hz, C-1’);  HRMS: C55H56O13 + Na+ requires: 942.36131, found 
947.36214. 
Phenyl-2,3,4,6-tetra-O-benzyl-1-thio-β-D-mannopyranoside (23): The title 
compound was prepared according to the general procedure for the synthesis 
of tetrabenzyl thioglycosides starting from phenyl-1-thio-β-D-
mannospyranoside (0.5 g, 1.84 mmol) yielding 23 as white solid (704 mg, 60%). IR (neat): 733, 841, 
907, 945, 999, 1026, 1072, 1130, 1207, 1254, 1273, 1308, 1362, 1396, 1454, 1481, 1497, 1582, 2858, 
3028; 1H NMR (400 MHz): δ =  3.54 (m, 1H, H-5), 3.63 (dd, 1H, J = 9.6 Hz, J = 3.2 Hz, H-3), 3.73 
(dd, 1H, J = 6.4 Hz, 6.4 Hz, H-6), 3.76 (dd, 1H, J= 9.6 Hz, 1.2 Hz, H-6), 3.94 (t, 1H, J = 9.6 Hz, H-4), 
4.15 (d, 1H, J = 2.4 Hz, H-2), 4.54-4.61 (m, 3H, CH2 Bn), 4.67 (d, 1H, J = 11.6 Hz, CH2 Bn), 4.73 (d, 
1H, J = 11.6 Hz, CH2 Bn), 4.77 (s, 1H, H-1), 4.87 (d, 1H, J = 11.6 Hz, CH2 Bn), 4.89 (d, 1H, J = 10.8 
Hz, CH2 Bn), 5.05 (d, 1H, J = 11.6 Hz, CH2 Bn), 7.19-7.36 (m, 23H, H Arom), 7.44-7.52 (m, 2H,  H 
Arom); 13C NMR (100 MHz): δ =  69.8 (C-6), 72.6 (CH2 Bn), 73.4 (CH2 Bn), 74.9 (C-4), 75.0 (CH2 
Bn), 75.2 (CH2 Bn), 77.5 (C-2), 80.1 (C-5), 84.3 (C-3), 87.6 (C-1), 127.0-130.52 (CH Arom), 135.7 
(Cq SPh), 138.0 (Cq Ph), 138.2 (Cq Ph), 138.2 (Cq Ph), 138.5 (Cq Ph). 
Methyl 2,3,4-tri-O-benzyl-6-O-(2,3,4,6-tetra-O-benzyl-α/β-D-
mannopyranoside)-α-D-glucopyranoside (28): 
Mannopyranoside 23 (95 mg, 0.15 mmol) was condensed with 
acceptor 25 according to the general procedure for glycosylations 
of thioglycosides, yielding disaccharide 28 (105 mg, 71%) as a mixture of anomers (α/β: 1/2). IR 
(neat): 729, 895, 1042, 1069, 1265, 1362, 1454, 1497, 2870;  1H NMR (400 MHz): δ =  3.30 (s, 1.55 
H, C-1α-OCH3), 3.33 (s, 3H, C-1β-OCH3), 3.36-3.47 (m, 5H), 3.51 (dd, 1H, J = 9.6 Hz,  3.2 Hz, H-
3’β), 3.58-3.62 (m, 2H), 3.65-3.73 (m, 3H), 3.76-3.85 (m, 5H), 3.95-4.04 (m, 2H, H-4’, H-3), 4.11 (s, 
1H, H-1’β), 4.16 (d, 1H, J = 10.8 Hz), 4.42-4.71 (m, 14H), 4.75-5.03 (m, 10H), 7.13-7.42 (m, 53 
H);13C NMR (100 MHz): δ =  55.0 (OCH3 β), 55.0 (OCH3 α), 65.7, 68.2, 69.0, 69.7, 71.5, 71.8, 71.9, 
72.0, 72.4, 73.6, 74.5, 74.7, 74.9, 75.0, 75.1, 75.6, 75.7, 75.9, 77.6, 79.5, 79.8, 79.9, 82.1, 82.2, 97.7 
(C-1 β), 97.7 (C-1 α) 98.2 (C-1’α), 101.4 (C-1’ β),  127.3-128.4 (CH Arom), 138.0 (Cq Ph), 138.1 (Cq 
Ph), 138.2 (Cq Ph), 138.3 (Cq Ph), 138.3 (Cq Ph), 138.4 (Cq Ph), 138.6 (Cq Ph), 138.6 (Cq Ph), 138.6 
(Cq Ph), 138.6 (Cq Ph), 138.8 (Cq Ph), 151.5 (Cq Ph), 151.6 (Cq Ph), 155.3 (Cq Ph). 13C-GATED NMR 
(100 MHz): δ = 98.2 (J = 164 Hz), 101.4 (J = 158 Hz); HRMS: C62H66O11 + NH4+ requires: 
1004.4943, found 1004.4957. 
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para-Methoxyphenyl-2-O-benzyl-3-O-(2,3,4,6-tetra-O-
benzyl-α/β-D-mannopyranoside)-4,6-benzylidene-β-D-
galactopyranoside (31): Mannopyranoside 23 (95 mg, 0.15 
mmol) was glycosylated with acceptor 26 as described in the 
general procedure for glycosylations of thioglycosides, affording 
the title compound 31 (77 mg, 52%) as a mixture of anomers 
(α/β: 1/1.6). IR (neat): 729, 826, 899, 999, 1026, 1061, 1219, 1265, 1366, 1454, 1504, 2858;  1H 
NMR (400 MHz): δ =  3.22 (dd, 1.6 H, J = 2.4 Hz, 9.2 Hz, H-3’β), 3.35-3.41 (m, 4H), 3.60 (d, 1H, J = 
10.4 Hz), 3.67-3.73 (m, 4H), 3.77-3.84 (m, 13H), 3.88-3.910 (m, 1.6 H), 4.00-4.07 (m, 7H), 4.22-4.23 
(m, 1.6 H), 4.27-4.40 (m, 10 H), 4.48-4.69 (m, 14 H), 4.76-4.79 (m, 3H), 4.82-4.88 (m, 3.5 H), 4.91-
4.95 (m, 6H), 5.09 (s, 1H, H-1’α), 5.44 (s, 1H, CHPh α benzylidene), 5.58 (s, 1.6 H, CHPh β 
benzylidene), 6.80-6.83 (m, 4H,  CH Arom pMP), 7.01-7.40 (m, 27 H, 2 H Arom Ph), 7.48-7.49 (m, 
1H, H Arom Ph), 7.53-7.58 (m, 1H, H Arom Ph); 13C NMR (100 MHz): δ =  55.6 (OCH3 pMP), 66.2, 
66.7, 68.1, 68.9, 69.0, 69.2, 69.9, 71.0, 71.3, 71.5, 72.1, 72.3, 72.7, 72.8, 73.3, 73.4, 74.3, 74.8, 74.9, 
75.2, 75.7, 75.7, 76.1, 78.0, 78.9, 79.9, 82.8, 93.3 (C-1’α), 100.8 (CHPh benzylidene β), 101.0 (CHPh 
benzylidene α), 102.8 (C-1’ β), 103.1 (C-1), 114.4 (CH Arom pMP), 114.5 (CH Arom pMP), 118.8 
(CH Arom pMP), 118.9 (CH Arom pMP), 126.3-139.0 (CH Arom), 130.9 (CH Arom), 137.7 (Cq Ph), 
138.0 (Cq Ph), 138.0 (Cq Ph), 138.1 (Cq Ph), 138.2 (Cq Ph), 138.2(Cq Ph), 138.3 (Cq Ph), 138.4 (Cq 
Ph), 138.5 (Cq Ph), 138.6 (Cq Ph), 138.8 (Cq Ph), 151.5 (Cq Ph), 151.6 (Cq Ph), 155.3 (Cq Ph).  13C-
GATED NMR (100 MHz): δ = 93.3 (J = 171 Hz, C-1’α), 102.8 (J = 156 Hz, C-1’β); HRMS: 
C61H62O12 + NH4+ requires: 1004.4580, found 1004.4593. 
Phenyl-2,3,4-tri-O-benzyl-1-thio-α-D-rhamnose (24): Rhamnopyranoside 24 
was prepared from Phenyl-1-thio-α-D-mannopyranoside (1.63 g, 6 mmol) 
according to the general procedure for the synthesis of 6-deoxy glycosides and  
24 was obtained as a clear oil (0.66 g, 21%). IR (neat): 694, 734, 1026, 1080, 
1732, 2870; 1H NMR (400 MHz): δ =1.34 (d, 3H, J = 6.4 Hz, H-6), 3.69 (t, 1H, J = 9.2 Hz, H-4), 3.84 
(dd, 1H, J = 2.8 Hz, 9.2 Hz, H-3), 3.98 (dd, 1H, J = 2 Hz, 3.2 Hz, H-2), 4.12-4.19 (m, 1H, H-5), 4.56 
(d, 1H, J = 11.6 Hz, CH2 Bn), 4.58-4.70 (m, 5H, CH2 Bn), 5.49 (d, 1H, J = 1.6 Hz, H-1), 7.12-7.34 
(m, 20H, H Arom); 13C NMR (100 MHz): δ = 17.8 (C-6), 69.2 (C-5), 72.0 (CH2 Bn), 72.0 (CH2 Bn), 
75.3 (CH2 Bn), 76.5 (C-2), 79.9 (C-3), 80.4 (C-4), 85.7 (C-1), 127.1-128.9 (CH Arom), 131.2 (CH 
Arom), 134.6 (Cq Arom), 137.9-138.4 (Cq Arom); HRMS: C33H34O4S + Na+ requires: 549.2070, 
found 549.2059. 
Methyl 2,3,4-tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl-α/β-D-
rhamnopyranoside)-α-D-glucopyranoside (29): 
Rhamnopyranoside 24 (79 mg, 0.15 mmol) was glycosylated 
with acceptor 25 as described in the general procedure for 
glycosylations of thioglycosides, affording the title compound 29 
(94 mg, 71%) as a mixture of anomers (α/β: 1/1.7). IR (neat): 732, 694, 1006, 1026, 1053, 1068, 
1362, 1454, 2866; 1H NMR (400 MHz): δ = 1.25 (d, 1.75 H, J = 4.8 Hz, C-6 α), 1.35 (d, 3 H, J = 6 
Hz, C-6 β); 13C NMR (100 MHz): δ = 17.8 (C-6’ β), 17.9 (C-6 α’), 98.2(C-1’ α), 101.2 (C-1’ β); 13C-
GATED NMR (100 MHz): δ = 98.2 (JC-1’, H-1’ = 168 Hz, C-1’ α), 103.2 (JC-1’, H-1’ = 153 Hz, C-1’ β); 
HRMS: C55H60O10 + Na+ requires:  903.4079, found 903.4077. 
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para-Methoxyphenyl-2-O-benzyl-3-O-(2,3,4-tri-O-benzyl-
α/β-D-rhamnopyranoside)-4,6-benzylidene-β-D-
galactopyranoside (32): Rhamnopyranoside 24 (79 mg, 0.15 
mmol) was glycosylated with acceptor 26 as described in the 
general procedure for glycosylations of thioglycosides, 
affording the title compound 32 (86 mg, 65%) as a mixture of 
anomers (α/β: 1/1). IR (neat): 694, 732, 995, 1026, 1061, 1218, 1454, 1504, 2341, 2873; 1H NMR 
(400 MHz): δ = 1.26 (d, 3H, J = 4.8 Hz, C-6), 1.35 (d, 3H, J = 6 Hz, C-6); 13C NMR (100 MHz): δ = 
17.9 (C-6’ β), 18.0 (C-6’ α), 93.4 (C-1’ α), 102.5 (C-1’ β); 13C-GATED NMR (100 MHz): δ =  97.7 
(JC-1, H-1 = 166 Hz, C-1’ α), 103.2 (JC-1’, H-1’ = 154 Hz, C-1’ β); HRMS: C54H56O11 + Na+ requires:  
903.3715, found 903.3712. 
Methyl (phenyl 2,3,4-tri-O-benzyl-1-thio-β-D-gulopyranosyluronate) (36): 
The title compound was prepared according to the general procedure for the 
synthesis of uronate esters starting from phenyl-1-thio-β-D-gulopyranoside 
(0.348 mg, 1.28 mmol) yielding 36 as a white solid (433 mg, 59%). [α]D = - 17.0 
(c = 0.02, DCM); IR (neat): 731, 897, 814, 939, 1026, 1074, 1126, 1209, 1265, 1304, 1358, 1420, 
1439, 1454, 1477, 1497, 1734, 1765, 2876; 1H NMR (400 MHz): δ =  3.72-3.75 (m, 4H, H-3, 
CO2CH3), 3.83 (dd, 1H, J = 3.2 Hz, 10 Hz, H-2), 3.91 (dd, 1H, J = 3.6 Hz, 1.6 Hz, H-4), 4.31 (d, 1H, 
J = 12.0 Hz, CH2 Bn), 4.39 (d, 1H, J = 12.0 Hz, CH2 Bn), 4.41 (d, 1H, J = 12.0 Hz, CH2 Bn), 4.56 (d, 
1H, J = 12 Hz, CH2 Bn), 4.60 (s, 1H, H-5), 4.61 (d, 1H, J = 12.0 Hz, CH2 Bn), 4.71 (d, 1H, J = 12.4 
Hz, CH2 Bn), 5.23 (d, 1H, J = 10.0 Hz, H-1); 13C NMR (100 MHz): δ =  52.1 (CO2CH3), 72.5 (CH2 
Bn), 72.7 (CH2 Bn), 72.7 (C-3), 72.2 (CH2 Bn), 73.9 (C-2), 74.7 (C-5), 76.2 (C-4),84.4 (C-1), 127.2-
128.6 (CH Arom), 132.4 (CH Arom), 133.7 (Cq Ph), 137.4 (Cq Ph), 137.7 (Cq Ph), 137.8 (Cq Ph), 
169.1 (CO2CH3); HRMS: C34H34O6S + Na+ requires: 593.1968, found 593.1975. 
Methyl 2,3,4-tri-O-benzyl-6-O-(methyl 2,3,4-tri-O-benzyl-α/β-L-
gulopyranosyluronate)-α-D-glucopyranoside (39): Guluronic acid 
36 (114 mg, 0.20 mmol) was glycosylated with glucoside 25 (139 
mg, 0.30 mmol) as described in the general procedure for 
glycosylations of thioglycuronates, yielding 39 (115 mg, 73%) as a 
mixture of anomers (α/β: 1/0.33). IR (neat): 731, 808, 910, 1026, 1047, 1070, 1207, 1265, 1304, 
1358, 1439, 1454, 1497, 1732, 1765, 2876, 3030; 1H NMR (400 MHz): δ = 3.28 (s, 3H, CH3 OMe), 
3.33 (s, 1H, CH3 OMe), 3.39 (dd, 1H, J = 3.6 Hz, 9.6 Hz), 3.49-3.53 (m, 0.3H), 3.59 (s, 3H, CH3 
COOMe), 3.61-3.65 (m, 1.3H), 3.66 (s, 1H, CH3 COOMe), 3.68-3.73 (m, 1H), 3.75-3.77 (m, 2.2H), 
3.80-3.82 (m, 1.6H), 3.85-3.87 (m, 1.3H), 3.90-4.02 (m, 3.6H), 4.22-4.99 (m, 18 H), 5.16 (d, 1H, J = 
4 Hz, H-1’); 13C NMR (100 MHz): δ = 51.9 (CH3 COOMe), 51.9 (CH3 COOMe), 54.8 (CH3 OMe), 
54.9 (CH3 OMe), 67.4, 67.6, 68.2, 70.1, 70.3, 71.2, 72.5, 72.6, 72.9, 72.9, 73.0, 73.1, 73.2, 73.2, 73.4, 
74.6, 74.7, 74.8, 75.5, 75.5, 75.7, 76.4, 76.9, 77.9, 78.1, 79.8, 80.0, 81.9, 82.0, 97.7 (C-1), 97.8 (C-1), 
98.0 (C-1’ α), 101.0 (C-1’ β), 127.3-128.3 (CH Arom), 137.4-138.8 (Cq Arom), 169.3 (Cq COOMe), 
170.0 (Cq COOMe); HRMS: C56H60O12 + Na+ requires: 947.3977, found 947.3985. 
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para-Methoxyphenyl-2-O-benzyl-3-O-(methyl 2,3,4-tri-O-
benzyl-α/β-L-gulopyranosyluronate)-4,6-benzylidene-β-D-
galactopyranoside (42): Guluronic acid 36 (114 mg, 0.20 mmol) 
was glycosylated with galactoside 26 (139 mg, 0.30 mmol) as 
described in the general procedure for glycosylations of 
thioglycuronates, yielding 42 (124 mg, 79%) as a mixture of anomers (α/β: 1/0.1). IR (neat): 731, 
826, 908, 997, 1026 1065, 1078, 1175, 1217, 1265, 1306, 1366, 1439, 1454, 1506, 175, 2870, 3030; 
1H NMR (400 MHz): δ = 3.43 (s, 3H, CH3 COOMe), 3.45 (bs, 1H), 3.72 (s, 3H, CH3 pMP), 3.88-3.90 
(m, 1H), 3.93-3.99 (m, 2H), 4.01-4.02 (m, 2H), 4.05-4.08 (m, 1H, H-6), 4.30-4.39 (m, 5H), 4.46 (m, 
2H), 4.55-4.68 (m, 4H), 4.84-4.90 (m, 2H), 4.97 (d, 1H, J = 1.6 Hz), 5.39 (d, 1H, J = 3.6 Hz, H-1’), 
5.56 (s, 1H, CHPh), 6.75-7.56 (m, 29H); 13C NMR (100 MHz): δ = 51.6 (CH3 COOMe), 55.5 (CH3 
OMe), 66.3, 67.6, 69.2, 70.9, 71.6, 72.4, 72.6, 73.3, 73.4, 74.6, 74.9, 76.3, 77.4, 92.9 (C-1’), 100.8 
(CHPh), 103.0 (C-1), 114.3 (CH Arom pMP), 118.9 (CH Arom pMP), 126.2-128.7 (CH Arom), 
137.5-138.6 (Cq Arom), 151.6 (Cq pMP), 155.1 (Cq pMP), 169.7 (Cq COOMe); HRMS: C55H56O13 + 
Na+ requires: 947.3613, found 947.3618. 
Phenyl-2,3,4,6-tetra-O-benzyl-1-thio-β-D-gulopyranoside (37): The title 
compound was prepared according to the general procedure for the synthesis of 
tetrabenzyl thioglycosides starting from phenyl-1-thio-β-L-gulopyranoside (1.37 
g, 5 mmol) yielding 37 as transparent oil (2.41 g, 89%). [α]D = - 9.17 (c = 0.02, 
DCM). IR (neat); 741, 1001, 1028, 1076, 1101, 1207, 1360, 1439, 1454, 1497, 
2866, 3032, 3061; 1H NMR (400 MHz): δ =  3.51 (m, 1H, H-4), 3.57-3.67 (m, 2H, H-6), 3.71 (t, 1H, J 
= 3.2 Hz, H-3), 3.75 (dd, 1H, J = 2.8 Hz, 10.0 Hz, H-2), 4.13 (t, 1H, J = 6.4 Hz, H-5), 4.26 (d, 1H, J = 
12.0 Hz, CH2 Bn), 4.31 (d, 1H, J = 12.0 Hz, CH2 Bn), 4.37 (d, 1H, J = 10.8 Hz, CH2 Bn), 4.40 (d, 1H, 
J = 8.8 Hz, CH2 Bn), 4.47-4.52 (m, 2H, CH2 Bn), 4.59 (d, 1H, J = 11.6 Hz, CH2 Bn), 4.66 (d, 1H, J = 
12.0 Hz, CH2 Bn), 5.23 (d, 1H, J = 10.0 Hz, H-1), 7.08-7.10 (m, 2H,  H Arom), 7.12-7.35 (m, 21 H, H 
Arom), 7.51-7.60 (m, 2H,  H Arom); 13C NMR (100 MHz): δ =  69.0 (C-6), 72.4 (CH2Ph), 72.8 
(CH2Ph), 73.1 (C-3), 73.2 (CH2Ph), 73.4 (CH2Ph), 74.4 (C-5), 74.8 (C-2), 74.9 (C-4), 84.3 (C-1), 
126.8-128.6 (CH Arom), 131.4 (CH Arom), 138.2 (Cq Ph); HRMS: C40H40O5S + Na+ requires:  
655.2489, found 655.2487. 
Methyl 2,3,4-tri-O-benzyl-6-O-(2,3,4,6-tetra-O-benzyl-α/β-L-
gulopyranoside)-α-D-glucopyranoside (40): Gulopyranoside 37 
(127  mg, 0.20 mmol) was condensed with acceptor 25 according to 
the general procedure for glycosylations of thioglycosides, yielding 
disaccharide 40 (150 mg, 76%) as a mixture of anomers (α/β: 1/0.1). 
IR (neat): 733, 820, 908, 1026, 1047, 1069, 1194, 1207, 1310, 1327, 1360, 1454, 1497, 2870, 3030, 
3063; 1H NMR (400 MHz): δ = 3.28 (s, 3H, OMe), 3.41 (dd, 1H, J = 3.6 Hz, 9.6 Hz), 3.54 (m, 2H), 
3.60 (bs, 1H), 3.66-3.78 (m, 3H), 3.81-3.82 (m, 2H), 3.95 (t, 1H, J = 9.2 Hz), 4.00 (dd, 1H, J = 4.0 
Hz, 11.6 Hz), 4.34-4.56 (m, 8H), 4.63-4.71 (m, 4H), 4.75 (d, 1 H, J = 12 Hz, CH2 Bn), 4.79 (d, 1 H, J 
= 10.8 Hz, CH2 Bn), 4.93 (d, 1 H, J = 10.8 Hz, CH2 Bn), 5.06 (bs, 1H, H-1’), 7.12-7.36 (m, 35H, H 
Arom); 13C NMR (100 MHz): δ =  54.9 (OMe), 65.7, 66.9, 68.7, 70.4, 70.9, 72.7, 73.1, 73.2, 73.2, 
73.9, 74.8, 75.5, 75.6, 77.9, 70.1, 82.0, 97.7 (C-1 or C-1’), 97.9 (C-1 or C-1’),127.2-128.9 (CH 
Arom), 137.9-139.0 (Cq Arom); HRMS: C62H66O11 + NH4+ requires: 1004.4943, found 1004.4958. 
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para-Methoxyphenyl-2-O-benzyl-(2,3,4,6-tetra-O-benzyl-α/β-L-
gulopyranoside)-4,6-benzylidene-β-D-galactopyranoside (43): 
Gulopyranoside 37 (127  mg, 0.20 mmol) was glycosylated with 
acceptor 26 according to the general procedure for glycosylations 
of thioglycosides, yielding disaccharide 43 (138 mg, 70%) as a 
mixture of anomers (α/β: 1/0.12). IR (neat): 731, 824, 872, 910, 997, 1026, 1065, 1080, 1173, 1217, 
1265, 1308, 1367, 1454, 1506, 2866, 3030; 1H NMR: (400 MHz): δ =  3.30 (s, 1H), 3.37 (dd, 1H, J = 
6 Hz, 10 Hz), 3.53 (bs, 1H), 3.61 (dd, 1H, J = 7.2 Hz, 10.4 Hz), 3.74 (s, 3H, CH3 pMP), 3.88-3.92 (m, 
2H), 4.00-4.08 (m, 3H), 4.22 (d, 1 H, J = 12 Hz, CH2 Bn), 4.28-4.46 (m, 8H), 4.57-4.64 (m, 3H), 4.68 
(d, 1 H, J = 10.8 Hz, CH2 Bn), 4.77 (m, 2H), 4.86 (d, 1 H, J = 10.8 Hz, CH2 Bn), 5.32 (d, 1 H, J = 3.2 
Hz, H-1’), 5.51 (s, 1H, CHPh), 6.77-7.54 (m, 34H, H Arom); 13C NMR (100 MHz): δ = 55.5 (OCH3 
pMP), 65.2, 66.3, 69.1, 69.3, 70.6, 71.3, 72.4, 72.5, 72.6, 73.3, 73.7, 74.6, 74.7, 76.0, 76.3, 91.9 (C-
1’), 101.0 (CHPh), 102.9 (C-1), 114.3 (CH Arom pMP), 118.9 (CH Arom pMP), 126.3-128.8 (CH 
Arom), 137.7-139.1 (Cq Arom), 151.8 (Cq pMP), 155.1(Cq pMP); HRMS: C61H62O12 + Na+ requires: 
1009.4134, found 1009.4140. 
 
Phenyl-2,3,4-tri-O-benzyl-1-thio-β-D-antiarose (38): Antiaropyranoside 38 was 
prepared from Phenyl-1-thio-β-D-gulopyranoside (2.82 g, 10.3 mmol) according 
to the general procedure for the synthesis of 6-deoxy glycosides and 38 was 
obtained as a clear oil (1.53 g, 28%). IR (neat): 694, 733, 1026, 1072, 1732, 1870; 
1H NMR (400 MHz): δ =1.20 (d, 3H, J = 6.4 Hz, H-6), 3.19 (d, 1H, J = 3.2 Hz, 
H-4), 3.71-3.77 (m, 2H, H-2, H-3), 4.02 (q, 1H, J = 6.4 Hz, H-5), 4.28 (d, 1H, J = 12.0 Hz, CH2 Bn), 
4.32 (d, 1H, J = 12.0 Hz, CH2 Bn), 4.35 (d, 1H, J = 11.6 Hz, CH2 Bn), 4.47 (d, 1H, J = 12.4 Hz, CH2 
Bn), 4.57 (d, 1H, J = 11.6 Hz, CH2 Bn), 4.68 (d, 1H, J = 12.4 Hz, CH2 Bn), 5.20 (d, 1H, J = 10.0 Hz, 
H-1), 7.11-7.59 (m, 20H, H Arom); 13C NMR (100 MHz): δ = 16.2 (C-6), 71.2 (C-5), 72.3 (CH2 Bn), 
72.6 (CH2 Bn), 73.1 (CH2 Bn), 73.2 (C-3), 74.4 (C-2), 77.4 (C-4), 84.0 (C-1), 126.6-128.8 (CH 
Arom), 131.3 (CH Arom), 134.4 (Cq Arom), 137.8-138.1 (Cq Arom); HRMS: C33H34O4S + Na+ 
requires: 549.2070, found 549.2061. 
Methyl 2,3,4-tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl-α/β-D-
antiaropyranoside)-α-D-glucopyranoside (41): Rhamnopyranoside 
38 (79 mg, 0.15 mmol) was glycosylated with acceptor 25 as 
described in the general procedure for glycosylations of 
thioglycosides, affording the title compound 41 (89 mg, 67%) as a 
mixture of anomers (α/β: 1/0.08). IR (neat): 633, 694, 1026, 1069, 1358, 2341, 2870, 3028; 1H NMR: 
(400 MHz): δ = 1.07 (d, 3H, J = 6.4 Hz, H-6’), 3.29 (s, 3H, CH3 OMe), 3.31-3.33 (m, 1H), 3.43 (dd, 
1H, J = 3.6 Hz, 9.6 Hz), 3.66-3.78 (m, 3H), 3.81-3.82 (m 2H), 3.93-4.00 (m 2H), 4.30 (dq, 1H, J = 
1.2 Hz, 6.4 Hz, H-5’), 4.39 (d, 1H, J = 12 Hz, CH2 Bn), 4.47-4.81 (m, 12H), 4.93 (d, 1H, J = 10.8 Hz, 
CH2 Bn), 5.00 (d, 1H, J = 2.8 Hz, H-1’), 7.13-7.38 (m, 30H, H Arom); 13C NMR (100 MHz): δ = 15.6 
(C-6’), 54.9 (CH3 OMe), 62.7 (C-5’), 66.9 (C-6), 70.1, 71.1, 72.7, 73.1, 73.3, 73.5, 73.9, 74.8, 75.5, 
77.7, 77.9, 80.1, 82.0, 97.8 (C-1’), 97.9 (C-1), 127.0-128.8 (CH Arom), 137.9-139.0 (Cq Arom); 
HRMS: C55H60O10 + Na+ requires: 903.4079, found 903.4073. 
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para-Methoxyphenyl-2-O-benzyl-3-O-(2,3,4-tri-O-benzyl-α/β-D-
antiapyranoside)-4,6-benzylidene-β-D-galactopyranoside (44): 
Rhamnopyranoside 38 (79 mg, 0.15 mmol) was glycosylated with 
acceptor 26 as described in the general procedure for glycosylations 
of thioglycosides, affording the title compound 44 (93 mg, 70%) as 
a mixture of anomers (α/β: 1/0.15). IR (neat): 694, 733, 995, 1026, 1060, 1219, 1454, 1504, 2341, 
2870; 1H NMR: (400 MHz): δ = 0.91 (d, 3H, J = 6.8 Hz, H-6’), 3.24 (d , 1H, J = 2.4 Hz), 3.45 (s, 
1H), 3.73 (s, 3H, CH3 pMP), 3.87-3.92 (m, 2H), 3.96 (dd, 1H, J = 3.6 Hz, 10 Hz), 4.03-4.07 (m, 2H), 
4.32-4.39 (m, 4H), 4.45 (q, 1H, J = 6 Hz, H-5’), 4.49 (d, 1H, J = 12 Hz, CH2 Bn), 4.57 (d, 1H, J = 12 
Hz, CH2 Bn), 4.62 (d, 1H, J = 11.6 Hz, CH2 Bn), 4.69 (d, 1H, J = 10.8 Hz, CH2 Bn), 4.73 (d, 1H, J = 
10.8 Hz, CH2 Bn), 4.85 (d, 1H, J = 11.6 Hz, CH2 Bn), 4.90 (d, 1H, J = 7.6 Hz, H-1), 5.24 (d, 1H, J = 
3.6 Hz, H-1’), 5.52 (s, 1H, CHPh), 6.76-7.54 (m, 29H, H Arom); 13C NMR (100 MHz): δ = 55.5 (CH3 
pMP), 65.2 (C-5’), 66.3, 69.1, 69.3, 70.6, 71.3, 72.4, 72.5, 72.6, 73.3, 73.7, 74.6, 74.7, 76.0, 76.3, 
91.9 (C-1’), 101.0 (CHPh), 102.9 (C-1), 114.3 (CH pMP), 118.9 (CH pMP), 126.3-128.8 (CH Arom), 
137.7-139.1 (Cq Arom), 151.8 (Cq pMP), 155.1 (Cq pMP); HRMS: C54H56O11 + Na+ requires: 
903.3715, found 903.3712. 
Methyl (phenyl 2,3,4-tri-O-benzyl-1-thio-β-D-glucopyranosyluronate) 
(48): The title compound was prepared according to the general procedure for 
the synthesis of uronate esters starting from phenyl-1-thio-β-D-
glucopyranoside (4.08 g, 15.0 mmol) yielding 48 as a white solid (5.5 g, 62%). [α]D = - 8.9 (c = 2, 
DCM); IR (neat): 745, 818, 868, 910, 980, 1026, 1076, 1153, 1207, 1288, 1358, 1439, 1454, 1497, 
1740, 2905; 1H NMR (400 MHz): δ =  3.52 (t, 1H, J = 9.6 Hz, H-2), 3.69-3.72 (m, 4H, H-3, 
CO2CH3), 3.84 (t, 1H, J = 9.2 Hz, H-4), 3.92 (d, 1H, J = 9.6 Hz, H-5), 4.61 (d, 1H, J = 10.8 Hz, CH2 
Bn), 4.68 (d, 1H, J = 10.0 Hz, H-1), 4.72 (d, 1H, J = 10.4 Hz, CH2 Bn), 4.87 (d, 1H, J = 10.8 Hz, CH2 
Bn), 4.83-4.90 (m, 3H,  CH2 Bn), 7.21-7.38 (m, 18H, H Arom), 7.55 (d, 2H, J = 7.2 Hz,  H Arom); 
13C NMR (100 MHz): δ =  52.5 (CO2CH3), 75.1 (CH2 Bn), 75.5 (CH2 Bn), 75.9 (CH2 Bn), 77.9 (C-5), 
79.2 (C-4), 80.2 (C-2), 85.8 (C-3), 88.3 (C-1), 127.8-129.0 (CH Arom), 132.2 (CH Arom), 133.1 (Cq 
SPh), 137.7 (Cq Ph), 137.8 (Cq Ph), 138.1 (Cq Ph), 168.6 (C=O CO2CH3); HRMS: C34H34O6S + Na+ 
requires: 593.1968, found 593.1950. 
Methyl 2,3,4-tri-O-benzyl-6-O-(methyl 2,3,4-tri-O-benzyl-α/β-
D-glucopyranosyluronate)-α-D-glucopyranoside (50): Donor 
48 (114 mg, 0.2 mmol) was condensed with acceptor 25 
following the general procedure for glycosylations of 
thioglycuronates, giving disaccharide 50 (0.14 mmol, 68%) as a mixture of anomers (α/β: 1/1.4). IR 
(neat): 737, 914, 1030, 1072, 1088, 1157, 1138 1200, 1285, 1358, 1454, 1497, 1751, 2912, 3032, 
3063;  1H NMR (400 MHz): δ =  3.35 (s, 3H, CO2CH3 β), 3.37 (s, 1.9 H, CO2CH3 α), 3.42-3.60 (m, 
1.6 H), 3.48-3.56 (m, 3.5 H), 3.57-3.65 (m, 5 H), 3.67 (s, 3H, OCH3 β), 3.67-3.86 (m, 6H), 3.94-4.01 
(m, 2.5 H), 4.12 (dd, 1H, J = 1.6 Hz, 10.8 Hz), 4.29 (d, 0.7 H, J  = 10.0 Hz), 4.38 (d, 1.1 H, J = 7.6 
Hz, H-1’β), 4.50 (d, J = 11.6 Hz), 4.55-4.60 (m, 4.6 H), 4.72-4.83 (m, 4.2 H), 4.72-4.83 (m, 8.9 H), 
4.88-4.98 (m, 6 H), 7.17-7.35 (m, 55H, H Arom); 13C NMR (100 MHz): δ =  52.3 (CO2CH3 α or β), 
52.3 (CO2CH3 α or β), 66.5 (C-6 α or β), 68.8 (C-6 α or β), 69.7 (OCH3 α or β), 70.3 (OCH3 α or β), 
72.5, 73.2, 73.3, 74.4, 74.8, 74.8, 74.9, 74.9, 75.5, 75.6, 75.6, 77.9, 79.1, 79.3, 79.5, 79.8, 78.0, 80.8, 
81.5, 81.8, 82.0, 83.8, 97.7 (C-1’α), 97.9 (C-1 α and β), 104.0 (C-1’β), 127.5-128.4 (CH Arom Ph), 
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137.8 (Cq Ph), 138.0 (Cq Ph), 138.1 (Cq Ph), 138.2 (Cq Ph), 138.2 (Cq Ph), 138.7 (Cq Ph), 168.7 (C=O 
CO2Me);  HRMS: C56H60O12 + Na+ requires: 947.3977, found 947.3985. 
para-Methoxyphenyl-2-O-benzyl-3-O-(Methyl 2,3,4-tri-O-
benzyl-α/β-D-glucopyranosyluronate)-4,6-benzylidene-β-D-
galactopyranoside (52): Donor 48 (114 mg, 0.2 mmol) was 
glycosylated with acceptor 26 as described as in the general 
procedure for glycosylations of thioglycuronates, yielding 
disaccharide 52 (159 mg, 86%) as a mixture of anomers (α/β: 1/0.6). IR (neat): 737, 826, 914, 991, 
1030, 1088, 1180, 1219, 1288, 1366, 1454, 1508, 1747, 2203, 2870, 3032;  1H NMR (400 MHz): δ =  
3.49 (s, 1.2 H), 3.53 (s, 0.6 H), 3.54-3.67 (m, 4.6 H), 3.70-3.73 (m, 3.2 H), 3.75-3.83 (m, 6.7 H), 3.85-
3.87 (d, J = 6.8 Hz), 3.97 (dd, 1.5 H, J = 3.6 Hz, J = 10 Hz, H-3’α), 4.05 (dd, 0.7 H, J = 3.6 Hz, J = 10 
Hz, H-3’β), 4.10-4.25 (m, 5H), 4.37-4.42 (m, 3.4 H), 4.80-4.88 (m, 3.6 H), 4.91-5.10 (m, 2.5 H), 5.13 
(d, 0.6 H, J = 7.3 Hz, H-1’β), 5.29 (d, 1H, J = 3.6 Hz, H-1’α), 5.60 (s, 1H, CHPh benzylidene α), 5.67 
(s, 0.6 H, CHPh benzylidene β), 6.85-6.88 (m, 3.7 H, H Arom pMP), 7.09-7.40 (m, 47 H, H Arom), 
7.45-7.48 (m, 2.4 H, H Arom), 7.62-7.64 (m, 3.6 H, H Arom); 13C NMR (100 MHz): δ =  52.2 
(CO2CH3 α), 52.3 (CO2CH3 β), 55.5 (OCH3 pMP), 66.2, 66.5, 68.8, 69.2, 70.2, 71.2, 72.1, 74.1, 74.4, 
74.7, 74.9, 75.0, 74.4, 75.0, 75.5, 75.7, 75.9, 76.5, 78.6, 78.8, 79.2, 79.7, 80.9, 81.0, 83.5, 92.7 (C-
1’α), 100.6, 101.3, 103.0 (C-1 α and β), 103.1, 103.4 (C-1’α), 114.4 (CH Arom pMP), 118.8 (CH 
Arom pMP), 126.2-129.0 (CH Arom Ph), 137.5 (Cq Ph), 137.7 (Cq Ph), 137.8 (Cq Ph), 138.0 (Cq Ph), 
138.0 (Cq Ph), 138.1 (Cq Ph), 138.2 (Cq Ph), 138.3 (Cq Ph), 138.4 (Cq Ph), 151.4 (Cq Ph), 151.5 (Cq 
Ph), 155.2 (Cq Ph), 155.3 (Cq Ph), 169.1 (C=O CO2Me β), 170.3 (C=O CO2Me α); HRMS: C55H56O13 
+ Na+ requires: 947.3613, found 947.3621. 
Phenyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucospyranoside (49): The title 
compound was prepared according to the general procedure for the synthesis 
of tetrabenzyl thioglycosides starting from phenyl-1-thio-β-D-
glucospyranoside (6.81 g, 25 mmol) yielding 49 as white crystals (15.4 g, 
94%).1H NMR (400 MHz): δ = 3.47-3.54 (m, 2H, H-2, H-5), 3.63-3.78 (m, 4H, H-3, H-4, H-6), 4.50 
(d, 1H, J = 12.0 Hz, CH2 Bn), 4.56-4.60 (m, 2H, CH2 Bn), 4.67 (d, 1H, J1,2 = 9.5 Hz, H-1), 4.72 (d, 
1H, J = 10.0 Hz, CH2 Bn), 4.81-4.91 (m, 4H, CH2 Bn), 7.04-7.39 (m, 23 H, H Arom), 7.56-7.61 (m, 
2H,  H Arom); 13C NMR (100 MHz): δ =  68.8 (C-6), 73.2 (CH2 Bn), 74.8 (CH2 Bn), 75.2 (CH2 Bn), 
75.6 (CH2 Bn), 77.6 (C-3 or C-4), 78.9 (C-5), 80.6 (C-2), 86.6 (C-3 or C-4), 87.2 (C-1), 127.2-128-7 
(CH Arom), 131.7 (CH Arom), 133.7 (Cq Ph), 137.9 (Cq Ph), 138.1 (Cq Ph), 138.2 (Cq Ph). 
Methyl 2,3,4-tri-O-benzyl-6-O-(2,3,4,6-tetra-O-benzyl-α/β-D-
glucospyranoside)-α-D-glucopyranoside (51): Donor 49 (127 
mg, 0.2 mmol) was glycosylated with acceptor 25 in the same 
way as described in the general procedure for glycosylations of 
thioglycosides, affording the title compound 51 (148 mg, 75%) as 
a mixture of anomers (α/β: 1/1.4). IR (neat): 737, 826, 910, 1042, 1069, 1157, 1207, 1265, 1327, 
1362, 1454, 1497, 1585, 2870, 2905, 3032, 3063;  1H NMR (400 MHz): δ =  3.29 (s, 5.1 H, OCH3), 
3.41-3.44 (m, 1 H), 3.47-3.52 (m, 5.4 H, OCH3), 3.54-3.63 (m, 4H), 3.71-4.00 (m, 10 H), 4.14 (d, 1H, 
J = 10 Hz), 4.31 (d, 1 H, J = 7.6 Hz, H-1’β), 4.34-4.44 (m, 3.6 H), 4.50-4.63 (m, 6.6 H), 4.75-4.86 (m, 
6.5 H), 4.90-4.97 (m, 4H), 5.00 (d, 1.4 H, J = 3.2 Hz, H-1’α), 7.15-7.32 (m, 35 H, 35 x H Arom); 13C 
NMR (100 MHz): δ =  55.0 (OCH3 α), 55.1 (OCH3 β), 66.3, 68.5, 68.6, 68.9, 69.3, 69.8, 70.2, 72.4, 
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72.7, 72.8, 73.2, 73.3, 73.4, 73.5, 74.5, 74.7, 74.7, 74.9, 75.0, 75.1, 75.6, 75.6, 76.5, 77.9, 78.1, 78.2, 
78.2, 78.8, 80.1, 81.9, 82.0, 82.2, 97.8 (C-1’α), 104.2 (C-1’β), 127.3- 128.3 (CH Arom), 137.8 (Cq 
Ph), 138.0 (Cq Ph), 138.1 (Cq Ph), 138.1 (Cq Ph), 138.3 (Cq Ph), 138.4 (Cq Ph), 138.7 (Cq Ph), 138.7 
(Cq Ph), 138.8 (Cq Ph); HRMS: C62H66O11 + NH4+ requires: 1004.4943, found 1004.4959. 
para-Methoxyphenyl-2-O-benzyl-(2,3,4,6-tetra-O-benzyl-
α/β-D-glucospyranoside)-4,6-benzylidene-β-D-
galactopyranoside (53): Donor 49 (127 mg, 0.2 mmol) was 
condensed with acceptor 26 according to the general procedure 
for glycosylations of thioglycosides, delivering disaccharide 53 
(176 mg, 89%) as a mixture of anomers (α/β: 1/1.7). IR (neat): 
737, 826, 1003, 1030, 1065, 1219, 1362, 1454, 1504, 2866, 3032;  1H NMR (400 MHz): δ =  3.37-
3.41 (m, 3H), 3.48-3.59 (m, 5H), 3.61-3.69 (m, 3.8 H), 3.73 (s, 3H, OCH3 β), 3.74 (s, 1.8 H, OCH3 α), 
3.90 (dd, 0.8 H, J  = 3.6 Hz, 10.0 Hz), 3.97-4.01 (m, 2.2 H), 4.03-4.06 (d, 0.8 H, J = 8.0 Hz), 4.10-
4.19 (m, 3.3 H), 4.26-4.35 (m, 4.3 H), 4.44-4.51 (m, 4H), 4.54-4.60 (m, 3.6 H), 4.78-4.89 (m, 8.9 H), 
4.95-5.04 (m, 4.8 H), 5.21 (d, 1H, J= 3.6 Hz, H-1’α), 5.55 (s, 0.6 H, CHPh benzylidene α), 5.60 (s, 
1H, CHPh benzylidene β), 6.79-6.82 (m, 3.7 H, H Arom pMP), 7.03-7.36 (m, 60 H, H Arom), 7.60-
7.62 (m, 3.6 H, H Arom); 13C NMR (100 MHz): δ =  55.5 (OCH3 pMP β), 55.5 (OCH3 pMP α), 66.3, 
66.6, 68.3, 68.8, 68.9, 69.8, 71.2, 71.8, 73.0, 74.1 (α), 74.4 (CH2Ph α), 74.4 (CH2 Bn β), 74.4 (CH2 Bn 
β), 74.8 (β), 74.9 (CH2 Bn α), 74.9 (CH2 Bn β), 75.5 (CH2 Bn β), 75.6 (CH2 Bn α), 75.6 (CH2 Bn α), 
75.9 (β), 76.2 (β), 76.5 (α), 77.5 (α), 77.7 (β), 78.7 (β), 79.2 (α), 81.6 (β), 81.9 (α), 84.4 (β), 92.0 (1’ 
α), 100.6 (CHPh benzylidene), 101.4 (CHPh benzylidene), 103.2 (C-1 β), 103.2 (C-1 α), 103.5 (C-1’ 
β); HRMS: C61H62O12 + Na+ requires: 1009.4134, found 1009.4141. 
Methyl (phenyl 2,3,4-tri-O-benzyl-1-thio-β-D-allopyranosyluronate) (54): 
The title compound was prepared according to the general procedure for the 
synthesis of uronate esters starting from phenyl-1-thio-β-D-allopyranoside 
(1.22 g, 4.50 mmol) yielding 54 as a white solid (1.30 g, 51%). [α]D = + 2.27 
(c = 0.06, CH2Cl2); IR (neat): 729, 895, 1026, 1076, 1207, 1265, 1358, 1439, 1497, 1747, 2882, 3055; 
1H NMR (400 MHz): δ =  3.31 (dd, 1H, J = 2.4 Hz, 9.6 Hz, H-2), 3.62 (dd, 1H, J = 9.6 Hz, 2.4 Hz, H-
4), 3.71 (s, 3H, CO2CH3), 4.08 (t, 1H, J = 2.4 Hz, H-3), 4.40 (d, 1H, J = 11.6 Hz, CH2 Bn), 4.44-4.51 
(m, 3H, H-5,  CH2 Bn), 4.57 (d, 1H, J = 11.6 Hz, CH2 Bn), 4.77 (d, 1H, J = 12.8 Hz, CH2 Bn), 4.80 
(d, 1H, J = 12.8 Hz, CH2 Bn), 5.22 (d, 1H, J = 10.0 Hz,, H-1), 7.19-7.33 (m, 18H, 1 H Arom), 7.34 
(d, 2H, J = 3.2 Hz,  H Arom); 13C NMR (100 MHz): δ =  52.2 (CO2CH3), 71.8 (CH2 Bn), 72.3 (CH2 
Bn), 73.2 (C-3), 74.2 (CH2 Bn), 74.5 (C-5), 77.0 (C-2), 77.2 (C-4), 84.2 (C-1), 127.3-128.7 (CH 
Arom), 131.9 (CH Arom), 133.2 (Cq Ph), 137.3 (Cq Ph), 137.4 (Cq Ph), 138.4 (Cq Ph), 169.5 (C=O 
CO2CH3); 13C-GATED NMR (125 MHz): 84.4 (JC-1, H-1 = 160 Hz, C-1); HRMS: C34H34O6S + Na+ 
requires: 593.1968, found 593.1965. 
Methyl 2,3,4-tri-O-benzyl-6-O-(methyl 2,3,4-tri-O-benzyl-α/β-
D-allopyranosyluronate)-α-D-glucopyranoside (56): Donor 
glycoside 54 (86 mg, 0.15 mmol) was condensed with glucoside 
25 (105 mg, 0.225 mmol, 1.5 eq.) following the general procedure 
for glycosylations of thioglycuronates, yielding 56 (126 mg, 76%) as a mixture of anomers (α/β: 
1/0.4). IR (neat): 737, 914, 1026, 1072, 1088, 1161, 1204, 1281, 1327, 1362, 1454, 1497 1747, 2905, 
3032, 3063;  1H NMR (400 MHz): δ =  3.26 (s, 3H, C-1-OCH3α), 3.30 (s, 1.1 H, C-1-OCH3 β), 3.37 
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(dd, 1H, J = 3.6 Hz, 9.6 Hz), 3.45-3.53 (m, 2H), 3.56 (dd, 1H, J = 2.4 Hz, 9.6 Hz), 3.67-3.68 (m, 4H), 
3.70 (s, 3H, CO2CH3 α), 3.91-3.99 (m, 2H), 4.06-4.17 (m, 0.4 H), 4.15 (m, 1H), 4.38 (d, 1H, J = 12.0 
Hz, CH2 Bn), 4.42-4.70 (m, 10H), 4.73-4.98 (m, 3H), 5.08 (d, 1H, J = 4.0 Hz, H-1α), 7.10-7.37 (m, 
45H, 4 H Arom); 13C NMR (100 MHz): δ =  52.1 (OCH3 β), 52.1 (OCH3 α), 54.9 (CO2CH3 α), 55.1 
(CO2CH3 β), 67.1 (α), 67.2 (C-6 α), 68.5 (C-6 β), 69.9 (β), 70.4 (Cα), 70.8 (CH2 Bn α), 71.2 (CH2 Bn 
α), 71.9 (CH2 Bn β), 72.5 (β), 72.9 (CH2 Bn β), 73.2 (β), 73.3 (CH2 Bn β), 74.0 (CH2 Bn β), 74.5 (β), 
75.0 (CH2 Bn α, 76.0 (α), 76.9 (α), 77.2 (β), 77.8 (α), 77.9 (β), 78.3 (β), 79.7 (β), 80.1 (α), 82.0 (α), 
97.8 (C-1’α), 97.9 (C-1 α), 101.3 (C-1’ β). 13C GATED NMR (100 MHz): δ =  97.8 (JC-1’α, H-1’α = 167 
Hz, C-1’α), 97.9 (JC-1α, H-1α = 166 Hz, C-1α); HRMS: C56H60O12 + NH4+ requires: 942.4423, found 
942.4437.  
para-Methoxyphenyl-2-O-benzyl-3-O-(Methyl 2,3,4-tri-O-
benzyl-α-D-allopyranosyluronate)-4,6-benzylidene-β-D-
galactopyranoside (58): Alluronic acid 54 (86 mg, 0.15 mmol) 
was glycosylated with galactoside 26 (105 mg, 0.225 mmol, 1.5 
eq.) as described in the general procedure for glycosylations of 
thioglycuronates giving α-linked disaccharide 58 (72 mg, 52%) 
as transparent oil. [α]D = + 26.3 (c = 0.2, DCM); IR (neat): 729, 826, 895, 999,1030, 1061, 1096, 
1180, 1215, 1265, 1366, 1454, 1508, 1744, 2866, 3055; 1H NMR (400 MHz): δ =  3.46 (s, 1H, H-5), 
3.54 (s, 3H, CO2CH3), 3.58 (t, 1H, J = 3.6 Hz, H-2’), 3.61 (dd, 1H, J = 9.6 Hz, 2.4 Hz, H-4’), 3.75 (s, 
3H, OCH3 pMP), 3.99-4.09 (m, 3H, H-2, H-4, H-6), 4.27 (m, 1H, H-3’), 4.34-4.40 (m, H-3, H-6,  CH2 
Bn), 5.52 (d, 1H, J = 11.6 Hz, CH2 Bn), 4.56 (d, 1H, J = 10.4 Hz, CH2 Bn), 4.61 (d, 1H, J = 11.2 Hz, 
CH2 Bn), 4.71 (d, 1H, J = 10.4 Hz, CH2 Bn), 4.80 (d, 1H, J = 11.6 Hz, CH2 Bn), 4.89-4.95 (m, 3H, H-
5’, H-1, CH2 Bn), 5.33 (d, 1H, J = 4.0 Hz, H-1’), 5.55 (s, 1H, CHPh benzylidene), 6.77 (d, 2H, J = 9.2 
Hz,  H Arom), 7.00 (d, 2H, J = 6.8 Hz,  H Arom), 7.02-7.30 (m, 23H, 2 H Arom), 7.51-7.58 (m, 2H,  
H Arom); 13C NMR (100 MHz): δ =  52.1 (CO2CH3), 55.6 (OCH3 pMP), 66.3 (C-5), 67.0 (C-5’), 69.3 
(C-6), 70.8 (CH2 Bn), 71.0 (CH2 Bn), 71.5 (C-3), 73.2 (C-3’), 74.1 (CH2 Bn), 75.0 (CH2 Bn), 75.4 (C-
2), 76.0 (C-4), 76.3 (C-2’), 77.0 (C-4’), 92.5 (C-1’), 101.0 (CHPh benzylidene), 102.8 (C-1), 114.3 
(CH Arom pMP), 118.8 (CH Arom pMP), 126.3, 137.1-128.9 (CH Arom), 137.7-139.0 (Cq Arom), 
151.7 (Cq pMP), 155.1 (Cq pMP), 171.5 (C=O CO2Me);  13C-GATED NMR (100 MHz): δ =  92.4 
(JC-1’, H-1’ = 164 Hz, C-1’), 102.7 (JC-1, H-1 = 160 Hz, C-1); HRMS: C55H56O13 + NH4+ requires:  
942.4059, found 942.4072. 
Phenyl-2,3,4,6-tetra-O-benzyl-1-thio-β-D-allopyranoside (55): The title 
compound was prepared according to the general procedure for the synthesis 
of tetrabenzyl thioglycosides starting from phenyl-1-thio-β-D-allopyranoside 
(1 g, 3.67 mmol) yielding 55 as white solid (1.66 g, 72%). [α]D = -1.16 (c = 
0.06, CH2Cl2); IR (neat): 729, 910, 1045, 1072, 1207, 1265, 1354, 1454, 1497, 1585, 2870, 3032; 1H 
NMR (400 MHz): δ =  3.31 (dd, 1H, J = 2.0 Hz, 9.6 Hz, H-2), 3.48 (dd, 1H, J = 1.6 Hz, 9.6 Hz, H-4), 
3.71 (dd, 1H, J = 4.4 Hz, 10.8 Hz, H-6), 3.79 (d, 1H, J = 10.0 Hz, H-6), 4.10 (m, 2H, H-3, H-5), 4.39 
(d, 1H, J = 11.6 Hz, CH2 Bn), 4.46-4.60 (m, 5H,  CH2 Bn), 4.77 (d, 1H, J = 12.0 Hz, CH2 Bn), 4.82 
(d, 1H, J = 12.0 Hz, CH2 Bn), 5.26 (d, 1H, J = 10.0 Hz, H-1), 7.11-7.56 (m, 23H, H Arom), 7.57-7.59 
(m, 2H,  H Arom); 13C NMR (100 MHz): δ =  69.2 (C-6), 71.4 (CH2 Bn), 72.2 (CH2 Bn), 73.2 (CH2 
Bn), 73.5 (C-3), 74.2 (CH2 Bn), 74.9 (C-5), 75.4 (C-4), 77.7 (C-2), 83.6 (C-1), 126.9-128.8 (CH 
Arom), 131.7 (CH Arom), 131.8 (CH Arom), 133.9 (Cq Ph), 137.7 (Cq Ph), 137.8 (Cq Ph), 138.4 (Cq 
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Ph), 138.7 (Cq Ph); 13C-GATED NMR (100 MHz): 83.6 (JC-1, H-1 = 158 Hz, C-1); HRMS: C40H40O5S 
+ Na+ requires: 655.2489, found 655.2486. 
Methyl 2,3,4-tri-O-benzyl-6-O-(2,3,4,6-tetra-O-benzyl-α/β-D-
allopyranoside)-α-D-glucopyranoside (57): Allopyranoside 55 
(95 mg, 0.15 mmol) was condensed with acceptor 25 according to 
the general procedure for glysolylations of thioglycosides, 
yielding disaccharide 57 (136 mg, 92%) as a mixture of anomers 
(α/β: 1/0.5). IR (neat): 729, 910, 1026, 1049, 1072, 1207, 1265, 1327, 1362, 1454, 1497, 2870, 3032;  
1H NMR (600 MHz): δ =  3.26 (s, 3H), 3.31-3.33 (m, 2H), 3.39 (dd, 0.5 H, J = 3.6 Hz, 9.6 Hz, H-2α), 
3.43-3.46 (m, 1.6 H), 3.51 (dd, 1H, J = 3.6 Hz, 9.6 Hz, H-2β), 3.55-3.60 (m, 2.5 H), 3.65-3.74 (m, 6.3 
H), 3.93 (t, 1H, J = 9.0 Hz), 3.97-4.00 (m, 1.5 H), 4.11 (m, 0.4 H), 4.17-4.18 (m, 1.5 H), 4.23-4.25 
(m, 1H), 4.37 (d, 1H, J = 7.6 Hz), 4.37 (d, 0.5 H, J = 7.6 Hz), 4.44 (d, 1H, J = 8.0 Hz), 4.48-4.69 (m, 
13 H), 4.73 (d, 0.5 H), 4.77-4.85 (m, 4.3 H), 4.90-4.97 (m, 3.2 H), 5.1 (d, 1H, J = 3.0 Hz, H-1’ α), 
7.07-7.36 (m, 53H, 5 H Arom); 13C NMR (125 MHz): δ =  54.9 (OCH3 β), 55.1 (OCH3 α), 66.2 (α), 
66.6, 68.1, 68.6, 69.4, 69.9, 70.4, 70.6, 70.8 (CH2 Bn α), 71.5 (CH2Ph β), 72.6 (CH2 Bn β), 72.8 (α), 
73.3 (CH2 Bn β), 73.3 (CH2 Bn α), 73.4 (CH2 Bn α), 73.5 (CH2 Bn α), 74.0 (CH2 Bn α), 74.4 (α), 74.5 
(CH2 Bn α), 74.6 (β), 74.8 (CH2 Bn α), 75.0 (CH2 Bn β), 75.5 (CH2 Bn α), 75.6 (β), 75.6 (α), 75.6 
(CH2 Bn β), 76.7 (β), 77.8 (β), 77.8 (α), 79.0 (β), 79.6 (β), 80.1 (α), 82.0 (α), 97.6 (C-1’α), 97.9 (C-1 
α), 98.0 (C-1 β), 101.1 (C-1’β), 127.0-128.4 (CH Arom), 137.8 (Cq Ph), 138.1 (Cq Ph), 138.1 (Cq Ph), 
138.3 (Cq Ph), 138.3 (Cq Ph), 138.4 (Cq Ph), 138.5 (Cq Ph), 138.7 (Cq Ph), 138.8 (Cq Ph), 138.9 (Cq 
Ph), 139.0 (Cq Ph), 137.4 (Cq Ph); 13C-GATED NMR (100 MHz): δ =  97.6 (JC-1’α, H-1’α = 167 Hz), 
101.1 (JC-1’β, H-1’β = 162 Hz); HRMS: C62H66O11 + NH4+ requires: 1004.4943, found 1004.4959. 
para-Methoxyphenyl-2-O-benzyl-(2,3,4,6-tetra-O-benzyl-α/β-
D-allopyranoside)-4,6-benzylidene-β-D-galactopyranoside 
(59): Allopyranoside 55 (95 mg, 0.15 mmol) was condensed 
with acceptor 26 according to the general procedure for 
glycosylations of thioglycosides, affording disaccharide 59 (105 
mg, 71%) as a mixture of anomers (α/β: 1/0.56). α isomer: [α]D 
= + 11.3 (c = 0.6, DCM); IR (neat): 729, 826, 907, 999, 1026, 1061, 1096, 1146, 1180, 1219, 1265 
1366, 1393, 1454, 1504, 2866, 3032. 1H NMR (400 MHz): δ =  3.40-3.45 (m, 3H, H-5, H-6’, H-6’), 
3.56-3.59 (m, 2H, H-2’, H-4’), 3.76 (s, 3H, OCH3 pMP), 3.98-4.00 (m, 2H, H-3, H-2),  4.08 (d, 1H, J 
= 11.2 Hz, CH2 Bn), 4.32-4.59 (m, 10H, H-4, H-3’, H-5’,  CH2 Bn), 4.66 (d, 1H, J = 11.6 Hz, CH2 
Bn), 4.78-4.83 (m, 2H, H-1, CH2 Bn), 4.99 (d, 1H, J = 11.6 Hz, CH2 Bn), 5.30 (d, 1H, J = 4.0 Hz, H-
1’), 5.57 (s, 1H, CHPh benzylidene), 6.78-6.80 (m, 2H,  H Arom), 7.02-7.36 (m, 28H,  H Arom), 
7.44-7.47 (m, 2H,  H Arom), 7.55-7.57 (m, 2H,  H Arom); 13C NMR (100 MHz): δ =  55.6 (OCH3 
pMP), 65.9 (C-5’), 66.4 (C-5), 68.7 (C-6’), 69.3 (C-6), 70.6 (CH2 Bn), 70.6 (CH2 Bn), 71.6 (C-4), 
73.0 (CH2 Bn), 73.5 (C-3), 74.2 (CH2 Bn), 74.6 (C-4’or C-2’), 74.7 (C-3 or C-2), 74.8 (CH2 Bn), 76.2 
(C-3 or C-2), 76.8 (C-2’ or C-4’), 92.4 (C-1’), 100.9 (CHPh benzylidene), 103.1 (C-1), 114.3 (CH 
Arom pMP), 118.9 (CH Arom pMP), 126.3-129.1 (CH Arom), 137.7 (Cq Ph), 138.0 (Cq Ph), 138.2 
(Cq Ph), 138.4 (Cq Ph), 138.5 (Cq Ph), 139.4 (Cq Ph), 151.8 (Cq pMP), 155.1 (Cq pMP); 13C-GATED 
NMR (100 MHz): δ =  92.4 (JC-1’, H-1’ = 162 Hz, C-1’), 103.1 (JC-1, H-1 = 154 Hz, C-1). HRMS; 
[M+NH4]+ calcd for C61H66O12N: calcd: 1004.45795, found 1004.45933. β isomer: [α]D = + 32.3 (c = 
1.2, DCM); IR: 737, 826, 1003, 1092 1223, 1366, 1454, 1504, 2866; 1H NMR (400 MHz): δ =  3.31 
O
OBn
OBn
BnO
OBn BnO
O
OBn
O
OBn
OMe
O
OBn
OBn
BnO
OBn
O
O
BnO
O
O
Ph
OpMP
Chapter 6 
126 
(dd, 1H, J = 7.6 Hz, 2.4 Hz, H-2’), 3.42-3.46 (m, 2H, H-4’, H-5), 3.65 (dd, 1H, J = 4.8 Hz, 10.8 Hz, 
H-6’), 3.73 (dd, 1H, J = 10.8 Hz, 2.0 Hz, H-6), 3.76 (s, 3H, OCH3 pMP), 3.96-3.99 (m, 2H, H-3, H-6), 
4.04-4.14 (m, 3H, H-5’, H-2, H-3’), 4.29-4.34 (m, 2H, H-6, H-4), 4.43 (d, 1H, J = 11.6 Hz, CH2 Bn), 
4.49 (d, 1H, J = 8.8 Hz, CH2 Bn), 4.58 (d, 1H, J = 12.4 Hz, CH2 Bn), 4.76 (d, 1H, J = 12.0 Hz, CH2 
Bn), 4.80-4.93 (m, 6H, H-1,  CH2 Bn), 5.42 (d, 1H, J = 8.0 Hz, H-1’), 5.56 (s, 1H, CHPh 
benzylidene), 6.79 (d, 2H, J = 6.8 Hz,  H Arom), 7.02-7.39 (m, 32H, 3 H Arom), 7.39-7.61 (m, 2H,  
H Arom); 13C NMR (100 MHz): δ =  55.6 (OCH3 pMP), 66.6 (C-4’), 69.0 (C-6), 69.53 (C-6’), 71.4 
(CH2 Bn), 72.0 (C-5’), 72.9 (CH2 Bn), 73.4 (CH2 Bn), 74.2 (CH2 Bn), 74.4 (C-2), 75.2 (CH2 Bn), 75.7 
(C-5), 77.0 (C-4), 77.3 (C-4), 78.3 (C-3’), 78.7 (C-2’), 100.8 (CHPh benzylidene), 101.9 (C-1’), 103.3 
(C-1), 114.4 (CH Arom pMP), 119.1 (CH Arom pMP), 126.4-128.7 (CH Arom), 137.8 (Cq Ph), 138.2 
(Cq Ph), 138.3 (Cq Ph), 138.4 (Cq Ph), 138.7 (Cq Ph), 139.1 (Cq Ph), 151.7 (Cq pMP), 155.3 (Cq pMP); 
HRMS: C61H62O12 + NH4+ requires: 1004.4580, found 1004.4594.  
Methyl (phenyl 2,3,4-tri-O-benzyl-1-thio-β-D-galactopyranosyluronate) 
(60): The title compound was prepared according to the general procedure for 
the synthesis of uronate esters starting from phenyl-1-thio-β-D-
galactopyranoside (3.08 g, 11.3 mmol) yielding 60 as a white solid (5.25 g, 
78%).. IR (neat): 694, 733, 1026, 1080, 1732, 2855; 1H NMR (400 MHz): δ =  3.64 (m, 1H, H-3), 
3.69 (s, 3H, CO2CH3), 3.94 (t, 1H, J = 9.6 Hz, H-2), 4.05 (s, 1H, H-5), 4.31 (d, 1H, J = 1.2 Hz, H-4), 
4.60 (d, 1H, J = 9.6 Hz, H-1), 4.63 (d, 1H, J = 12.8 Hz, CH2 Bn), 4.70-4.76 (m, 3H,  CH2 Bn), 4.81 
(d, 1H, J = 10.4 Hz, CH2 Bn), 4.90 (d, 1H, J = 11.6 Hz, CH2 Bn), 7.20-7.39 (m, 18H, 1 H Arom), 
7.63-7.64 (m, 2H, H Arom); 13C NMR (100 MHz): δ =  52.1 (CO2CH3), 72.8 (CH2 Bn), 74.4 (CH2 
Bn), 75.0 (C-4), 75.6 (CH2 Bn), 76.6 (C-2), 77.2 (C-5), 83.3 (C-3), 87.8 (C-1), 127.5-128.8 (CH 
Arom), 132.4 (CH Arom), 133.5 (Cq Ph), 137.9 (Cq Ph), 138.1 (Cq Ph), 138.2 (Cq Ph), 168.5 (C=O 
CO2CH3). 
Methyl 2,3,4-tri-O-benzyl-6-O-(methyl 2,3,4-tri-O-benzyl-α/β-
D-galactopyranosyluronate)-α-D-glucopyranoside (62): 
Galacturonic acid 60 (114 mg, 0.20 mmol) was condensed with 
glucoside 25 (139 mg, 0.30 mmol) as described in the general 
procedure for glycosylations of thioglycuronates yielding 62 (91 
mg, 49%) as a mixture of anomers (α/β: 1/2.3). IR (neat): 733, 818, 914, 1026, 1049, 1068, 1092, 
1211, 1269, 1358, 1454, 1497, 1605, 1732, 1767, 2870, 3032;  1H NMR (400 MHz): δ =  3.28 (s, 3 H, 
OCH3 α), 3.29 (s, 8 H, OCH3 β), 3.40 (dd, 1H, J = 3.6 Hz, J = 9.6 Hz), 3.44-54 (m, 10 H), 3.58 (s, 
3H, CO2CH3 α), 3.62 (s, 7H, OCH3 pMP, CO2CH3 β), 3.65 (dd, 2H, J = 5.6 Hz, 10.8 Hz), 3.85-3.89 
(m, 7H), 3.91-4.02 (m, 5H), 4.06 (dd, 1H, J = 3.6 Hz, 9.6 Hz), 4.20-4.23 (m, 6H), 4.29 (d, 2H, J = 8.0 
Hz), 4.40 (bs, 1H), 4.50-4.72 (m, 16 H), 4.73-4.83 (m, 4 H), 4.97 (dd, 6H, J = 2.0 Hz, 10.8 Hz), 5.07 
(d, 1H, J = 3.6 Hz, H-1’α), 7.18-7.36 (m, 16 H, H Arom Ph);  13C NMR (100 MHz): δ =  53.0 (OCH3 
C-1-OCH3), 55.0 (OCH3 CO2CH3), 66.8 (C-6 α), 68.6 (C-6 β), 69.9 (β), 70.1 (α), 70.7 (α), 72.7 (CH2 
Bn α), 72.9 (CH2 Bn α), 73.2 (CH2 Bn α), 73.2 (CH2 Bn β), 73.8 (β), 74.4, 74.7 (CH2 Bn α), 74.9 (β), 
75.0 (CH2 Bn β), 75.5 (CH2 Bn β), 75.6 (CH2 Bn α), 75.8 (α), 76.5 (α), 77.2 (α), 77.8 (α), 79.8 (β), 
78.0 (α), 81.3 (β), 81.9 (β), 82.0 (α), 97.7 (C-1 β), 97.7 (C-1 α), 98.1 (C-1’α), 103.7 (C-1’β), 137.3-
128.3 (CH Arom), 138.0-138.8 (Cq Arom), 168.4 (C=O CO2CH3 β), 169.2 (C=O CO2CH3 α); HRMS: 
C56H60O12 + NH4+ requires: 942.4423, found 942.4437. 
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para-Methoxyphenyl-2-O-benzyl-3-O-(Methyl 2,3,4-tri-O-
benzyl-α/β-D-allopyranosyluronate)-4,6-benzylidene-β-D-
galactopyranoside (64): Galacturonic acid 60 (114 mg, 0.20 
mmol) was glycosylated with glucoside 26 (139 mg, 0.30 mmol, 
1.5 eq.) as described in the general procedure for glycosylations 
of thioglycuronates yielding 64 (159 mg, 86%) as a mixture of anomers (α/β: 1/0.4). IR (neat): 737, 
826, 922, 999, 1030, 1065, 1096 1219, 1366, 1396, 1454, 1504, 1759, 2870, 3032;  1H NMR (400 
MHz): δ =  3.31 (s, 0.7 H, pMP β), 3.41-3.44 (m, 2H), 3.45 (s, 3H, pMP α), 3.56 (s, 1H, CO2CH3 β), 
3.72 (s, 3H, CO2CH3 α), 3.83 (s, 0.4 H), 3.87 (dd, 1H, J = 3.2 Hz, J = 10.0 Hz), 3.95 (dd, 1H, J = 2.8 
Hz, 10.0 Hz), 4.01-4.07 (m, 3H), 4.09-4.17 (m, 3H), 4.28-4.32 (m, 2H), 4.34 (d, 0.4 H, J = 3.6 Hz),  
4.50-4.55 (m, 1.4 H), 4.60 (d, 3H, J = 12.0 Hz), 4.67 (d, 2H, J = 11.2 Hz,  CH2 Bn), 4.74-4.92 (m, 
6H), 4.97 (d, 0.4 H, J = 8.0 Hz, H-1’β), 4.53 (d, 1 H, J = 11.2 Hz, CH2 Bn α), 5.05 (d, 0.4 H, J =11.6 
Hz, CH2 Bn β), 5.28 (d, 1H, J = 3.6 Hz, H-1’α), .55 (s, 1H, CHPh benzylidene α), 5.61 (s, 0.4 H, 
CHPh benzylidene β), 6.78 (d, 3H, J = 2.0 Hz, H Arom pMP α, pMP β), 6.80 (s, 3H, J = 2.0 Hz, H 
Arom pMP α, pMP β), 7.02- 7.39 (m, 38.5 H, H Arom), 7.54-7.56 (m, 2H, H Arom), 7.60-7.60 (m, 
0.8 H, H Arom); 13C NMR (100 MHz): δ =  51.7 (OCH3 pMP α), 52.0 (OCH3 pMP β), 55.5 (CO2CH3 
α, CO2CH3 β), 66.3 (α), 66.6 (β), 68.7 (CH2 Bn β), 69.1 (CH2 Bn α), 70.5 (α), 71.3 (α), 72.2 (CH2 Bn), 
73.2 (CH2 Bn), 73.8 (α), 74.3 (CH2 Bn), 74.6 (CH2 Bn), 74.7 (CH2 Bn), 75.1 (β), 75.2 (CH2 Bn), 75.3 
(α), 75.5 (β), 76.2 (α), 76.8 (α), 77.6 (α), 78.3 (β), 79.1 (β), 81.0 (β), 93.0 (C-1’α), 100.5 (CHPh 
benzylidene β), 101.1 (CHPh benzylidene α), 103.0 (C-1’β), 103.1 (C-1 α, C-1β), 114.3 (CH Arom 
pMP), 118.6 (CH Arom pMP), 126.1-128.8 (CH Arom), 137.6-138.5 (Cq Arom), 151.4 (Cq pMP), 
155.2 (Cq pMP), 168.8 (C=O CO2Me α); HRMS: C55H56O13 + NH4+ requires: 942.4059, found 
942.4073. 
Phenyl-2,3,4,6-tetra-O-benzyl-1-thio-β-D-galactopyranoside (61): The title 
compound was prepared according to the general procedure for the synthesis of 
tetrabenzyl thioglycosides starting from phenyl-1-thio-β-D-galactopyranoside 
(6.81 g, 25 mmol) yielding 61 as white solid (15.0 g, 92%).  [α]D = + 13.1 (c = 
0.2, DCM); IR (neat): 737, 810, 841, 880, 914, 941, 988, 1015, 1049, 1080, 1146, 1219, 1269, 1292, 
1369, 1454, 1477, 1497, 1582, 2882, 3032, 3059; 1H NMR (400 MHz): δ =  3.59- 3.66 (m, 4H, H-3, 
H-5, H-6), 3.93 (t, 1H, J = 9.2 Hz, H-2), 3.98 (d, 1H, J = 2.8 Hz, H-4), 4.41 (d, 1H, J = 11.6 Hz, CH2 
Bn), 4.47 (d, 1H, J = 11.6 Hz, CH2 Bn), 4.60 (d, 1H, J = 11.2 Hz, CH2 Bn), 4.64 (d, 1H, J = 9.6 Hz, 
H-1), 4.69-4.75 (m, 3H,  CH2 Bn), 4.78 (d, 1H, J = 10.0 Hz, CH2 Bn), 4.96 (d, 1H, J = 11.2 Hz, CH2 
Bn), 7.14-7.31 (m, 23H, 2 H Arom), 7.52-7.59 (m, 2H,  H Arom); 13C NMR (100 MHz): δ =  68.7 (C-
6), 72.7 (CH2 Bn), 73.5 (C-4), 73.5 (CH2 Bn), 74.4 (CH2 Bn), 75.6 (CH2 Bn), 77.2 (C-2 + C-5), 84.1 
(C-3), 87.7 (C-1); HRMS: C40H40O5S + Na+ requires: 655.2489, found 655.2486. 
Methyl 2,3,4-tri-O-benzyl-6-O-(2,3,4,6-tetra-O-benzyl-α/β-D-
galactopyranoside)-α-D-glucopyranoside (63): Galactoside 61 
(127 mg, 0.20 mmol) was condensed with glucoside 25 (139 mg, 
0.30 mmol, 1.5 eq.) according to the general procedure for 
glycosylations of thioglycosides, yielding 63 (132 mg, 67%) as a 
mixture of anomers (α/β: 1/3). IR (neat): 733, 818, 910, 1026, 
1065, 1092, 1157, 1207, 1265, 1362, 1454, 1497, 1585, 1605, 1956, 2870, 3032, 3063;  1H NMR (400 
MHz): δ =  3.33 (s, 3H, OCH3 β), 3.35 (s, 1H, OCH3 α), 3.43-3.73 (m, 12 H), 3.71-3.84 (m, 1.7 H), 
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3.96-4.02 (m, 1.7 H), 4.18 (d, 1H, J = 10.4 Hz, CH2 Bn), 4.35 (d, 1H, J = 8.0 Hz, H-1’ β), 4.40-4.47 
(m, 0.7 H), 4.50-4.66 (m, 8 H), 4.69-4.84 (m, 8 H), 4.91 (m, 1.6 H, CH2 Bn), 4.97 (m, 2 H, CH2 Bn 
and C-1’ α), 7.13-7.42 (m, 59H, 5 H Arom); 13C NMR (100 MHz): δ =  55.1 (OCH3 α), 55.1 (OCH3 
β), 66.0, 68.4, 68.5, 69.8, 70.2, 70.3, 72.3 (CH2 Bn), 73.3 (CH2 Bn), 74.8 (CH2 Bn), 74.9 (CH2 Bn), 
75.0, 75.4 (CH2 Bn), 75.6 (CH2 Bn), 75.6 (CH2 Bn), 77.5, 77.7, 77.8, 77.9, 79.7, 79.9, 80.1, 81.6, 
81.9, 82.0, 84.7, 97.2 (C-1’α), 97.9 (C-1 α), 98.0 (C-1 β), 103.7 (C-1’β), 127.5-128.4 (CH Arom), 
138.0 (Cq Ph), 138.1 (Cq Ph), 138.1 (Cq Ph), 138.2 (Cq Ph), 138.3 (Cq Ph), 138.3 (Cq Ph), 138.5 (Cq 
Ph), 138.8 (Cq Ph); HRMS: C62H66O11 + NH4+ requires: 1004.4943, found 1004.4958. 
para-Methoxyphenyl-2-O-benzyl-(2,3,4,6-tetra-O-benzyl-α/β-
D-galactospyranoside)-4,6-benzylidene-β-D-
galactopyranoside (65): Galactoside 61 (127 mg, 0.20 mmol) 
was glycosylated with galactoside 26 (139 mg, 0.30 mmol, 1.5 
eq.) following the general procedure for glycosylations of 
thioglycosides, giving disaccharide 65 (0.142 mg, 72%) as a mixture of anomers (α/β: 1/0.1). IR 
(neat): 737, 826, 907, 999, 1061, 1099, 1223, 1312, 1366, 1454, 1504, 2168, 2866, 3032; 1H NMR 
(400 MHz): δ = 5.24 (d, 1H, J = 3.6 Hz, H-1’α), 5.50 (s, 1H, CHPh-α benzylidene), 5.55 (s, 0.1 H, 
CHPh-β benzylidene). α-anomer: 3.25-3.29 (m, 2H, H-5, H-6’), 3.53-3.57 (m, 1H, H-6’), 3.69 (d, 1H, 
J = 2.0 Hz, H-4’), 3.73 (s, 3H, OCH3 pMP), 3.88 (dd, 1H, J = 3.2 Hz, 10.0 Hz, H-3), 3.92-3.99 (m, 
2H, H-3’, H-6), 4.07 (d, 1H, J = 3.6 Hz, H-2’), 4.09-4.14 (m, 1H, H-2), 4.18 (t, 1H, J = 6.4 Hz, H-5’), 
4.26-4.29 (m, 4H, H-6, H-4,  CH2 Bn), 4.53 (d, 1H, J = 11.6 Hz, CH2 Bn), 4.58 (m, 2H,  CH2 Bn), 
4.66 (d, 1H, J = 12.0 Hz, CH2 Bn), 4.76-4.81 (m, 3H, H-1,  CH2 Bn), 4.92 (d, 1 H, CH2 Bn), 5.01 (d, 
1H, J = 10.8 Hz, CH2 Bn), 5.24 (d, 1H, J = 3.6 Hz, H-1’α), 5.50 (s, 1H, CHPh-α benzylidene), 6.79 
(d, 2H, J = 2.0 Hz,  H Arom pMP), 6.81 (d, 2H, J = 2.0 Hz,  H Arom pMP), 7.01-7.37 (m, 28 H, 2 H 
Arom Ph), 7.52-7.55 (m, 2H,  H Arom Ph);  13C NMR (100 MHz): δ =  55.5 (OCH3 pMP), 66.2 (C-5 
or C-5’), 69.3 (C-5 or C-5’), 69.2 (C-6 or C-6’), 69.3 (C-6 or C-6’), 71.3 (C-4), 71.9 (CH2 Bn), 72.6 
(CH2 Bn), 72.9 (CH2 Bn), 73.7 (C-3), 74.6 (CH2 Bn), 75.1 (C-4), 75.2 (CH2 Bn), 76.0 (C-2’), 76.8 (C-
2), 78.5 (C-3), 92.6 (C-1’ α), 100.5 (C-1’β), 101.2 (CHPh benzylidene), 103.1 (C-1 α), 103.6 (C-1 β); 
HRMS: C61H62O12 +NH4+ requires: 1004.4580, found 1004.4594. 
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Chapter 7 
Summary and Future Prospects 
Summary 
Synthetic carbohydrate chemistry is an ongoing field of research that studies the 
preparation of naturally occurring carbohydrates as well as carbohydrate derivatives that are 
designed to function as tools to elucidate or to influence biological processes. The 
development of protective group and glycosylation strategies occupy a central position in 
carbohydrate synthesis. The protective groups of both the donor and acceptor glycosides, 
the reaction partners in a glycosylation reaction, effect the regioselectivity, the 
stereoselectivity and the yield of the coupling reaction. Ideally, a suitable glycosyl donor 
should allow a productive and stereoselective coupling with any hydroxyl function of any 
acceptor. However, despite major advances in the synthesis of oligosaccharides such as 
solid phase and one-pot procedures, improvements are still necessary. For instance the 
stereoselective introduction of some 1,2-cis glycosidic bonds still presents a major 
challenge. Studies on the mechanism of glycosylations may give an entry to the 
development of stereoselective glycosylations. Chapter 1 presents a view on the 
mechanisms involved in glycosylation reactions, which can be roughly classified as SN2 
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and SN1 like pathways. Neighboring group participation, the nature of solvents and 
anomeric leaving groups are briefly discussed as factors which induce “SN2” type 
glycosylations. The stereochemical outcome of “SN1” type mechanisms and the role of the 
intermediate oxacarbenium ion allow for more debate. On the one hand a widely supported 
postulate entails that SN1 like glycosylation proceed via a late transition state leading to a 
stereochemical outcome that is governed by the anomeric effect. On the other hand studies 
on O- and in particular C-glycosylations support the hypothesis that the stabilities of the 
half chair oxacarbenium ion conformers are of prime importance for the stereochemical 
outcome of “SN1” type glycosylations.  
In carbohydrate chemistry thioglycosides are widely used building blocks, as these 
compounds are stabile during protecting group manipulations and easily activated to induce 
glycosylations. A general method to hydrolyze thioglycosides is not available. Reported 
methods are not fail-safe in their application on different thioglycosides. Chapter 2 reveals 
a new method for the hydrolysis of thioglycosides. The NIS/TFA reagent combination 
proved to be an efficient and broadly applicable reagent combination for the hydrolysis of 
thioglycosides. Both highly reactive (armed) and less reactive (disarmed) thioglycosides 
were hydrolyzed readily and it was shown that acid labile protective groups tolerated this 
method.  The NIS/TFA mediated hydrolysis was used to attain valuable building blocks en 
route to hyaluronic acid (HA) oligomers.  
In this thesis two routes of synthesis of HA oligomers are described and the first one is 
discussed in Chapter 3. Aith the aid of a new strategy a HA dimer, trimer and pentamer, 
having a glucuronic acid at the reducing end were prepared. The strategy is based on the 
finding that donor 1-hydroxysugars can be chemoselectively condensed with acceptor 1-
thioglycosides to afford a 1-thiodisaccharide amenable for elongation at both reducing end 
and non-reducing end. The yields of subsequent glycosylations to higher oligosaccharides 
proved to be reasonable but required fine-tuning of the amount of base. The acid lability of 
the benzylidene protective groups on the one hand and the requirement to reduce the 
amount of base to avoid orthoester formation during the glycosylations on the other hand 
were conflicting. In the second route of synthesis of HA oligomers, described in Chapter 4, 
the benzylidene group was replaced by the more acid stabile di-tert-butylsilylidene (DTBS) 
protective group. Indeed, the glycosylations using DTBS protected glucosamine building 
blocks could be executed under acidic conditions and resulted in higher yields. A HA tri, 
penta and heptasaccharide with a glucosamine at the reducing end were efficiently 
synthesized using a dimer building block. The required dimer was readily synthesised by 
the chemoselective condensation of a glucosamine N-phenyl trifluoroimidate and a S-
phenyl glucuronate ester. The glucosamine N-phenyl trifluoroimidate donor was prepared 
in an efficient four step procedure from the HCl salt of glucosamine. 
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Chapter 5 describes the synthesis of an alginate trisaccharide consisting of 1,4-linked-α-L-
guluronic acid residues. It was found that the glycosylations with guluronic acid donors 
were less cis-selective than the corresponding D-mannuronic acid donors. In addition it was 
shown that L-gulose donors have an intrinsic preference for the formation of 1,2-cis-
glycosidic bonds. Thus, a gulose trimer was assembled using non-oxidized gulopyranose 
building blocks and subsequently oxidized to yield the target alginate trisaccharide. The 
stereoselectivities of gulose and guluronic acid donors were explained by the hypothesis 
that these glycosylations proceed by an “SN1” type mechanisms, in which the acceptor 
attacks the most stable oxacarbenium ion conformer. Theoretical and experimental data 
indicates that the 3H4 conformation of the oxacarbenium ion of L-gulose is the most 
favorable. Axial attack from the top side of this conformer leads to the formation of 1,2-cis 
product. The scope of this hypothesis is the subject of Chapter 6. With the aid of two 
model acceptors the glycosylating properties of a series of carbohydrate epimers was 
investigated. The effect of the nature of the C-5 substituent was investigated using suitably 
protected D-mannose and D-gulose donors as well as the corresponding C-5 methyl and C-
5-uronate ester donors. The results support the finding that the electron withdrawing methyl 
ester favors a pseudo axial orientation in the oxacarbenium ion intermediate whereas the C-
5 methyl group preferentially adopts an equatorial orientation. The hypothesis on the 
stability of oxacarbenium ions can be used to predict the stereochemical outcome of 
glycosylations in case all substituents adopt the most favorable position in one of the 
oxacarbenium ion conformers. In systems having conflicting substituent preferences, steric 
factors in both the ground state of the ions and product forming transition states become 
important for the outcome of the reaction, as revealed by experiments using glucose, 
galactose and allose. 
Future Prospects 
The research described in this Thesis has contributed to the elucidation of the mechanisms 
of glycosylation reactions and the development of synthetic strategies towards anionic 
oligosaccharides. The moderate stereoselective introduction of 1,2-cis galactose and the 
poor stereoselective introduction 1,2-cis glucose glycosidic linkages were explained by a 
less pronounced difference in stability between the 3H4 and 4H3 conformers and 
destabilizing steric interactions in the respective oxacarbenium ions and the corresponding 
transition states. An interesting ability to further confirm the proposed glycosylation 
mechanism is the design, synthesis and evaluation of the glycosylating properties of 
modified glycosyl donors having the galacto- or gluco configuration. It is envisaged that the 
unfavorable steric interactions in either the 3H4 or the 4H3 conformer of the oxacarbenium 
ion can be diminished by the replacement of a particular benzyloxy substituent with either a 
methyl or a proton. For instance, replacement of the benzyloxy substituent at C-3 in 
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galactoside 1 with a methyl group (2) or an hydrogen atom (3) would enhance the stability 
of the 4H3 conformer (5) in comparison with the 3H4 conformer (4), resulting in enhanced α-
selectivity. Similarly, the benzyloxy substituents at C-3 and/or at C-4 in glucoside 9 can be 
replaced by a methyl group or a hydrogen atom. The oxacarbenium ion model predicts that 
both glycosyl donor 10 and 11 are stronger α-directing than the parent tetrabenzyl glucoside 
9.  
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Glucosyl and galactosyl oxacarbenium ions modified substituents at C3 and C4. Reagents and 
conditions: Donor, DCM, Ph2SO, -78 °C, 15 min, acceptor (ROH), warm to 0 °C. 
To obtain 1,2-cis selectivity in systems having conflicting substituent preferences methods 
have to be developed to suppress reaction via an oxacarbenium ion pathway. As described 
in Chapter 1, the 3-O-acyl can have an α-directing effect in glycosylations. It is interesting 
to investigate the influence of an acyl function in 17 with a variety of acceptors.  
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3-O-acyl study on galacoside 17. Reagents and conditions: Donor 17, DCM, Ph2SO, -78 °C, 15 min, 
acceptor (ROH), warm to 0 °C.  
From a synthetic point of view, pectin, a linear oligosaccharide composed of all α-1-4 
linked galacturonic acids, presents an interesting target. Two general synthetic strategies to 
pectin oligomers, which use either a post-glycosylation oxidation1 or a pre-glycosylation 
oxidation2 procedure, have been reported, which both strategies have their drawbacks. The 
post-glycosylation oxidation route entails a precarious oxidation step of multiple primary 
alcohols at the end of the synthesis while the pre-glycosylation oxidation approach is 
accompanied by a drop in glycosylation efficiency above the dimer level. The latter is due 
to the low reactivity of galacturonate esters donors as well as the low nucleophilicity of the 
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axial 4-OH of α-galactopyranose acceptors.3 Lactonization of the galacturonic acid C5-
carboxylate with the C3 hydroxyl4 results in a conformational flip, leading to an 
equatorially oriented C-4-OH which could enhance its nucleophilicity. Moreover, as 
presented in Chapters 1, 5 and 6, axial hetero atom at the C-3- and C-4 positions in the 
pyranose core contribute favorably to the reactivity of a glycosyl donor compared to the 
corresponding equatorial ones. It was revealed by van den Bos et al.4 that galactono-3,6-
lactones are reactive, highly α-selective donors making them ideal building blocks for the 
synthesis of pectin oligosaccharides. On the basis of these considerations, it is proposed to 
study the donor and acceptor characteristics of galactono-3,6-lactones. Competition 
experiments with galacto lactone 19 and galacturonate methyl ester 20 will show the 
difference in reactivity of the lactone donor and the corresponding galacturonate methyl 
ester galactoside. The ease of activation and the ease of glycosylation are two variables that 
can be determined (Scheme 3). The difference in ease of activation can be monitored using 
a limited amount of activator (experiment A) and subsequent reaction with an appropriate 
acceptor. The difference in glycosylation potential can be monitored using a limited amount 
of acceptor (experiment B). 
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The nucleophilic properties of the lactones can be assessed by competition experiments in 
which equimolar amounts of a lactone acceptor 24 and a galacturonate methyl ester 25 are 
allowed to react with a half an equivalent of an activated donor 23 (Scheme 4).  
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Competition experiments of galacturonate ester and lactone acceptors. Reagents and conditions: 
Donor 23 (1 eq), Ph2SO (1 eq), TTBP (3 eq), -60 °C, Tf2O (1 eq), 5 min, -78 °C, lactone 24 (1 eq), 
galacturonate methyl ester 25 (1 eq), warm to 0 °C.  
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Having the properties of galactono-3,6-lactones as donor and acceptor assessed, the pectin 
oligosaccharide 30 can be assembled using the Ph2SO Tf2O activation system and a 
stepwise elongation approach (Scheme 5). At the end of the synthesis the lactone rings can 
be opened using either methanol or water to yield the galacturonate methyl esters or the 
galacturonic acids, respectively. After hydrogenation the pectin oligomers are obtained. 
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Synthesis of pectin oligosaccharides using galactono-3,6-lactones. Reagents and conditions: a) i. 
Ph2SO, TTBP, DCM, Tf2O; ii. Deprotection 4-OH; b) i. MeOH, pTsOH); ii. H2O, MeOH, Pd/C, H2; 
c) i. THF, LiOH; ii. H2O, MeOH, Pd/C, H2. 
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Samenvatting 
De synthetische koolhydraatchemie houdt zich bezig met het ontwikkelen van nieuwe 
methoden en technieken om in de natuur voorkomende koolhydraten en derivaten daarvan 
te bereiden. Dit levert niet alleen nieuwe fundamentele organische chemische kennis op 
maar maakt het ook mogelijk de gesynthetiseerde koolhydraatstructuren te gebruiken om 
biologische processen, waar koolhydraten bij betrokken zijn te analyseren en te 
beïnvloeden. Om de synthese van fragmenten van koolhydraatpolymeren of 
oligosacchariden te verbeteren richt het onderzoek zich niet alleen op de ontwikkeling van 
nieuwe methoden om beschermgroepen in te voeren en te verwijderen maar ook op nieuwe 
glycosyleringsmethoden en strategieën. Vaste-drager synthese en één-pots procedures zijn 
veelbelovende nieuwe glycosyleringsstrategieën. Van het allergrootste belang bij alle 
strategieën is de opbrengst en de stereoselectiviteit van de glycosyleringsreactie. Bij een 
glycosyleringsreactie wordt een donor suiker molecuul stereoselectief, dat wil zeggen 1,2-
trans of 1,2-cis gekoppeld aan een hydroxyl groep van een acceptor suiker molecuul. 
Terwijl 1,2-trans glycosidische bindingen op relatief betrouwbare wijze stereoselectief 
kunnen worden ingevoerd, leidt de invoering van 1,2-cis glycosidische bindingen veelal tot 
mengsels. Onderzoek naar het mechanisme van glycosyleringen is noodzakelijk om betere 
stereoselectieve reacties te ontwikkelen. In Hoofdstuk 1 wordt een overzicht gegeven van 
de verschillende mechanismen van glycosyleringsreacties, waarbij een onderscheid 
gemaakt kan worden tussen een SN1 en een SN2 type reactie. Door het installeren van een 
ester beschermende groep op de C2-OH functie van een donor glycoside vindt er bij 
activatie zogenoemde anchimere hulp plaats en verloopt de reactie via een SN2 type 
mechanisme. Bij dergelijke reacties wordt gewoonlijk het 1,2-trans product gevormd. 
Zonder een sturende ester functie op de 2 positie moeten andere middelen worden 
aangewend om SN2 type reacties te bewerkstelligen. Onderzoeksresultaten waarbij 
bijvoorbeeld anomere halides en verschillende oplosmiddelen worden toegepast om SN2 
type reacties te induceren worden kort besproken. Glycosyleringen die een SN1 type 
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mechanisme volgen, en het gevolg daarvan op de stereochemische uitkomst, zijn onderwerp 
van toenemende discussie. Enerzijds zou een glycosylering via een SN1 type mechanisme 
een late overgang toestand hebben waardoor de stereochemie van het product gestuurd 
wordt door het anomere effect. Anderzijds zijn er voorbeelden van C- en O-glycosyleringen 
waar de selectiviteit verklaard wordt door een aanval van het nucleofiel op de meest 
stabiele halve stoel conformatie van het intermediaire oxacarbenium ion. 
Thioglycosides worden in de koolhydraatchemie veel gebruikt als uitgangsstoffen vanwege 
hun stabiliteit tijdens beschermende groep manipulaties en het scala aan mogelijkheden om 
deze verbindingen te activeren. Er is echter geen standaard protocol om deze thioglycosides 
the hydrolyseren. In Hoofdstuk 2 wordt een nieuwe en algemene methode beschreven om 
deze transformatie uit te voeren. De combinatie van N-iodosuccinimide (NIS) en trifluoro 
azijnzuur (TFA) bleek een geschikte methode om een grote variëteit aan 1-thioglycosides te 
hydrolyseren. De reactie verloopt voorspoedig met zowel reactieve als inreactieve 
thioglycosides en is dusdanig mild dat de meeste zuur labiele beschermende groepen onder 
de gebruikte condities stabiel zijn. De NIS/TFA methode werd gebruikt om één van de 
intermediaire bouwstenen in de synthese van hyaluronan (HA) te vervaardigen.  
Dit proefschrift beschrijft twee syntheseroutes naar HA oligomeren waarvan de eerste in 
Hoofdstuk 3 staat. Deze syntheseroute leverde een HA tri-, tetra- en pentameer op met een 
glucuronzuur aan het reducerende einde. Er werd gebruik gemaakt van een nieuwe 
glycosyleringstrategie waarbij een hemiacetaal donor glycoside met een thioglycoside 
accepter werd gecondenseerd. Op deze wijze werd een thio-dimeer verkregen, die geschikt 
is voor uitbreiding aan de reducerende en niet-reducerende kant. De opbrengsten van de 
glycosyleringen tot het tetra- en pentameer waren redelijk. Een voorwaarde om deze 
opbrengsten te bereiken was dat de hoeveelheid base, die in de koppelingsreactie werd 
gebruikt, werd geoptimaliseerd. De achtergrond hiervan is de zuurlabiliteit van de gebruikte 
benzylidene beschermende groep en de kans op ongewenste orthoester en oxazolidine 
vorming onder basische omstandigheden. Een tweede syntheseroute naar HA fragmenten, 
maar nu met een glucosamine op het reducerende einde wordt beschreven in Hoofdstuk 4. 
De benzylidene beschermende groep werd vervangen door de stabielere di-tert-
butylsilylidene (DTBS) groep. De glycosyleringen met DTBS beschermde glucosamine 
donoren en acceptoren konden inderdaad onder meer zure condities worden uitgevoerd, 
hetgeen resulteerde in hogere opbrengsten. Een HA tri-, penta- en heptameer werden 
efficiënt gesynthetiseerd met behulp van een blok-koppelings strategie. De repeterende 
dimeer bouwsteen werd bereid met behulp van een N-phenyltrifluoroimidaat glucosamine 
en een thioglucuronaat. Beide bouwstenen konden op grote schaal en in een gering aantal 
reactiestappen worden vervaardigd.  
Hoofdstuk 5 beschrijft de synthese van een alginaat trimeer, die uit α-gekoppelde L-
guluronzuren bestaat. De glycosyleringsreacties met L-guluronaat donoren bleken minder 
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stereoselectief te zijn dan die met de overeenkomstige D-mannuronaat donoren. Ook werd 
aangetoond dat in glycosyleringsreacties gebenzyleerde L-gulose donoren α-selectiever 
koppelden dan gebenzyleerde L-guluronaat donoren. Op grond hiervan werd een alginaat 
trimeer gesynthetiseerd door eerst een gulose trimeer te bereiden en deze vervolgens te 
oxideren. De stereochemische uitkomsten van deze glycosyleringen  konden worden 
verklaard met de hypothese dat deze reacties via een SN1 type mechanisme verlopen en dat 
de acceptor de meest stabiele oxacarbenium ion conformeer aanvalt. Gesteund door 
publicaties over C-glycosyleringen en theoretische modellen van glycosyleringen werd 
gepostuleerd dat de 3H4 conformatie van het oxacarbenium ion van L-gulose het meest 
stabiel is. Axiale aanval op dit oxacarbenium ion conformeer leidt tot de vorming van het 
1,2-cis product. Een onderzoek naar de toepasbaarheid van deze hypothese wordt 
beschreven in Hoofdstuk 6. Met behulp van twee acceptoren werd de stereoselectiviteit in 
glycosyleringsreacties van verschillende thioglycoside epimeren bepaald. In het bijzonder 
werd de invloed van de C-5 substituent getoetst door tetrabenzyl D-mannose en D-gulose 
donoren te vergelijken en tevens hun 6-deoxy en uronaat analoga. De uitkomst van deze 
experimenten ondersteunt de aanname dat in oxacarbenium ionen een C-5 ester een axiale 
positie verkiest terwijl voor de C-5 methyl (6-deoxy) een equatoriale positie het gunstigst 
is. Om een duidelijke voorkeur te verkrijgen voor één van de twee mogelijke 
reactieproducten van een glycosyleringsreactie is het nodig dat alle substituenten in één van 
de oxacarbonium ion conformeren een gunstige positie aannemen. De resultaten van de 
glycosyleringen van glucose, galactose en allose laten zijn dat de selectiviteit wegvalt 
wanneer één van de substituenten in een ongunstige positie zit in het oxacarbenium ion. De 
sterische factoren in de grondtoestand van de oxacarbenium ion conformeren, en bij de 
overgangstoestand van de glycosylering, worden dan beslissend voor de stereoselectiviteit. 
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Nawoord 
Het is dan eindelijk zover, mijn proefschrift af! Geen proefjes, NMR’etjes en massaatjes 
meer om in te voeren. Klaar voor de verdediging van mijn proefschrift en de verdiende 
borrel na afloop. Maar eerst wil ik graag van deze gelegenheid gebruik maken om terug te 
blikken op vier jaar Biosyn.   
Vier jaar lang van beschermende groep naar orthogonale koppeling en dan alles er weer 
afslopen om de ontschermde oligo’s in handen te krijgen. In den beginne was er de 
onvermijdelijke zwarte bagger, maar met hulp van Remy en Leendert begon ik het dan toch 
in de vingers te krijgen. Na een paar maanden kwam de eerste student, Ruben Lindenburg 
(de Citroëndealer), even oefenen hoe het is om studenten te begeleiden. Dat was wel nodig 
want niet veel later kwam Wouter (Fouter) Hogendorf zijn hoofdvakstage lopen. De 
experimenten hebben geleid tot een mooi artikel in Chemistry en de borrels buiten het lab 
tot mooie momenten in ietwat beschonken toestand. Jop en Rick, beide goede werkers in 
het lab, hebben mij veel geduld bijgebracht. Met Chung, ”de harige Chinees”, heb ik erg 
goed kunnen dollen. De moeilijkheden in het lab werden gepareerd met ranzige filmpjes op 
internet en ernstig slechte Nederlandstalige muziek! De hulp van hoofdvakstudent Ana Rae 
(geleend van Jeroen!) heb ik goed kunnen gebruiken voor het synthetiseren van alle 
verbindingen in het laatste hoofdstuk van mijn boekje. Niet alleen mijn studenten maar ook 
al mijn collega’s hebben bijgedragen aan de totstandkoming van dit proefschrift. Ondanks 
het vele verhuizen zorgde de sfeer op elk lab weer voor een goede werkomgeving. Serieus 
labwerk werd zo af en toe onderbroken door hilarische momenten. Zonder de vele borrels 
en labweekendjes zou het leven in Leiden er heel anders uit hebben gezien. Hans heeft 
zonder veel zeuren al mijn massa’s gemeten, en onder de leiding van Hans en Rian hebben 
we nu een modern chemicaliënsysteem gekregen, nooit meer iets kwijt! Of toch wel…..? 
Ontschermde suikers heb ik altijd bij Nico in kunnen leveren, om alle troep die ik er tijdens 
de synthese vakkundig bij had gestopt, te verwijderen. Bij Fons en Kees kon ik altijd 
terecht met NMR-problemen of het meten bij koude temperatuur, alles beter dan vaste stof-
NMR. Gijs en Hermen, en later ook Jeroen, hebben mij heel veel geleerd. Zonder de 
moeilijk te lezen kraaienpoten van Hermen in de kantlijn en de vele discussies met Gijs en 
Jeroen onder het genot van een veel te sterk bakkie pleur was dit boekje niet tot stand 
gekomen. 
Essa, dank je… 
 
